<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006913.pub2" GROUP_ID="IBD" ID="020907011017503070" MERGED_FROM="" MODIFIED="2011-06-21 19:12:05 +0200" MODIFIED_BY="John MacDonald" REVIEW_NO="81" REVMAN_SUB_VERSION="5.1.2" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2011-06-21 19:12:05 +0200" MODIFIED_BY="John MacDonald">
<TITLE>Psychological interventions for treatment of inflammatory bowel disease</TITLE>
<CONTACT MODIFIED="2011-06-21 19:12:05 +0200" MODIFIED_BY="John MacDonald"><PERSON ID="C3DB143C82E26AA2014A559479172D27" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Antje</FIRST_NAME><LAST_NAME>Timmer</LAST_NAME><SUFFIX>MD, MSc.</SUFFIX><EMAIL_1>timmer@bips.uni-bremen.de</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Epidemiology</DEPARTMENT><ORGANISATION>Bremen Institute for Prevention Research and Social Medicine</ORGANISATION><ADDRESS_1>Achterstrasse 30</ADDRESS_1><CITY>Bremen</CITY><ZIP>28359</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 421 218-56750</PHONE_1><PHONE_2>+49 89 7095-7486</PHONE_2></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2011-06-21 19:12:05 +0200" MODIFIED_BY="John MacDonald"><PERSON ID="C3DB143C82E26AA2014A559479172D27" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Antje</FIRST_NAME><LAST_NAME>Timmer</LAST_NAME><SUFFIX>MD, MSc.</SUFFIX><EMAIL_1>timmer@bips.uni-bremen.de</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Epidemiology</DEPARTMENT><ORGANISATION>Bremen Institute for Prevention Research and Social Medicine</ORGANISATION><ADDRESS_1>Achterstrasse 30</ADDRESS_1><CITY>Bremen</CITY><ZIP>28359</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 421 218-56750</PHONE_1><PHONE_2>+49 89 7095-7486</PHONE_2></ADDRESS></PERSON><PERSON ID="88CBE64682E26AA20104C58E3174DA4D" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jan</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Preiss</LAST_NAME><POSITION>Resident</POSITION><EMAIL_1>jan.preiss@charite.de</EMAIL_1><ADDRESS><DEPARTMENT>Med. Klinik I</DEPARTMENT><ORGANISATION>Charité - Universitätsmedizin Berlin</ORGANISATION><ADDRESS_1>Campus Benjamin Franklin</ADDRESS_1><ADDRESS_2>Hindenburgdamm 30</ADDRESS_2><CITY>Berlin</CITY><ZIP>12203</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 30 8445 2347</PHONE_1><FAX_1>+49 30 8445 4481</FAX_1></ADDRESS></PERSON><PERSON ID="12126" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Edith</FIRST_NAME><LAST_NAME>Motschall</LAST_NAME><POSITION>Medical Librarian</POSITION><EMAIL_1>motschall@imbi.uni-freiburg.de</EMAIL_1><URL>http://www.imbi.uni-freiburg.de/biblio/</URL><ADDRESS><DEPARTMENT>German Cochrane Centre</DEPARTMENT><ORGANISATION>Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg</ORGANISATION><ADDRESS_1>Stefan-Meier-Str. 26</ADDRESS_1><CITY>Freiburg</CITY><ZIP>79104</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 761 203 6723</PHONE_1><FAX_1>+49 761 203 6711</FAX_1></ADDRESS></PERSON><PERSON ID="0CFB145382E26AA2005EE6A627852244" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Gerta</FIRST_NAME><LAST_NAME>Rücker</LAST_NAME><POSITION>Statistician</POSITION><EMAIL_1>ruecker@imbi.uni-freiburg.de</EMAIL_1><ADDRESS><DEPARTMENT>German Cochrane Centre</DEPARTMENT><ORGANISATION>Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg</ORGANISATION><ADDRESS_1>Stefan-Meier-Str. 26</ADDRESS_1><CITY>Freiburg</CITY><ZIP>79104</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 761 203 6673</PHONE_1><FAX_1>+49 761 203 6680</FAX_1></ADDRESS></PERSON><PERSON ID="0CE29D5382E26AA2005EE6A6F6330594" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Günther</FIRST_NAME><LAST_NAME>Jantschek</LAST_NAME><ADDRESS><ORGANISATION>Universitätsklinikum Schleswig-Holstein, Campus Lübeck</ORGANISATION><CITY>Lubeck</CITY><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS><FOOTNOTE>Deceased</FOOTNOTE></PERSON><PERSON ID="07FA256182E26AA2005EE6A6D164AA46" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Gabriele</FIRST_NAME><LAST_NAME>Moser</LAST_NAME><EMAIL_1>gabriele.moser@meduniwien.ac.at</EMAIL_1><EMAIL_2>gabriele.moser@univie.ac.at</EMAIL_2><ADDRESS><DEPARTMENT>Clinic of Internal Medicine III</DEPARTMENT><ORGANISATION>Medical University of Vienna</ORGANISATION><ADDRESS_1>Waehringer Guertel 18-20</ADDRESS_1><CITY>A-1090 Vienna</CITY><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>43 1 40400 4741</PHONE_1><FAX_1>43 1 40400 4735</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2011-03-25 13:53:21 -0400" MODIFIED_BY="John MacDonald">
<UP_TO_DATE>
<DATE DAY="30" MONTH="4" YEAR="2010"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="4" YEAR="2010"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="1" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2008"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2011"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2011"/>
</DATES>
<WHATS_NEW MODIFIED="2011-06-21 13:05:48 -0400" MODIFIED_BY="John K MacDonald">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-06-21 13:05:48 -0400" MODIFIED_BY="John K MacDonald">
<DATE DAY="21" MONTH="6" YEAR="2011"/>
<DESCRIPTION>
<P>Minor edit to Acknowledgements section</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2011-06-21 13:05:38 -0400" MODIFIED_BY="John K MacDonald">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-06-21 13:05:38 -0400" MODIFIED_BY="John K MacDonald">
<DATE DAY="7" MONTH="4" YEAR="2011"/>
<DESCRIPTION>
<P>Minor corrections based on feedback from Cochrane Editorial Unit </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2011-04-07 11:49:15 -0400" MODIFIED_BY="John K MacDonald">
<DATE DAY="10" MONTH="1" YEAR="2011"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-04-21 09:15:19 -0400" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>German Ministry of Health</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2009-04-21 09:15:19 -0400" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-04-21 09:15:19 -0400" MODIFIED_BY="[Empty name]">
<NAME>Federal Ministry of Education and Research</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION>
<P>FKZ 01KG0810 (Grant programme for systematic reviews)</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2011-06-21 13:05:28 -0400" MODIFIED_BY="John K MacDonald">
<SUMMARY MODIFIED="2011-04-07 11:55:27 -0400" MODIFIED_BY="John K MacDonald">
<TITLE MODIFIED="2010-06-07 10:33:12 -0400" MODIFIED_BY="[Empty name]">Psychological interventions in inflammatory bowel disease</TITLE>
<SUMMARY_BODY MODIFIED="2011-04-07 11:55:27 -0400" MODIFIED_BY="John K MacDonald">
<P>This review examined the effect of psychological interventions in patients with inflammatory bowel diseases (Crohn's disease and ulcerative colitis) on health related quality of life, emotional state and disease activity. Overall, 21 studies were included in the review, but not all provided sufficient data for the different study questions. All studies were of low methodological quality. Most studies examined combination therapies, often aimed at improving stress management. For example, a therapy might include patient information sessions, training in relaxation techniques and psychotherapy sessions, such as group therapy. Others were restricted to just providing information materials to patients. None of the included studies reported any side effects of psychological interventions.</P>
<P>In adults, psychotherapy was not effective at 6 and 12 months for all outcomes (quality of life, emotional status/depression and relapse/disease activity), based on 3 studies. There was no difference by type of disease (Crohn's disease versus ulcerative colitis) or intensity of the therapy. In adolescents, there was a small positive effect for all outcomes (quality of life, coping, depression and anxiety), but only short term effects were reported in this group. Disease activity and relapse rates were not examined in adolescents. In adults, educational interventions were also not effective to improve quality of life and the course of the disease over 1 year, based on 5 studies. </P>
<P>Generally, at this moment, it can not be recommended that all patients with IBD receive psychotherapy. We assume that adolescents, and patients with special needs (e.g. emotional problems) may benefit from psychological therapy. More research is needed to examine the effect of psychotherapy focusing on the individual psychological situation of IBD patients.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2011-04-07 11:51:03 -0400" MODIFIED_BY="John K MacDonald">
<ABS_BACKGROUND MODIFIED="2010-07-30 13:41:25 -0400" MODIFIED_BY="[Empty name]">
<P>The effect of psychological interventions in inflammatory bowel diseases (IBD) is controversial.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2011-01-07 13:47:19 -0500" MODIFIED_BY="John K MacDonald">
<P>To assess the effects of psychological interventions (psychotherapy, patient education, relaxation techniques) on health related quality of life, coping, emotional state and disease activity in IBD.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2011-01-14 08:40:51 -0500" MODIFIED_BY="John K MacDonald">
<P>We searched the specialized register of the IBD/FBD Group, CENTRAL (Issue 5, 2010) and from inception to April 2010: Medline, Embase, LILACS, Psyndex, CINAHL, PsyInfo, CCMed, SOMED and Social SciSearch. Conference abstracts and reference lists were also checked.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-01-14 08:41:40 -0500" MODIFIED_BY="John K MacDonald">
<P>Randomized, quasi-randomized and non randomized controlled trials of psychological interventions in children or adults with IBD with a minimum follow up time of 2 months.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-01-07 13:47:55 -0500" MODIFIED_BY="John K MacDonald">
<P>Data were extracted and study quality was independently assessed by two raters. Pooled standardized mean differences (SMD) and 95% confidence intervals (CI) were calculated using a random effects model.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2011-04-07 11:51:01 -0400" MODIFIED_BY="John K MacDonald">
<P>Twenty-one studies were eligible for inclusion (1745 participants; 19 in adults, 2 in adolescents). Most studies used multimodular approaches. The risk of bias was high for all studies. In adults, psychotherapy had no effect on quality of life at around 12 months (3 studies, 235 patients, SMD -0.07; 95% CI -0.33 to 0.19), emotional status (depression, 4 studies, 266 patients, SMD 0.03; 95% CI -0.22 to 0.27) or proportion of patients not in remission (5 studies, 287 patients, OR 0.85; 95% CI 0.48 to 1.48). Results were similar at 3 to 8 months. There was no evidence for statistical heterogeneity or subgroup effects based on type of disease or intensity of the therapy. In adolescents, there were positive short term effects of psychotherapy on most outcomes assessed including quality of life (2 studies, 71 patients, SMD 0.70; 95% CI 0.21 to 1.18) and depression (1 study, 41 patients, SMD -0.62; 95% CI -1.25 to 0.01). Educational interventions had no effect on quality of life at 12 months (5 studies, 947 patients, SMD 0.11; 95% CI -0.02 to 0.24), depression (3 studies, 378 patients, SMD -0.08; 95% CI -0.29 to 0.12) and proportion of patients not in remission (3 studies, 434 patients, OR 1.00; 95% CI 0.65 to 1.53). No adverse events were reported in any of the included studies. </P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-04-07 11:51:03 -0400" MODIFIED_BY="John K MacDonald">
<P>There is no evidence for efficacy of psychological therapy in adult patients with IBD in general. In adolescents, psychological interventions may be beneficial, but the evidence is limited. Further evidence is needed to assess the efficacy of these therapies in subgroups identified as being in need of psychological interventions, and to identify what type of therapy may be most useful.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2011-04-07 11:51:15 -0400" MODIFIED_BY="John K MacDonald">
<BACKGROUND MODIFIED="2011-01-14 08:44:03 -0500" MODIFIED_BY="John K MacDonald">
<CONDITION MODIFIED="2010-12-12 12:02:14 -0500" MODIFIED_BY="[Empty name]">
<P>Inflammatory bowel disease (IBD) has a negative impact on all realms of quality of life. The greatest impairment may be in emotional behavior (<LINK REF="REF-Drossman-1989" TYPE="REFERENCE">Drossman 1989</LINK>). Changes in IBD-disease activity over time significantly affect psychological distress and are closely related to corresponding increases and decreases in anxiety and depression (<LINK REF="REF-Porcelli-1996" TYPE="REFERENCE">Porcelli 1996</LINK>). The degree of psychological disturbance appears to correlate with disease severity. However, psychological distress and disturbances may also influence the course of disease (<LINK REF="REF-Mawdsley-2005" TYPE="REFERENCE">Mawdsley 2005</LINK>). </P>
</CONDITION>
<INTERVENTION MODIFIED="2011-01-07 13:48:02 -0500" MODIFIED_BY="John K MacDonald">
<P>Psychological treatment encompasses a wide range of interventions (<LINK REF="REF-Goodhand-2009" TYPE="REFERENCE">Goodhand 2009</LINK>). Traditionally, in IBD, there have been attempts to solve underlying conflicts believed to impact on the occurrence or course of the disease by psychodynamically oriented therapies (PDT). Of late, cognitive-behavioural approaches are more common, often in the context of multimodular interventions aiming at improved self management (<LINK REF="REF-Barlow-2010" TYPE="REFERENCE">Barlow 2010</LINK>). These psychological interventions may work via improved coping skills, alleviation of associated anxiety or depression or provision of social support. Often, educational aspects are also considered.</P>
<P>Educational interventions strive to improve the patients's knowledge about the disease (<LINK REF="REF-Barlow-2010" TYPE="REFERENCE">Barlow 2010</LINK>). Relaxation techniques may also be applied to alleviate stress and improve coping. Examples include autogenic training and feedback techniques (<LINK REF="REF-Coulter-2001" TYPE="REFERENCE">Coulter 2001</LINK>).</P>
<P>While psychotherapy requires the provision by a trained psychotherapist, psychological interventions in the broader sense may be applied in any form and setting, including nurse led interventions, peer group support and written materials.</P>
</INTERVENTION>
<THEORY MODIFIED="2011-01-07 13:48:03 -0500" MODIFIED_BY="John K MacDonald">
<P>Prospective studies suggest that Crohn's disease patients with depressive mood and associated anxiety are at higher risk of further disease activity (<LINK REF="REF-Mittermaier-2004" TYPE="REFERENCE">Mittermaier 2004</LINK>; <LINK REF="REF-Mardini-2004" TYPE="REFERENCE">Mardini 2004</LINK>). In patients with ulcerative colitis, life stress was found to be associated with both objective (rectal mucosal inflammation) and subjective (symptom reporting) features. In a prospective long-term follow up study Levenstein found that at any given study visit high long-term perceived stress tripled the risk of exacerbation over the next eight months (<LINK REF="REF-Levenstein-2000" TYPE="REFERENCE">Levenstein 2000</LINK>). Therefore, attention to the psychosocial factors associated with IBD may have consequences not only on psychosocial well-being and health related quality of life (HRQL), but also on the activity of the disease itself. </P>
</THEORY>
<IMPORTANCE MODIFIED="2011-01-14 08:44:03 -0500" MODIFIED_BY="John K MacDonald">
<P>Psychotherapy has been applied to patients with IBD almost since these conditions were first described, but the evidence is still controversial. Well designed clinical trials were performed, but remained underpowered due to problems in patient accrual (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>, see comment in <LINK REF="REF-Guthrie-2004" TYPE="REFERENCE">Guthrie 2004</LINK>). A first meta-analysis of results has been tried as early as 1982 (<LINK REF="REF-Rohrmeier-1982" TYPE="REFERENCE">Rohrmeier 1982</LINK>). Several more recent non-quantitative reviews are available on different aspects of psychological interventions in IBD (<LINK REF="REF-von-Wietersheim-2006" TYPE="REFERENCE">von Wietersheim 2006</LINK>; <LINK REF="REF-Barlow-2010" TYPE="REFERENCE">Barlow 2010</LINK>; <LINK REF="REF-Goodhand-2009" TYPE="REFERENCE">Goodhand 2009</LINK>; <LINK REF="REF-Coulter-2001" TYPE="REFERENCE">Coulter 2001</LINK>), suggesting that positive effects may be restricted to subgroups of patients. However, due to the heterogeneity of trials and difficulties in retrieving exact data on relevant outcomes, conclusive results have not been available. With respect to patient education, of particular concern are results of a potentially deleterious effect on the course of the disease (<LINK REF="STD-Borgaonkar-2002" TYPE="STUDY">Borgaonkar 2002</LINK>). There is also a need to systematically assess sources of bias in these studies.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2011-01-07 13:48:05 -0500" MODIFIED_BY="John K MacDonald">
<P>This review examines the efficacy of psychological interventions as supportive therapy for inflammatory bowel disease. The interventions to be assessed included psychotherapy, educational interventions, relaxation techniques and combinations of these. The following questions were addressed:</P>
<P>1. Are psychological interventions effective for maintaining or improving health related quality of life (HRQL) and coping skills in patients with acute or long term IBD?<BR/>2. What type of therapy is particularly helpful, if any?<BR/>3. Are psychological interventions effective for induction and maintenance of remission in patients with acute and long term IBD?</P>
</OBJECTIVES>
<METHODS MODIFIED="2011-01-14 12:45:19 -0500" MODIFIED_BY="John K MacDonald">
<SELECTION_CRITERIA MODIFIED="2011-01-07 13:48:09 -0500" MODIFIED_BY="John K MacDonald">
<CRIT_STUDIES MODIFIED="2010-06-02 08:10:58 -0400" MODIFIED_BY="[Empty name]">
<P>All controlled clinical trials were considered for inclusion (randomized (RCT), quasi-randomized (QRCT) and non randomized (NRCT)). Follow up was to be at least 2 months for induction trials, and 6 months for maintenance. However, as information on disease activity was often not reported, separation between induction and maintenance trials was not feasible and a minimum follow up of 2 months was required for all studies.</P>
<P>Randomisation included any truly random procedures, both blind and open, such as computer generated random numbers, open random tables, or coin toss. Quasi-randomisation refers to some pseudo-random rule, such as allocation based on date of birth or hospital ID number. Convenience based allocation procedures such as availability of therapist or travel distance were considered non randomized. The potential for bias from mode of allocation was examined using sensitivity analysis.</P>
<P>Studies were included if published in any form and language. Unpublished studies, and studies published in abstract form could be included if sufficient information was available for the assessment of whether inclusion criteria were fulfilled.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2011-01-07 13:48:06 -0500" MODIFIED_BY="John K MacDonald">
<P>Trials included patients of any age with ulcerative colitis or Crohn's disease, or both, with or without unclassified IBD or indeterminate colitis. For studies including several entities, data were extracted separately by disease type. Trials not separating type of IBD were also included. Trials with mixed populations, such as functional bowel disease and IBD, were not included, as none of these studies included subgroup analyses restricted to IBD patients.</P>
<P>Patients with major psychiatric comorbidity could be included but should either form a minority of patients (&lt; 50%), or be assessed as a separate group. This was not the case in any of the eligible trials.</P>
<P>There was no restriction by disease activity or type of medication.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-05-17 10:30:34 -0400" MODIFIED_BY="[Empty name]">
<P>All types of psychotherapy were considered, including, for example, psychodynamic therapy, cognitive behavioural therapy, systemic therapy, brief therapy, and supportive therapy. Trials on relaxation techniques and patient education programs aiming to improve self management skills, coping and social integration were also included. Comparison groups were allowed to receive no treatment, or any other type of therapy, including other psychosocial therapy, sham or standard medical therapy. Concomitant medication was allowed, if applied to both groups.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-01-07 13:48:09 -0500" MODIFIED_BY="John K MacDonald">
<P>We included all trials in which outcome was assessed at any time from 2 months of follow up. For the review, main outcomes were planned to be assessed at 12 months, or 6 months for shorter trials. As times of follow up assessment varied, we used a more comprehensive categorization. Long term assessment related to follow up evaluations from 9 months to 18 months following initiation of treatment. Short term assessment included follow up evaluations between 2 to 8 months.</P>
<P>
<B>Primary outcome measures</B>:<BR/>The primary outcome measures included HRQL, coping / stress management skills and emotional status, in particular depression and anxiety. HRQL was assessed as mean absolute values at the prespecified times. Change in HRQL scores, failure to improve HRQL or failure to maintain HRQL at follow up would have been considered as alternative outcomes but were rarely available. Disease specific measures were preferred over generic measures for studies where both were assessed. If disease specific measures were not reported the results for generic HRQL were used.<BR/>
<B>
<BR/>Secondary outcomes:</B>
<BR/>Planned secondary outcome measures included induction and maintenance of remission, time off work or school, improvement of associated psychopathology, adverse events and trial withdrawal. However, most of these outcomes were not sufficiently reported. Secondary outcome assessment was therefore restricted to the comparison of patients not in remission over or at the prespecified time (short term 2 to 8 months, long term 9 to 18 months) and disease activity at follow up.</P>
<P>Drop out due to non compliance was considered a particularly relevant problem. Withdrawal rates by type of therapy were therefore examined.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2011-01-14 09:57:25 -0500" MODIFIED_BY="John K MacDonald">
<ELECTRONIC_SEARCHES MODIFIED="2011-01-14 09:57:25 -0500" MODIFIED_BY="John K MacDonald">
<P>The databases searched and time periods covered are presented in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. These searches were last performed in April 2010. In addition, several publisher supplied or temporarily only available databases were searched in December 2008 only (Springer, Thieme, Karger, Kluwer, Somed, Social Sci-Search, Science direct).</P>
<P>Detailed search strategies included synonyms for the various psychotherapeutic interventions (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>). Disease terms were used in MEDLINE, EMBASE, and CENTRAL. For MEDLINE and EMBASE, the highly sensitive search strategy for clinical trials was used to increase precision. Lilacs, Psyndex, and Psychinfo were searched based on disease terms only (Lilacs: in Spanish and Portuguese; Psyndex: in German and English, Psychinfo: in English). For Central, there was no restriction for publication type. There were no time period or language restrictions.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2010-07-15 05:11:18 -0400" MODIFIED_BY="[Empty name]">
<P>We did hand searches for those major gastroenterological and IBD related conferences not yet covered in the specialized register of the Inflammatory Bowel Disease and Functional Bowel Disorders Group when searched in December 2008. This included the following conferences: DDW 2009 and 2010, DGVS 2008 and 2009, P-IBD 2009, ECCO 2009 and 2010, UEGW/WCOG 2008 and 2009, GPGE 2009 and 2010.</P>
<P>Specialists in the fields were questioned, and reference lists of available reviews and relevant publications were searched, including those identified via DARE, HTAD and NHS-EED (The Cochrane Library).</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2011-01-14 12:45:19 -0500" MODIFIED_BY="John K MacDonald">
<STUDY_SELECTION MODIFIED="2010-05-18 08:06:43 -0400" MODIFIED_BY="[Empty name]">
<P>Two authors (AT, JP) screened all identified citations based on title and abstract (if available). All potentially eligible studies were made available in full text. Eligibility was checked based on the predefined criteria, and assessed independently by two authors. In case of disagreement, all other authors were included and a decision made by consensus of content experts.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-01-07 13:48:10 -0500" MODIFIED_BY="John K MacDonald">
<P>Data were extracted independently by two authors (AT, JP) using standardized extraction sheets. Information was extracted on data source; participants (age range, exclusion criteria, pre-treatment, disease entity); details of intervention (type of therapy, frequency and duration of treatment) and comparison treatment; outcomes studied and duration of follow up; study design features (including method of allocation, concealment, intention-to-treat analysis); and results, including adverse events and loss to follow up. Discrepancies in data extraction were resolved by consensus. If agreement was not total, a third review author could have been included in the discussion to serve as the final arbiter. Investigators were approached to get relevant missing information or clarify unclear data.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2011-01-07 13:48:11 -0500" MODIFIED_BY="John K MacDonald">
<P>The studies were assessed for internal validity using criteria based on the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). This included an assessment of the likelihood for selection bias (randomization, concealment of allocation, control for confounding / comparability of baseline characteristics), performance bias (blinding of patients and caregivers, co-interventions), attrition bias (completeness of follow up, intention-to-treat analysis) and detection bias (blinding of outcome assessment, robustness of endpoint / validated instruments). These features were included in the risk of bias summaries and risk of bias graph. Trials were included irrespective of quality; yet effects of bias were examined using sensitivity analysis (see <LINK TAG="INTERVENTION_EFFECTS" TYPE="SECTION">Effects of interventions</LINK>).</P>
<P>Grading was done independently by at least two review authors (AT, JP). Disagreements were discussed by these authors. If a consensus was not reached the remaining authors could have acted as arbiter. This did not occur.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2011-01-11 12:52:49 -0500" MODIFIED_BY="John K MacDonald">
<P>Results were pooled based on standardized mean differences (SMD) for continuous outcomes using different scales (e.g., HRQL), and odds ratios (OR) for dichotomous data. If scales used different directions, the results were transformed. E.g. higher scores for HRQL scores always described higher HRQL (better), and higher scores in disease activity always described higher disease activity (worse).</P>
<P>Superiority of the experimental intervention is expressed by an SMD &gt; 0 for HRQL and coping, and SMD &lt; 0 for emotional state and disease activity. With respect to the dichotomous outcomes (patients not in remission at/during), an OR &lt; 1.0 denotes superiority of the experimental treatment. Results are presented with 95% confidence intervals.</P>
<P>Outcome assessment was planned for 6 and 12 months following initiation of treatment. However, these were difficult to ascertain, as time periods varied and were often inadequately reported. We pooled the results as follows: 2 to 8 months: short term; 9 to 18 months: long term.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2011-01-14 10:19:27 -0500" MODIFIED_BY="John K MacDonald">
<P>Studies using educational interventions are particularly vulnerable to contamination issues (i.e. patients in the control group receive information from patients in the active groups), so cluster allocation was expected to be applied in this context. Cluster allocation was explicitly considered in the analyses applied in the studies concerned, as confirmed by the author in personal communication. Therefore, we used the standard deviation as provided by the investigators for HRQL and depression and did not apply any additional adjustment.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2011-01-14 12:45:19 -0500" MODIFIED_BY="John K MacDonald">
<P>Authors were approached for missing data. Otherwise, data were used as provided. Missing outcome data were presented in an ITT approach for dichotomous outcomes (not well at follow up), using the worst case scenario (i.e. all loss to follow up will be considered treatment failure). For continuous outcomes we used a per protocol analysis as available from the reports (i.e. results are based on the number of patients at follow up).</P>
</MISSING_DATA>
<BIAS_ASSESSMENT MODIFIED="2011-01-07 13:48:19 -0500" MODIFIED_BY="John K MacDonald">
<P>Outcome reporting bias was minimized by requesting data on our predefined outcomes from the authors if not presented in the publication.</P>
<P>To examine publication bias, a funnel plot is shown, including main results from all trials. The following results were used preferentially as available (in successive order): HRQL around month 12, HRQL around month 6, disease activity around month 12, disease activity around month 6, any other psychometric measure as available around month 12, or if unavailable, around month 6.</P>
<P>In addition to the graphical display, we applied the Egger's Test for continuous outcomes using R.<I> </I>
</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2011-01-07 13:48:24 -0500" MODIFIED_BY="John K MacDonald">
<P>As heterogeneity was expected with respect to interventions and populations we used random effects modelling (inverse variance method, RevMan5). Separate meta-analyses were performed by type of therapy (psychotherapy, educational interventions). Where multimodular therapies were used and differentiation by type of therapy was difficult, the respective trial could be included in several meta-analyses. Studies in adults and studies in children or adolescents were considered separately.</P>
<P>Although originally planned, we did not separate between induction and maintenance trials as this was not specified in any of the trials. Based on the reported relapse rates within the control groups, we assume that most trials examined the effects on maintenance of remission.</P>
<P>There are different ways to determine a minimal clinically relevant difference (<LINK REF="REF-Guyatt-2002" TYPE="REFERENCE">Guyatt 2002</LINK>). For the IBDQ, a MD of 16 is considered the minimal clinically relevant difference. Clinically relevant differences for HRQL based on SMD tend to be around 0.5 standard deviations (<LINK REF="REF-Norman-2003" TYPE="REFERENCE">Norman 2003</LINK>).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2011-01-07 13:48:56 -0500" MODIFIED_BY="John K MacDonald">
<P>All meta-analyses were performed including subgroup analyses by disease type (Crohn's disease, ulcerative colitis). Results from trials without separate reporting by disease type were included within a subgroup "unspecified IBD".</P>
<P>We also performed subgroup analyses by treatment intensity. We defined intensive therapy as any therapy exceeding 20 hours of application. For educational trials (which were all low intensity), we separated between educational only, and multicomponent therapy.</P>
<P>Other preplanned subgroup analyses (patients' comorbidity (e.g. patients with psychiatric comorbidity such as depression), age and sex, or disease specific variables as available (e.g. disease duration, presence of complications, disease behaviour and extent, smoking) could not be performed, either to lack of studies or lack of information on the characteristics at question.</P>
<P>Heterogeneity was examined by calculating the I<SUP>2</SUP> value (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>) and performing the chi-square test. Meta-analysis was carried out even if there was substantial concern about heterogeneity, but results were interpreted with caution in these cases and additional subgroup analyses were performed as appropriate. There were no pooled analyses with a sufficient number of studies to formally examine sources of heterogeneity using meta-regression techniques.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2011-01-07 13:48:57 -0500" MODIFIED_BY="John K MacDonald">
<P>Sensitivity analyses were planned to examine the impact of the following variables on the pooled effect:</P>
<UL>
<LI>- mode of allocation (randomized, quasi-randomized, non-randomized)</LI>
<LI>- concealment of allocation</LI>
</UL>
<P>Mode of allocation and concealment of allocation were closely related so this was reduced to a single sensitivity analysis, and this was restricted to the main analysis (HRQL at around 12 months). Other planned sensitivity analyses were dropped, as either no such studies were identified, or differentiation of studies by this characteristic were difficult to make. These included studies with mixed disease activity populations vs. induction/maintenance only trials, high quality studies, and studies using appropriate ITT techniques.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2011-04-07 11:51:15 -0400" MODIFIED_BY="John K MacDonald">
<STUDY_DESCRIPTION MODIFIED="2011-04-07 11:51:15 -0400" MODIFIED_BY="John K MacDonald">
<SEARCH_RESULTS MODIFIED="2011-01-14 09:59:48 -0500" MODIFIED_BY="John K MacDonald">
<P>The electronic search identified 3842 citations. Of these, 3276 could be excluded based on titles and/or abstracts alone. Two hundred and seven citations were examined in more detail, including review articles selected to check reference lists.</P>
<P>The search of conference abstracts identified abstracts on two ongoing trials (<LINK REF="STD-Boye-2010" TYPE="STUDY">Boye 2010</LINK>; <LINK REF="STD-Andrews-2010" TYPE="STUDY">Andrews 2010</LINK>), and two completed studies (<LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>; <LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>). Abstract authors provided follow up publications upon request for one of the completed trials (<LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>), the other study remained unpublished (<LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>).</P>
<P>Overall, 21 studies were included. Four of these studies did not report results in detail and could not be included in any of the pooled analyses. These 4 studies included a controlled trial on hypnosis in ulcerative colitis (<LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>), an abstract based report on patient education in IBD using a CD-ROM (<LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>), a trial on the effect of a multicomponent behavioural therapy package in 22 patients with IBD (<LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>) and a trial examining the effect of support meetings (<LINK REF="STD-Oliveira-2007" TYPE="STUDY">Oliveira 2007</LINK>).</P>
<P>All but one study (<LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>, German) were published in English. For several studies published in English, foreign language publications were also available. In particular, we extracted additional information from German language reports for 2 studies (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>, <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2011-04-07 11:51:15 -0400" MODIFIED_BY="John K MacDonald">
<SUBSECTION>
<HEADING LEVEL="4">Types of studies</HEADING>
<P>All studies used an interventional design with standard therapy as a comparator. In one study, a three arm design was used, including two treatment arms and a control group (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>). Nine studies were confirmed or potential RCTs, 4 used a quasi-randomized randomized design, and 8 used unclear or convenience procedures of allocation (see <LINK TAG="STUDY_QUALITY" TYPE="SECTION">Risk of bias in included studies</LINK>, <LINK TAG="ALLOCATION" TYPE="SECTION">Allocation</LINK>). Several studies included a rule that allowed control patients to be switched to active treatment once the trial was finished. In one instance, it was not explicitly stated that all analyses took place before switch over, so this may have been a cross over trial (<LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>). We decided that this was not very likely, but since the authors did not respond to our inquiry, the exact nature of the trial remained obscure.</P>
<P>In two related studies, randomization was clustered by hospitals, and this was adjusted for in the analysis of the individual trials (<LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>).</P>
<P>Study size ranged from 21 patients (<LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>) to 532 patients (<LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>). Most studies were small (&lt; 50 patients).</P>
<P>In 11 studies, follow up was 12 months or longer (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>; <LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>; <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>; <LINK REF="STD-Oliveira-2007" TYPE="STUDY">Oliveira 2007</LINK>; <LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>; <LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). The longest study took 5 years (<LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>). This study included yearly assessments, but results were not reported in detail. In four studies the last assessment was scheduled at 3 months (<LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>; <LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>). In the remaining studies, data were reported for time intervals of 4 to 10 months, or the exact time point remained obscure.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Populations</HEADING>
<P>Most studies were done in adult patients. There were two studies performed in adolescents (<LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>; <LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>). Both studies included mixed populations with respect to type of IBD and disease activity without presenting stratified results.</P>
<P>Settings were variable, including single and multi-center studies, hospital and community based settings, GP and specialist recruitment, and mixed approaches where volunteers were recruited along with hospital patients. Almost all studies were from Western, economically advanced countries (Germany 7, UK 4, USA 3, Sweden 2, Canada 2, The Netherlands 1, Spain 1, Brazil 1).</P>
<P>Among the studies in adults, there were 3 studies in CD (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>; <LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>), 4 in ulcerative colitis (<LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>, <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>, <LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>, <LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>), and the remainder including any IBD. Wherever possible, separate results by disease were extracted, or requested from the author if unavailable from the report. This was successful in 5 studies (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>, <LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>, <LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). Overall, data from 8 studies could be used in the subgroup analyses for CD, and 9 for UC. The remainder were coded as "IBD combined", and excluded from the subgroup analyses examining differences by disease type</P>
<P>Disease activity was rarely specifically defined as an inclusion criterion in the individual papers. Commonly, mixed activity populations were used. Since most studies were performed in ambulatory patients, it may be expected that the majority of patients had only mild disease or were in remission. A particularly obvious example of a very healthy group was shown in one study, in which 44 of 45 patients remained in remission over one year (<LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>).</P>
<P>Emotional state at baseline was addressed as an inclusion criterion in one pediatric, and one adult study. In the pediatric study, the children were all suffering from mild depression, based on HADS Screenig and subsequent clinical assessment (<LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>). One study of an educational intervention in adults was restricted to patients with high anxiety levels (based on a HAD-Score of &gt; 8) (<LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>The scope of interventions varied widely, and many used a multimodular approach. Therefore, a clear differentiation by type of intervention (educational, psychotherapy, relaxation) was not always possible.</P>
<P>Ten studies were identified as being primarily educational, aiming to improve self management by enhancing knowledge about the disease (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>; <LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>; <LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>; <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>; <LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>; <LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>).</P>
<P>There were 3 studies focusing on stress management with strong educational components which also included some element of psychotherapy, mostly group based (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). These studies were included in pooled analyses of both education and psychotherapy interventions.</P>
<P>The remaining 8 studies were classified as evaluating psychotherapy, either alone or as the predominant part of therapy. Both pediatric studies and 2 more studies in adults had strong components of cognitive-behavioural therapy within a multimodular approach, also including IBD education (<LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>; <LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>). Two studies used psychodynamically oriented interventions (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>). Lastly, there was one study examining the effect of attending a support group (<LINK REF="STD-Oliveira-2007" TYPE="STUDY">Oliveira 2007</LINK>) and a single study on hypnotherapy (<LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>). These two studies were reported in insufficient detail to allow for inclusion into any of the meta-analyses.</P>
<P>The ongoing studies will be classified as psychotherapy (cognitive-behavioural approach) once ready for inclusion (<LINK REF="STD-Boye-2010" TYPE="STUDY">Boye 2010</LINK>; <LINK REF="STD-Andrews-2010" TYPE="STUDY">Andrews 2010</LINK>).</P>
<P>The intensity of the interventions varied widely, from the mere provision of a guidebook (<LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>) to a 60 hour comprehensive life style modification programme including behavioural therapy, spread out over 3 months (<LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>). The following studies were rated as high intensity interventions (&gt; 20 hours overall): (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>; <LINK REF="STD-Oliveira-2007" TYPE="STUDY">Oliveira 2007</LINK>). All other studies were considered to examine low intensity interventions. All primarily educational studies were low intensity. These were further subclassified as multimodular (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>; <LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>; <LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>;<LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>) or educational only (<LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK> <LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>).</P>
<P>Relaxation programmes were not applied as isolated interventions in any of the studies, but frequently constituted a component among other interventions, both behavioural and educational. Relaxation techniques included autogenic training / self hypnosis (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>; <LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>), progressive muscle relaxation (<LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>; <LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>) and biofeedback (<LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>). In some instances relaxation instructions were applied from audiotapes, but often the exact mode of application was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Health Related Quality of life (HRQL)</HEADING>
<P>Of the disease specific HRQL measures, the McMaster Inflammatory Bowel Disease Questionnaire (IBDQ, <LINK REF="REF-Guyatt-1989" TYPE="REFERENCE">Guyatt 1989</LINK>) was the instrument most commonly applied, used in 10 studies of 21 (<LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>; <LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>; <LINK REF="STD-Oliveira-2007" TYPE="STUDY">Oliveira 2007</LINK>; <LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>; <LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>). Some of these studies only report P-values, subscores or single item responses (<LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Oliveira-2007" TYPE="STUDY">Oliveira 2007</LINK>; <LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>; <LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>); and could not be used. Two investigators used the Rating Form of IBD related Patient Concerns (RFIPC, <LINK REF="REF-Drossman-1989" TYPE="REFERENCE">Drossman 1989</LINK>) in addition to the IBDQ (<LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>); in these cases priority was given to the IBDQ.</P>
<P>In the two studies of educational interventions from Regensburg, Germany the Eypasch HRQL Instrument (<LINK REF="REF-Eypasch-1995" TYPE="REFERENCE">Eypasch 1995</LINK>) was used which is not specifically validated for use in IBD (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>). Lange et al. used rank correlation statistics for analysis to avoid problems with scores insufficiently validated for use on an interval scale. Therefore, score results could not be used from this study.</P>
<P>The SF36 (<LINK REF="REF-Ware-1995" TYPE="REFERENCE">Ware 1995</LINK>) was the most commonly used generic QOL instrument (<LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>), but was only extracted from the one study for which disease specific HRQL data were not available (<LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). In the pediatric Dutch study, the Dutch Children's AZL/TNO Quality of life questionnaire (DUX25, <LINK REF="REF-Kolsteren-2001" TYPE="REFERENCE">Kolsteren 2001</LINK>) was used (<LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>).</P>
<P>Several studies did not explicitly examine quality of life. Where similar concepts were examined, we extracted those as HRQL life measures. This concerned a "Life satisfaction score" in the study by Jantschek (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>), and a global functioning scale in the pediatric study by Szigethy (Children's global assessment scale, CGAS, <LINK REF="REF-Shaffer-1983" TYPE="REFERENCE">Shaffer 1983</LINK>) (<LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>).</P>
<P>In 5 studies, there were no data on HRQL or related outcomes (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>; <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>; <LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Coping</HEADING>
<P>A variety of instruments and constructs were used, including measures of Sense of Coherence (SoC, <LINK REF="REF-Antonovsky-1993" TYPE="REFERENCE">Antonovsky 1993</LINK>) (<LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>; <LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>) or patient enablement (PEI, <LINK REF="REF-Howie-1998" TYPE="REFERENCE">Howie 1998</LINK>) (<LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>), "scales of self-management and self-efficacy" (not further specified) (<LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>), cognitive processing (PCSC, Weisz 1994) (<LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>) and the comparative assessment of control strategies (<LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>; <LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). The latter included the combination of scores which were difficult to interpret as a single effect. For example, the Cognitive Control Strategies Scale (CCSS; <LINK REF="REF-Grootenhuis-2001" TYPE="REFERENCE">Grootenhuis 2001</LINK>) facilitates comparison of various strategies, e.g. being optimistic (predictive control), attributing power to the care giver (vicarious control), or searching for information (interpretative control). We extracted information for predictive control, as this score seemed to most comprehensively describe coping in general (<LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>). Similarly, the Styles and Strategies Questionnnaire (<LINK REF="REF-Roger-1989" TYPE="REFERENCE">Roger 1989</LINK>) reported in the study by Smith represents patterns rather than a single score. From this array, we have included results from the "maladaptive" score in the analysis (<LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). We are aware that the selection of a single score out of a number of scores constitutes a simplistic approach.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Emotional status</HEADING>
<P>For the assessment of emotional status, most frequently, the Hospital Anxiety and Depression Scale (HADS, <LINK REF="REF-Snaith-1986" TYPE="REFERENCE">Snaith 1986</LINK>) was used, which is a validated internationally accepted short screening instrument (<LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>; <LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>).</P>
<P>Other instruments for the assessment of depressive state were the Center for Epidemiologic Studies depression scale (ADS/CES-D Skala, <LINK REF="REF-Meyer-2003" TYPE="REFERENCE">Meyer 2003</LINK>) (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>), and the Becks Depression Inventory (BDI, <LINK REF="REF-Beck-1961" TYPE="REFERENCE">Beck 1961</LINK>) (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>). From the Szigethy study, we used the data from the Children's Depression Inventory (CDI-CP <LINK REF="REF-Kovacs-1992" TYPE="REFERENCE">Kovacs 1992</LINK>) (<LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>) for depression.</P>
<P>Anxiety was also assessed as State and Trait Anxiety (STAI or STAI-II, <LINK REF="REF-Spielberger-1970" TYPE="REFERENCE">Spielberger 1970</LINK>) (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>). Grootenhuis et al used a modified version of this instrument for children in Dutch (<LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>). Where both state and trait anxiety were presented, results for state anxiety were extracted.</P>
<P>In the remaining studies, data on emotional status were not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Disease activity</HEADING>
<P>In most studies, established and well validated measures of disease activity were used, such as the Crohn's Disease Activity Index, Clinical Activity Index, Harvey-Bradshaw, van Hees Index, or the pediatric Kozarek index or the PCDAI (<LINK REF="REF-D_x0027_Haens-2007" TYPE="REFERENCE">D'Haens 2007</LINK>; <LINK REF="REF-Sandborn-2002" TYPE="REFERENCE">Sandborn 2002</LINK>) (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>; <LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>; <LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>) (for details, see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
<P>Some investigators used self developed constructs of disease course, such as a ranking of disease states (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>), symptom change scores or single symptom improvement (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>), the number of flares (<LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>) or some informal, unspecified assessment of patient well-being (<LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>). Where we were able to extract information on the number of patients well at or over the time period in question, we used information from these constructs in the meta-analyses on "not in remission at..." (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>). The symptom change concepts were not considered valid and could not be used.</P>
<P>In one instance, results from the bowel symptom subscore of the IBDQ were available as a proxy for disease activity (<LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>). In 8 studies, disease activity was not assessed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Other outcomes</HEADING>
<P>No adverse events were reported in any of the included studies. </P>
<P>Economic outcomes (health care use and costs, time trade off measures, difference in quality adjusted life years (QALYs)) were assessed in 2 studies (<LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>). Detailed results were available from a separate publication for the Kennedy study (<LINK REF="REF-Richardson-2006" TYPE="REFERENCE">Richardson 2006</LINK>). Days in hospital or days on sick leave were reported in a single study (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>).</P>
<P>Some of the psychological studies used elaborate test batteries including personality profiles, behavioural problem assessment and/or measures of self perception and social functioning (<LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>; <LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>). This was particularly obvious for the pediatric studies and the psychodynamically oriented programme interventions. Of these outcomes, only those related to HRQL, coping and depression were extracted (see above).</P>
<P>Other outcomes not used for meta-analysis included perceived stress or hassles (<LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>), knowledge gain (<LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>) and patient satisfaction (programme satisfaction, life satisfaction) (<LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>).</P>
<P>For one of the included studies (<LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>), short term effects on cellular immune and hormonal measures are reported in a separate publication (<LINK REF="REF-Elsenbruch-2005" TYPE="REFERENCE">Elsenbruch 2005</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2011-01-14 12:42:42 -0500" MODIFIED_BY="John K MacDonald">
<P>The vast majority of scrutinized papers were narrative reports, including case studies and introductory papers, and uncontrolled case series or before-after comparisons.</P>
<P>There were several interesting controlled observational historical studies (<LINK REF="STD-Grace-1954" TYPE="STUDY">Grace 1954</LINK>; <LINK REF="STD-O_x0027_Connor-1964" TYPE="STUDY">O'Connor 1964</LINK>). In particular the report by Grace presents data on groups with severe ulcerative colitis treated with supportive psychotherapy in the context of a very high background mortality in the pre-steroid era. It was unclear from the report whether this report presented a prospective, or retrospective analysis, but a secondary source confirmed the latter (<LINK REF="REF-Kellner-1975" TYPE="REFERENCE">Kellner 1975</LINK>), so the study was eventually excluded. Similarly, the 1964 report by O'Connor (<LINK REF="STD-O_x0027_Connor-1964" TYPE="STUDY">O'Connor 1964</LINK>) was clearly described as retrospective in the overview by Kellner. In this study most patients in the treatment group (but not the control group) had comorbid major psychiatric disorder, including schizophrenia, representing further reason for exclusion. Interesting data, albeit short term only, are also available on comparative treatment of different disease entities, including IBD (<LINK REF="STD-Hochgerner-1998" TYPE="STUDY">Hochgerner 1998</LINK>).</P>
<P>Two studies were excluded due to insufficient time of follow up (<LINK REF="STD-Eaden-2002" TYPE="STUDY">Eaden 2002</LINK>; <LINK REF="STD-Shaw-1987" TYPE="STUDY">Shaw 1987</LINK>). In a number of studies on patient education outcome assessment focused on gain in knowledge, rather than HRQL or other criteria of disease course (<LINK REF="STD-Eaden-2002" TYPE="STUDY">Eaden 2002</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>; <LINK REF="STD-Quan-2003" TYPE="STUDY">Quan 2003</LINK>). These studies could not be included, unless information on disease activity and / or HRQL was also supplied (<LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>). Also, we could not include studies focusing on specific isolated symptoms, such as pain in a study on muscle relaxation (<LINK REF="STD-Shaw-1987" TYPE="STUDY">Shaw 1987</LINK>).</P>
<P>A very interesting short report on the effect of physician's awareness of patients' psychological status was not included, as the effects of psychological interventions were only indirectly assessed - interventions were applied if physicians had been made aware of the patients need for treatment (<LINK REF="STD-Mickocka_x002d_Walus-2009" TYPE="STUDY">Mickocka-Walus 2009</LINK>). Lastly, there are a number of excluded studies on self management of patients focusing on access to health care rather than the psychological aspects of patient self care (<LINK REF="STD-Robinson-2001" TYPE="STUDY">Robinson 2001</LINK>; <LINK REF="REF-Saibil-2008" TYPE="REFERENCE">Saibil 2008</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2011-01-14 12:43:32 -0500" MODIFIED_BY="John K MacDonald">
<P>The risk of bias was high for all studies. For details see also <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2011-01-07 13:49:31 -0500" MODIFIED_BY="John K MacDonald">
<P>Several studies appeared to be randomized, but there were only three studies for which the method of sequence generation could be ascertained in sufficient detail to confirm true randomization (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>). These studies also applied measures to conceal allocation. Concealment of allocation was confirmed for a fourth study with uncertain sequence generation (<LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>), and this study is also likely to be a true RCT and was therefore considered as such.</P>
<P>Although we tried to get author information on all studies, we were unable to establish the exact mode of sequence generation for a number of studies, for which true random allocation may have been used (<LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>, <LINK REF="STD-Lecouturier-2003" TYPE="STUDY">Lecouturier 2003</LINK>, <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>, <LINK REF="STD-Oliveira-2007" TYPE="STUDY">Oliveira 2007</LINK>, <LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>). It also remained unclear whether concealed allocation was maintained for these studies.</P>
<P>Four studies were quasi-randomized, using date of submission (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>, <LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>), hospital registration numbers (<LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>) or some other unspecified random rule for allocation (<LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>). These procedures were considered to carry a moderate (unclear) risk of bias for sequence generation, and a high risk of bias due to unconcealed allocation. Some of these studies had been described as randomized in the published report but were "downgraded" once exact information on the allocation methods were received from the authors.</P>
<P>For two studies the method of allocation could not be confirmed (<LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>). These studies were described as randomized, but convenience allocation may have been used and an unclear potential for bias was assumed. In one case, open allocation was evident (high risk of bias).</P>
<P>In six studies, convenience procedures were used for allocation. These included allocation based on distance of living place of the patient to the clinic (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>, <LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>, <LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>), treatment center (<LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>) and time interval (<LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>). Since place of living, treating physician and time interval may all be related to prognostic variables other than the treatment, these procedures were considered to carry a high risk of selection bias. Also, open allocation is inherent to all convenience procedures.</P>
</ALLOCATION>
<BLINDING MODIFIED="2011-01-07 13:49:33 -0500" MODIFIED_BY="John K MacDonald">
<P>None of the studies applied blinding of the patients or investigators using any sham procedures, but a few tried blinded outcome assessment (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>, <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>, <LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>). It remains unclear how blinded outcome assessment was maintained and whether this contributed to alleviating the risk of bias.</P>
<P>While failure to blind may be considered inherent to the interventions at question, the resulting bias still requires consideration and contributed to the high risk of bias classification of all included studies.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2011-01-14 12:43:32 -0500" MODIFIED_BY="John K MacDonald">
<P>A specific concern were differential drop out rates. High drop out rates in the control groups might have biased the results to overly optimistic estimations of efficacy of the active treatment, in particular, if a worst case scenario was applied as planned. We have therefore included an analysis examining the number of drop outs by treatment group but could not confirm differences by treatment group. On average, 27% of the treated patients, and 29% of the control patients dropped out or were lost to follow up (RR: 0.98; 95% CI 0.92 to 1.05; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2011-01-07 13:49:36 -0500" MODIFIED_BY="John K MacDonald">
<SUBSECTION>
<HEADING LEVEL="4">Publication / small study bias</HEADING>
<P>A funnel plot is presented in <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK> for results based on HRQL and does not appear to suggest small study bias. Similarly, the results of the linear regression test of funnel plot asymmetry (Egger's Test) did not show evidence of bias (t = 0.5734, df = 10, P = 0.579).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcome reporting bias</HEADING>
<P>Selective outcome reporting was a frequent issue in the studies identified, and included reporting of results for subgroups only, or failure to report quantitative results at all for certain outcomes. For example, in one study on the effects of an educational study, results for HRQL were reported only for those with poor HRQL to begin with, rather than for the complete groups (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>). In these cases we tried to retrieve the full information from the authors, and were able to do so in the majority of cases.</P>
</SUBSECTION>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2011-01-10 14:22:20 -0500" MODIFIED_BY="John K MacDonald">
<SUBSECTION>
<HEADING LEVEL="4">Control for confounding</HEADING>
<P>Lack of control of confounding was a problem in both RCTs too small to be likely to render balanced comparison groups, as well as in non randomized groups and was therefore introduced as a specific item into the Risk of Bias Summary. Unbalanced groups at baseline, giving risk to a high risk of selection bias, were considered specifically problematic in the following studies: <LINK REF="STD-Lange-1996" TYPE="STUDY">Lange 1996</LINK>; <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>; <LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>.</P>
<P>Of the not truly randomized trials, only 3 studies adjusted for confounding by using multivariate analyses (<LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>; <LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Use of validated outcome assessment instruments</HEADING>
<P>We restricted the assessment of the validity of the instruments used to one psychometric and one somatic outcome (HRQL and disease activity). Details are presented in the section on <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, <LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK> and in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>. Generally, if HRQL was assessed and reported, in most of the studies, a valid instrument was used, but some studies were performed before any such instruments were available.</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2011-01-14 12:46:10 -0500" MODIFIED_BY="John K MacDonald">
<SUBSECTION>
<HEADING LEVEL="3">Psychotherapy</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Health Related Quality of Life</HEADING>
<P>For the main outcome in adults, HRQL at around 12 months, results were available from 235 adult patients in 3 studies<BR/>(<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>) (129 CD, 106 UC) (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). The overall effect was close to zero (SMD -0.07; 95% CI -0.33 to 0.19), excluding a relevant effect. There was no evidence for statistical heterogeneity. For short term results, data were available from 3 studies (<LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>) including 173 patients (50 CD, 80 UC, 43 mixed). A small positive effect may be possible but the result was not statistically significant (SMD 0.28; 95% CI -0.02 to 0.59).</P>
<P>Subgroup analyses excluded a differential effect by type of disease (ulcerative colitis or Crohn's), or length of intervention (neither long-term, nor short-term). Also, there was no difference by intensity of treatment: both high intensity (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>) (SMD -0.13; 95% CI -0.48 to 0.21) and low intensity trials (<LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>) (SMD 0.01; 95% CI -0.38 to 0.41) were ineffective with respect to HRQL at 12 months (P for subgroup differences: 0.58, I<SUP>2</SUP> = 0%)</P>
<P>Based on the two pediatric studies, a significant and relevant positive short term effect of psychotherapy in adolescents could be demonstrated (SMD 0.70; 95% CI 0.21 to 1.18) (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). This result is significantly different from the effect in adults. Long term results were not available for children.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Coping</HEADING>
<P>Coping in adults following psychotherapy was rarely assessed in a way that results could be included in meta-analysis. For example, in one study, mean values for Sense of Coherence were reported, but measures of variance were unavailable (<LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>). Our results are based on a single study in 50 CD patients, using a styles and strategies questionnaire (<LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). The effect was close to unity at 6 months (SMD -0.01; 95% CI -0.56 to 0.55), and showed a small positive effect at 12 months (SMD -0.43; 95% CI -0.99 to 0.14), which was neither statistically significant nor likely to be clinically relevant.</P>
<P>In adolescents, coping was significantly improved by psychological interventions (SMD 0.75; 95% CI 0.26 to 1.25), based on 2 studies with overall 69 patients with IBD (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). There was no indication for statistical heterogeneity (I<SUP>2</SUP> = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Emotional status</HEADING>
<P>Depression at 12 months was assessed in 4 studies, comprising 266 patients (160 CD, 106 UC) (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). Psychotherapy was not effective (SMD 0.03; 95% CI -0.22 to 0.27), and this was true for both CD and UC, as well as for high intensity and low intensity interventions (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>). There was no evidence for statistical heterogeneity. Similarly, psychological interventions were not effective at 6 months, based on a different set of studies (SMD 0.12; 95% CI -0.16 to 0.40) (<LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Schwarz-1991" TYPE="STUDY">Schwarz 1991</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>).</P>
<P>As for HRQL, the single study in children (<LINK REF="STD-Szigethy-2007" TYPE="STUDY">Szigethy 2007</LINK>) showed a positive (albeit not statistically significant) effect on depression in favour of the intervention at 3 months of follow up (SMD 0.62; 95% CI -0.01 to 1.25) (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>).</P>
<P>Anxiety at 12 and/or 6 months was assessed in 4 studies of psychological interventions (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). Results were inconclusive, but a strong effect seems unlikely (12 months (SMD 0.04; 95% CI -0.22 to 0.30), 6 months (SMD -0.06; 95% CI -0.34 to 0.21)). For adolescents, results were inconclusive (SMD 0.58; 95% CI -0.15 to 1.31), based on a single study (<LINK REF="STD-Grootenhuis-2009" TYPE="STUDY">Grootenhuis 2009</LINK>) (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Disease activity</HEADING>
<P>Sixty-three of 165 patients (22%) in the intervention groups, and 47 of 122 patients (39%) in the control groups were not in remission over or at 12 months. This corresponds to an OR of 0.85 (95% CI 0.48 to 1.48) (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>), based on 5 studies (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>; <LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>; <LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Langhorst-2007" TYPE="STUDY">Langhorst 2007</LINK>; <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>).</P>
<P>Changes in disease activity scores were available for fewer studies, and did not show significant effects (long term: SMD 0.03; 95% CI -0.28 to 0.35).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other outcomes</HEADING>
<P>Based on a single study in 81 patients with CD, both days off work and days in hospital were significantly reduced by an intense multimodular psychotherapy (off work: mean difference (MD) -59.10; 95% CI -102.49 to -15.71, in hospital: MD -13.90; 95% CI -25.54 to -2.26) (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Psychotherapy - sensitivity analyses</HEADING>
<P>Neither restricting the analysis to truly randomized trials (<LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>), nor excluding non randomized trials (<LINK REF="STD-K_x00fc_nsebeck-1987" TYPE="STUDY">Künsebeck 1987</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>) altered any of the results in a relevant (or significant) way. Most trials on psychological interventions were quasi-randomized or possibly randomized.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Educational interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">HRQL</HEADING>
<P>Twelve month results are based on 947 patients from 5 studies (73 CD, 221 UC, 532 IBD not specified) (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). Overall there was a small positive effect which was not statistically significant (SMD 0.11; 95% CI -0.02 to 0.24) (<LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>). Based on subgroup analysis by type of disease, the effect seems restricted to patients with ulcerative colitis (SMD 0.26; 95% CI -0.01 to 0.53). In CD, the difference between the groups was close to zero (SMD -0.08; 95% CI -0.54 to 0.38). However, the differential effect by type of disease was not statistically significant (test for subgroup differences P = 0.20, I<SUP>2</SUP> 38%).</P>
<P>Short term results were reported for 7 studies (596 patients) (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>; <LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>). The overall effect was similar to those for 12 months (SMD 0.10; 95% CI -0.08 to 0.28, I2 12%). In subgroup analysis, effects were similar for CD and UC, but considerable statistical heterogeneity was obvious within the set of UC trials and remained unexplained (I<SUP>2</SUP> for UC trials = 53%, P = 0.10).</P>
<P>Subgroup analysis by educational only versus multicomponent approach did not identify a difference; neither group showed an effect of the intervention.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Coping</HEADING>
<P>Sufficiently detailed results on coping were available from 3 studies (<LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>; <LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). Based on 85 patients for the long term results (2 studies, 73 CD, 12 UC), and 204 for short term assessment (3 studies, 102 CD, 56 UC, 36 unspecified IBD), there was no evidence for a positive effect of educational interventions on coping. Results at 12 months were not statistically significant (SMD -0.45; 95% CI -1.34 to 0.45). This was statistically significant for the small trial which constituted the only contributor to the subgroup of trials in ulcerative colitis (<LINK REF="STD-Oxelmark-2007" TYPE="STUDY">Oxelmark 2007</LINK>; n = 36, SMD -1.87; 95% CI -3.46 to -0.28). The result from this trial differed significantly from the pooled results for CD (SMD -0.13; 95% CI -0.82 to 0.56) (test for subgroup differences P = 0.05, I<SUP>2</SUP> = 74%).</P>
<P>The analyses on coping were characterized by a substantial degree of statistical heterogeneity (12 months: I<SUP>2</SUP> 66%, P = 0.05; 6 months I<SUP>2</SUP> 47%, P = 0.09). This was insufficiently explained by the negative effect in patients with ulcerative colitis: following exclusion of the UC trial, I<SUP>2</SUP> was 50% (P = 0.16) (2 trials, CD only).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Emotional status</HEADING>
<P>Educational interventions had no effect on depression at 12 months, based on 378 patients from 3 studies (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>) (SMD -0.08; 95% CI -0.29 to 0.12). Similarly, there was no effect at 6 months (4 studies, 430 patients, SMD -0.07; 95% CI -0.26 to 0.12) (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Kennedy-2003" TYPE="STUDY">Kennedy 2003</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). These analyses did not show evidence of statistical heterogeneity. Results for subgroups by type of disease or subtype of intervention did not differ.</P>
<P>Data on anxiety were limited (1 trial, 100 patients) for long term, 2 trials (143 patients) for short term) (<LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>). There was no effect of educational interventions on anxiety, neither long term (SMD -0.14; 95% CI -0.70 to 0.41) nor short term (SMD -0.14; 95% CI -0.47 to 0.19).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Disease activity</HEADING>
<P>Data on the proportion of patients in remission were available from 4 studies (<LINK REF="STD-Garcia_x002d_Vega-2004" TYPE="STUDY">Garcia-Vega 2004</LINK>; <LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>; <LINK REF="STD-Jaghult-2007" TYPE="STUDY">Jaghult 2007</LINK>; <LINK REF="STD-Milne-1986" TYPE="STUDY">Milne 1986</LINK>) (short term: 221 patients, long term: 434 patients). There was no effect: The OR was 1.00 for long term effects (95% CI 0.65 to 1.53) (<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>) and 1.35 (95% CI 0.73 to 2.48) for short term effects.</P>
<P>Similarly, there was no difference in disease activity scores at 12 months (SMD 0.09; 95% CI -0.21 to 0.39) (2 studies, 171 patients) (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>) or 6 months ((SMD -0.15; 95% CI -0.37 to 0.06) (4 studies, 336 patients, no evidence for heterogeneity or subgroup effects) (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>; <LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>; <LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>; <LINK REF="STD-Waters-2005" TYPE="STUDY">Waters 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Costs of care</HEADING>
<P>Meta-analysis of economic outcomes could not be performed due to the paucity of studies reporting on these types of outcomes. Detailed results are available based on a single British study in 19 hospitals (cluster randomization) and showed a mean reduction of costs by 148 pounds per patient year, and 0.00022 quality adjusted life years per patient (<LINK REF="STD-Kennedy-2004" TYPE="STUDY">Kennedy 2004</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Educational interventions - sensitivity analyses</HEADING>
<P>For the main outcome (HRQL at 12 months), exclusion of the single NRCT (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>) resulted in a stronger effect in favour of educational therapy which was statistically significant (SMD 0.14, 95% 0.00 to 0.28) with no evidence for heterogeneity, based on 826 patients in 5 studies (<LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>). Further restricting the analysis to RCTs only, the effect size was similar, but the result was not statistically significant (SMD 0.11. 95% CI -0.05 to 0.26) (2 studies, 259 patients) (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2011-01-14 12:46:16 -0500" MODIFIED_BY="John K MacDonald">
<SUMMARY_OF_RESULTS MODIFIED="2011-01-14 12:46:11 -0500" MODIFIED_BY="John K MacDonald">
<P>In our pooled analysis, psychotherapy was ineffective in improving HRQL, emotional problems and disease activity in unselected adult patients with IBD. A type II error is unlikely as confidence intervals were sufficiently narrow to exclude relevant effects. The data were not sufficient to identify specific subgroups or interventions that might be associated with a positive effect.</P>
<P>In contrast, in children, behavioural therapy may improve psychological status, in terms of HRQL, depression, anxiety and coping. The strength of the effect seems to be relevant, if a threshold of 0.5 is assumed (<LINK REF="REF-Norman-2003" TYPE="REFERENCE">Norman 2003</LINK>). These results are based on limited data, as only 2 studies were available, and none reported long term results. Power was not sufficient for all outcomes, but the consistency of the direction of effects on various outcome criteria suggests a true effect.</P>
<P>The majority of studies focused on educational interventions, including complex stress management programmes, in adult patients with IBD. No relevant, nor significant effect could be demonstrated. However, sensitivity analysis excluding convenience based trials raised the suspicion that selection bias may have weakened a possible small positive effect on HRQL. Eligible educational trials in children were not identified.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2011-01-14 12:46:15 -0500" MODIFIED_BY="John K MacDonald">
<P>Insufficient and non standard reporting were a problem in several studies but for most of them we were able to obtain additional data from the investigators. The applicability of the evidence may be compromised by poor definitions of the patient populations. In most studies there was little information on the disease activity at baseline, or mixed populations were included. Furthermore there were no separate results by baseline emotional status which could have facilitated subgroup analyses to identify patient groups which might benefit.</P>
<P>It seems likely that the majority of patients were relatively well. Emotional status is closely correlated with disease activity. Some authors have suggested that the failure to show a positive effect is due to low baseline scores (i.e. little emotional disturbance), so there was not much room for further improvement ("floor problem") (<LINK REF="REF-Graff-2009" TYPE="REFERENCE">Graff 2009</LINK>; <LINK REF="REF-von-Wietersheim-2006" TYPE="REFERENCE">von Wietersheim 2006</LINK>). The inclusion of patients with higher depression or anxiety scores might have resulted in a better power to detect a positive effect. However, the single study which used preselected patients based on HADS anxiety levels was equally unable to show efficacy of the intervention (<LINK REF="STD-Larsson-2003" TYPE="STUDY">Larsson 2003</LINK>), and the results of this study were not significantly different from those of other studies.</P>
<P>In contrast, in adolescents, both the study restricting inclusion to adolescents with mild depression as well as the study including unselected adolescents showed positive results. More data would have been needed to examine the importance of pre-trial emotional and inflammatory status in more detail.</P>
<P>Similarly, we were unable to show differential effects by type of disease, apart from some heterogeneity in the analyses on coping (UC versus CD). It has previously been suggested that CD might be more amenable to psychological therapy as this disease is associated with a higher degree of HRQL impairment and emotional maladjustment.</P>
<P>Generally, there is now a substantial amount of research on stress management programmes and patient education. There were no studies that examined the efficacy of relaxation techniques as a "stand alone" intervention. Hypnotherapy was applied as a psychotherapy (<LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>) and was thus not counted as a relaxation technique although it may be occasionally applied as such. Besides, reporting in this study was insufficient to assess the effectiveness of this intervention.</P>
<P>We can not exclude that in the presence of more studies examining well defined patient groups subgroup analyses may have shown a benefit for certain types of therapy. For example, a specific type of therapy might be effective in either active or quiescent disease, if a certain degree of emotional distress is present. At this moment, the evidence generated in this review only applies to psychotherapy or educational interventions in general, applied to unselected IBD patients.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2011-01-14 10:18:09 -0500" MODIFIED_BY="John K MacDonald">
<P>All studies were rated low quality, although in several instances, potential sources of bias were thoughtfully considered, and several studies used adequate procedures for allocation concealment. Inherent to the type of intervention, none of the studies used blinding. Placebo responses could not have been excluded if a positive effect would have been found (and need, of course, be considered for the pediatric studies).</P>
<P>Waiting list or standard care were frequently used as comparison treatments. None of the studies used sham therapy as controls, or document regularly scheduled visits in analogy to the active treatment. We appreciate that controversy is warranted on to what extent separation of the placebo effect from the true effect of therapy, and thus, the use of a sham procedure is necessary and applicable in psychological therapy. A placebo effect may, by some, be considered a necessary and welcome part of these types of intervention. However, even where treatment as usual was used, generally, more information on the treatment of the control groups would have been preferable. Also, investigators generally failed to report if and what measures were used to ensure that as many conditions were kept equal between the groups. As an example, regular appointments in analogy to the active groups might have been feasible. This was particularly problematic in those studies where there was, in addition, a high risk of selection bias from convenience sampling.</P>
<P>Sensitivity analysis showed that exclusion of the NRCT from the analysis on educational interventions increased the strength of the intervention. This was somewhat unexpected but may be explained by over sampling of patients with a poorer short term prognosis in the treatment group (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>). It is conceivable that patients likely to undergo more frequent visits at the university hospital for disease activity might have been more inclined to attend sessions since they were coming in anyway.</P>
<P>Selection bias was also evident from frequent problems in the comparability of baseline criteria, either due to non random sampling, or to insufficient sample size in randomised controlled trials. We did not note a systematic effect, but some bias may have been arising, for which the direction is currently unknown (possibly indifferential, diminishing the expected effect).</P>
<P>Generally, very small sample sizes in most studies were also a problem.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2011-01-14 12:46:16 -0500" MODIFIED_BY="John K MacDonald">
<P>Statistical testing and graphical display did not show evidence of publication bias, but the sample size may have been insufficient to detect a small effect. Our search was above standard for comprehensiveness; however, reporting bias was also present. Some of the studies with insufficient reporting to be included in the meta-analyses reported positive effects (<LINK REF="STD-Schmidt-1992" TYPE="STUDY">Schmidt 1992</LINK>; <LINK REF="STD-Schreiber-1999" TYPE="STUDY">Schreiber 1999</LINK>). The extent to which this may have increased the pooled effect if they could have been included is speculative.</P>
<P>Seven of the 21 studies included were from Germany. It can be speculated that this is evidence of the strong tradition of psychotherapy and psychosomatic medicine in Austria and Germany. We made an effort to minimize language bias, for example by extending our search to non-English databases, specifically LILACS, and by hand searching conferences known to attract submissions from all over the world. During the screening process, titles and abstracts were identified in various languages for which translation help was sought, including those in Polish, Spanish, Russian, French and Turkish. None of these was found to be eligible for further scrutiny. However, we can not exclude that, in addition to the well known retrieval bias in favour of studies published in English, there was some bias in favour of studies from German speaking countries as this is our native language. Access may have been easier.</P>
<P>Problems may also have arisen from our failure to control for baseline imbalance, as discussed above. Furthermore, we pooled studies on very diverse interventions and populations, and this may also have resulted in a blurred effect. Overall, there was surprisingly little evidence for statistical heterogeneity in spite of the obviously substantial clinical heterogeneity. To some degree this may be due to a low power to detect heterogeneity.</P>
<P>Some discussion is warranted on the choice of endpoints. We have excluded a few studies restricted to the assessment of knowledge gain. Similarly, we did not examine patient or programme satisfaction. In the light of patient empowerment, these outcomes may be considered relevant criteria to justify interventions, and consideration of these interim parameters might have resulted in a more positive view on the success of interventions, in particular, educational programmes.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2011-01-12 12:26:27 -0500" MODIFIED_BY="John K MacDonald">
<P>Previous reviews on the effect of psychological interventions in IBD have refrained from attempting data synthesis in view of the clinical heterogeneity of patients, interventions and settings (<LINK REF="REF-Barlow-2010" TYPE="REFERENCE">Barlow 2010</LINK>; <LINK REF="REF-Goodhand-2009" TYPE="REFERENCE">Goodhand 2009</LINK>; <LINK REF="REF-von-Wietersheim-2006" TYPE="REFERENCE">von Wietersheim 2006</LINK>). Still, they arrived at similar conclusions. These authors have argued that pooled results might be difficult to interpret. We agree that the variability may indeed be a problem. However, overall, those studies that did provide sufficient details were remarkably similar in the choice of patients, the common application of multimodular approaches and the use of study endpoints. Interestingly, there was also no statistical evidence of major heterogeneity. Our analysis was not able to identify subgroup effects by certain characteristics of the intervention applied, e.g. dosing, type of therapist or duration. Our conclusions remain necessarily general - psychological interventions in general, if applied to unselected patients with IBD, are not likely to have a relevant positive effect. This seems to be in contrast to a recent meta-analysis on short term psychodynamic therapy for somatic disorders (<LINK REF="REF-Abbass-2009" TYPE="REFERENCE">Abbass 2009</LINK>). Based on overall 23 studies on various disorders, significant improvements were calculated for most outcomes, both short- and long term, including those within relevant magnitudes. For example, the SMD for short term alleviation of depression was -0.97 (-1.19 to -0.74), and long term somatic complaints were improved by an SMD of 0.49 (-0.77 to -0.21). There was very high heterogeneity in these analyses but subgroup analysis was not performed. Possibly, these interventions work better in conditions other than IBD (1 study included (<LINK REF="STD-Jantschek-1998" TYPE="STUDY">Jantschek 1998</LINK>)), such as irritable bowel (IBS, 3 studies included). This is also confirmed by a Cochrane review on psychological interventions in IBS, which showed small superiority of active treatment (<LINK REF="REF-Zijdenbos-2009" TYPE="REFERENCE">Zijdenbos 2009</LINK>).</P>
<P>Previous studies on patient education in IBD had raised concern that improved knowledge may actually worsen HRQL and disease activity. This was particularly evident from a short term RCT in 36 patients on the use of informational books (<LINK REF="STD-Borgaonkar-2002" TYPE="STUDY">Borgaonkar 2002</LINK>), but might also be supported from the study by Bregenzer included in our review (<LINK REF="STD-Bregenzer-2005" TYPE="STUDY">Bregenzer 2005</LINK>). Others did not find an association between level of knowledge and HRQL using a survey (<LINK REF="REF-Verma-2001" TYPE="REFERENCE">Verma 2001</LINK>). This may, of course, be confounded by the fact that sicker patients may seek more information than those who are well. Borgaonkar et al. did not report long term results, so this study was not eligible for inclusion in the review and was not formally assessed for risk of bias. The study by Bregenzer was an NRCT which could be shown to bias the pooled results away from a positive effect, towards no effect. We cannot exclude that patient information may initially lead to deterioration. However, we would refrain from overemphasizing the results of single small studies. Based on our results there is no evidence that patient education is deleterious in the long run; and there may even be a small positive effect on both HRQL and emotional status.</P>
<P>Current international guidelines recommend psychotherapy for IBD patients with associated psychological disorders, decreased HRQL from psychological distress, or maladaptive coping (<LINK REF="REF-Caprilli-2006" TYPE="REFERENCE">Caprilli 2006</LINK>), or remain vague ("better stress management may improve symptoms on patients' approach to their disease.... attention to comorbid psychiatric illness is mandatory") (<LINK REF="REF-Bernstein-2010" TYPE="REFERENCE">Bernstein 2010</LINK>). We do not find evidence that patients in general benefit from better stress management. However, the importance of psychological therapy in adolescents should be stressed.</P>
<P>Several self- and expert rating instruments are now available to identify patients in need of psychological treatment (<LINK REF="REF-Miehsler-2004" TYPE="REFERENCE">Miehsler 2004</LINK>; <LINK REF="REF-Miehsler-2008b" TYPE="REFERENCE">Miehsler 2008b</LINK>; <LINK REF="REF-Miehsler-2008a" TYPE="REFERENCE">Miehsler 2008a</LINK>; <LINK REF="REF-Kunzendorf-2007" TYPE="REFERENCE">Kunzendorf 2007</LINK>). These still await validation as to whether they do actually identify patients which will profit from therapy. Future trials might want to include these or similar screening instruments to identify appropriate patient groups for the evaluation of psychological interventions.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2011-01-07 13:50:37 -0500" MODIFIED_BY="John K MacDonald">
<IMPLICATIONS_PRACTICE MODIFIED="2011-01-07 13:50:37 -0500" MODIFIED_BY="John K MacDonald">
<P>Adolescents with IBD may benefit from psychological treatment. In adults, the need of psychological interventions should be assessed and psychotherapy, stress management programmes or educational training offered on an individual basis. General application of psychological therapy in adult patients with IBD is not recommended.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2011-01-07 13:50:37 -0500" MODIFIED_BY="John K MacDonald">
<P>Future research should focus on identifying subgroups of patients most likely to benefit from psychological interventions. If proven successful, more research into the comparative evaluation of different psychological treatment options is needed. Methodological standards of clinical trials on psychological therapy need to be improved. More studies are needed to identify optimal treatment strategies and long term effects in children and adolescents.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2011-06-21 13:05:28 -0400" MODIFIED_BY="John K MacDonald">
<P>Alexandra Bauer did the hand searches and helped with retrieving publications and additional study information. She was funded by the German Federal Ministry for Education and Research (BMBF).</P>
<P>Hannah Kempe helped with literature searching and retrieving publications.</P>
<P>We wish to express our sincere thanks to all investigators providing additional information on their studies: Nicole Bregenzer and Tilo Andus, Elena Garcia-Vega, Susanna Jaghult, Maria Pritsch (Jantschek 1998), Anne Kennedy, Hans-Werner Künsebeck, Eva Haslbeck and husband (Lange 1996), Jost Langhorst, Janet Lecouturier, Lena Oxelmark, Burkhard Peter (for Christian-Frank Schmidt), Stefan Schreiber, Shirley Schwarz McMorris, Louise Jensen. We also received help from several investigators of studies which were eventually excluded.</P>
<P>The following authors were approached but did not respond: Kjerstin Larsson, Gloria Joachim (for Barbara Milne), Silvio Oliveira.</P>
<P>Funding for the IBD/FBD Review Group (September 1, 2010 - August 31, 2015) has been provided by the Canadian Institutes of Health Research (CIHR) Knowledge Translation Branch (CON - 105529) and the CIHR Institutes of Nutrition, Metabolism and Diabetes (INMD); and Infection and Immunity (III).</P>
<P>Miss Ila Stewart has provided support for the IBD/FBD Review Group through the Olive Stewart Fund.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2011-01-10 10:05:56 -0500" MODIFIED_BY="John K MacDonald">
<P>Günther Jantschek (deceased) was involved in studies included in this review. Both he and Gabriele Moser served as coauthors on clinical practice guidelines in IBD focusing on issues of psychological therapy. </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-01-14 10:18:52 -0500" MODIFIED_BY="John K MacDonald">
<P>Antje Timmer conceived the study, wrote the protocol (and a successful funding proposal), participated in devising the search strategy, screened the literature, selected the studies, extracted the data, did the quality assessments of included papers, analysed the data and wrote the manuscript.</P>
<P>Jan Preiss screened the literature, did the hand search, selected the studies, extracted the data and did the quality assessments of included papers.</P>
<P>Edith Motschall devised the search strategy, performed the electronic searches and wrote the methods section (search strategy).</P>
<P>Gerta Rücker was the consulting statistician, participated in writing the protocol and review methods sections, and performed the statistical tests on small study bias.</P>
<P>Günther Jantschek served as consulting expert (psychosomatic gastroenterology), wrote the introduction section of the protocol and consulted on the writing of the manuscript.</P>
<P>Gabriele Moser was the consulting expert (psychosomatic gastroenterology), wrote the introduction section of the protocol and consulted on the writing of the manuscript. She also did the major part of the revisions following peer review.</P>
<P>All authors contributed to and approved of the version of the manuscript when first submitted, and all but Günther Jantschek approved of the final version.</P>
<P>
<I>"Günther Jantschek has not lived to see this review published. We have lost an extraordinary scientist, physician and friend. Gabriele Moser, for the authors.</I>"</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2011-01-07 13:50:47 -0500" MODIFIED_BY="John K MacDonald">
<P>Inclusion criteria: non randomised trials (NRCT) were also included as distinction between random, quasi-random and convenience based could often not be made on accounts of the reports alone. Quasi-random and convenience procedures are common for psychological intervention trials. Of note this was in the original version of the protocol but was changed due to reviewer suggestions. The current criteria form a compromise between our original plan (which included also prospectively controlled observational studies) and the reviewers' wish (RCT only).</P>
<P>Assessment of study quality and examination of heterogeneity were modified to better adhere to the recommendations by the Cochrane Collaboration published with RevMan 5, and recent criticism on preset criteria for I<SUP>2</SUP> values. Grade C quality papers were not excluded as policies on quality/bias assessment have changed in the Cochrane Collaboration. Also, all papers were C quality. This is reflected by the Summary of Bias tables.</P>
<P>Handsearch: As abstracts of the major conferences to be included in the handsearch are included in the specialized IBD registry, handsearching for relevant conference abstracts was restricted to conferences taking place between fall 2008 and May 2010. Screening of conference abstracts up to 2008 (summer) was done based on the special registry.</P>
<P>Time of follow up - due to the diversity of study length and variability between, and at times, within studies, 12 months assessment comprised follow up assessments between 9 and 18 months, and 6 month assessment included 3 to 8 months of follow up.</P>
<P>Pooling of results: There was no differentiation between induction and maintenance therapy, as most studies used mixed populations, and there were no explicit studies on induction of remission. In consequence, subgroup analysis by intention of therapy (maintenance vs. induction) could not be performed.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2011-04-06 09:57:09 -0400" MODIFIED_BY="John K MacDonald">
<STUDIES MODIFIED="2011-01-05 14:16:52 -0500" MODIFIED_BY="John K MacDonald">
<INCLUDED_STUDIES MODIFIED="2011-01-05 13:26:25 -0500" MODIFIED_BY="John K MacDonald">
<STUDY DATA_SOURCE="PUB" ID="STD-Bregenzer-2005" MODIFIED="2010-02-22 05:37:40 -0500" MODIFIED_BY="[Empty name]" NAME="Bregenzer 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-02-22 05:37:40 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Bregenzer N, Lange A, Furst A, Gross V, Scholmerich J, Andus T</AU>
<TI>Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being</TI>
<SO>Unpublished manuscript (previous version)</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-02-22 05:36:04 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bregenzer N, Lange A, Furst A, Gross V, Scholmerich J, Andus T</AU>
<TI>Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being</TI>
<SO>Zeitschrift fur Gastroenterologie</SO>
<YR>2005</YR>
<VL>43</VL>
<NO>4</NO>
<PG>367-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia_x002d_Vega-2004" MODIFIED="2010-05-25 09:52:54 -0400" MODIFIED_BY="[Empty name]" NAME="Garcia-Vega 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-05-25 09:52:54 -0400" MODIFIED_BY="[Empty name]" NOTES="Intervencion psicologica en la enfermedad de Crohn" NOTES_MODIFIED="2010-05-25 09:52:54 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia Vega Elena</AU>
<TI>Intervencion psicologica en la enfermedad de Crohn</TI>
<SO>Analisis y Modificacion de Conducta</SO>
<YR>1995</YR>
<VL>21</VL>
<NO>75</NO>
<PG>99-121</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-04 07:57:58 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia-Vega E, Fernandez-Rodriguez C</AU>
<TI>A stress management programme for Crohn's disease</TI>
<SO>Behaviour Research &amp; Therapy</SO>
<YR>2004</YR>
<VL>42</VL>
<NO>4</NO>
<PG>367-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grootenhuis-2009" MODIFIED="2011-01-05 13:21:37 -0500" MODIFIED_BY="John K MacDonald" NAME="Grootenhuis 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-05 13:21:37 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grootenhuis MA, Maurice-Stam H, Derkx BH, Last BF</AU>
<TI>Evaluation of a psychoeducational intervention for adolescents with inflammatory bowel disease</TI>
<SO>Eur J Gastroenterol Hepatol</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>4</NO>
<PG>430-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jaghult-2007" MODIFIED="2009-04-23 10:59:56 -0400" MODIFIED_BY="[Empty name]" NAME="Jaghult 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-04-23 10:59:56 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jaghult S, Larson J, Wredling R, Kapraali M, Jaghult Susanna, Larson Jenny, et al</AU>
<TI>A multiprofessional education programme for patients with inflammatory bowel disease: a randomized controlled trial</TI>
<SO>Scandinavian Journal of Gastroenterology</SO>
<YR>2007</YR>
<VL>42</VL>
<NO>12</NO>
<PG>1452-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jantschek-1998" MODIFIED="2011-01-05 13:22:09 -0500" MODIFIED_BY="John K MacDonald" NAME="Jantschek 1998" YEAR="2001">
<REFERENCE MODIFIED="2010-07-15 04:24:39 -0400" MODIFIED_BY="[Empty name]" NOTES="Evidence-based psychotherapy with chronic inflammatory bowel disease patients" NOTES_MODIFIED="2010-07-15 04:24:39 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Balck F</AU>
<TI>Evidence-based psychotherapy with chronic inflammatory bowel disease patients</TI>
<SO>Medizinische Welt</SO>
<YR>2003</YR>
<VL>54</VL>
<NO>12</NO>
<PG>359-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-17 10:12:35 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burgdorf F, Schreyogg J, Keller W, von Wietersheim J, Deter HC, German Study Group on Psychosocial Intervention in Crohn's Disease, et al</AU>
<TI>[Predictors of health-care utilization of patients with Crohn's disease: results of a prospective randomized multicenter trial]</TI>
<TO>Prädiktoren für medizinische Inanspruchnahme bei Morbus Crohn</TO>
<SO>Medizinische Klinik</SO>
<YR>2007</YR>
<VL>102</VL>
<NO>11</NO>
<PG>881-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-05 13:22:09 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deter HC, Keller W, von Wietersheim J, Jantschek G, Duchmann R, Zeitz M, et al</AU>
<TI>Psychological treatment may reduce the need for healthcare in patients with Crohn's disease</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>6</NO>
<PG>745-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-03-26 12:35:21 -0400" MODIFIED_BY="[Empty name]" NOTES="English Abstract" NOTES_MODIFIED="2010-03-26 12:35:21 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deter HC, Manz R, Becker M, Gladisch R</AU>
<TI>[Social support and its relation to physical and emotional findings in Crohn's disease patients]</TI>
<SO>Zeitschrift fur Psychosomatische Medizin und Psychoanalyse</SO>
<YR>1991</YR>
<VL>37</VL>
<NO>1</NO>
<PG>45-59</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-30 13:51:40 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;2010-04&lt;br&gt;High-utilizing Crohn's disease patients under psychosomatic therapy&lt;br&gt;Accession Number: 2008-16283-001. First Author &amp;amp; Affiliation: Deter, Hans-Christian; Department of Psychosomatics and Psychotherapy, Charit&amp;#199;&amp;#184; Campus Benjamin Franklin, Berlin, Germany. Institutional Authors: German Study Group on Psychosocial Intervention in Crohn's Disease. Release Date: 20090420. Publication Type: Journal, (0100); Peer Reviewed Journal, (0110); . Media Covered: Electronic. Media Available: Electronic; Print. Document Type: Journal Article. Language: English. Major Descriptor: Disease Course; Health Care Utilization; Health Care Seeking Behavior; Physical Disorders; Quality of Life. Minor Descriptor: Psychosomatic Medicine; Psychotherapy. Classification: Health &amp;amp; Mental Health Treatment &amp;amp; Prevention (3300) . Population: Human (10); Male (30); Female (40); . Location: Germany. Age Group: Adulthood (18 yrs &amp;amp; older) (300) Young Adulthood (18-29 yrs) (320) Thirties (30-39 yrs) (340) Middle Age (40-64 yrs) (360) . Grant Information: This study was supported by a grant from the German Ministry of Research and Technology &amp;#402;_&amp;quot; BMFT. (FKZ: 07016412). Tests &amp;amp; Measures: State Trait Anxiety Inventory; Beck Depression Inventory; . Methodology: Empirical Study; Quantitative Study; Treatment Outcome/Clinical Trial. References Available: Y.. Page Count: 1.. ArtID: 18.. Issue Publication Date: Oct, 2008&lt;br&gt;psycinfo 2010&lt;/p&gt;" NOTES_MODIFIED="2010-07-30 13:51:40 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deter HC, von Wietersheim JC, Jantschek GC, Burgdorf F, Blum B, Keller W</AU>
<TI>High-utilizing Crohn's disease patients under psychosomatic therapy</TI>
<SO>BioPsychoSocial Medicine</SO>
<YR>2008</YR>
<VL>2</VL>
<PG>doi:10.1186/1751-0759-2-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-02-12 10:05:46 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Feiereis</AU>
<SO>Abschlussbericht des Projekts "Wirksamkeit psychotherapeutischer Massnahmen bei Morbus Crohn - eine multizentrische Studie"</SO>
<YR>1995</YR>
<PB>Medizinische Universität zu Lübeck</PB>
<CY>Lübeck</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-28 11:25:08 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jantschek G, Zeitz M, Pritsch M, Wirsching M, Klor HU, Studt HH, et al</AU>
<TI>Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease</TI>
<SO>Scandinavian Journal of Gastroenterology</SO>
<YR>1998</YR>
<VL>33</VL>
<NO>12</NO>
<PG>1289-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-28 11:41:48 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keller W, Pritsch M, von Wietersheim J, Scheib P, Osborn W, Balck F, et al</AU>
<TI>Effect of psychotherapy and relaxation on the psychosocial and somatic course of Crohn's disease: main results of the German Prospective Multicenter Psychotherapy Treatment study on Crohn's Disease.[see comment]</TI>
<SO>Journal of Psychosomatic Research</SO>
<YR>2004</YR>
<VL>56</VL>
<NO>6</NO>
<PG>687-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-24 11:29:15 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeitz M, Riecken E, Pritsch M, Doppl W, Klor H, Spamer C</AU>
<TI>Psychosocial intervention in Crohn's disease: results of a prospective randomized multicenter treatment study (Abstract)</TI>
<SO>Gastroenterology</SO>
<YR>1995</YR>
<VL>108</VL>
<NO>4</NO>
<PG>A 948</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-28 11:25:04 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>von Wietersheim J, Scheib P, Keller W, Osborn W, Pritsch M, Balck F, et al</AU>
<TI>[The effects of psychotherapy on Crohn's disease patients--results of a randomized multicenter study]</TI>
<TO>Die Wirksamkeit psychotherapeutischer Massnahmen bei Morbus Crohn</TO>
<SO>Psychotherapie, Psychosomatik, Medizinische Psychologie</SO>
<YR>2001</YR>
<VL>51</VL>
<NO>1</NO>
<PG>2-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-29 07:37:07 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>von Wietersheim J</AU>
<SO>[Effectiveness of psychotherapy as experienced by patients with Crohn's disease. Results of a multi center study]</SO>
<YR>1999</YR>
<PG>1-140</PG>
<PB>VAS - Verlag für akademische Studien</PB>
<CY>Frankfurt a. Main</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kennedy-2003" MODIFIED="2011-01-05 13:22:48 -0500" MODIFIED_BY="John K MacDonald" NAME="Kennedy 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-01-05 13:22:48 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kennedy A, Robinson A, Hann M, Thompson D, Wilkin D, North-West Region Gastrointestinal Research Group, et al</AU>
<TI>A cluster-randomised controlled trial of a patient-centred guidebook for patients with ulcerative colitis: effect on knowledge, anxiety and quality of life</TI>
<SO>Health &amp; Social Care in the Community</SO>
<YR>2003</YR>
<VL>11</VL>
<NO>1</NO>
<PG>64-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kennedy-2004" MODIFIED="2009-05-12 12:13:47 -0400" MODIFIED_BY="[Empty name]" NAME="Kennedy 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-05-12 12:13:47 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kennedy A, Gask L, Rogers A, Kennedy Anne, Gask Linda, Rogers Anne</AU>
<TI>Training professionals to engage with and promote self-management</TI>
<SO>Health Education Research</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>5</NO>
<PG>567-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-12 11:11:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kennedy A, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, et al</AU>
<TI>A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease</TI>
<SO>Health Technology Assessment (Winchester, England)</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>28</NO>
<PG>iii</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-12 11:11:54 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kennedy AP, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, et al</AU>
<TI>A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease.[see comment]</TI>
<SO>Gut</SO>
<YR>2004</YR>
<VL>53</VL>
<NO>11</NO>
<PG>1639-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-12 11:23:12 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kennedy AP, Rogers AE</AU>
<TI>Improving patient involvement in chronic disease management: the views of patients, GPs and specialists on a guidebook for ulcerative colitis</TI>
<SO>Patient Education &amp; Counseling</SO>
<YR>2002</YR>
<VL>47</VL>
<NO>3</NO>
<PG>257-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-12 11:16:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richardson G, Sculpher M, Kennedy A, Nelson E, Reeves D, Roberts C, et al</AU>
<TI>Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel disease</TI>
<SO>Journal of Health Services &amp; Research Policy</SO>
<YR>2006</YR>
<VL>11</VL>
<NO>4</NO>
<PG>225-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-K_x00fc_nsebeck-1987" MODIFIED="2011-01-05 13:23:45 -0500" MODIFIED_BY="John K MacDonald" NAME="Künsebeck 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-06-15 10:19:49 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Freyberger H, Kunsebeck HW, Lempa W, Wellmann W, Avenarius HJ</AU>
<TI>Psychotherapeutic interventions in alexithymic patients. With special regard to ulcerative colitis and Crohn patients</TI>
<SO>Psychotherapy &amp; Psychosomatics</SO>
<YR>1985</YR>
<VL>44</VL>
<NO>2</NO>
<PG>72-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-05 13:23:45 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Kunsebeck HW, Lempa W, Freyberger H</AU>
<TI>Short- and long-term effects of supplementary psychotherapy in patients with Crohn's disease</TI>
<TO>Kurz- und Langzeiteffekte ergaenzender Psychotherapie bei Patienten mit Morbus Crohn.</TO>
<SO>Spezialisierung und Integration in Psychosomatik und Psychotherapie. Deutsches Kollegium fuer psychosomatische Medizin</SO>
<YR>1987</YR>
<PG>253-62</PG>
<ED>Lamprecht F</ED>
<PB>Springer, Berlin</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-09 11:54:50 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Kunsebeck HW, Liedtke R, Wellmann W, Lempa W, Freyberger H</AU>
<TI>Effekte kombinierter internistisch-psychosomatischer Behandlung bei Patienten mit Morbus Crohn (Eine kontrollierte Follow-up Therapiestudie)</TI>
<SO>Klinische Wochenschrift</SO>
<YR>1985</YR>
<VL>63</VL>
<PG>26-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lange-1996" MODIFIED="2010-07-30 13:47:48 -0400" MODIFIED_BY="[Empty name]" NAME="Lange 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-07-30 13:47:48 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Haslbeck E</AU>
<TI>Evaluation of the effectiveness of an patient education programme for IBD</TI>
<TO>Überprüfung der Effektivität einer Patientenschulung für chronisch-entzündliche Darmerkrankungen</TO>
<SO>Thesis, University of Regensburg, Department of Clinical Psychology</SO>
<YR>1993</YR>
<PG>1-116</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-03-30 04:45:04 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lange A, Haslbeck E, Andus T, Bregenzer N, Gross V, Scholmerich J, et al</AU>
<TI>[Ambulatory education of patient with Crohn disease/ulcerative colitis]</TI>
<TO>Ambulante Schulung bei Patienten mit Morbus Crohn / Colitis ulcerosa</TO>
<SO>Zeitschrift fur Gastroenterologie</SO>
<YR>1996</YR>
<VL>34</VL>
<NO>7</NO>
<PG>411-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Langhorst-2007" MODIFIED="2009-06-17 03:45:34 -0400" MODIFIED_BY="[Empty name]" NAME="Langhorst 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-04-21 09:15:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elsenbruch S, Langhorst J, Popkirowa K, Muller T, Luedtke R, Franken U, et al</AU>
<TI>Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis</TI>
<SO>Psychotherapy &amp; Psychosomatics</SO>
<YR>2005</YR>
<VL>74</VL>
<NO>5</NO>
<PG>277-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-17 03:44:57 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Langhorst J, Mueller T, Luedtke R, Franken U, Paul A, Michalsen A, et al</AU>
<TI>Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up</TI>
<SO>Scandinavian Journal of Gastroenterology</SO>
<YR>2007</YR>
<VL>42</VL>
<NO>6</NO>
<PG>734-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Larsson-2003" MODIFIED="2009-04-23 10:22:58 -0400" MODIFIED_BY="[Empty name]" NAME="Larsson 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-04-23 10:22:58 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larsson K, Sundberg Hjelm M, Karlbom U, Nordin K, Anderberg UM, Loof L</AU>
<TI>A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis</TI>
<SO>Scandinavian Journal of Gastroenterology</SO>
<YR>2003</YR>
<VL>38</VL>
<NO>7</NO>
<PG>763-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lecouturier-2003" MODIFIED="2011-01-05 13:24:28 -0500" MODIFIED_BY="John K MacDonald" NAME="Lecouturier 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-12-18 10:25:27 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corbett S, McColl E, Lecouturier J, Devine Z, Welfare M</AU>
<TI>Implementing a colitis education and support programme</TI>
<SO>Gastrointestinal Nursing</SO>
<YR>2006</YR>
<VL>4</VL>
<NO>4</NO>
<PG>12-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-05 13:24:28 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corbett S, Weinell E, Devine Z,  Lecouturier J, Speed C, McColl E, James P, Welfare M.</AU>
<TI>A reflective process used to develop a health professional-led colitis self-management programme</TI>
<SO>Reflective Practice</SO>
<YR>2007</YR>
<VL>8</VL>
<NO>2</NO>
<PG>209-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-13 04:15:17 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lecouturier J</AU>
<TI>Does a customised self-management programme have any impact on the quality of life of people with ulcerative colitis? [abstract]</TI>
<SO>Quality of Life Research</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>7</NO>
<PG>768</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Milne-1986" MODIFIED="2009-04-27 11:02:31 -0400" MODIFIED_BY="[Empty name]" NAME="Milne 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-04-27 11:02:31 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Milne B, Joachim G, Niedhardt J</AU>
<TI>A stress management programme for inflammatory bowel disease patients</TI>
<SO>Journal of Advanced Nursing</SO>
<YR>1986</YR>
<VL>11</VL>
<NO>5</NO>
<PG>561-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oliveira-2007" MODIFIED="2009-06-04 11:21:32 -0400" MODIFIED_BY="[Empty name]" NAME="Oliveira 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-06-04 11:21:32 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oliveira S, Zaltman C, Elia C, Vargens R, Leal A, Barros R, et al</AU>
<TI>Quality-of-life measurement in patients with inflammatory bowel disease receiving social support</TI>
<SO>Inflammatory Bowel Diseases</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>4</NO>
<PG>470-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oxelmark-2007" MODIFIED="2011-01-05 13:24:52 -0500" MODIFIED_BY="John K MacDonald" NAME="Oxelmark 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-01-05 13:24:52 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oxelmark L, Magnusson A, Lofberg R, Hilleras P, Oxelmark Lena, Magnusson Anne, et al</AU>
<TI>Group-based intervention program in inflammatory bowel disease patients: effects on quality of life</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>2</NO>
<PG>182-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmidt-1992" MODIFIED="2011-01-05 13:25:28 -0500" MODIFIED_BY="John K MacDonald" NAME="Schmidt 1992" YEAR="1992">
<REFERENCE MODIFIED="2011-01-05 13:25:28 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt CF</AU>
<TI>Hypnotic suggestions and imaginations in the treatment of colitis ulcerosa</TI>
<SO>Hypnos</SO>
<YR>1992</YR>
<VL>x</VL>
<PG>237-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schreiber-1999" MODIFIED="2010-03-16 10:15:03 -0400" MODIFIED_BY="[Empty name]" NAME="Schreiber 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-03-16 10:15:03 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schreiber S, Hamling J, Wedel S, Nikolaus SN, Buhr HJ, Raedler A</AU>
<TI>Efficacy of patient education in chronic inflammatory bowel disease in a prospective controlled multicenter trial (G 3535)</TI>
<SO>Gastroenterology</SO>
<YR>1999</YR>
<VL>116</VL>
<NO>4</NO>
<PG>A 815</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwarz-1991" MODIFIED="2010-07-30 13:47:17 -0400" MODIFIED_BY="[Empty name]" NAME="Schwarz 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-05-26 03:22:04 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwarz SP, Blanchard EB</AU>
<TI>Evaluation of a psychological treatment for inflammatory bowel disease</TI>
<SO>Behaviour Research &amp; Therapy</SO>
<YR>1991</YR>
<VL>29</VL>
<NO>2</NO>
<PG>167-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-30 13:47:17 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Schwarz SP</AU>
<TI>Treatment of inflammatory bowel disease: Comparing a multicomponent psychological treatment to a waiting-list control group</TI>
<SO>Dissertation Abstracts International</SO>
<YR>1990</YR>
<PG>5919-20</PG>
<PB>ProQuest Information &amp; Learning, Dissertation Abstracts International</PB>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2002" MODIFIED="2009-06-03 11:10:36 -0400" MODIFIED_BY="[Empty name]" NAME="Smith 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-06-03 11:10:36 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith GD, Watson R, Roger D, McRorie E, Hurst N, Luman W, et al</AU>
<TI>Impact of a nurse-led counselling service on quality of life in patients with inflammatory bowel disease</TI>
<SO>Journal of Advanced Nursing</SO>
<YR>2002</YR>
<VL>38</VL>
<NO>2</NO>
<PG>152-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Szigethy-2007" MODIFIED="2011-01-05 13:26:25 -0500" MODIFIED_BY="John K MacDonald" NAME="Szigethy 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-01-05 13:26:25 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Szigethy E, Craig AE, Lobst EA, Grand RJ, Keljo D, DeMaso D, et al</AU>
<TI>Profile of depression in adolescents with inflammatory bowel disease: implications for treatment</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>1</NO>
<PG>69-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-03 09:57:07 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Szigethy E, Kenney E, Carpenter J, Hardy DM, Fairclough D, Bousvaros A, et al</AU>
<TI>Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression</TI>
<SO>Journal of the American Academy of Child and Adolescent Psychiatry</SO>
<YR>2007</YR>
<VL>46</VL>
<NO>10</NO>
<PG>1290-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="17885570"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Waters-2005" MODIFIED="2009-07-13 10:47:29 -0400" MODIFIED_BY="[Empty name]" NAME="Waters 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-07-13 10:47:16 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Misra T, Waters B, Jensen L, Fedorak R</AU>
<TI>The Effect Of Education on Health Care Utilization in Patients with Inflammatory Bowel Disease</TI>
<SO>Gastroenterology</SO>
<YR>2005</YR>
<VL>128</VL>
<NO>4</NO>
<PG>A17-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-07-13 10:47:29 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Waters BM, Jensen L, Fedorak RN, Waters Barbara M, Jensen Louise, Fedorak Richard N</AU>
<TI>Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial</TI>
<SO>Canadian Journal of Gastroenterology</SO>
<YR>2005</YR>
<VL>19</VL>
<NO>4</NO>
<PG>235-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2011-01-05 14:16:52 -0500" MODIFIED_BY="John K MacDonald">
<STUDY DATA_SOURCE="PUB" ID="STD-Boamah-2010" MODIFIED="2011-01-05 13:36:09 -0500" MODIFIED_BY="John K MacDonald" NAME="Boamah 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-01-05 13:36:09 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boamah LM, Bohren JR, Pentiuk S, Baker R, Yi M, Moyer MS</AU>
<TI>Development and testing of a CD-ROM Program for improing adolescent knowledge of inflammatory bowel disease</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2010</YR>
<VL>50</VL>
<NO>5</NO>
<PG>521-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Borgaonkar-2002" MODIFIED="2011-01-05 13:37:00 -0500" MODIFIED_BY="John K MacDonald" NAME="Borgaonkar 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-01-05 13:37:00 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borgaonkar MR, Townson G, Donnelly M, Irvine EJ, Borgaonkar MR, Townson G, et al</AU>
<TI>Providing disease-related information worsens health-related quality of life in inflammatory bowel disease</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2002</YR>
<VL>8</VL>
<NO>4</NO>
<PG>264-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bruning-1991" MODIFIED="2010-07-30 14:00:30 -0400" MODIFIED_BY="[Empty name]" NAME="Bruning 1991" YEAR="1991">
<REFERENCE MODIFIED="2010-07-30 14:00:30 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bruning DJ</AU>
<TI>The effects of autogenic training on subjective stress levels, subjective symptoms and coping strategies in women with ulcerative colitis</TI>
<SO>Dissertation Abstracts International</SO>
<YR>1991</YR>
<PG>4774</PG>
<PB>ProQuest Information &amp; Learning,</PB>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cabras-1985" MODIFIED="2010-07-19 06:47:22 -0400" MODIFIED_BY="[Empty name]" NAME="Cabras 1985" YEAR="1985">
<REFERENCE MODIFIED="2010-07-19 06:47:22 -0400" MODIFIED_BY="[Empty name]" NOTES="Applicazione del training autogeno alle psicosomatosi gastrointestinali" NOTES_MODIFIED="2010-07-19 06:47:22 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cabras PL, la Malfa GP, Giovannini F, Giardinelli L</AU>
<TI>Applicazione del training autogeno alle psicosomatosi gastrointestinali</TI>
<SO>Medicina Psicosomatica</SO>
<YR>1985</YR>
<VL>30</VL>
<NO>4</NO>
<PG>315-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cabras-1986" MODIFIED="2010-07-19 06:47:26 -0400" MODIFIED_BY="[Empty name]" NAME="Cabras 1986" YEAR="1986">
<REFERENCE MODIFIED="2010-07-19 06:47:26 -0400" MODIFIED_BY="[Empty name]" NOTES="Variazioni dell'immagine corporea nella pratica del training autogeno in pazienti con psicosomatosi gastrointestinali" NOTES_MODIFIED="2010-07-19 06:47:26 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cabras Pier L, Giardinelli Lisa, la Malfa Gian P, Galassi Ferdinando</AU>
<TI>Variazioni dell'immagine corporea nella pratica del training autogeno in pazienti con psicosomatosi gastrointestinali</TI>
<SO>Bollettino di Psicologia Applicata</SO>
<YR>1986</YR>
<VL>178</VL>
<PG>27-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Diaz-2007" MODIFIED="2010-06-02 19:49:05 -0400" MODIFIED_BY="[Empty name]" NAME="Diaz 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-05-27 08:09:59 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Diaz Sibaja MA, Comeche Moreno MI, Mas Hesse B</AU>
<TI>[Protocolized cognitive-behavioural group therapy for inflammatory bowel disease]</TI>
<SO>Revista Espanola de Enfermedades Digestivas</SO>
<YR>2007</YR>
<VL>99</VL>
<NO>10</NO>
<PG>593-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-02 19:49:05 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;2010-04&lt;br&gt;Tratamiento psicol&amp;#199;&amp;#252;gico protocolizado en grupo de las enfermedades inflamatorias intestinales: Efectos sobre la calidad de vida&lt;br&gt;Accession Number: 2008-17752-005. First Author &amp;amp; Affiliation: D&amp;#199;&amp;#240;az-Sibaja, Miguel &amp;#199;_ngel; Facultativo Especialista de Area en Psicologia Clinica, Equipo de Salud Mental de Distrito (ESMD) de Algeciras, Spain. Translated Title: Protocolized group psychological treatment of inflammatory bowel disease: Its impact on quality of life.. Release Date: 20091102. Publication Type: Journal, (0100); Peer Reviewed Journal, (0110); . Media Covered: Print. Media Available: Print. Document Type: Journal Article. Language: Spanish. Major Descriptor: Chronic Illness; Colon Disorders; Psychotherapy; Quality of Life. Minor Descriptor: Cognitive Behavior Therapy; Patients; Treatment. Classification: Health &amp;amp; Mental Health Treatment &amp;amp; Prevention (3300) . Population: Human (10); . Tests &amp;amp; Measures: Inflammatory Bowel Disease Questionnaire-Short Form; Quality of Life; . Methodology: Empirical Study; Quantitative Study. References Available: Y.. Issue Publication Date: 2008&lt;br&gt;psycinfo 2010&lt;/p&gt;" NOTES_MODIFIED="2010-06-02 19:49:05 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Diaz-Sibaja MigÇ¬l Ç_ngel, Comeche-Moreno MarÇa Isabel, Mas-Hesse Blanca, GarcÇa Marta DÇaz, Pareja MigÇ¬l Ç_ngel Vallejo</AU>
<TI>Tratamiento psicolÇügico protocolizado en grupo de las enfermedades inflamatorias intestinales: Efectos sobre la calidad de vida</TI>
<SO>ClinÇðca y Salud</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>2</NO>
<PG>231-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eaden-1999" MODIFIED="2011-01-05 13:37:50 -0500" MODIFIED_BY="John K MacDonald" NAME="Eaden 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-06-02 20:10:48 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eaden JA, Abrams K, Mayberry JF</AU>
<TI>Does patient knowledge affect the colorectal cancer risk in ulcerative colitis?</TI>
<SO>Postgraduate medical journal</SO>
<YR>2002</YR>
<VL>78</VL>
<NO>924</NO>
<PG>615-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="12415086"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-05 13:37:50 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eaden JA, Abrams K, Mayberry JF</AU>
<TI>The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease</TI>
<SO>Am J Gastroenterol</SO>
<YR>1999</YR>
<VL>94</VL>
<NO>12</NO>
<PG>3560-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="10606319"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eaden-2002" MODIFIED="2011-01-05 13:38:38 -0500" MODIFIED_BY="John K MacDonald" NAME="Eaden 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-01-05 13:38:38 -0500" MODIFIED_BY="John K MacDonald" NOTES="Nov" NOTES_MODIFIED="2011-01-05 13:38:38 -0500" NOTES_MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eaden J, Abrams K, Shears J, Mayberry J</AU>
<TI>Randomized controlled trial comparing the efficacy of a video and information leaflet versus information leaflet alone on patient knowledge about surveillance and cancer risk in ulcerative colitis</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2002</YR>
<VL>8</VL>
<NO>6</NO>
<PG>407-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Genthin-2009" MODIFIED="2011-01-05 13:39:06 -0500" MODIFIED_BY="John K MacDonald" NAME="Genthin 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-05 13:39:06 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gethins S, Duckett T, Shtafort C, Robinson RRJ</AU>
<TI>Guided self management for patients with ulcerative colitis and Crohn's disease</TI>
<SO>Gut</SO>
<YR>2009</YR>
<VL>58</VL>
<NO>Supplement (meeting abstracts)</NO>
<PG>153</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grace-1954" MODIFIED="2011-01-05 13:39:31 -0500" MODIFIED_BY="John K MacDonald" NAME="Grace 1954" YEAR="1954">
<REFERENCE MODIFIED="2011-01-05 13:39:31 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grace WJ, Pinsky RH, Wolff HG</AU>
<TI>The treatment of ulcerative colitis II</TI>
<SO>Gastroenterology</SO>
<YR>1954</YR>
<VL>26</VL>
<NO>3</NO>
<PG>462-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayutin-2009" MODIFIED="2011-01-05 13:39:50 -0500" MODIFIED_BY="John K MacDonald" NAME="Hayutin 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-05 13:39:50 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayutin LG, Blount RL, Lewis JD, Simons LE, McCormick ML</AU>
<TI>Skills-based group intervention for adolescent girls with inflammatory bowel disease</TI>
<SO>Clinical Case Studies</SO>
<YR>2009</YR>
<VL>8</VL>
<NO>5</NO>
<PG>355-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hershfield-1993" MODIFIED="2010-07-15 09:26:25 -0400" MODIFIED_BY="[Empty name]" NAME="Hershfield 1993" YEAR="1993">
<REFERENCE MODIFIED="2010-07-15 09:26:25 -0400" MODIFIED_BY="[Empty name]" NOTES="Formation En Meditation Comme Traitement D'appoint Dans Le Traitement De La Maladie De Crohn - Etude Pilote" NOTES_MODIFIED="2010-07-15 09:26:25 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hershfield NB, Kubryn W, Sutherland LR</AU>
<TI>Formation En Meditation Comme Traitement D'appoint Dans Le Traitement De La Maladie De Crohn - Etude Pilote</TI>
<SO>Canadian Journal of Gastroenterology</SO>
<YR>1993</YR>
<VL>7</VL>
<NO>8</NO>
<PG>613-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hochgerner-1998" MODIFIED="2010-07-15 11:12:18 -0400" MODIFIED_BY="[Empty name]" NAME="Hochgerner 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-07-15 11:12:18 -0400" MODIFIED_BY="[Empty name]" NOTES="Somato-psycho-soziale Therapie als integriertes Gesamtkonzept zur Behandlung psychosomatisch Erkrankter. Eine Untersuchung zum Erfolg stationaerer psychosomatischer Behandlung. Somatopsychosocial therapy as an integrated general concept for the treatment of psychosomatic patients: A study on psychosomatic inpatient treatment outcomes" NOTES_MODIFIED="2010-07-15 11:12:18 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hochgerner Markus, Pany-Posch Ingrid, Piringer Swanhild, Weiss Peter, Voracek Martin</AU>
<TI>Somato-psycho-soziale Therapie als integriertes Gesamtkonzept zur Behandlung psychosomatisch Erkrankter. Eine Untersuchung zum Erfolg stationaerer psychosomatischer Behandlung. Somatopsychosocial therapy as an integrated general concept for the treatment of psychosomatic patients: A study on psychosomatic inpatient treatment outcomes</TI>
<SO>Psychotherapie Forum</SO>
<YR>1998</YR>
<VL>6</VL>
<NO>1</NO>
<PG>1-19</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Huguet-2009" MODIFIED="2011-01-05 13:40:38 -0500" MODIFIED_BY="John K MacDonald" NAME="Huguet 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-05 13:40:38 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Huguet JM, Ruiz L, Latorre M, Carbajo E, Gallego AM, Suarez P, et al</AU>
<TI>Psychological treatment of patients with inflammatory bowel disease</TI>
<SO>ECCO conference Hamburg - meeting abstract</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joachim-1983" MODIFIED="2011-01-05 13:41:04 -0500" MODIFIED_BY="John K MacDonald" NAME="Joachim 1983" YEAR="1983">
<REFERENCE MODIFIED="2011-01-05 13:41:04 -0500" MODIFIED_BY="John K MacDonald" NOTES="The effects of two stress management techniques on feelings of well-being in patients with inflammatory bowell [sic] disease" NOTES_MODIFIED="2011-01-05 13:41:04 -0500" NOTES_MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joachim G</AU>
<TI>The effects of two stress management techniques on feelings of well-being in patients with inflammatory bowell [sic] disease</TI>
<SO>Nursing Papers: Perspectives In Nursing</SO>
<YR>1983</YR>
<VL>15</VL>
<NO>4</NO>
<PG>5-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaneko-2009" MODIFIED="2010-06-09 05:33:54 -0400" MODIFIED_BY="[Empty name]" NAME="Kaneko 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-06-09 05:33:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaneko M</AU>
<TI>[Psychiatric liaison nursing intervention method for stress management: relaxation and cognitive behavioral therapy in inflammatory bowel disease patients][Japanese]</TI>
<SO>Journal of Japan Academy of Nursing Science</SO>
<YR>2009</YR>
<VL>29</VL>
<NO>3</NO>
<PG>76-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karush-1968" MODIFIED="2011-01-05 13:42:22 -0500" MODIFIED_BY="John K MacDonald" NAME="Karush 1968" YEAR="1968">
<REFERENCE MODIFIED="2011-01-05 13:42:22 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karush A, Daniels GE, O'Connor JF, Stern LO</AU>
<TI>The response to psychotherapy in chronic ulcerative colitis. I. Pretreatment factors</TI>
<SO>Psychosomatic Medicine</SO>
<YR>1968</YR>
<VL>30</VL>
<NO>3</NO>
<PG>255-76</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="5655683"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-05 13:42:02 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karush A, Daniels GE, O'Connor JF, Stern LO</AU>
<TI>The response to psychotherapy in chronic ulcerative colitis. II. Factors arising from the therapeutic situation</TI>
<SO>Psychosomatic Medicine</SO>
<YR>1969</YR>
<VL>31</VL>
<NO>3</NO>
<PG>201-26</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="5790112"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khorana-1983" MODIFIED="2010-07-21 11:04:36 -0400" MODIFIED_BY="[Empty name]" NAME="Khorana 1983" YEAR="1983">
<REFERENCE MODIFIED="2010-07-21 11:04:36 -0400" MODIFIED_BY="[Empty name]" NOTES="A study of psychological factors and psychotherapy on ulcerative colitis" NOTES_MODIFIED="2010-07-21 11:04:36 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khorana Suman</AU>
<TI>A study of psychological factors and psychotherapy on ulcerative colitis</TI>
<SO>Indian Journal of Clinical Psychology</SO>
<YR>1983</YR>
<VL>10</VL>
<NO>2</NO>
<PG>459-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maunder-2001" MODIFIED="2009-04-28 11:18:49 -0400" MODIFIED_BY="[Empty name]" NAME="Maunder 2001" YEAR="1998">
<REFERENCE MODIFIED="2009-04-28 11:17:23 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maunder RG, Esplen MJ</AU>
<TI>Supportive-expressive group psychotherapy for persons with inflammatory bowel disease</TI>
<SO>Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie</SO>
<YR>2001</YR>
<VL>46</VL>
<NO>7</NO>
<PG>622-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-27 10:03:29 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maunder RG, Lancee WJ, Esplen MJ, Greenberg GR</AU>
<TI>Improvement in inflammatory bowel disease-related quality of life, days off work and somatization associated with group psychotherapy</TI>
<SO>Gastroenterology</SO>
<YR>1998</YR>
<VL>114</VL>
<NO>Supplement 1</NO>
<PG>A1034</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mawdsley-2008" MODIFIED="2011-01-05 13:43:28 -0500" MODIFIED_BY="John K MacDonald" NAME="Mawdsley 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-05 13:43:28 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mawdsley JE, Jenkins DG, Macey MG, Langmead L, Rampton DS</AU>
<TI>The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis</TI>
<SO>Am J Gastroenterol</SO>
<YR>2008</YR>
<VL>103</VL>
<NO>6</NO>
<PG>1460-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mickocka_x002d_Walus-2009" MODIFIED="2011-01-05 13:46:26 -0500" MODIFIED_BY="John K MacDonald" NAME="Mickocka-Walus 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-05 13:46:26 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mickocka-Walus AA, Turnbull DA, Andrews JM, Moulding NT, Wilson IG, Holtmann G</AU>
<TI>Does doctor's knowledge of inflammatory bowel disease patients' psychological status affect patients' clinical outcomes: a pilot randomized controlled trial</TI>
<SO>Eur J Gastroenterol Hepatol</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>4</NO>
<PG>484-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-2002" MODIFIED="2011-01-05 13:46:47 -0500" MODIFIED_BY="John K MacDonald" NAME="Miller 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-01-05 13:46:47 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller L, Caton S, Lynch D</AU>
<TI>Telephone clinic improves quality of follow up care for chronic bowel disease</TI>
<SO>Nursing Times</SO>
<YR>2002</YR>
<VL>98</VL>
<NO>31</NO>
<PG>36-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-2008" MODIFIED="2010-03-05 10:51:55 -0500" MODIFIED_BY="[Empty name]" NAME="Miller 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-03-05 10:51:55 -0500" MODIFIED_BY="[Empty name]" NOTES="Jul" NOTES_MODIFIED="2010-03-05 10:51:55 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller V, Whorwell PJ, Miller Vivien, Whorwell Peter J</AU>
<TI>Treatment of inflammatory bowel disease: a role for hypnotherapy?</TI>
<SO>International Journal of Clinical &amp; Experimental Hypnosis</SO>
<YR>2008</YR>
<VL>56</VL>
<NO>3</NO>
<PG>306-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moody-1993" MODIFIED="2011-01-05 13:47:23 -0500" MODIFIED_BY="John K MacDonald" NAME="Moody 1993" YEAR="1993">
<REFERENCE MODIFIED="2011-01-05 13:47:23 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moody GA, Bhakta P, Mayberry JF</AU>
<TI>Disinterest in local self-help groups amongst patients with inflammatory bowel disease in Leicester</TI>
<SO>International Journal of Colorectal Disease</SO>
<YR>1993</YR>
<VL>8</VL>
<NO>4</NO>
<PG>181-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="8163888"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mussell-2003" MODIFIED="2010-06-08 07:33:52 -0400" MODIFIED_BY="[Empty name]" NAME="Mussell 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-08 07:33:52 -0400" MODIFIED_BY="[Empty name]" NOTES="Jul" NOTES_MODIFIED="2010-06-08 07:33:52 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mussell M, Bocker U, Nagel N, Olbrich R, Singer MV</AU>
<TI>Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness</TI>
<SO>Scandinavian Journal of Gastroenterology</SO>
<YR>2003</YR>
<VL>38</VL>
<NO>7</NO>
<PG>755-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Connor-1964" MODIFIED="2010-03-26 11:25:01 -0400" MODIFIED_BY="[Empty name]" NAME="O'Connor 1964" YEAR="1964">
<REFERENCE MODIFIED="2010-03-26 11:25:01 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O'Connor JF, Daniels G, Flood C, Karush A, Moses L, Stern LO</AU>
<TI>An evaluation of the effectiveness of psychotherapy in the treatment of ulcerative colitis</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1964</YR>
<VL>60</VL>
<PG>587-602</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="14138879"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-03-26 11:24:48 -0400" MODIFIED_BY="[Empty name]" NOTES="Feb" NOTES_MODIFIED="2010-03-26 11:24:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O'Connor JF, Daniels G, Karush A, Moses L, Flood C, Stern LO</AU>
<TI>The effects of psychotherapy on the course of ulcerative colitis - a preliminary report</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1964</YR>
<VL>120</VL>
<PG>738-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Quan-2003" MODIFIED="2010-06-09 11:39:48 -0400" MODIFIED_BY="[Empty name]" NAME="Quan 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-09 11:39:48 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quan H, Present JW, Sutherland LR</AU>
<TI>Evaluation of educational programs in inflammatory bowel disease</TI>
<SO>Inflammatory bowel diseases</SO>
<YR>2003</YR>
<VL>9</VL>
<NO>6</NO>
<PG>356-62</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="14671484"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Robinson-2001" MODIFIED="2010-03-26 11:54:37 -0400" MODIFIED_BY="[Empty name]" NAME="Robinson 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-03-23 11:54:45 -0400" MODIFIED_BY="[Empty name]" NOTES="Apr" NOTES_MODIFIED="2010-03-23 11:54:45 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kurbegow AC, Ferry GD, Kurbegow Amethyst C, Ferry George D</AU>
<TI>Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial</TI>
<SO>Journal of Pediatric Gastroenterology &amp; Nutrition</SO>
<YR>2002</YR>
<VL>34</VL>
<NO>4</NO>
<PG>428-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-13 10:35:58 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robinson A, Thompson DG, Wilkin D, Roberts C, Northwest Gastrointestinal Research Group</AU>
<TI>Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial.[see comment]</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>358</VL>
<NO>9286</NO>
<PG>976-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-10 10:08:43 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robinson A, Thompson DG, Wilkin D</AU>
<TI>Guided self-management in ulcerative colitis: Quicker treatment and more efficient use of health services [abstract]</TI>
<SO>Gut</SO>
<YR>1999</YR>
<VL>44</VL>
<NO>Suppl 1</NO>
<PG>A12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-10 10:30:13 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robinson A</AU>
<TI>Review article: inflammatory bowel disease--empowering the patient and improving outcome</TI>
<SO>Alimentary Pharmacology &amp; Therapeutics</SO>
<YR>2004</YR>
<VL>20 Suppl 4</VL>
<PG>84-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rogers-2005" MODIFIED="2011-01-05 14:11:42 -0500" MODIFIED_BY="John K MacDonald" NAME="Rogers 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-05-13 05:04:44 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rogers A, Kennedy A, Nelson E, Robinson A, Rogers Anne, Kennedy Anne, et al</AU>
<TI>Uncovering the limits of patient-centeredness: implementing a self-management trial for chronic illness</TI>
<SO>Qualitative Health Research</SO>
<YR>2005</YR>
<VL>15</VL>
<NO>2</NO>
<PG>224-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-05 14:11:42 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rogers A, Kennedy A, Nelson E, Robinson A</AU>
<TI>Patients' experiences of an open access follow up arrangement in managing inflammatory bowel disease</TI>
<SO>Quality &amp; Safety in Health Care</SO>
<YR>2004</YR>
<VL>13</VL>
<NO>5</NO>
<PG>374-8</PG>
<IDENTIFIERS MODIFIED="2009-05-13 05:11:09 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="15465941"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanchez_x002d_Roman-2006" MODIFIED="2009-06-03 11:11:09 -0400" MODIFIED_BY="[Empty name]" NAME="Sanchez-Roman 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-06-03 11:11:09 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanchez-Roman S, Velasco-Furlong L, Rodriguez-Carvajal R, Baranda-Sepulveda J</AU>
<TI>Effectiveness of a cognitive-behavioural program to reduce anxiety in medically ill patients</TI>
<TO>Eficacia de un programa cognitivo-conductual para la disminucion de la ansiedad en pacientes medicamente enfermos.</TO>
<SO>Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion</SO>
<YR>2006</YR>
<VL>58</VL>
<NO>6</NO>
<PG>540-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="17432284"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shaw-1987" MODIFIED="2009-05-14 08:44:07 -0400" MODIFIED_BY="[Empty name]" NAME="Shaw 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-05-14 08:44:07 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shaw L, Ehrlich A</AU>
<TI>Relaxation training as a treatment for chronic pain caused by ulcerative colitis</TI>
<SO>Pain</SO>
<YR>1987</YR>
<VL>29</VL>
<NO>3</NO>
<PG>287-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shepanski-2005" MODIFIED="2010-03-18 12:05:59 -0400" MODIFIED_BY="[Empty name]" NAME="Shepanski 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-03-18 12:05:59 -0400" MODIFIED_BY="[Empty name]" NOTES="Feb" NOTES_MODIFIED="2010-03-18 12:05:59 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shepanski MA, Hurd LB, Culton K, Markowitz JE, Mamula P, Baldassano RN, et al</AU>
<TI>Health-related quality of life improves in children and adolescents with inflammatory bowel disease after attending a camp sponsored by the Crohn's and Colitis Foundation of America</TI>
<SO>Inflammatory Bowel Diseases</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>2</NO>
<PG>164-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Shetty-2004" MODIFIED="2010-06-08 08:04:35 -0400" MODIFIED_BY="[Empty name]" NAME="Shetty 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-08 08:04:34 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shetty A, Kalantzis C, Polymeros D, Vega R, Abraham S, Forbes AG</AU>
<TI>Hypnotherapy for inflammatory bowel disease - a randomised, placebo-controlled trial</TI>
<SO>Gut</SO>
<YR>2004</YR>
<VL>53</VL>
<PG>(Abstract)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smart-1986" MODIFIED="2010-07-30 13:57:45 -0400" MODIFIED_BY="[Empty name]" NAME="Smart 1986" YEAR="1986">
<REFERENCE MODIFIED="2010-07-30 13:57:45 -0400" MODIFIED_BY="[Empty name]" NOTES="3" NOTES_MODIFIED="2010-07-30 13:57:45 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Smart H, Mayberry J, Calcraft B, Morris JS, Rhodes J</AU>
<TI>Effect of information booklet on patients' anxiety levels and consultation rates in Crohn's disease</TI>
<SO>Public Health</SO>
<YR>1986</YR>
<VL>100</VL>
<PG>184-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Szigethy-2008" MODIFIED="2011-01-05 14:16:21 -0500" MODIFIED_BY="John K MacDonald" NAME="Szigethy 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-05 14:16:21 -0500" MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Szigethy E, Hardy D, Craig AE, Low C, Kukic S</AU>
<TI>Girls connect: Effects of a support group for teenage girls with inflammatory bowel disease and their mothers</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2008</YR>
<VL>15</VL>
<PG>1127-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="18972566"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Verma-2001" MODIFIED="2011-01-05 14:16:52 -0500" MODIFIED_BY="John K MacDonald" NAME="Verma 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-01-05 14:16:52 -0500" MODIFIED_BY="John K MacDonald" NOTES="Apr" NOTES_MODIFIED="2011-01-05 14:16:52 -0500" NOTES_MODIFIED_BY="John K MacDonald" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Verma S, Tsai HH, Giaffer MH</AU>
<TI>Does better disease-related education improve quality of life? A survey of IBD patients</TI>
<SO>Dig Dis Sci</SO>
<YR>2001</YR>
<VL>46</VL>
<NO>4</NO>
<PG>865-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wahed-2010" MODIFIED="2010-03-24 08:56:15 -0400" MODIFIED_BY="[Empty name]" NAME="Wahed 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-03-24 08:56:01 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wahed M, Corser M, Goodhand JR, Rampton DS</AU>
<TI>Does psychological counseling alter the natural history of inflammatory bowel disease?</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2010</YR>
<VL>16</VL>
<PG>664-669</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2000" MODIFIED="2010-06-08 03:56:14 -0400" MODIFIED_BY="[Empty name]" NAME="Williams 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-06-08 03:56:14 -0400" MODIFIED_BY="[Empty name]" NOTES="Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study" NOTES_MODIFIED="2010-06-08 03:56:14 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams JG, Cheung WY, Russell IT, Cohen DR, Longo M, Lervy B</AU>
<TI>Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study</TI>
<SO>BMJ: British Medical Journal</SO>
<YR>2000</YR>
<VL>320</VL>
<NO>7234</NO>
<PG>544-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2010-07-30 14:03:41 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Sachse-2006" MODIFIED="2010-07-30 14:03:41 -0400" MODIFIED_BY="[Empty name]" NAME="Sachse 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-07-28 07:24:46 -0400" MODIFIED_BY="[Empty name]" NOTES="English Abstract" NOTES_MODIFIED="2010-07-28 07:24:46 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ruger U, Ruger Ulrich</AU>
<TI>["Psychological psychotherapy" in chronic inflammatory intestinal disorders]</TI>
<SO>Zeitschrift Fuer Psychosomatische Medizin und Psychotherapie</SO>
<YR>2007</YR>
<VL>53</VL>
<NO>4</NO>
<PG>404-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-28 05:09:27 -0400" MODIFIED_BY="[Empty name]" NOTES="Psychologische Psychotherapie bei chronisch entzuendlichen Darmerkrankungen. Psychological psychotherapy of chronic inflammatory bowel diseases" NOTES_MODIFIED="2010-07-28 05:09:27 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Sachse Rainer</AU>
<SO>Psychologische Psychotherapie bei chronisch entzuendlichen Darmerkrankungen. Psychological psychotherapy of chronic inflammatory bowel diseases</SO>
<YR>2006</YR>
<PB>Hogrefe</PB>
<CY>Goettingen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-30 14:03:41 -0400" MODIFIED_BY="[Empty name]" NOTES="Klaerungsorientierte Psychotherapie bei chronisch entzuendlichen Darmerkrankungen. Solution-oriented psychotherapy of chronic inflammatory bowel disease" NOTES_MODIFIED="2010-07-30 14:03:41 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Sachse Rainer</AU>
<TI>Solution-oriented psychotherapy of chronic inflammatory bowel disease</TI>
<TO>Klaerungsorientierte Psychotherapie bei chronisch entzuendlichen Darmerkrankungen.</TO>
<SO>Gespraechspsychotherapie. Die therapeutische Vielfalt des personzentrierten Ansatzes</SO>
<YR>2007</YR>
<PG>286-294</PG>
<ED>Kriz J, Slunecko T</ED>
<PB>Facultas, Vienna</PB>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2010-07-30 14:06:10 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Andrews-2010" MODIFIED="2010-07-30 14:04:10 -0400" MODIFIED_BY="[Empty name]" NAME="Andrews 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-07-30 14:04:10 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andrews JM, Bond M, Persson J, Holloway R, Hughes P, Blackshaw a, Burke A, Collins K, Pilichiewicz A, Holtamnn G, Mikocka-Walus A</AU>
<TI>Does cognitive behavioural therapy (CBT) improve outcomes in IBD? Feasibility, patient acceptance and preliminary results</TI>
<SO>ECCO abstracts</SO>
<YR>2010</YR>
<VL>P</VL>
<PG>156</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-05-25 09:45:42 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Mickocka-Walus AA, Bond M, Holloway RH, Persson J, Pilichiewicz AM, Huges PA, Burke A, Collins K, Blackshaw A, Holtmann G, Andrews JM</AU>
<TI>Does cognitive-behavioural therapy (CBT) improve outcomes in inflammatory bowel disease? Initial feasibility report on a pilot randomised controlled trial</TI>
<SO>Gastroenterology</SO>
<YR>2010</YR>
<VL>Supplement (DDW abstract)</VL>
<PG>T 1253</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Boye-2010" MODIFIED="2010-07-30 14:06:10 -0400" MODIFIED_BY="[Empty name]" NAME="Boye 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-02-12 10:03:06 -0500" MODIFIED_BY="[Empty name]" NOTES="May" NOTES_MODIFIED="2010-02-12 10:03:06 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boye B, Johnsen J, Mokleby K, Leganger S, Jantschek G, Jantschek I, et al</AU>
<TI>The INSPIRE study: Are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?</TI>
<SO>Inflammatory Bowel Diseases</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>5</NO>
<PG>680-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-27 05:19:00 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boye B, Leganger S, Moekleby J, Heldal A, Leiknes KA, Dahlstrom A, Wojniusz S, Blomhoff S, Hausken T, Jahnsen J, Vatn M, Lundin K, Wilhelmsen I, Jantschek H, Malt MF</AU>
<TI>The impact of biological factors in inflammatory bowel disease (Abstract)</TI>
<SO>J Psychosom Res</SO>
<YR>2004</YR>
<VL>65</VL>
<PG>600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-30 14:06:10 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boye B, Lundin KE, Leganger S, Mokleby K, Jantschke G, Jantschek I, Kunzendorf S, Benninghofen D</AU>
<TI>The INSPIRE Study: Are different personality traits related to disease specific quality of life in distressed patients with ulcerative colitis and Crohn's disease?</TI>
<SO>Inflammatory Bowel Diseases</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>680</NO>
<PG>686</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-30 14:04:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="UNPUBLISHED">
<AU>Boye B, Lundin KE, Leganger S, Mokleby K, Tangen T, Jantschek I, Pripp AH, Wojniusz S, Dahlstrom A, Rivelsrud AC, Benninghoven D, Jantschek G, Hausken T, Rodseth A, Kunzendorf S, Wilhelmsen I, Sharpe M, Blomhoff S, Malt UF, Jahnsen J</AU>
<TI>The INSPIRE study: Does stress management intervention improve the course of IBD and diseases specific quality of life in distressed patients with ulcerative colitis and Crohn's disease? A randomized controlled intervention study</TI>
<SO>manuscript under review</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-30 14:05:24 -0400" MODIFIED_BY="[Empty name]" NOTES="70. The INSPIRE study stress-management psychotherapy improves disease specific quality of life in distressed patients with ulcerative colitis but not in distressed patients with Crohn's disease" NOTES_MODIFIED="2010-07-30 14:05:24 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boye B, Lundin KEA, Mokleby K, Leganger S, Wojniusz S, Dahlstrom A</AU>
<TI>70. The INSPIRE study stress-management psychotherapy improves disease specific quality of life in distressed patients with ulcerative colitis but not in distressed patients with Crohn's disease</TI>
<SO>Brain, Behavior, and Immunity</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>4, Supplement 1</NO>
<PG>21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-03-04 09:15:46 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Jahnsen J, Lundin KEA, Mokleby K, Leganger S, Wojniusz A, Roseth A, Wilhelmsen I, Tangen T, Hausken T, Rivenes A, Jantschek G, Jantschek I, Benninghoven D, Kunzendorf S, Blomhoff S, Sharpe M, Malt UF, Boye B</AU>
<TI>Does stress-management psychotherapy improve disease course in distressed patients with ulcerative colitis or Crohn's disease? The INSPIRE study</TI>
<SO>GUT</SO>
<YR>2008</YR>
<VL>57 Supple II</VL>
<PG>A 137</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-27 05:27:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jantschek G, Boye , Leganger S, Moekleby K, Heldal A, Leiknes KA, Dahlstrom A, Wojniusz S, Blomhoff S, Hausken T, Jahnsen J, Vatn M, Wilhelmsen I, Lundin K, Malt UF</AU>
<TI>Psychobiological factors in inflammatory bowel disease. The design of the Norwegian-German multicenter stress intervention study (Abstract)</TI>
<SO>J Psychosom Res</SO>
<YR>2004</YR>
<VL>56</VL>
<PG>611</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-27 05:39:17 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharpe DM, Wilhelmsen I, Blomhoff S, Malt UF, Jahnsen J</AU>
<TI>The INSPIRE study: do personality traits predict general quality of life (SF 36) in distressed pateints with ulcerative colitis and Crohn's disease?</TI>
<SO>Scand J Gastroenterol</SO>
<YR>2008</YR>
<VL>43</VL>
<PG>15051513</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2011-04-06 09:57:09 -0400" MODIFIED_BY="John K MacDonald">
<ADDITIONAL_REFERENCES MODIFIED="2011-04-06 09:57:09 -0400" MODIFIED_BY="John K MacDonald">
<REFERENCE ID="REF-Abbass-2009" MODIFIED="2011-01-05 14:18:30 -0500" MODIFIED_BY="John K MacDonald" NAME="Abbass 2009" TYPE="JOURNAL_ARTICLE">
<AU>Abbass A, Kisely S, Kroenke K</AU>
<TI>Short-term psychodynamic psychotherapy for somatic disorders. Systematic review and meta-analysis of clinical trials</TI>
<SO>Psychotherapy and Psychosomatics</SO>
<YR>2009</YR>
<VL>78</VL>
<NO>5</NO>
<PG>265-74</PG>
<IDENTIFIERS MODIFIED="2010-07-21 09:21:47 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="19602915"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Antonovsky-1993" MODIFIED="2011-01-05 14:18:45 -0500" MODIFIED_BY="John K MacDonald" NAME="Antonovsky 1993" TYPE="JOURNAL_ARTICLE">
<AU>Antonovsky A</AU>
<TI>The structure and properties of the sense of coherence scale</TI>
<SO>Social Science &amp; Medicine (1982)</SO>
<YR>1993</YR>
<VL>36</VL>
<NO>6</NO>
<PG>725-33</PG>
<IDENTIFIERS MODIFIED="2010-05-19 12:42:09 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8480217"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Barlow-2010" MODIFIED="2011-01-05 14:18:55 -0500" MODIFIED_BY="John K MacDonald" NAME="Barlow 2010" TYPE="JOURNAL_ARTICLE">
<AU>Barlow C, Cook D, Mulligan K, Bekc E, Newman S</AU>
<TI>A critical review of self-management and educational interventions in inflammatory bowel disease</TI>
<SO>Gastroenterol Nursing</SO>
<YR>2010</YR>
<VL>33</VL>
<NO>1</NO>
<PG>11-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beck-1961" MODIFIED="2011-01-05 14:19:12 -0500" MODIFIED_BY="John K MacDonald" NAME="Beck 1961" TYPE="JOURNAL_ARTICLE">
<AU>Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J</AU>
<TI>An inventory for measuring depression</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1961</YR>
<VL>4</VL>
<PG>561-71</PG>
<IDENTIFIERS MODIFIED="2010-05-20 11:58:06 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="13688369"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bernstein-2010" MODIFIED="2010-07-19 10:59:11 -0400" MODIFIED_BY="[Empty name]" NAME="Bernstein 2010" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, et al</AU>
<TI>World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010</TI>
<SO>Inflammatory bowel diseases</SO>
<YR>2010</YR>
<VL>16</VL>
<NO>1</NO>
<PG>112-24</PG>
<IDENTIFIERS MODIFIED="2010-07-19 10:59:08 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="19653289"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Caprilli-2006" MODIFIED="2010-12-21 13:10:19 -0500" MODIFIED_BY="John K MacDonald" NAME="Caprilli 2006" TYPE="JOURNAL_ARTICLE">
<AU>Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, et al</AU>
<TI>European evidence based consensus on the diagnosis and management of Crohn's disease: special situations</TI>
<SO>Gut</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>Suppl 1</NO>
<PG>i36-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coulter-2001" MODIFIED="2011-01-05 14:19:50 -0500" MODIFIED_BY="John K MacDonald" NAME="Coulter 2001" TYPE="JOURNAL_ARTICLE">
<AU>Coulter JD, Hardy ML, Favreau JT, Elfenbaum PD, Morton SC, Roth EA, et al</AU>
<TI>Mind-body interventions for gastrointestinal conditions</TI>
<SO>AHRQ Evidence Reports</SO>
<YR>2001</YR>
<VL>40</VL>
<PG>i</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-D_x0027_Haens-2007" MODIFIED="2010-12-21 14:34:33 -0500" MODIFIED_BY="John K MacDonald" NAME="D'Haens 2007" TYPE="JOURNAL_ARTICLE">
<AU>D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, et al</AU>
<TI>A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis</TI>
<SO>Gastroenterology</SO>
<YR>2007</YR>
<VL>132</VL>
<NO>2</NO>
<PG>763-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Drossman-1989" MODIFIED="2010-12-21 14:34:42 -0500" MODIFIED_BY="John K MacDonald" NAME="Drossman 1989" TYPE="JOURNAL_ARTICLE">
<AU>Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI</AU>
<TI>Health-related quality of life in inflammatory bowel disease: Functional status and patient worries and concerns</TI>
<SO>Dig Dis Sci</SO>
<YR>1989</YR>
<VL>34</VL>
<NO>9</NO>
<PG>1379-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elsenbruch-2005" MODIFIED="2010-06-08 07:42:10 -0400" MODIFIED_BY="[Empty name]" NAME="Elsenbruch 2005" TYPE="JOURNAL_ARTICLE">
<AU>Elsenbruch S, Langhorst J, Popkirowa K, Muller T, Luedtke R, Franken U, et al</AU>
<TI>Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis</TI>
<SO>Psychotherapy &amp; Psychosomatics</SO>
<YR>2005</YR>
<VL>74</VL>
<NO>5</NO>
<PG>277-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eypasch-1995" MODIFIED="2010-05-20 11:58:08 -0400" MODIFIED_BY="[Empty name]" NAME="Eypasch 1995" TYPE="JOURNAL_ARTICLE">
<AU>Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, et al</AU>
<TI>Gastrointestinal Quality of Life Index: development, validation and application of a new instrument</TI>
<SO>The British journal of surgery</SO>
<YR>1995</YR>
<VL>82</VL>
<NO>2</NO>
<PG>216-22</PG>
<IDENTIFIERS MODIFIED="2010-05-20 11:58:06 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="7749697"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Goodhand-2009" MODIFIED="2011-01-05 14:20:58 -0500" MODIFIED_BY="John K MacDonald" NAME="Goodhand 2009" TYPE="JOURNAL_ARTICLE">
<AU>Goodhand JR, Wahed M, Rampton DS</AU>
<TI>Management of stress in inflammatory bowel disease: a therapeutic option?</TI>
<SO>Expert Review of Gastroenterology &amp; Hepatology</SO>
<YR>2009</YR>
<VL>3</VL>
<NO>6</NO>
<PG>661-79</PG>
<IDENTIFIERS MODIFIED="2010-06-08 11:52:22 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="19929586"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Graff-2009" MODIFIED="2011-01-05 14:21:20 -0500" MODIFIED_BY="John K MacDonald" NAME="Graff 2009" TYPE="JOURNAL_ARTICLE">
<AU>Graff LA, Walker JR, Bernstein CN</AU>
<TI>Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>7</NO>
<PG>1105-18</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="19161177"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Grootenhuis-2001" MODIFIED="2010-05-19 12:42:13 -0400" MODIFIED_BY="[Empty name]" NAME="Grootenhuis 2001" TYPE="JOURNAL_ARTICLE">
<AU>Grootenhuis MA, Last BF</AU>
<TI>Children with cancer with different survival perspectives: defensiveness, control strategies, and psychological adjustment</TI>
<SO>Psycho-oncology</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>4</NO>
<PG>305-14</PG>
<IDENTIFIERS MODIFIED="2010-05-19 12:42:09 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11462229"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guthrie-2004" MODIFIED="2010-12-21 14:35:13 -0500" MODIFIED_BY="John K MacDonald" NAME="Guthrie 2004" TYPE="JOURNAL_ARTICLE">
<AU>Guthrie E</AU>
<TI>Psychological treatment in Crohn's disease.[comment]</TI>
<SO>Journal of Psychosomatic Research</SO>
<YR>2004</YR>
<VL>56</VL>
<NO>6</NO>
<PG>697</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-1989" MODIFIED="2010-05-20 11:58:08 -0400" MODIFIED_BY="[Empty name]" NAME="Guyatt 1989" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al</AU>
<TI>A new measure of health status for clinical trials in inflammatory bowel disease</TI>
<SO>Gastroenterology</SO>
<YR>1989</YR>
<VL>96</VL>
<NO>3</NO>
<PG>804-10</PG>
<IDENTIFIERS MODIFIED="2010-05-20 11:58:06 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2644154"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2002" MODIFIED="2011-01-05 14:23:45 -0500" MODIFIED_BY="John K MacDonald" NAME="Guyatt 2002" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR</AU>
<TI>Methods to explain the clinical significance of health status measures</TI>
<SO>Mayo Clin Proc</SO>
<YR>2002</YR>
<VL>77</VL>
<NO>4</NO>
<PG>371-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2010-12-21 14:35:25 -0500" MODIFIED_BY="John K MacDonald" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins J, Thompson S, Deeks J, Altman D</AU>
<TI>Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice</TI>
<SO>J Health Serv Res Policy</SO>
<YR>2002</YR>
<VL>7</VL>
<NO>1</NO>
<PG>51-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2010-07-15 05:15:26 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Green S</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<PB>Wiley-Blackwell</PB>
<CY>Chichester</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Howie-1998" MODIFIED="2011-01-05 14:24:13 -0500" MODIFIED_BY="John K MacDonald" NAME="Howie 1998" TYPE="JOURNAL_ARTICLE">
<AU>Howie JG, Heaney DJ, Maxwell M, Walker JJ</AU>
<TI>A comparison of a Patient Enablement Instrument (PEI) against two established satisfaction scales as an outcome measure of primary care consultations</TI>
<SO>Family Practice</SO>
<YR>1998</YR>
<VL>15</VL>
<NO>2</NO>
<PG>165-71</PG>
<IDENTIFIERS MODIFIED="2010-05-19 12:42:09 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9613486"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kellner-1975" MODIFIED="2010-12-21 14:35:32 -0500" MODIFIED_BY="John K MacDonald" NAME="Kellner 1975" TYPE="JOURNAL_ARTICLE">
<AU>Kellner R</AU>
<TI>Psychotherapy in psychosomatic disorders</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1975</YR>
<VL>32</VL>
<NO>8</NO>
<PG>1021-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kolsteren-2001" MODIFIED="2010-05-20 11:58:08 -0400" MODIFIED_BY="[Empty name]" NAME="Kolsteren 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kolsteren MM, Koopman HM, Schalekamp G, Mearin ML</AU>
<TI>Health-related quality of life in children with celiac disease</TI>
<SO>The Journal of pediatrics</SO>
<YR>2001</YR>
<VL>138</VL>
<NO>4</NO>
<PG>593-5</PG>
<IDENTIFIERS MODIFIED="2010-05-20 11:58:06 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11295729"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kovacs-1992" MODIFIED="2010-05-20 11:10:12 -0400" MODIFIED_BY="[Empty name]" NAME="Kovacs 1992" TYPE="BOOK">
<AU>Kovacs M</AU>
<SO>Children's Depression Inventory (CDI) Manual</SO>
<YR>1992</YR>
<PB>Multi-Health Systems</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kunzendorf-2007" MODIFIED="2010-07-27 07:06:32 -0400" MODIFIED_BY="[Empty name]" NAME="Kunzendorf 2007" TYPE="JOURNAL_ARTICLE">
<AU>Kunzendorf S, Jantschek G, Straubinger K, Heberlein I, Homann N, Ludwig D, et al</AU>
<TI>The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease</TI>
<SO>Inflammatory bowel diseases</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>1</NO>
<PG>33-41</PG>
<IDENTIFIERS MODIFIED="2010-07-27 07:06:31 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="17206637"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Levenstein-2000" MODIFIED="2010-12-21 12:17:37 -0500" MODIFIED_BY="John K MacDonald" NAME="Levenstein 2000" TYPE="JOURNAL_ARTICLE">
<AU>Levenstein S, Prantera C, Voarvo V, Scribano ML, Andreoli A, Luzi G, et al</AU>
<TI>Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission</TI>
<SO>Am J Gastroenterol</SO>
<YR>2000</YR>
<VL>95</VL>
<NO>5</NO>
<PG>1213-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mardini-2004" MODIFIED="2010-12-21 14:35:38 -0500" MODIFIED_BY="John K MacDonald" NAME="Mardini 2004" TYPE="JOURNAL_ARTICLE">
<AU>Mardini HE, Kip KE, Wilson JW</AU>
<TI>Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity</TI>
<SO>Dig Dis Sci</SO>
<YR>2004</YR>
<VL>49</VL>
<NO>3</NO>
<PG>492-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mawdsley-2005" MODIFIED="2010-12-21 12:17:02 -0500" MODIFIED_BY="John K MacDonald" NAME="Mawdsley 2005" TYPE="JOURNAL_ARTICLE">
<AU>Mawdsley JE, Rampton DS</AU>
<TI>Psychological stress in IBD: new insights into pathogenic and therapeutic implications</TI>
<SO>Gut</SO>
<YR>2005</YR>
<VL>54</VL>
<NO>10</NO>
<PG>1481-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meyer-2003" MODIFIED="2010-05-20 11:58:08 -0400" MODIFIED_BY="[Empty name]" NAME="Meyer 2003" TYPE="JOURNAL_ARTICLE">
<AU>Meyer TD, Hautzinger M</AU>
<TI>The structure of affective symptoms in a sample of young adults</TI>
<SO>Comprehensive psychiatry</SO>
<YR>2003</YR>
<VL>44</VL>
<NO>2</NO>
<PG>110-6</PG>
<IDENTIFIERS MODIFIED="2010-05-20 11:58:06 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12658619"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Miehsler-2004" MODIFIED="2011-01-05 14:26:12 -0500" MODIFIED_BY="John K MacDonald" NAME="Miehsler 2004" TYPE="JOURNAL_ARTICLE">
<AU>Miehsler W, Weichselberger M, Offerlbauer-Ernst A, Dejaco C, Reinisch W, Vogelsang H, et al</AU>
<TI>Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2004</YR>
<VL>10</VL>
<NO>5</NO>
<PG>637-45</PG>
<IDENTIFIERS MODIFIED="2010-06-08 11:52:22 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="15472527"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Miehsler-2008a" MODIFIED="2011-01-05 14:28:13 -0500" MODIFIED_BY="John K MacDonald" NAME="Miehsler 2008a" TYPE="OTHER">
<AU>Miehsler W, Dejaco C, Moser G</AU>
<TI>Factor analysis of ADAPT questionnaire for assessment of subjective need for psychological interventions</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>1</NO>
<PG>142-3</PG>
<IDENTIFIERS MODIFIED="2010-06-08 11:52:22 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="17828775"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Miehsler-2008b" MODIFIED="2011-01-05 14:28:28 -0500" MODIFIED_BY="John K MacDonald" NAME="Miehsler 2008b" TYPE="JOURNAL_ARTICLE">
<AU>Miehsler W, Weichselberger M, Offerlbauer-Ernst A, Dejaco C, Reinisch W, Vogelsang H, et al</AU>
<TI>Which patients with IBD need psychological interventions? A controlled study</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>9</NO>
<PG>1273-80</PG>
<IDENTIFIERS MODIFIED="2010-06-08 11:52:22 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18393373"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mittermaier-2004" MODIFIED="2010-12-21 14:35:45 -0500" MODIFIED_BY="John K MacDonald" NAME="Mittermaier 2004" TYPE="JOURNAL_ARTICLE">
<AU>Mittermaier C, Dejaco C, Waldhoer T, Öfferlbauer-Ernst A, Miehsler W, Beier M, et al</AU>
<TI>Impact of depressive mood on relapse in patients with inflammatory bowel diesease: a prospective 18-month follow-up study</TI>
<SO>Psychosom Med</SO>
<YR>2004</YR>
<VL>66</VL>
<NO>1</NO>
<PG>79-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Norman-2003" MODIFIED="2011-01-05 14:29:20 -0500" MODIFIED_BY="John K MacDonald" NAME="Norman 2003" TYPE="JOURNAL_ARTICLE">
<AU>Norman GR, Sloan JA, Wyrwich KW</AU>
<TI>Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation</TI>
<SO>Medical Care</SO>
<YR>2003</YR>
<VL>41</VL>
<NO>5</NO>
<PG>582-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Porcelli-1996" MODIFIED="2010-12-21 14:35:51 -0500" MODIFIED_BY="John K MacDonald" NAME="Porcelli 1996" TYPE="JOURNAL_ARTICLE">
<AU>Porcelli P, Leoci C, Guerra V</AU>
<TI>A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease</TI>
<SO>Scand J Gastroenterol</SO>
<YR>1996</YR>
<VL>31</VL>
<NO>8</NO>
<PG>792-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Richardson-2006" MODIFIED="2010-06-09 07:23:23 -0400" MODIFIED_BY="[Empty name]" NAME="Richardson 2006" TYPE="JOURNAL_ARTICLE">
<AU>Richardson G, Sculpher M, Kennedy A, Nelson E, Reeves D, Roberts C, et al</AU>
<TI>Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel disease</TI>
<SO>Journal of Health Services &amp; Research Policy</SO>
<YR>2006</YR>
<VL>11</VL>
<NO>4</NO>
<PG>225-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Roger-1989" MODIFIED="2010-05-19 08:15:33 -0400" MODIFIED_BY="[Empty name]" NAME="Roger 1989" TYPE="JOURNAL_ARTICLE">
<AU>Roger D, Najarian B</AU>
<TI>The construction and validation of a new scale for measuring emotional control</TI>
<SO>Personality and Individual Differences</SO>
<YR>1989</YR>
<VL>10</VL>
<PG>845-853</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rohrmeier-1982" MODIFIED="2010-12-21 14:35:56 -0500" MODIFIED_BY="John K MacDonald" NAME="Rohrmeier 1982" TYPE="BOOK">
<AU>Rohrmeier Franz</AU>
<SO>Langzeiterfolge psychosomatischer Therapien. Longterm effects of psychosomatic therapies</SO>
<YR>1982</YR>
<PB>Berlin: Springer (1982). 289 Seiten Series: Lehr- und Forschungstexte Psychologie, Nr. 3</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Saibil-2008" MODIFIED="2010-12-21 12:36:57 -0500" MODIFIED_BY="John K MacDonald" NAME="Saibil 2008" TYPE="JOURNAL_ARTICLE">
<AU>Saibil F, Lai E, Hayward A, Yip J, Gilbert C</AU>
<TI>Self-management for people with inflammatory bowel disease</TI>
<SO>Can J Gastroenterol</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>3</NO>
<PG>281-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sandborn-2002" MODIFIED="2011-01-05 14:29:55 -0500" MODIFIED_BY="John K MacDonald" NAME="Sandborn 2002" TYPE="JOURNAL_ARTICLE">
<AU>Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Lofberg R, Modigliani R, et al</AU>
<TI>A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease</TI>
<SO>Gastroenterology</SO>
<YR>2002</YR>
<VL>122</VL>
<NO>2</NO>
<PG>512-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shaffer-1983" MODIFIED="2010-05-20 11:58:08 -0400" MODIFIED_BY="[Empty name]" NAME="Shaffer 1983" TYPE="JOURNAL_ARTICLE">
<AU>Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, et al</AU>
<TI>A children's global assessment scale (CGAS)</TI>
<SO>Archives of general psychiatry</SO>
<YR>1983</YR>
<VL>40</VL>
<NO>11</NO>
<PG>1228-31</PG>
<IDENTIFIERS MODIFIED="2010-05-20 11:58:06 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="6639293"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Snaith-1986" MODIFIED="2010-12-21 14:36:01 -0500" MODIFIED_BY="John K MacDonald" NAME="Snaith 1986" TYPE="JOURNAL_ARTICLE">
<AU>Snaith RP, Zigmond AS</AU>
<TI>The hospital anxiety and depression scale</TI>
<SO>Br Med J (Clin Res Ed)</SO>
<YR>1986</YR>
<VL>292</VL>
<NO>6516</NO>
<PG>344</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spielberger-1970" MODIFIED="2010-05-20 11:00:33 -0400" MODIFIED_BY="[Empty name]" NAME="Spielberger 1970" TYPE="BOOK">
<AU>Spielberger CD, Gorsuch RL, Lushene RE</AU>
<SO>Manual for the state-trait anxiety inventory</SO>
<YR>1970</YR>
<PB>Consulting Psychologist Press</PB>
<CY>Palo Alto, CA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Verma-2001" MODIFIED="2011-01-05 14:30:36 -0500" MODIFIED_BY="John K MacDonald" NAME="Verma 2001" TYPE="JOURNAL_ARTICLE">
<AU>Verma S, Tsai HH, Giaffer MH</AU>
<TI>Does better disease-related education improve quality of life? A survey of IBD patients</TI>
<SO>Dig Dis Sci</SO>
<YR>2001</YR>
<VL>46</VL>
<NO>4</NO>
<PG>865-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="11330426"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-von-Wietersheim-2006" MODIFIED="2010-12-21 14:36:05 -0500" MODIFIED_BY="John K MacDonald" NAME="von Wietersheim 2006" TYPE="JOURNAL_ARTICLE">
<AU>von Wietersheim J, Kessler H</AU>
<TI>Psychotherapy with chronic inflammatory bowel disease patients: a review</TI>
<SO>Inflamm Bowel Dis</SO>
<YR>2006</YR>
<VL>12</VL>
<NO>12</NO>
<PG>1175-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ware-1995" MODIFIED="2010-12-21 14:36:08 -0500" MODIFIED_BY="John K MacDonald" NAME="Ware 1995" TYPE="JOURNAL_ARTICLE">
<AU>Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A</AU>
<TI>Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study</TI>
<SO>Med Care</SO>
<YR>1995</YR>
<VL>33</VL>
<NO>4 Suppl</NO>
<PG>AS264-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zijdenbos-2009" MODIFIED="2011-04-06 09:57:09 -0400" MODIFIED_BY="John K MacDonald" NAME="Zijdenbos 2009" TYPE="COCHRANE_REVIEW">
<AU>Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO</AU>
<TI>Psychological treatments for the management of irritable bowel syndrome</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>1</NO>
<PG>CD006442</PG>
<IDENTIFIERS MODIFIED="2011-04-06 09:57:09 -0400" MODIFIED_BY="John K MacDonald">
<IDENTIFIER MODIFIED="2011-04-06 09:57:09 -0400" MODIFIED_BY="John K MacDonald" TYPE="DOI" VALUE="10.1002/14651858.CD006442.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2010-07-28 08:27:25 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Kron-1984" MODIFIED="2009-05-29 07:44:12 -0400" MODIFIED_BY="[Empty name]" NAME="Kron 1984" NOTES="Effects of group psychotherapy on ileitis and colitis patients and their spouses" NOTES_MODIFIED="2009-05-29 07:44:12 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Kron Lawrence</AU>
<TI>Effects of group psychotherapy on ileitis and colitis patients and their spouses</TI>
<YR>1984</YR>
<PG>3200</PG>
<PB>ProQuest Information &amp; Learning, Dissertation Abstracts International</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Landet-1956" MODIFIED="2010-07-28 08:27:25 -0400" MODIFIED_BY="[Empty name]" NAME="Landet 1956" NOTES="PSYCHOTHERAPY IN ULCERATIVE COLITIS" NOTES_MODIFIED="2010-07-28 08:27:25 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<TI>Psychotherapy in ulcerative colitis</TI>
<SO>The Lancet</SO>
<YR>1956</YR>
<VL>268</VL>
<NO>6938</NO>
<PG>357</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Waldecker-1988" MODIFIED="2009-05-29 07:44:12 -0400" MODIFIED_BY="[Empty name]" NAME="Waldecker 1988" NOTES="Providing educational and emotional support to pediatric inflammatory bowel disease patients -- an expanding role for the GIA" NOTES_MODIFIED="2009-05-29 07:44:12 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Waldecker C</AU>
<TI>Providing educational and emotional support to pediatric inflammatory bowel disease patients -- an expanding role for the GIA</TI>
<SO>SGA Journal</SO>
<YR>1988</YR>
<VL>11</VL>
<NO>1</NO>
<PG>40-2</PG>
<IDENTIFIERS/>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2011-01-10 14:36:20 -0500" MODIFIED_BY="John K MacDonald">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2011-01-10 14:36:02 -0500" MODIFIED_BY="John K MacDonald" SORT_BY="STUDY" USER_DEF_1_ENABLED="YES" USER_DEF_1_NAME="Setting" USER_DEF_2_ENABLED="YES" USER_DEF_2_NAME="Duration of follow up" USER_DEF_3_ENABLED="YES" USER_DEF_3_NAME="Comparison treatment, cointerventions">
<INCLUDED_CHAR MODIFIED="2011-01-07 13:50:50 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Bregenzer-2005">
<CHAR_METHODS MODIFIED="2010-07-28 09:59:52 -0400" MODIFIED_BY="[Empty name]">
<P>NRCT (non randomised trial), not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-30 12:37:42 -0400" MODIFIED_BY="[Empty name]">
<P>Ulcerative colitis and Crohn's Disease, activity not reported, age 18-65</P>
<P>Exclusion criteria: not reported</P>
<P>Sample size experimental/controls: CD 32/41; UC 27/21</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-02-15 10:26:33 -0500" MODIFIED_BY="[Empty name]">
<P>Patient education programme: pathogenesis, diagnostic procedures, course, treatment, nutrition, social problems, stress management and coping</P>
<P>Type of contact: group sessions held by health care professionals (physician, psychologist, nutritionist, social worker)</P>
<P>Duration and dosing: 4 x 2 hours</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:50:49 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: semi-disease related (gastrointestinal symptoms) (GLQI (Eypasch))</P>
<P>Other psychological endpoints: depression (ADS (Hautzinger))</P>
<P>Somatic endpoints: clinical activity (CDAI, CAI)</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2010-07-28 09:59:56 -0400" MODIFIED_BY="[Empty name]">
<P>Single centre and community, Germany</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-04-22 10:27:35 -0400" MODIFIED_BY="[Empty name]">
<P>10 months following treatment</P>
<P>Outcome assessment at 3,6 and 10 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2010-02-15 10:16:34 -0500" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: waiting list - standard medical therapy</P>
<P>Co-Interventions: none</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2011-01-07 13:50:50 -0500" MODIFIED_BY="John K MacDonald">
<P>High risk of selection bias / allocation based on distance from study center. Additional results provided by authors (unpublished material on HRQL and depression, study details)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:50:51 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<CHAR_METHODS MODIFIED="2010-03-19 10:23:11 -0400" MODIFIED_BY="[Empty name]">
<P>QRCT, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-30 12:37:49 -0400" MODIFIED_BY="[Empty name]">
<P>Crohn's disease, in remission, age range 19 - 52 years. All must be on sulfasalazine or 5 ASA</P>
<P>Exclusion criteria: dietary restrictions</P>
<P>Sample size experimental/controls: CD 30/15</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-17 04:21:40 -0400" MODIFIED_BY="[Empty name]">
<P>stress management programme : a) guided stress management (relaxation practice, problem solving, coping in every day life) b) self-directed stress management (personal planning skills, autogenic training)</P>
<P>type of contact: a) face to face; delivered by psychotherapist b) introduction by psychotherapist, written guide and audiotape</P>
<P>duration and dosing: a) 2 sessions, followed by weekly sessions over 6 weeks, daily practice b) 2 sessions, daily practice for 8 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:50:51 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: baseline only; coping: not reported</P>
<P>other psychological endpoints: not reported</P>
<P>somatic endpoints: a) Harvey Bradshow disease activity index: baseline only. b) "symptom reduction score", for individual symptoms in those afflicted only. Not uniform across patient groups.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-05-04 08:14:23 -0400" MODIFIED_BY="[Empty name]">
<P>Single center in Spain, gastroenterology department (transfer to psychosomatics)</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-05-04 08:14:37 -0400" MODIFIED_BY="[Empty name]">
<P>12 months</P>
<P>Outcome assessment at 6 and 12 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-11-24 10:11:20 -0500" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: none (standard medical therapy)</P>
<P>Co-Interventions: 5-ASA compounds</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-02-22 07:01:27 -0500" MODIFIED_BY="[Empty name]">
<P>3 arm trial (2 experimental, 1 control). </P>
<P>Additional information on numbers and study design was supplied by the author, but results were not available in sufficient detail to be included in the review (October 2009)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:29 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Grootenhuis-2009">
<CHAR_METHODS MODIFIED="2010-03-19 10:23:48 -0400" MODIFIED_BY="[Empty name]">
<P>NRCT, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-20 07:09:28 -0400" MODIFIED_BY="[Empty name]">
<P>IBD, disease activity not specified, age 12 - 18, disease duration &gt;= 6 months</P>
<P>Exclusion criteria: not specified</P>
<P>Sample size experimental/controls: IBD unspecified 22/18</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-03-19 10:29:28 -0400" MODIFIED_BY="[Empty name]">
<P>Psychoeducational group intervention: cognitive-behavioural approach, relaxation techniques, encouraging information seeking behaviour </P>
<P>type of contact: group sessions, face to face</P>
<P>duration and dosing: 6 sessions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:29 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: Dutch Children's AZL / TNO quality of Life Questionnaire (DUX-25); coping: Cognitive Control Strategies Scale for pediatric patients</P>
<P>other psychological endpoints: self perception (Self-Perception Profile for Adolescents), anxiety (state-trait inventory for children / ZBV-K), patients behavioral emotional problems (Dutch Child Behavior Check List/CBCL)</P>
<P>somatic endpoints: not assessed</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2010-03-19 10:35:04 -0400" MODIFIED_BY="[Empty name]">
<P>Single center plus national patient organization, The Netherlands</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2010-03-19 10:35:43 -0400" MODIFIED_BY="[Empty name]">
<P>6 to 8 months</P>
<P>Outcome assessment: during/following treatment, 6 to 8 months past treatment</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2010-03-19 10:35:58 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: therapy as usual / waiting list</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-03-19 10:49:01 -0400" MODIFIED_BY="[Empty name]">
<P>Pediatric study! Combined results only for UC and CD. Identified during analysis, authors not yet approached</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:50:57 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Jaghult-2007">
<CHAR_METHODS MODIFIED="2010-03-29 12:37:43 -0400" MODIFIED_BY="[Empty name]">
<P>QRCT, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-30 12:28:38 -0400" MODIFIED_BY="[Empty name]">
<P>IBD patients in clinical remission, disease duration &lt;= 2 years, age range 17-75</P>
<P>Exclusion criteria: acute therapy, disease duration &gt; 2 years, language problems</P>
<P>Sample size experimental/controls: CD 26/20, UC 29/24</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-23 11:16:28 -0400" MODIFIED_BY="[Empty name]">
<P>patient education programme: pathogenesis, diagnostic procedures, course, treatment, nutrition, social issues, stress management and coping</P>
<P>type of contact: group sessions held by health care professionals (physician, nutritionist, specialized nurse, social worker)</P>
<P>duration and dosing: 3x2 hours, sessions once a week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:50:56 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: disease related (IBDQ, RFIPC)</P>
<P>other psychological endpoints; coping/sense of coherence (SOC)</P>
<P>somatic endpoints: not assessed</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-04-23 11:17:50 -0400" MODIFIED_BY="[Empty name]">
<P>Single center study, Sweden</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-04-23 11:14:40 -0400" MODIFIED_BY="[Empty name]">
<P>6 months</P>
<P>Main outcome assessment at 6 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-04-23 11:14:40 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: not reported</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2011-01-07 13:50:57 -0500" MODIFIED_BY="John K MacDonald">
<P>Results not reported by type of disease. Need SD of results. Study details not evident from the report were provided by the authors upon request (treatment allocation, numbers and outcome data by disease type, SD).</P>
<P>Caution: IBDQ Swedish Version uses reverse direction for HRQL (higher score, lower HRQL). Outcomes have been mirrored for analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-10 14:33:54 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Jantschek-1998">
<CHAR_METHODS MODIFIED="2010-03-30 06:56:33 -0400" MODIFIED_BY="[Empty name]">
<P>RCT, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-24 10:12:11 -0400" MODIFIED_BY="[Empty name]">
<P>Crohn's disease, any activity (duration of remission &lt; 2 years), age 18-55</P>
<P>Exclusion criteria: immunosuppressive therapy, recent or pending surgery, entero/colostomy, previous or current psychotherapy</P>
<P>Sample size experimental/controls: CD 53/31</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-07 13:21:55 -0500" MODIFIED_BY="John K MacDonald">
<P>Psychodynamically oriented psychotherapy in combination with relaxation techniques (as determined by therapist). Type varied by center</P>
<P>Type of contact: group, family or individual; face to face; delivered by psychotherapist</P>
<P>Duration and dosing: at least 20 hours over 1 year, variable intervals/session time</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:50:57 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: life satisfaction (modified from oncology research); coping: not assessed</P>
<P>Other psychological endpoints: depression as assessed by BDI, anxiety as assessed with STAI-X2, psychological interview (PSKB), days in hospital, days off work</P>
<P>Somatic endpoints: ranking of disease course over 1-2 years (4 categories). Best: no relapse. Worst: refractory disease course, surgery</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-05-04 08:04:37 -0400" MODIFIED_BY="[Empty name]">
<P>Multicenter: 4 referral centers in Germany, gastroenterology and psychosomatics departments</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2011-01-10 14:33:54 -0500" MODIFIED_BY="John K MacDonald">
<P>Main outcome 24 months following randomization</P>
<P>Also assessed at 12 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-05-04 08:04:37 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: none (standard medical therapy only)</P>
<P>Co-Interventions: standardized tapering scheme if active (steroids). Otherwise as needed / standard medical therapy</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-06-24 10:13:32 -0400" MODIFIED_BY="[Empty name]">
<P>Results reported across various articles. Study details available from investigator</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:50:59 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Kennedy-2003">
<CHAR_METHODS MODIFIED="2009-05-07 09:28:24 -0400" MODIFIED_BY="[Empty name]">
<P>Cluster-RCT, not blinded (hospitals randomized)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-30 12:29:35 -0400" MODIFIED_BY="[Empty name]">
<P>Ulcerative colitis, activity not specified, age 16 and over</P>
<P>Exclusion criteria: inability to read English</P>
<P>Sample size experimental/controls: UC 68/91</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-22 04:07:10 -0400" MODIFIED_BY="[Empty name]">
<P>Provision with a patient-centered guidebook</P>
<P>type of contact, dosing: information supplied from book, no further intervention</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:50:59 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: IBDQ; coping: not assessed</P>
<P>other psychological endpoints: depression (HADS-D), anxiety (HADS-A), knowledge (self derived)</P>
<P>somatic endpoints: not assessed (baseline only)</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-05-07 09:32:53 -0400" MODIFIED_BY="[Empty name]">
<P>Multicenter: 6 hospitals in UK (out patient clinics)</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-05-07 09:33:18 -0400" MODIFIED_BY="[Empty name]">
<P>9 months</P>
<P>Outcome assessment at 1 and 9 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-05-07 09:33:30 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: none (standard medical therapy only)</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2009-12-10 09:19:22 -0500" MODIFIED_BY="[Empty name]">
<P>Cluster randomized - 2 x 3 hospitals. Pilot study to Kennedy 2004. Additional information was provided by the author. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-10 14:34:16 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Kennedy-2004">
<CHAR_METHODS MODIFIED="2009-05-12 12:17:47 -0400" MODIFIED_BY="[Empty name]">
<P>Cluster-RCT, not blinded (hospitals randomized)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-20 07:09:33 -0400" MODIFIED_BY="[Empty name]">
<P>IBD, activity not specified, age 16 and over</P>
<P>Exclusion criteria: inability to read English, participation in pilot study</P>
<P>Sample size experimental/controls: IBD unspecified 236/296</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-10 14:34:16 -0500" MODIFIED_BY="John K MacDonald">
<P>Provision with a patient-centered guidebook and written self management plan, training of doctors, provision of free access</P>
<P>type of contact, dosing: on demand counselling/patient centered consultation, information supplied from book</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:27 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: IBDQ, SF36 subscales; coping: PEI</P>
<P>other psychological endpoints: depression &amp; anxiety (HADS), patient satisfaction (CSQ)</P>
<P>somatic endpoints: number of relapses, course of disease.</P>
<P>economic endpoints: EDQ50, out of pocket costs, doctor visits etc</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-05-12 12:22:35 -0400" MODIFIED_BY="[Empty name]">
<P>Multicenter: 19 hospitals in UK (out patient clinics)</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-05-12 12:22:41 -0400" MODIFIED_BY="[Empty name]">
<P>12 months</P>
<P>Outcome assessment at 12 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-05-12 12:17:47 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: none (standard medical therapy only)</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2009-05-12 12:23:19 -0400" MODIFIED_BY="[Empty name]">
<P>Cluster randomized - 10 &amp; 9 hospitals. No separate data by disease type</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:25 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<CHAR_METHODS MODIFIED="2009-05-04 05:54:30 -0400" MODIFIED_BY="[Empty name]">
<P>NRCT (allocation based on time interval), not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-30 12:30:27 -0400" MODIFIED_BY="[Empty name]">
<P>Crohn's disease, in-patients, mostly active, mean age 23</P>
<P>Exclusion criteria: previous or current psychotherapy</P>
<P>Sample size experimental/controls: CD 14/15</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-05-04 05:56:15 -0400" MODIFIED_BY="[Empty name]">
<P>supportive psychotherapy</P>
<P>type of contact: face to face; delivered by final year medical students</P>
<P>duration and dosing: up to once daily, mean 22 sessions, duration not reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:25 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: not assessed; coping: not assessed</P>
<P>other psychological endpoints: depression as assessed by BKS, FPI3, anxiety as assessed with STAI, personality (FPI)</P>
<P>somatic endpoints: disease activity (van Hees &gt; 150), surgery</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-05-04 05:58:05 -0400" MODIFIED_BY="[Empty name]">
<P>Single center - university hospital in Germany, gastroenterology department</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-05-04 06:00:02 -0400" MODIFIED_BY="[Empty name]">
<P>1 year (13 months)</P>
<P>Outcome assessment at 4 and 13 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-05-04 06:00:38 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: none (standard medical therapy only)</P>
<P>Co-Interventions: standardized antiinflammatory therapy including parenteral nutrition</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-07-27 09:30:31 -0400" MODIFIED_BY="[Empty name]">
<P>Article in German. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:04 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Lange-1996">
<CHAR_METHODS MODIFIED="2010-03-23 10:19:25 -0400" MODIFIED_BY="[Empty name]">
<P>NRCT (non randomized trial), not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-20 07:09:34 -0400" MODIFIED_BY="[Empty name]">
<P>Ulcerative colitis and Crohn's Disease, activity not reported, age range 18 to 54 years. Disease duration &gt;= 1 year</P>
<P>Exclusion criteria: not reported</P>
<P>Sample size experimental/controls: IBD unspecified 18/18</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-03-23 10:40:13 -0400" MODIFIED_BY="[Empty name]">
<P>Patient education programme: pathogenesis, diagnostic procedures, course, treatment, nutrition, social problems, stress management and coping</P>
<P>Type of contact: group sessions held by health care professionals (physician, psychologist, nutritionist)</P>
<P>duration and dosing: 4x 2 hours (2 weeks) (&lt; 20 hours)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:04 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: semi-disease related (gastrointestinal symptoms) (GLQI (Eypasch))</P>
<P>other psychological endpoints: depression (ADS (Hautzinger)); IBD knowledge, sense of control, self-activity (?)</P>
<P>somatic endpoints: not reported (or: self-activity?)</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2010-03-23 10:39:57 -0400" MODIFIED_BY="[Empty name]">
<P>hospital based, volunteers (press release) and regional patient support group, Germany</P>
<P>Recruitment period 1992 to 1993</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-06-10 11:24:23 -0400" MODIFIED_BY="[Empty name]">
<P>3 months following treatment</P>
<P>Outcome assessment at end of therapy and 3 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2010-03-23 10:21:30 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: as usual. Informationmaterials handed out at end of study</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-03-23 10:40:42 -0400" MODIFIED_BY="[Empty name]">
<P>Pilot to Bregenzer 2005. Outcomes not available as means were not considered appropriate (instruments not validated for interval scaling - used rank correlation for analysis)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-10 14:34:36 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Langhorst-2007">
<CHAR_METHODS MODIFIED="2010-03-29 12:37:52 -0400" MODIFIED_BY="[Empty name]">
<P>QRCT, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-07 13:51:24 -0500" MODIFIED_BY="John K MacDonald">
<P>Ulcerative colitis, any activity, age 18-65, disease duration &gt; 1 year</P>
<P>Exclusion criteria: immunosuppressive therapy or currently on steroids, previous surgery, stenosis, any comorbidity interfering with HRQL, previous or current psychotherapy</P>
<P>Sample size experimental/controls: UC 30/26</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-10 14:34:36 -0500" MODIFIED_BY="John K MacDonald">
<P>mind-body-therapy / comprehensive life style modification, including behavioral therapy, stress management training, life style modification (moderate exercise, Mediterranean diet) and self care strategies (not specified)</P>
<P>type of contact: face to face, individual</P>
<P>duration and dosing: 60 hours over 10 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:06 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: generic (SF36), disease related (IBDQ)</P>
<P>other psychological endpoints: perceived stress (Cohen PSS), depression (HADS) anxiety (HADS)</P>
<P>somatic endpoints: clinical activity (CAI), remission</P>
<P>other: laboratory results (e.g. cell counts, stress hormones, TNF) (short term only)</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-05-14 10:17:44 -0400" MODIFIED_BY="[Empty name]">
<P>Community based: volunteers recruited via newspaper and patient organization, Germany</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-05-14 10:59:41 -0400" MODIFIED_BY="[Empty name]">
<P>outcome assessment end of therapy (Elsenbruch), 3 and 12 months (Langhorst)</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2010-01-11 05:18:36 -0500" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: none (waiting list, standard medical therapy )</P>
<P>Co-Interventions: as needed (e.g. 5 ASA; probiotics)</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-01-11 05:51:35 -0500" MODIFIED_BY="[Empty name]">
<P>Further details and outcome data provided by author. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:09 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Larsson-2003">
<CHAR_METHODS MODIFIED="2010-03-30 03:35:18 -0400" MODIFIED_BY="[Empty name]">
<P>QRCT, possibly cross over design, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-20 07:09:36 -0400" MODIFIED_BY="[Empty name]">
<P>High anxiety IBD patients (HADS &gt; 8), activity not reported, age range 21-65</P>
<P>Exclusion criteria: previous education, anxiety score &lt;= 8</P>
<P>Sample size experimental/controls: IBD unspecified 26/17</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-23 10:28:06 -0400" MODIFIED_BY="[Empty name]">
<P>patient education programme: pathogenesis, diagnostic procedures, course, treatment, nutrition, social issues, stress management and coping</P>
<P>type of contact: group sessions held by health care professionals (physician/surgeon, psychiatrist, nutritionist, stoma nurse, social worker, patient group, physiotherapist)</P>
<P>duration and dosing: 8x2-3 hours, sessions once a week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:08 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: IBDQ (subscores only), SF36 (subscores only); coping: not assessed</P>
<P>other psychological endpoints: anxiety and depression as assessed by HADS, satisfaction (VAS, self made)</P>
<P>somatic endpoints: not assessed (we used bowel domain of HRQL instrument as a proxy)</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-04-23 10:29:51 -0400" MODIFIED_BY="[Empty name]">
<P>Population sample, Sweden</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-05-13 04:15:59 -0400" MODIFIED_BY="[Empty name]">
<P>6 months</P>
<P>Main outcome assessment at 6 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-04-23 10:30:18 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: not reported</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2011-01-07 13:51:09 -0500" MODIFIED_BY="John K MacDonald">
<P>Combined results only for UC and CD, subscores only for HRQL. Maybe crossover, but data handling not clear. Author was approached for more information, but did not respond</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:10 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Lecouturier-2003">
<CHAR_METHODS MODIFIED="2010-03-30 03:34:07 -0400" MODIFIED_BY="[Empty name]">
<P>RCT, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-30 12:32:38 -0400" MODIFIED_BY="[Empty name]">
<P>ulcerative colitis, low IBDQ subscores on social and emotional domains, activity not reported, age not reported</P>
<P>Exclusion criteria: none</P>
<P>Sample size experimental/controls: not known</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-03-11 11:45:07 -0500" MODIFIED_BY="[Empty name]">
<P>group based self management training, led by health professionals, e.g. nurses, or skilled group facilitators</P>
<P>type of contact: group sessions</P>
<P>duration and dosing: six sessions held weekly, each 120 minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:10 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: IBDQ (items only), coping: "scales of self-management and self-efficacy"</P>
<P>other psychological endpoints: anxiety and depression as assessed by HADS</P>
<P>somatic endpoints: not reported</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2010-03-11 11:47:07 -0500" MODIFIED_BY="[Empty name]">
<P>Community setting, various recruitment strategies including local press release. UK</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-05-13 04:20:50 -0400" MODIFIED_BY="[Empty name]">
<P>12 months</P>
<P>Outcome assessment at 6 and 12 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-05-13 04:21:14 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: "factual information package"</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2009-12-18 10:16:17 -0500" MODIFIED_BY="[Empty name]">
<P>Abstract only available, no quantitative data. Authors has been contacted (13 May 09) but did not supply data. Full papers on qualitative issues only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-10 14:34:56 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Milne-1986">
<CHAR_METHODS MODIFIED="2009-04-27 11:03:19 -0400" MODIFIED_BY="[Empty name]">
<P>RCT - blinded outcome assessment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-20 07:09:40 -0400" MODIFIED_BY="[Empty name]">
<P>Ambulatory IBD patients "under active medical supervision", activity not reported, age 18-55</P>
<P>Exclusion criteria: comorbidity requiring daily medication, language problems, pregnancy</P>
<P>Sample size experimental/controls: IBD unspecified 40/37</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-27 11:20:30 -0400" MODIFIED_BY="[Empty name]">
<P>stress management programme: personal planning skills, communication skills, relaxation (autogenic training)</P>
<P>type of contact: group sessions held by health care professionals (nurse, social worker)</P>
<P>duration and dosing: 6 x 3 hours</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:11 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: not assessed; coping: see stress index</P>
<P>other psychological endpoints: stress, disease related (IBD-stress index), stress, general (ISA)</P>
<P>somatic endpoints: remission/relapse as defined by CDAI; CDAI</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-04-27 11:08:17 -0400" MODIFIED_BY="[Empty name]">
<P>5 GI practices, patient organization; Canada</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-04-27 11:09:10 -0400" MODIFIED_BY="[Empty name]">
<P>12 months</P>
<P>Outcome assessment: 4,8,12 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-04-27 11:02:59 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: not reported</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2011-01-10 14:34:56 -0500" MODIFIED_BY="John K MacDonald">
<P>Combined results only for UC and CD. P-values only reported for stress index. Comparison groups highly unbalanced. Incomplete reporting of outcomes.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-10 14:35:17 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Oliveira-2007">
<CHAR_METHODS MODIFIED="2009-06-04 11:21:45 -0400" MODIFIED_BY="[Empty name]">
<P>RCT, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-20 07:09:43 -0400" MODIFIED_BY="[Empty name]">
<P>IBD, activity not reported, age 18-65</P>
<P>Exclusion criteria: any other chronic disease, HIV seropositivity, language problems</P>
<P>Sample size experimental/controls: IBD unspecified 27/12</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-25 04:36:16 -0400" MODIFIED_BY="[Empty name]">
<P>support meetings: discussion rounds, informative sessions</P>
<P>type of contact: not specified</P>
<P>duration and dosing: once per month, up to 2 years</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:14 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: IBDQ, SF 36; coping: not assessed</P>
<P>other psychosocial endpoints: not assessed</P>
<P>somatic endpoints: not assessed</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-06-04 11:24:40 -0400" MODIFIED_BY="[Empty name]">
<P>single center, Brazil</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-06-04 11:25:03 -0400" MODIFIED_BY="[Empty name]">
<P>planned 2 years (one year therapy, one year "katamnesis")</P>
<P>Main outcome assessment at: not reported ("4 moments")</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-06-04 11:25:16 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: no support</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2011-01-10 14:35:17 -0500" MODIFIED_BY="John K MacDonald">
<P>Results not reported (P values within groups only)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-10 14:35:30 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Oxelmark-2007">
<CHAR_METHODS MODIFIED="2010-03-29 12:38:26 -0400" MODIFIED_BY="[Empty name]">
<P>QRCT, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-30 12:34:19 -0400" MODIFIED_BY="[Empty name]">
<P>IBD, remission or mild disease, must have had &lt;=1 serious flare and steroids in the past, age range 18-71</P>
<P>Exclusion criteria: previous bowel surgery, blood in stools</P>
<P>Sample size experimental/controls: CD 11/12, UC 9/3</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-10 14:35:30 -0500" MODIFIED_BY="John K MacDonald">
<P>group based educational programme: IBD education - e.g. surgery, therapy, diet. Coping and stress management strategies</P>
<P>type of contact: group therapy and lectures, delivered by multidisciplinary team (specialized nurse, gastroenterologist, social worker/psychotherapist)</P>
<P>duration and dosing: 9 x 1.5 hours (3 months)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:20 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: IBDQ; coping: Sense of Coherence (SoC)</P>
<P>other psychological endpoints: none</P>
<P>somatic endpoints: not reported</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-06-04 09:24:38 -0400" MODIFIED_BY="[Empty name]">
<P>1 hospital, volunteers, USA</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-06-04 09:33:20 -0400" MODIFIED_BY="[Empty name]">
<P>12 months</P>
<P>Outcome assessment: 6 months, 12 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-06-04 09:31:17 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: standard / as needed</P>
<P>Co-Interventions: as needed</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-03-19 06:28:28 -0400" MODIFIED_BY="[Empty name]">
<P>Combined results only for UC and CD in the report, but separate results provided by author. Excellent reporting. Very "healthy" study group (relapse rate 1 / 46 - 98% stayed in remission over 1 year!)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:51 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Schmidt-1992">
<CHAR_METHODS MODIFIED="2010-03-29 12:52:58 -0400" MODIFIED_BY="[Empty name]">
<P>Possibly RCT, matched controls, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-07 13:51:34 -0500" MODIFIED_BY="John K MacDonald">
<P>Ulcerative colitis, activity not specified, age not specified</P>
<P>Exclusion criteria: not specified</P>
<P>treatment group 11, control group 12</P>
<P>Sample size experimental/controls: UC 11/12</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-15 11:07:31 -0400" MODIFIED_BY="[Empty name]">
<P>Combined hypnotherapy plus peer group sessions </P>
<P>type of contact: group or individual: not specified, delivered by psychotherapist</P>
<P>duration and dosing: 18 sessions, duration not specified</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:51 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: not reported; coping: not reported</P>
<P>other psychological endpoints: not reported</P>
<P>somatic endpoints: not reported / not details</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2010-03-16 08:31:59 -0400" MODIFIED_BY="[Empty name]">
<P>Germany (GDR), from 1986</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2010-03-16 08:30:10 -0400" MODIFIED_BY="[Empty name]">
<P>5 years</P>
<P>Outcome assessment: every 4 months, but not presented in detail</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-06-15 11:08:32 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: standard / as needed</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-03-16 08:30:38 -0400" MODIFIED_BY="[Empty name]">
<P>Insufficient reporting. Single author, deceased. Detailed results were not available.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:38 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Schreiber-1999">
<CHAR_METHODS MODIFIED="2010-03-16 09:19:51 -0400" MODIFIED_BY="[Empty name]">
<P>NRCT - allocation by clinic (1 active center, 2 control centers)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-07-27 09:31:25 -0400" MODIFIED_BY="[Empty name]">
<P>IBD, activity not specified, age not specified</P>
<P>Exclusion criteria: not specified</P>
<P>Sample size experimental/controls: IBD unspecified 30/60</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-03-16 09:21:42 -0400" MODIFIED_BY="[Empty name]">
<P>Multimedia CD-ROM</P>
<P>type of contact: group or individual: not specified, CD-ROM</P>
<P>duration and dosing: minimum 12 hours CD exposure per month over 3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:38 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: IBDQ, SF36</P>
<P>other psychological endpoints: anxiety (not specified), time trade off, compliance, health care resource use</P>
<P>somatic endpoints: CDAI, CAI</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2010-03-16 09:24:46 -0400" MODIFIED_BY="[Empty name]">
<P>Multicenter, Germany</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2010-03-16 09:25:57 -0400" MODIFIED_BY="[Empty name]">
<P>9 months</P>
<P>Outcome assessment: 3 months diary, follow up assessment at 6 and 9 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2010-03-16 09:26:04 -0400" MODIFIED_BY="[Empty name]">
<P>not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-03-16 09:26:23 -0400" MODIFIED_BY="[Empty name]">
<P>abstract only, full results not available</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:42 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Schwarz-1991">
<CHAR_METHODS MODIFIED="2010-03-29 12:45:52 -0400" MODIFIED_BY="[Empty name]">
<P>Controlled trial, uncertain allocation procedure, not blinded,</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-20 07:09:53 -0400" MODIFIED_BY="[Empty name]">
<P>IBD, activity not specified, age mean 45.3 years, range 25-71</P>
<P>Exclusion criteria: major psychiatric comorbidity</P>
<P>Sample size experimental/controls: IBD unspecified 11/10</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-07 13:51:40 -0500" MODIFIED_BY="John K MacDonald">
<P>multicomponent behavioral treatment: IBD education, progressive muscle relaxation, thermal biofeedback, cognitive coping strategies</P>
<P>type of contact: individual, face to face, delivered by PhD student psychology</P>
<P>duration and dosing: 12 x 1 hour (2 months)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:42 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: not assessed; coping: not assessed</P>
<P>other psychological endpoints: stress, disease related (IBD-stress index), depression (BDI), anxiety (STAI), hassles (number, severity)</P>
<P>somatic endpoints: single symptoms, symptomatic change scores</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-05-27 07:32:20 -0400" MODIFIED_BY="[Empty name]">
<P>1 hospital, volunteers, USA</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-05-27 07:32:39 -0400" MODIFIED_BY="[Empty name]">
<P>3 months</P>
<P>Outcome assessment: 2 months, 3 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-05-27 07:32:46 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: waiting list</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-02-15 07:07:18 -0500" MODIFIED_BY="[Empty name]">
<P>Combined results only for UC and CD. Control groups highly unbalanced. incomplete outcome reporting, no measure of precision. Unvalidated symptom change score.</P>
<P>Additional information was supplied by the author, but insufficient for inclusion (no information on measures of variance)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:45 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Smith-2002">
<CHAR_METHODS MODIFIED="2009-06-03 11:39:57 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (embedded in case control study - non IBD controls not considered for extraction)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-30 12:36:08 -0400" MODIFIED_BY="[Empty name]">
<P>IBD, IBD activity not specified, age range 17 - 68</P>
<P>Exclusion criteria: not specified</P>
<P>Sample size experimental/controls: CD 25/25, UC 25/25</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-03 11:44:27 -0400" MODIFIED_BY="[Empty name]">
<P>Nurse led counselling service: IBD education, relaxation techniques, coping strategies, stress management, patient peer support if needed, nurse support if needed</P>
<P>type of contact: individual, mixed: face to face, booklets, audiotapes</P>
<P>duration and dosing: as needed (minimum: one session at baseline. Mean: 3.25 sessions/year)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:45 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: SF 36 (mental score reported only, only for CD) coping: Styles and strategies questionnaire (Roger 1989)</P>
<P>other psychological endpoints: depression and anxiety (HADS)</P>
<P>somatic endpoints: CDAI / modified CDAI</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-06-03 11:44:48 -0400" MODIFIED_BY="[Empty name]">
<P>1 hospital, UK</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-06-03 11:48:33 -0400" MODIFIED_BY="[Empty name]">
<P>12 months</P>
<P>Outcome assessment: 6 and 12 months</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-06-03 11:48:29 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: standard treatment</P>
<P>Co-Interventions: as needed</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2010-06-08 05:31:45 -0400" MODIFIED_BY="[Empty name]">
<P>Excellent outcome reporting. This study was also included in the Cochrane Review on Nursing interventions in IBD (Belling 2009)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-07 13:51:56 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Szigethy-2007">
<CHAR_METHODS MODIFIED="2010-03-18 10:43:52 -0400" MODIFIED_BY="[Empty name]">
<P>RCT - not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-07 13:51:55 -0500" MODIFIED_BY="John K MacDonald">
<P>IBD AND mild/subsyndromal depression, IBD activity not specified, age 11 - 17</P>
<P>Exclusion criteria: major psychiatric comorbidity including severe depression, antidepressive therapy</P>
<P>Sample size experimental/controls: IBD unspecified 19/8</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-03 10:03:17 -0400" MODIFIED_BY="[Empty name]">
<P>Cognitive behavioral treatment (PASCET-PI): IBD education, problem solving skills, behavioural activation, social skills training, parent sessions, relaxation techniques, cognitive coping strategies</P>
<P>type of contact: individual, mixed: face to face, phone, parent sessions, handbook</P>
<P>duration and dosing: 9 - 11 x 1 hour (2 months ?)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:56 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: global functioning (CGAS); coping: Cognitive procession (PCSC)</P>
<P>other psychological endpoints: depression (K-SADS-PI, CDI, CDI-P)</P>
<P>somatic endpoints: remission, mild activity, severe activity based on PCDAI and Kozarek Clinical Index</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-06-03 10:06:02 -0400" MODIFIED_BY="[Empty name]">
<P>2 hospitals, USA</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-06-03 10:06:48 -0400" MODIFIED_BY="[Empty name]">
<P>3 months (12 - 14 weeks)</P>
<P>Outcome assessment: 3 months (12 - 14 weeks) - need to clarify</P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-06-03 10:07:02 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: information leaflet and therapy as usual</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2009-06-03 10:07:22 -0400" MODIFIED_BY="[Empty name]">
<P>Pediatric study! Combined results only for UC and CD. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-10 14:36:02 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Waters-2005">
<CHAR_METHODS MODIFIED="2009-07-06 08:55:58 -0400" MODIFIED_BY="[Empty name]">
<P>RCT, not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-30 12:37:17 -0400" MODIFIED_BY="[Empty name]">
<P>IBD, any activity, age 17+</P>
<P>Exclusion criteria: &gt; 2 hours drive from center, short gut syndrome, for ulcerative colitis: inflammation confined to rectum (proctitis), proctocolectomy. Ostomy, total parenteral nutrition, pending surgery</P>
<P>Sample size experimental/controls:CD 31/26, UC 14/18</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-10 14:36:02 -0500" MODIFIED_BY="John K MacDonald">
<P>group based educational programme: IBD education - e.g. surgery, therapy, diet. Provided by specialized nurse, dietician, surgeon</P>
<P>type of contact: group, face to face</P>
<P>duration and dosing: 4 times 3 hours over 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:51:57 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: IBDQ, RFIPC; coping: not assessed</P>
<P>other psychological endpoints: knowledge, programme satisfaction</P>
<P>somatic endpoints: disease activity (CDAI, AI)</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-07-06 09:01:43 -0400" MODIFIED_BY="[Empty name]">
<P>single center, Canada</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2009-07-06 09:02:16 -0400" MODIFIED_BY="[Empty name]">
<P>3 months (8 weeks post treatment)</P>
<P>Outcome assessment: 3 months, 1 month (end of treatment) </P>
</CHAR_USER_DEF_2>
<CHAR_USER_DEF_3 MODIFIED="2009-07-06 09:02:21 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison treatment: standard care</P>
<P>Co-Interventions: not reported</P>
</CHAR_USER_DEF_3>
<CHAR_NOTES MODIFIED="2009-07-06 09:02:45 -0400" MODIFIED_BY="[Empty name]">
<P>IBDQ and disease activity scores not reported. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2011-01-07 13:51:59 -0500" MODIFIED_BY="John K MacDonald" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2010-05-27 09:01:34 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Boamah-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-27 09:01:34 -0400" MODIFIED_BY="[Empty name]">
<P>Not a controlled trial (before-after comparison), assessed gain in knowledge</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 07:02:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borgaonkar-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 07:02:47 -0400" MODIFIED_BY="[Empty name]">
<P>Follow up too short (14 days)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 07:02:59 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bruning-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 07:02:59 -0400" MODIFIED_BY="[Empty name]">
<P>Follow up too short (6 weeks)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-19 06:48:30 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cabras-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-19 06:48:30 -0400" MODIFIED_BY="[Empty name]">
<P>Not a controlled trial - compares psychotherapy by disease group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-19 06:48:31 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cabras-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-19 06:48:31 -0400" MODIFIED_BY="[Empty name]">
<P>Not a controlled trial - compares psychotherapy by disease group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-05-27 08:10:49 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Diaz-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-05-27 08:10:49 -0400" MODIFIED_BY="[Empty name]">
<P>Uncontrolled follow up (controls were dropped at end of treatment)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 07:04:21 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eaden-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 07:04:21 -0400" MODIFIED_BY="[Empty name]">
<P>Not at controlled trial (instrument development, case-control study)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 07:03:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eaden-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 07:03:47 -0400" MODIFIED_BY="[Empty name]">
<P>Follow up too short (1 month), assessed knowledge gain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 07:04:30 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Genthin-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 07:04:30 -0400" MODIFIED_BY="[Empty name]">
<P>Not a controlled trial (feasibility study, no control group; insufficient information)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-10 10:50:52 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grace-1954">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-10 10:50:52 -0500" MODIFIED_BY="[Empty name]">
<P>Retrospective design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 05:39:02 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hayutin-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 05:39:02 -0400" MODIFIED_BY="[Empty name]">
<P>Uncontrolled design (case series, before-after measurements)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-15 09:26:49 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hershfield-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-15 09:26:49 -0400" MODIFIED_BY="[Empty name]">
<P>Uncontrolled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-15 11:13:07 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hochgerner-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-15 11:13:07 -0400" MODIFIED_BY="[Empty name]">
<P>No untreated control group (compares effect based on disease entity), short term effects only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-24 08:47:41 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huguet-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-24 08:47:41 -0500" MODIFIED_BY="[Empty name]">
<P>Uncontrolled design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-04 12:12:13 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Joachim-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-04 12:12:13 -0500" MODIFIED_BY="[Empty name]">
<P>Uncontrolled design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-09 05:34:25 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaneko-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-09 05:34:25 -0400" MODIFIED_BY="[Empty name]">
<P>Uncontrolled design (before-after comparison)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-15 11:53:21 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karush-1968">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-15 11:53:21 -0400" MODIFIED_BY="[Empty name]">
<P>Part I: No control group for intervention (compares psychotic vs. non psychotic UC patients)</P>
<P>Part II: No formal control group, follow up and outcome criteria insufficiently specified</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-21 11:05:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khorana-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-21 11:05:10 -0400" MODIFIED_BY="[Empty name]">
<P>Case-control design, no intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-24 08:47:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maunder-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-24 08:47:57 -0500" MODIFIED_BY="[Empty name]">
<P>Uncontrolled design (feasibility study)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 07:04:57 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mawdsley-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 07:04:57 -0400" MODIFIED_BY="[Empty name]">
<P>Follow up too short (examines immediate effects during short term therapy)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-07 13:51:59 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Mickocka_x002d_Walus-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-07 13:51:59 -0500" MODIFIED_BY="John K MacDonald">
<P>Effect of knowing about emotional state (possibly leading to initiating psychological intervention) is examined rather than the effect of an intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-26 11:48:22 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miller-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-26 11:48:22 -0400" MODIFIED_BY="[Empty name]">
<P>Uncontrolled design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-05 10:52:10 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miller-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-05 10:52:10 -0500" MODIFIED_BY="[Empty name]">
<P>Uncontrolled design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-13 11:13:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moody-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-13 11:13:18 -0400" MODIFIED_BY="[Empty name]">
<P>Outcome criteria not relevant to review question (assessed interest in group support)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 07:34:21 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mussell-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 07:34:21 -0400" MODIFIED_BY="[Empty name]">
<P>Uncontrolled design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 07:34:49 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Connor-1964">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 07:34:49 -0400" MODIFIED_BY="[Empty name]">
<P>Retrospective design. High proportion of major psychiatric morbidity in treatment group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-09 11:40:20 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Quan-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-09 11:40:20 -0400" MODIFIED_BY="[Empty name]">
<P>Examined knowledge gain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-05-14 10:09:54 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Robinson-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-05-14 10:09:54 -0400" MODIFIED_BY="[Empty name]">
<P>Organizational/structural changes (open access) and procedural outcomes overrule patient related issues (to be discussed)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-05-13 05:06:34 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rogers-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-05-13 05:06:34 -0400" MODIFIED_BY="[Empty name]">
<P>Uncontrolled qualitative data only (spin off to Kennedy 2004)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-05 10:52:48 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sanchez_x002d_Roman-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-05 10:52:48 -0500" MODIFIED_BY="[Empty name]">
<P>IBD as comorbid condition in some patients, no separate results for IBD patients (information provided by author)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-13 11:13:29 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shaw-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-13 11:13:29 -0400" MODIFIED_BY="[Empty name]">
<P>Outcome criteria not relevant to review question (assessed short term pain relief)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-18 12:06:26 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shepanski-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-18 12:06:26 -0400" MODIFIED_BY="[Empty name]">
<P>No control group, no follow up (before after evaluation)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 08:05:14 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shetty-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 08:05:14 -0400" MODIFIED_BY="[Empty name]">
<P>Follow up too short (6 weeks)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 07:05:41 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smart-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 07:05:41 -0400" MODIFIED_BY="[Empty name]">
<P>Not a controlled trial (uncontrolled survey)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-18 11:46:51 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Szigethy-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-18 11:46:51 -0400" MODIFIED_BY="[Empty name]">
<P>No control group (before after evaluation)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 07:23:16 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Verma-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 07:23:16 -0400" MODIFIED_BY="[Empty name]">
<P>Not a controlled trial (uncontrolled survey)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 07:23:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wahed-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 07:23:18 -0400" MODIFIED_BY="[Empty name]">
<P>Retrospective design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 03:56:46 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Williams-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 03:56:46 -0400" MODIFIED_BY="[Empty name]">
<P>Not a psychological intervention (management issue)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2010-07-28 07:25:19 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2010-07-28 05:17:49 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sachse-2006">
<CHAR_METHODS MODIFIED="2010-07-28 05:11:07 -0400" MODIFIED_BY="[Empty name]">
<P>seems an NRCT but control group possibly retrospectively ascertained</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-07-28 05:15:47 -0400" MODIFIED_BY="[Empty name]">
<P>CD and UC volunteers (news paper ads etc.), sample size intervention/active control/untreated control: CD 40/9/10, UC 48/11/15</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-28 05:17:33 -0400" MODIFIED_BY="[Empty name]">
<P>active controls: autogenous training, untreated: self help group meeting attenders</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-07-28 05:17:49 -0400" MODIFIED_BY="[Empty name]">
<P>Unclear, various aspects of coping; might choose BDI for depression, functional stress management, symptom improvement (unclear what symptoms)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-07-28 05:09:48 -0400" MODIFIED_BY="[Empty name]">
<P>Book, not peer reviewed, German language only. Need to get more information from author</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2011-01-10 14:36:20 -0500" MODIFIED_BY="John K MacDonald" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2010-03-24 10:20:05 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Andrews-2010">
<CHAR_STUDY_NAME MODIFIED="2010-03-24 10:12:39 -0400" MODIFIED_BY="[Empty name]">
<P>CBT in IBD</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2010-03-24 10:13:03 -0400" MODIFIED_BY="[Empty name]">
<P>RCT - not blinded (not confirmed as yet; abstract information only). multicenter trial, details not reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-03-24 10:14:52 -0400" MODIFIED_BY="[Empty name]">
<P>Crohn's disease and ulcerative colitis, mild or quiescent disease, age &gt;= 18 years, suitable for cognitive behavioural therapy as judged by clinical psychologist</P>
<P>Exclusion criteria: not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-03-24 10:16:51 -0400" MODIFIED_BY="[Empty name]">
<P>cognitive behavioural therapy (CBT)</P>
<P>type of contact: group sessions</P>
<P>duration and dosing: 1 session per week, each 2 hours, 10 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-03-24 10:17:46 -0400" MODIFIED_BY="[Empty name]">
<P>"improved psychological status" (not specified), assessed at 10 weeks, 6 and 12 months</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2010-03-24 10:19:17 -0400" MODIFIED_BY="[Empty name]">
<P>(recruitment ongoing according to preliminary meeting abstract 2010)</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2010-03-24 10:20:05 -0400" MODIFIED_BY="[Empty name]">
<P>JM Andrews, A ;Mikocka-Walus, Adelaide, Australia</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2010-03-24 10:18:42 -0400" MODIFIED_BY="[Empty name]">
<P>report problems with low response rate</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2011-01-10 14:36:20 -0500" MODIFIED_BY="John K MacDonald" STUDY_ID="STD-Boye-2010">
<CHAR_STUDY_NAME MODIFIED="2009-12-11 05:39:44 -0500" MODIFIED_BY="[Empty name]">
<P>INSPIRE</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2009-12-11 07:08:15 -0500" MODIFIED_BY="[Empty name]">
<P>RCT - not blinded (not confirmed as yet; abstract information only). multicenter trial, details not reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-12-11 07:07:45 -0500" MODIFIED_BY="[Empty name]">
<P>Crohn's disease and ulcerative colitis, active disease / recent activity, age not reported. All must be distressed (perceived stress questionnaire, PSQ &gt; 60).</P>
<P>Exclusion criteria: serious mental or physical co-conditions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-10 14:36:20 -0500" MODIFIED_BY="John K MacDonald">
<P>stress management psychotherapy : "psychoeducation", problem solving, relaxation (3 sessions), individualized cognitive behaviour methods (6-9 sessions)</P>
<P>type of contact: group and individual sessions</P>
<P>duration and dosing: 9 to 12 sessions (see above)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-07 13:52:36 -0500" MODIFIED_BY="John K MacDonald">
<P>HRQL: not reported</P>
<P>other psychological endpoints: not reported</P>
<P>somatic endpoints: simple CD index, clinical activity index</P>
<P>Outcome assessment at 0,3,6,12 and 18 months</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2009-12-11 07:11:22 -0500" MODIFIED_BY="[Empty name]">
<P>Study is completed, manuscript currently under review</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2010-03-24 10:20:02 -0400" MODIFIED_BY="[Empty name]">
<P>Dr. Jantschek (Coauthor of the Cochrane review), Lübeck, Germany</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2009-12-11 07:08:42 -0500" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2011-01-07 13:51:58 -0500" MODIFIED_BY="John K MacDonald">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2010-07-28 05:09:27 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:04:15 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bregenzer-2005">
<DESCRIPTION>
<P>Allocation based on distance of home from center - high risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:08:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<DESCRIPTION>
<P>Allocation performed by day of submission (author information) - moderate risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:03:52 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grootenhuis-2009">
<DESCRIPTION>
<P>Allocation based on distance of home from center - high risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:08:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jaghult-2007">
<DESCRIPTION>
<P>Allocation performed by date of submission - moderate risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-24 10:14:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jantschek-1998">
<DESCRIPTION>
<P>"Random allocation using a balanced procedure", computer generated (personal information)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-24 10:12:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2003">
<DESCRIPTION>
<P>Method not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:33:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2004">
<DESCRIPTION>
<P>"Prepared sequence of random numbers, drawn out of a hat"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:06:08 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<DESCRIPTION>
<P>Treatment allocation based on time of admission - high risk of selection and performance bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:04:23 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lange-1996">
<DESCRIPTION>
<P>Allocation based on distance of home from center - high risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:11:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Langhorst-2007">
<DESCRIPTION>
<P>"Any other "random" rule" (author information) - moderate risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:35:26 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Larsson-2003">
<DESCRIPTION>
<P>"Randomly assigned regarding the period of participation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:40:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lecouturier-2003">
<DESCRIPTION>
<P>"Randomised trial", method not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:39:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Milne-1986">
<DESCRIPTION>
<P>Method not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:36:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2007">
<DESCRIPTION>
<P>Method not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:12:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oxelmark-2007">
<DESCRIPTION>
<P>Allocation based on registration numbers (even and odd) (author information) - moderate risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:39:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schmidt-1992">
<DESCRIPTION>
<P>Method not reported in detail, detailed matching used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:07:11 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schreiber-1999">
<DESCRIPTION>
<P>Allocation based on treatment center - high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-15 07:08:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwarz-1991">
<DESCRIPTION>
<P>Not reported; convenience procedure likely ("all patients received the treatment by the investigator")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:37:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smith-2002">
<DESCRIPTION>
<P>Method not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:38:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Szigethy-2007">
<DESCRIPTION>
<P>Method not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:42:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waters-2005">
<DESCRIPTION>
<P>Random cards (author information)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-07-28 05:09:27 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bregenzer-2005">
<DESCRIPTION>
<P>Allocation based on distance of home from center - open allocation - high risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:08:42 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<DESCRIPTION>
<P>Allocation was performed by therapist - open allocation - high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:04:04 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grootenhuis-2009">
<DESCRIPTION>
<P>Allocation based on distance of home from center - open allocation - high risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:09:06 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jaghult-2007">
<DESCRIPTION>
<P>Treatment allocation performed by investigator - open allocation - high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-24 10:14:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jantschek-1998">
<DESCRIPTION>
<P>Central phone call used for informing investigators following inclusion (personal information)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:41:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kennedy-2003">
<DESCRIPTION>
<P>Method not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:33:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2004">
<DESCRIPTION>
<P>Allocation through a "statistician not associated with the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:05:57 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<DESCRIPTION>
<P>"Time interval plan" - open allocation - high risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:04:50 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lange-1996">
<DESCRIPTION>
<P>Allocation based on distance of home from center - open allocation - high risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:12:11 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Langhorst-2007">
<DESCRIPTION>
<P>Allocation performed by therapist - open allocation - high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:35:29 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Larsson-2003">
<DESCRIPTION>
<P>"Randomly assigned regarding the period of participation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:40:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lecouturier-2003">
<DESCRIPTION>
<P>Method not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:40:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Milne-1986">
<DESCRIPTION>
<P>Randomization followed inclusion / assessment of base line criteria, method not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:37:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2007">
<DESCRIPTION>
<P>Method not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:12:38 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oxelmark-2007">
<DESCRIPTION>
<P>Allocation by investigator based on registration numbers (author information) - open allocation - high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:39:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schmidt-1992">
<DESCRIPTION>
<P>Method not reported, allocation likely to have been performed by investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:07:06 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schreiber-1999">
<DESCRIPTION>
<P>Allocation based on center - open allocation - high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-29 13:08:17 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwarz-1991">
<DESCRIPTION>
<P>Allocation performed by investigator - open allocation - high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:37:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-2002">
<DESCRIPTION>
<P>Opaque sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:38:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Szigethy-2007">
<DESCRIPTION>
<P>Method not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:42:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waters-2005">
<DESCRIPTION>
<P>Sealed envelopes prepared by third party (author information)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2010-07-28 05:09:27 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.04" NO="4">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2009-11-25 06:44:32 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bregenzer-2005">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-03-19 10:23:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias. Blinded outcome assessment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-03-19 10:36:59 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grootenhuis-2009">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2009-12-09 08:55:25 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jaghult-2007">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2009-12-09 08:55:38 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jantschek-1998">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2009-12-10 07:58:12 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kennedy-2003">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2009-12-18 10:17:42 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kennedy-2004">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2009-12-18 10:17:49 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-03-23 10:23:32 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lange-1996">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2009-12-18 10:18:01 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Langhorst-2007">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2009-12-09 09:58:49 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Larsson-2003">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2009-12-18 10:18:12 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lecouturier-2003">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-03-15 09:09:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Milne-1986">
<DESCRIPTION>
<P>Blind outcome assessment, subjects and investigator not blinded </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-03-15 10:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oliveira-2007">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-03-15 10:43:26 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oxelmark-2007">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-03-29 12:54:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schmidt-1992">
<DESCRIPTION>
<P>Blinding of investigators reported, but uncertain how this might have been possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-03-15 11:11:31 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schreiber-1999">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-01-21 11:03:13 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwarz-1991">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-01-21 11:36:49 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Smith-2002">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-02-11 10:05:49 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Szigethy-2007">
<DESCRIPTION>
<P>Blind outcome assessment. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.04" MODIFIED="2010-02-12 05:37:00 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Waters-2005">
<DESCRIPTION>
<P>Blinding not possible - inherent high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="GROUP" NO="9">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="GROUP" NO="10">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2011-01-07 13:51:43 -0500" MODIFIED_BY="John K MacDonald" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.03" NO="3">
<NAME>Disease activity</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>Quality of life</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-02-22 06:49:39 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bregenzer-2005">
<DESCRIPTION>
<P>Assume complete case analysis only. Some uncertainty about number of cases in analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-02-22 06:50:14 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bregenzer-2005">
<DESCRIPTION>
<P>Complete case analysis, exact number provided. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-02-22 06:55:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<DESCRIPTION>
<P>All patients in analysis (author information)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-02-22 06:55:52 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<DESCRIPTION>
<P>All patients in analysis (author information)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-19 10:38:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grootenhuis-2009">
<DESCRIPTION>
<P>Examined for responder bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-19 10:37:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grootenhuis-2009">
<DESCRIPTION>
<P>disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-02-23 11:57:40 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jaghult-2007">
<DESCRIPTION>
<P>Number of dropouts presented. Per protocol analysis was performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-02-23 11:58:15 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jaghult-2007">
<DESCRIPTION>
<P>Not applicable (not assessed)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-07 13:50:58 -0500" MODIFIED_BY="John K MacDonald" RESULT="YES" STUDY_ID="STD-Jantschek-1998">
<DESCRIPTION>
<P>ITT analysis, all patients assessed at 12 months (psychological assessment)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2011-01-07 13:50:59 -0500" MODIFIED_BY="John K MacDonald" RESULT="YES" STUDY_ID="STD-Jantschek-1998">
<DESCRIPTION>
<P>ITT analysis, almost all patients assessed at 12 months (somatic assessment), bias unlikely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-05-21 07:24:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2003">
<DESCRIPTION>
<P>ITT analysis. Missing data for HRQL imputed. Standard errors adjusted using bootstrap methods. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-05 10:09:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kennedy-2003">
<DESCRIPTION>
<P>not applicable (not assessed)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-05-21 07:24:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2004">
<DESCRIPTION>
<P>ITT analysis. Missing data for HRQL imputed. Standard errors adjusted using bootstrap methods.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-05-21 07:24:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2004">
<DESCRIPTION>
<P>ITT analysis. Missing data for HRQL imputed. Standard errors adjusted using bootstrap methods.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-07 13:51:02 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<DESCRIPTION>
<P>n/a - HRQL not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-08 10:18:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<DESCRIPTION>
<P>examined for responder bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-23 10:25:14 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lange-1996">
<DESCRIPTION>
<P>per protocol analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-23 10:23:50 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lange-1996">
<DESCRIPTION>
<P>disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-01-11 05:18:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Langhorst-2007">
<DESCRIPTION>
<P>ITT (LOCF) (author information)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-01-11 05:18:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Langhorst-2007">
<DESCRIPTION>
<P>ITT (LOCF) (author information)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-10 11:14:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Larsson-2003">
<DESCRIPTION>
<P>exact numbers of dropouts given; examined for responder bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-10 11:06:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Larsson-2003">
<DESCRIPTION>
<P>n/a - disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-30 03:34:29 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lecouturier-2003">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-30 03:34:32 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lecouturier-2003">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-07 13:51:12 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-Milne-1986">
<DESCRIPTION>
<P>n/a - HRQL not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-15 09:23:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Milne-1986">
<DESCRIPTION>
<P>n/a (no drop outs)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-15 10:15:12 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oliveira-2007">
<DESCRIPTION>
<P>per protocol analysis performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-15 10:15:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2007">
<DESCRIPTION>
<P>n/a - disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-19 06:22:55 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oxelmark-2007">
<DESCRIPTION>
<P>per protocol analysis (author information)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-19 06:22:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oxelmark-2007">
<DESCRIPTION>
<P>n/a - disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-16 08:26:27 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schmidt-1992">
<DESCRIPTION>
<P>exact numbers per analysis not presented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-16 08:26:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schmidt-1992">
<DESCRIPTION>
<P>not sure whether disease activity was assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-16 09:27:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schreiber-1999">
<DESCRIPTION>
<P>number of drop outs reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-16 09:27:29 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schreiber-1999">
<DESCRIPTION>
<P>number of drop outs reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-07 13:51:43 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-Schwarz-1991">
<DESCRIPTION>
<P>HRQL not measured</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-02-15 07:08:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwarz-1991">
<DESCRIPTION>
<P>Disease activity data not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-01-21 11:37:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-2002">
<DESCRIPTION>
<P>outcome data were complete</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-01-21 11:37:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-2002">
<DESCRIPTION>
<P>outcome data were complete</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-02-11 10:06:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szigethy-2007">
<DESCRIPTION>
<P>ITT, LOCF</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-02-11 10:06:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szigethy-2007">
<DESCRIPTION>
<P>ITT, LOCF</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-19 08:06:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Waters-2005">
<DESCRIPTION>
<P>Per protocol analysis. Data on drop outs and reason for dropouts provided by author</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2010-03-19 08:06:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Waters-2005">
<DESCRIPTION>
<P>Per protocol analysis. Data on drop outs and reason for dropouts provided by author</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2011-01-07 13:51:33 -0500" MODIFIED_BY="John K MacDonald" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-25 06:45:11 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bregenzer-2005">
<DESCRIPTION>
<P>Some results reported for subgroups only. High risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-22 07:07:49 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<DESCRIPTION>
<P>Changes reported for selected single complaints </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-19 10:45:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grootenhuis-2009">
<DESCRIPTION>
<P>results presented on all outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-23 11:59:14 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jaghult-2007">
<DESCRIPTION>
<P>Only positive results reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-31 12:05:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jantschek-1998">
<DESCRIPTION>
<P>Disease activity not reported, outcomes are reported across several studies</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-05 10:09:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2003">
<DESCRIPTION>
<P>All outcome data reported as assessed. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-05 11:03:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2004">
<DESCRIPTION>
<P>All outcome data reported as assessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-08 10:23:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<DESCRIPTION>
<P>results reported in insufficient detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-23 10:25:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lange-1996">
<DESCRIPTION>
<P>results presented on most outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-09 11:18:27 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Langhorst-2007">
<DESCRIPTION>
<P>not all results presented, but data were supplied on request</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-09 09:59:41 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Larsson-2003">
<DESCRIPTION>
<P>selected subscores presented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:34:34 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lecouturier-2003">
<DESCRIPTION>
<P>Ssubscores only in abstract</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-07 13:51:12 -0500" MODIFIED_BY="John K MacDonald" RESULT="NO" STUDY_ID="STD-Milne-1986">
<DESCRIPTION>
<P>main outcome not reported (psychological functioning)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-15 10:21:23 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oliveira-2007">
<DESCRIPTION>
<P>results reported for treatment group only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-07 13:51:33 -0500" MODIFIED_BY="John K MacDonald" RESULT="YES" STUDY_ID="STD-Oxelmark-2007">
<DESCRIPTION>
<P>all results on HRQL reported as planned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 08:27:01 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schmidt-1992">
<DESCRIPTION>
<P>results are not presented in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:27:47 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schreiber-1999">
<DESCRIPTION>
<P>results not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-15 07:08:13 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwarz-1991">
<DESCRIPTION>
<P>Not all results reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-21 11:46:11 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Smith-2002">
<DESCRIPTION>
<P>SF36 - mental score only reported. Some outcomes only reported for subgroup with CD</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-28 04:33:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Szigethy-2007">
<DESCRIPTION>
<P>Disease activity not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-19 08:07:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waters-2005">
<DESCRIPTION>
<P>All results reported, more details provided by author</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2011-01-07 13:51:58 -0500" MODIFIED_BY="John K MacDonald" NO="7">
<NAME>Control for confounding</NAME>
<DESCRIPTION>
<P>Non randomized studies: were relevant confounders controlled for?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-22 06:53:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bregenzer-2005">
<DESCRIPTION>
<P>Neither randomized, not control for confounding, but balanced groups reported. Some risk of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-22 07:07:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<DESCRIPTION>
<P>RCT, reported balanced groups. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-19 10:37:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grootenhuis-2009">
<DESCRIPTION>
<P>Multiple regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-23 12:00:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jaghult-2007">
<DESCRIPTION>
<P>No randomization; balanced groups; no control for confounding in analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-24 10:14:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jantschek-1998">
<DESCRIPTION>
<P>used "balanced procedure" to match groups; randomized</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-05 10:10:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2003">
<DESCRIPTION>
<P>Logistic regression used to examine effect of confounders in multilevel analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-05 11:03:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2004">
<DESCRIPTION>
<P>Logistic regression used to examine effect of confounders in multilevel analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-08 10:21:14 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<DESCRIPTION>
<P>slightly unbalanced groups, no randomization, no multivariate analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-23 10:24:14 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lange-1996">
<DESCRIPTION>
<P>severe unbalance at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-09 11:20:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Langhorst-2007">
<DESCRIPTION>
<P>randomised, balanced groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-10 11:07:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Larsson-2003">
<DESCRIPTION>
<P>some matching procedures applied, not specified in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-30 03:34:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lecouturier-2003">
<DESCRIPTION>
<P>Nnot reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-15 09:09:48 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Milne-1986">
<DESCRIPTION>
<P>Severe unbalance between groups, no multivariate analysis, high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-07 13:51:23 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2007">
<DESCRIPTION>
<P>randomization, somewhat unbalanced groups, but little detail given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-19 06:59:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oxelmark-2007">
<DESCRIPTION>
<P>groups dissimilar at baseline (quality of life) - problematic for review as mean scores were used. controlled for in primary study as change score were used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 08:27:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schmidt-1992">
<DESCRIPTION>
<P>matching procedures applied, analysis offers potential for adjustment, but not reported in detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:27:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schreiber-1999">
<DESCRIPTION>
<P>details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-15 07:06:29 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwarz-1991">
<DESCRIPTION>
<P>Highly unbalanced groups, no control for confounding. Bias is likely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-17 08:27:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-2002">
<DESCRIPTION>
<P>randomization, balanced groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 05:25:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szigethy-2007">
<DESCRIPTION>
<P>RCT, balanced baseline characteristics</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-07 13:51:58 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-Waters-2005">
<DESCRIPTION>
<P>Groups dissimilar at baseline (HRQL) - problematic for review as mean scores were used. controlled for in primary study as change score were used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2011-01-07 13:51:43 -0500" MODIFIED_BY="John K MacDonald" NO="8">
<NAME>Validated score used</NAME>
<DESCRIPTION>
<P>Was the score used to assess quality of life validated for psychometric properties?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>Quality of life</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.02" NO="2">
<NAME>Disease activity</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-01-07 13:50:50 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-Bregenzer-2005">
<DESCRIPTION>
<P>Eypasch GI HRQL score. Some validation, but not explicitly validated for use in IBD.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2009-12-09 08:52:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bregenzer-2005">
<DESCRIPTION>
<P>CDAI</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-02-22 07:07:41 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2009-12-09 08:54:41 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Garcia_x002d_Vega-2004">
<DESCRIPTION>
<P>Only single item reductions reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-03-19 10:38:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grootenhuis-2009">
<DESCRIPTION>
<P>Dutch Children's AZL / TNO quality of Life Questionnaire (DUX-25); some internal validation presented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-19 10:38:08 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grootenhuis-2009">
<DESCRIPTION>
<P>n/a - disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-02-23 12:01:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jaghult-2007">
<DESCRIPTION>
<P>IBDQ; Swedish validation paper available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-02-23 11:58:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jaghult-2007">
<DESCRIPTION>
<P>Not applicable (not assessed)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2009-12-09 08:56:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jantschek-1998">
<DESCRIPTION>
<P>Life satisfaction score</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-31 12:12:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jantschek-1998">
<DESCRIPTION>
<P>CDAI, but not reported (used composite dichotomous endpoint and scoring system including information from CDAI)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2009-12-10 07:58:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2003">
<DESCRIPTION>
<P>IBDQ</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-05 10:10:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kennedy-2003">
<DESCRIPTION>
<P>not applicable (not assessed)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-03-05 11:04:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kennedy-2004">
<DESCRIPTION>
<P>IBDQ</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-05 12:12:29 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kennedy-2004">
<DESCRIPTION>
<P>self reported disease relapse (number of flares)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-01-07 13:51:03 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<DESCRIPTION>
<P>n/a - HRQL not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-08 10:20:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-K_x00fc_nsebeck-1987">
<DESCRIPTION>
<P>van Hees index</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-01-07 13:51:24 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-Lange-1996">
<DESCRIPTION>
<P>Eypasch HRQL scale - insufficiently validated for use in IBD</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-23 10:23:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lange-1996">
<DESCRIPTION>
<P>n/a - disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-03-09 11:18:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Langhorst-2007">
<DESCRIPTION>
<P>IBDQ</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-09 11:19:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Langhorst-2007">
<DESCRIPTION>
<P>CAI</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2009-12-09 09:59:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Larsson-2003">
<DESCRIPTION>
<P>IBDQ, but presented only subscores</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-10 11:06:46 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Larsson-2003">
<DESCRIPTION>
<P>n/a - disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2009-12-18 10:18:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lecouturier-2003">
<DESCRIPTION>
<P>IBDQ</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-30 03:34:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lecouturier-2003">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-01-07 13:51:13 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-Milne-1986">
<DESCRIPTION>
<P>n/a - HRQL not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-15 09:23:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Milne-1986">
<DESCRIPTION>
<P>CDAI, but seems to have been used also for ulcerative colitis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-03-15 10:18:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oliveira-2007">
<DESCRIPTION>
<P>IBDQ, but total scores not presented; SF 36</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-15 10:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2007">
<DESCRIPTION>
<P>n/a - disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-03-15 10:54:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oxelmark-2007">
<DESCRIPTION>
<P>IBDQ</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-15 10:55:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oxelmark-2007">
<DESCRIPTION>
<P>n/a - disease activity not assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-03-16 08:28:20 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schmidt-1992">
<DESCRIPTION>
<P>status informally assessed by investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-16 08:28:27 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schmidt-1992">
<DESCRIPTION>
<P>status informally assessed by investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-03-16 09:28:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schreiber-1999">
<DESCRIPTION>
<P>IBDQ, SF36</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-16 09:28:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schreiber-1999">
<DESCRIPTION>
<P>CDAI, CAI</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-01-07 13:51:43 -0500" MODIFIED_BY="John K MacDonald" RESULT="UNKNOWN" STUDY_ID="STD-Schwarz-1991">
<DESCRIPTION>
<P>HRQL not measured</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-01-21 11:05:04 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwarz-1991">
<DESCRIPTION>
<P>Used symptomatic change scores and single symptoms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-03-17 08:26:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-2002">
<DESCRIPTION>
<P>SF36</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-03-17 08:28:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-2002">
<DESCRIPTION>
<P>modified CDAI</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-02-11 10:07:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szigethy-2007">
<DESCRIPTION>
<P>CGAS, PCSC</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-02-11 10:07:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szigethy-2007">
<DESCRIPTION>
<P>PCDAI, CI</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2010-02-12 05:38:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waters-2005">
<DESCRIPTION>
<P>IBDQ, RFIPC</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2010-02-12 05:38:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waters-2005">
<DESCRIPTION>
<P>CDAI, AI</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2010-06-01 19:25:06 -0400" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2010-06-01 19:24:03 -0400" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2010-06-01 19:24:03 -0400" MODIFIED_BY="Grade Profiler">Psychotherapy in adults for treatment of inflammatory bowel disease</TITLE>
<TABLE COLS="7" ROWS="51">
<TR>
<TD COLSPAN="7">
<P>
<B>Psychotherapy in adults for treatment of inflammatory bowel disease</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with treatment of inflammatory bowel disease<BR/>
<B>Settings:</B> <BR/>
<B>Intervention:</B> Psychotherapy in adults<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Psychotherapy in adults</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life (3 to 8 months)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Quality of life (3 to 8 months) in the intervention groups was<BR/>
<B>0.28 standard deviations higher</B>
<BR/>(0.02 lower to 0.59 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>173<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.28 (-0.02 to 0.59)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life (9 to 18 months)</B>
<BR/>Follow-up: median 12 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Quality of life (9 to 18 months) in the intervention groups was<BR/>
<B>0.07 standard deviations lower</B>
<BR/>(0.33 lower to 0.19 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>235<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.07 (-0.33 to 0.19)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Depression (3 to 8 months)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Depression (3 to 8 months) in the intervention groups was<BR/>
<B>0.12 standard deviations higher</B>
<BR/>(0.16 lower to 0.4 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>219<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.12 (-0.16 to 0.4)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Depression (9 to 18 months)</B>
<BR/>Follow-up: median 12 months<SUP>4</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Depression (9 to 18 months) in the intervention groups was<BR/>
<B>0.03 standard deviations higher</B>
<BR/>(0.22 lower to 0.27 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>266<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.03 (-0.22 to 0.27)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Not in remission at/during month 3 to 8</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>OR 1.25 </B>
<BR/>(0.58 to 2.71)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>182<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>183 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>219 per 1000</B>
<BR/>(115 to 378)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>162 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>195 per 1000</B>
<BR/>(101 to 344)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Not in remission at/during month 9 to 18</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>OR 0.85 </B>
<BR/>(0.48 to 1.48)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>287<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>385 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>347 per 1000</B>
<BR/>(231 to 481)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>219 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>192 per 1000</B>
<BR/>(119 to 293)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio; </P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect. <BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Includes NRCT and qRCT<BR/>
<SUP>2</SUP> Small sample size, limited number of studies<BR/>
<SUP>3</SUP> Some evidence for publication bias<BR/>
<SUP>4</SUP> varies 9 to 18 months<BR/>
<SUP>5</SUP> No explanation was provided</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2010-06-01 19:05:40 -0400" MODIFIED_BY="Grade Profiler" NO="2" READONLY="YES">
<TITLE MODIFIED="2010-06-01 19:05:40 -0400" MODIFIED_BY="Grade Profiler">Psychotherapy in adolescents for treatment of inflammatory bowel disease</TITLE>
<TABLE COLS="7" ROWS="6">
<TR>
<TD COLSPAN="7">
<P>
<B>Psychotherapy in adolescents for treatment of inflammatory bowel disease</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with treatment of inflammatory bowel disease<BR/>
<B>Settings:</B> <BR/>
<B>Intervention:</B> Psychotherapy in adolescents<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Psychotherapy in adolescents</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life and coping at 3 to 8 months - Quality of life</B>
<BR/>Follow-up: median 6 months<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Quality of life and coping at 3 to 8 months - Quality of life in the intervention groups was<BR/>
<B>0.7 standard deviations higher</B>
<BR/>(0.21 to 1.18 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>71<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.7 (0.21 to 1.18)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life and coping at 3 to 8 months - Coping</B>
<BR/>Follow-up: median 6 months<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Quality of life and coping at 3 to 8 months - Coping in the intervention groups was<BR/>
<B>0.75 standard deviations higher</B>
<BR/>(0.26 to 1.25 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>69<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.75 (0.26 to 1.25)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Depression and anxiety at 3 to 8 months - Depression</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Depression and anxiety at 3 to 8 months - Depression in the intervention groups was<BR/>
<B>0.62 standard deviations lower</B>
<BR/>(1.25 lower to 0.01 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>41<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.62 (-1.25 to 0.01)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Depression and anxiety at 3 to 8 months - Anxiety</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Depression and anxiety at 3 to 8 months - Anxiety in the intervention groups was<BR/>
<B>0.58 standard deviations lower</B>
<BR/>(1.31 lower to 0.15 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>31<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,4,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.58 (-1.31 to 0.15)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; </P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect. <BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> range 3 to 8 months<BR/>
<SUP>2</SUP> NRCT included<BR/>
<SUP>3</SUP> 2 small studies only<BR/>
<SUP>4</SUP> Publication bias can not be appropriately assessed<BR/>
<SUP>5</SUP> Single small study</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2010-06-01 19:25:06 -0400" MODIFIED_BY="[Empty name]" NO="3" READONLY="YES">
<TITLE MODIFIED="2010-06-01 19:24:38 -0400" MODIFIED_BY="Grade Profiler">Patient education in adults for treatment of inflammatory bowel disease</TITLE>
<TABLE COLS="7" ROWS="49">
<TR>
<TD COLSPAN="7">
<P>
<B>Patient education in adults for treatment of inflammatory bowel disease</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with treatment of inflammatory bowel disease<BR/>
<B>Settings:</B> <BR/>
<B>Intervention:</B> Patient education in adults<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Patient education in adults</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life (3 to 8 months)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Quality of life (3 to 8 months) in the intervention groups was<BR/>
<B>0.1 standard deviations higher</B>
<BR/>(0.08 lower to 0.28 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>596<BR/>(7 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.1 (-0.08 to 0.28)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life (9 to 18 months)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Quality of life (9 to 18 months) in the intervention groups was<BR/>
<B>0.11 standard deviations higher</B>
<BR/>(0.02 lower to 0.24 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>947<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.11 (-0.02 to 0.24)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Depression (3 to 8 months)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Depression (3 to 8 months) in the intervention groups was<BR/>
<B>0.07 standard deviations lower</B>
<BR/>(0.26 lower to 0.12 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>430<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.07 (-0.26 to 0.12)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Depression (9 to 18 months)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Depression (9 to 18 months) in the intervention groups was<BR/>
<B>0.08 standard deviations lower</B>
<BR/>(0.29 lower to 0.12 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>378<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.08 (-0.29 to 0.12)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Not in remission at/during month 3 to 8</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>OR 1.35 </B>
<BR/>(0.73 to 2.48)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>221<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>281 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>345 per 1000</B>
<BR/>(222 to 492)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>281 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>345 per 1000</B>
<BR/>(222 to 492)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Not in remission at/during month 9 to 18</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>OR 1 </B>
<BR/>(0.65 to 1.53)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>434<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>586 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>586 per 1000</B>
<BR/>(479 to 684)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>219 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>219 per 1000</B>
<BR/>(154 to 300)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio; </P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect. <BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> NRCT included<BR/>
<SUP>2</SUP> publication bias can not be excluded<BR/>
<SUP>3</SUP> wide CI</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2010-07-28 04:35:00 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2010-07-28 04:34:28 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-06-24 10:45:06 -0400" MODIFIED_BY="[Empty name]">Databases searched</TITLE>
<TABLE COLS="5" ROWS="11">
<TR>
<TD>
<P>
<B>Database (Host)</B>
</P>
</TD>
<TD>
<P>
<B>Time span</B>
</P>
</TD>
<TD>
<P>
<B>Date searched</B>
</P>
<P>
<B>(yyyy-mm-dd)</B>
</P>
</TD>
<TD>
<P>
<B>Citations in Database</B>
</P>
</TD>
<TD>
<P>
<B>Citations after duplicate check: </B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Medline, Medline in Process &amp; Other Non-Indexed Citations (OvidSP)</P>
</TD>
<TD>
<P>1950 to April Week 3 2010</P>
</TD>
<TD>
<P>2010-04-29</P>
</TD>
<TD>
<P>832</P>
</TD>
<TD>
<P>832</P>
</TD>
</TR>
<TR>
<TD>
<P>Clinical Trials (CENTRAL)</P>
<P>(Wiley Interscience)</P>
</TD>
<TD>
<P>Issue 2/2010</P>
</TD>
<TD>
<P>2010-04-29</P>
</TD>
<TD>
<P>128</P>
</TD>
<TD>
<P>64</P>
</TD>
</TR>
<TR>
<TD>
<P>PSYNDEXplus Literature and Audiovisual Media (OvidSP)</P>
</TD>
<TD>
<P>1977 to March 2010</P>
</TD>
<TD>
<P>2010-04-26</P>
</TD>
<TD>
<P>349</P>
</TD>
<TD>
<P>315</P>
</TD>
</TR>
<TR>
<TD>
<P>PsycInfo  (via EBSCO)</P>
</TD>
<TD>
<P>1800s to April 2010 (weekly update)</P>
</TD>
<TD>
<P>2010-04-26</P>
</TD>
<TD>
<P>930</P>
</TD>
<TD>
<P>753</P>
</TD>
</TR>
<TR>
<TD>
<P>CCMed  (via DIMDI)</P>
</TD>
<TD>
<P>01.01.2000 - 18.02.2010</P>
</TD>
<TD>
<P>2010-05-03</P>
</TD>
<TD>
<P>19</P>
</TD>
<TD>
<P>13</P>
</TD>
</TR>
<TR>
<TD>
<P>CINAHL  (via EBSCO)</P>
</TD>
<TD>
<P>1981 to April 2010 (weekly update)</P>
</TD>
<TD>
<P>2010-05-06</P>
</TD>
<TD>
<P>706</P>
</TD>
<TD>
<P>589</P>
</TD>
</TR>
<TR>
<TD>
<P>Lilacs (www.bireme.br)</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>2010-05-03</P>
</TD>
<TD>
<P>806</P>
</TD>
<TD>
<P>803</P>
</TD>
</TR>
<TR>
<TD>
<P>Embase (DIMDI)</P>
<P> </P>
<P> </P>
<P>Embase-Alert (DIMDI)</P>
</TD>
<TD>
<P>01.01.1974 - 29.04.2010</P>
<P> </P>
<P>01.03.2010 - 29.04.2010</P>
</TD>
<TD>
<P>2010-04-29</P>
</TD>
<TD>
<P>853</P>
<P> </P>
</TD>
<TD>
<P>473</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Total</B>
</P>
</TD>
<TD>
<P>
<B> </B>
</P>
</TD>
<TD>
<P>
<B> </B>
</P>
</TD>
<TD>
<P>
<B>4623</B>
</P>
</TD>
<TD>
<P>
<B>3842</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2011-01-05 14:55:23 -0500" MODIFIED_BY="John K MacDonald">
<COMPARISON ID="CMP-001" MODIFIED="2011-01-05 14:52:19 -0500" MODIFIED_BY="John K MacDonald" NO="1">
<NAME>Psychotherapy in adults</NAME>
<CONT_OUTCOME CHI2="0.5045857690373476" CI_END="0.5851388617139797" CI_START="-0.017978390140863387" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.2835802357865581" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2011-01-05 14:46:53 -0500" MODIFIED_BY="John K MacDonald" NO="1" P_CHI2="0.9178828449698424" P_Q="0.7787129333886255" P_Z="0.06531230785690262" Q="0.500225640254333" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="82" UNITS="" WEIGHT="100.00000000000003" Z="1.8431144098753156">
<NAME>Quality of life (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.8680137207305931" CI_START="-0.24791706989277157" DF="0" EFFECT_SIZE="0.31004832541891075" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.01" MODIFIED="2010-05-21 09:44:47 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.2761070889188372" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="29.209826767200315" Z="1.0891061639200126">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.8680137207305931" CI_START="-0.24791706989277157" EFFECT_SIZE="0.31004832541891075" ESTIMABLE="YES" MEAN_1="68.7" MEAN_2="65.2" MODIFIED="2010-05-21 09:44:47 -0400" MODIFIED_BY="[Empty name]" ORDER="79" SD_1="11.6" SD_2="10.6" SE="0.2846814531863045" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="29.209826767200315"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.004360128783014662" CI_END="0.8073203565029956" CI_START="-0.07726375661329482" DF="1" EFFECT_SIZE="0.36502829994485037" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" MODIFIED="2010-05-21 09:44:47 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9473529289588632" P_Z="0.10575336818681616" STUDIES="2" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="46.48632693425247" Z="1.6175789517841739">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="1.0676197403087" CI_START="-0.3759985130756212" EFFECT_SIZE="0.34581061361653936" ESTIMABLE="YES" MEAN_1="176.8" MEAN_2="167.5" MODIFIED="2010-05-21 09:44:46 -0400" MODIFIED_BY="[Empty name]" ORDER="22" SD_1="21.1" SD_2="30.4" SE="0.3682767297693727" STUDY_ID="STD-Langhorst-2007" TOTAL_1="15" TOTAL_2="15" WEIGHT="17.454152790524418"/>
<CONT_DATA CI_END="0.9362519118570021" CI_START="-0.18308795309062026" EFFECT_SIZE="0.3765819793831909" ESTIMABLE="YES" MEAN_1="69.2" MEAN_2="65.4" MODIFIED="2010-05-21 09:44:47 -0400" MODIFIED_BY="[Empty name]" ORDER="80" SD_1="9.1" SD_2="10.7" SE="0.2855511309842508" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="29.03217414372805"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7076764143093895" CI_START="-0.5157116706582884" DF="0" EFFECT_SIZE="0.0959823718255506" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.03" MODIFIED="2011-01-05 14:46:53 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="1.0" P_Z="0.7584303838517286" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="17" WEIGHT="24.303846298547235" Z="0.3075426256644986">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.7076764143093895" CI_START="-0.5157116706582884" EFFECT_SIZE="0.0959823718255506" ESTIMABLE="YES" MEAN_1="45.5" MEAN_2="43.3" MODIFIED="2010-05-21 09:43:18 -0400" MODIFIED_BY="[Empty name]" ORDER="93" SD_1="23.8" SD_2="20.3" SE="0.3120945319958956" STUDY_ID="STD-Larsson-2003" TOTAL_1="26" TOTAL_2="17" WEIGHT="24.303846298547235"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5906530262825582" CI_END="0.19153727480859217" CI_START="-0.3287122494804473" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.06858748733592757" ESTIMABLE="YES" I2="0.0" I2_Q="26.382884751500065" ID="CMP-001.02" MODIFIED="2010-05-21 04:57:20 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6615110845159115" P_Q="0.24381864996381042" P_Z="0.6053051008330452" Q="1.3583797689225219" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="131" TOTAL_2="104" UNITS="" WEIGHT="100.0" Z="0.516786652144363">
<NAME>Quality of life (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.1227682333936478" CI_END="0.14282398151557626" CI_START="-0.5682225791708232" DF="1" EFFECT_SIZE="-0.21269929882762348" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.01" MODIFIED="2010-05-18 10:27:27 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7260513609660537" P_Z="0.24096037010875992" STUDIES="2" TAU2="0.0" TOTAL_1="76" TOTAL_2="53" WEIGHT="53.533705241329415" Z="1.1725897804403473">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.19724250523566456" CI_START="-0.7286609821827471" EFFECT_SIZE="-0.2657092384735413" ESTIMABLE="YES" MEAN_1="68.4" MEAN_2="73.9" MODIFIED="2009-12-09 07:37:18 -0500" MODIFIED_BY="[Empty name]" ORDER="38" SD_1="22.4" SD_2="16.4" SE="0.2362042095471703" STUDY_ID="STD-Jantschek-1998" TOTAL_1="51" TOTAL_2="28" WEIGHT="31.57126210726307"/>
<CONT_DATA CI_END="0.41856493319475946" CI_START="-0.6915587470438251" EFFECT_SIZE="-0.1364969069245328" ESTIMABLE="YES" MEAN_1="60.7" MEAN_2="62.2" MODIFIED="2010-05-18 10:27:27 -0400" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="11.4" SD_2="10.2" SE="0.28320002025422364" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="21.962443134066348"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.10950502396638873" CI_END="0.4790471661771213" CI_START="-0.28416040542296017" DF="1" EFFECT_SIZE="0.09744338037708054" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.02" MODIFIED="2010-05-18 10:27:26 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7407084024946344" P_Z="0.6167363008542217" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="51" WEIGHT="46.466294758670585" Z="0.5004811880220464">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.561726203879134" CI_START="-0.48869511759230666" EFFECT_SIZE="0.03651554314341368" ESTIMABLE="YES" MEAN_1="173.2" MEAN_2="171.9" MODIFIED="2010-01-11 05:22:47 -0500" MODIFIED_BY="[Empty name]" ORDER="23" SD_1="32.3" SD_2="38.1" SE="0.26796954682765345" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="26" WEIGHT="24.529930998673695"/>
<CONT_DATA CI_END="0.7209664906698461" CI_START="-0.3898168871225929" EFFECT_SIZE="0.1655748017736266" ESTIMABLE="YES" MEAN_1="68.0" MEAN_2="66.2" MODIFIED="2010-05-18 10:27:26 -0400" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="10.8" SD_2="10.6" SE="0.2833683135389621" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="21.936363759996894"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5906530262825582" CI_END="0.19153727480859217" CI_START="-0.3287122494804473" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.06858748733592757" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2010-07-30 14:09:33 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6615110845159115" P_Q="0.5799567767227989" P_Z="0.6053051008330452" Q="0.30630469253404696" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="131" TOTAL_2="104" UNITS="" WEIGHT="100.0" Z="0.516786652144363">
<NAME>Quality of life by intensity (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.7158287013413034" CI_END="0.21372954080099169" CI_START="-0.48085584752082067" DF="1" EFFECT_SIZE="-0.1335631533599145" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.01" MODIFIED="2010-07-30 14:09:33 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39751608201056576" P_Z="0.45098707691798445" STUDIES="2" TAU2="0.0" TOTAL_1="81" TOTAL_2="54" WEIGHT="56.101193105936765" Z="0.7537704496765084">
<NAME>High intensity</NAME>
<CONT_DATA CI_END="0.19724250523566456" CI_START="-0.7286609821827471" EFFECT_SIZE="-0.2657092384735413" ESTIMABLE="YES" MEAN_1="68.4" MEAN_2="73.9" MODIFIED="2010-05-18 10:29:46 -0400" MODIFIED_BY="[Empty name]" ORDER="180" SD_1="22.4" SD_2="16.4" SE="0.2362042095471703" STUDY_ID="STD-Jantschek-1998" TOTAL_1="51" TOTAL_2="28" WEIGHT="31.57126210726307"/>
<CONT_DATA CI_END="0.561726203879134" CI_START="-0.48869511759230666" EFFECT_SIZE="0.03651554314341368" ESTIMABLE="YES" MEAN_1="173.2" MEAN_2="171.9" MODIFIED="2010-05-18 10:29:48 -0400" MODIFIED_BY="[Empty name]" ORDER="181" SD_1="32.3" SD_2="38.1" SE="0.26796954682765345" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="26" WEIGHT="24.529930998673695"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.5685196324072079" CI_END="0.40705377846334545" CI_START="-0.37815533817450764" DF="1" EFFECT_SIZE="0.014449220144418887" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.02" MODIFIED="2010-07-30 14:09:33 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.45084789293316896" P_Z="0.9424956458757047" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="43.89880689406324" Z="0.07213352593004374">
<NAME>Low intensity</NAME>
<CONT_DATA CI_END="0.7209664906698461" CI_START="-0.3898168871225929" EFFECT_SIZE="0.1655748017736266" ESTIMABLE="YES" MEAN_1="68.0" MEAN_2="66.2" MODIFIED="2010-05-18 10:29:51 -0400" MODIFIED_BY="[Empty name]" ORDER="182" SD_1="10.8" SD_2="10.6" SE="0.2833683135389621" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="21.936363759996894"/>
<CONT_DATA CI_END="0.41856493319475946" CI_START="-0.6915587470438251" EFFECT_SIZE="-0.1364969069245328" ESTIMABLE="YES" MEAN_1="60.7" MEAN_2="62.2" MODIFIED="2010-05-18 10:29:53 -0400" MODIFIED_BY="[Empty name]" ORDER="183" SD_1="11.4" SD_2="10.2" SE="0.28320002025422364" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="21.962443134066348"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.5476538654388271" CI_START="-0.5610725802233908" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.006709357392281878" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2010-05-21 05:13:08 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.9810750848644157" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.023721088100186506">
<NAME>Coping, Sense of Coherence (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5476538654388271" CI_START="-0.5610725802233908" DF="0" EFFECT_SIZE="-0.006709357392281878" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.01" MODIFIED="2010-03-17 11:20:41 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9810750848644157" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.023721088100186506">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.5476538654388271" CI_START="-0.5610725802233908" EFFECT_SIZE="-0.006709357392281878" ESTIMABLE="YES" MEAN_1="13.79" MEAN_2="13.82" MODIFIED="2010-03-17 11:20:41 -0400" MODIFIED_BY="[Empty name]" ORDER="153" SD_1="4.3" SD_2="4.5" SE="0.2828435763125523" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.02" MODIFIED="2010-03-17 11:03:06 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Ulcerative colitis</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.13575799377921827" CI_START="-0.9864931552330335" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4253675807269076" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2010-05-21 05:13:12 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.13733921644681102" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.4857728399734014">
<NAME>Coping, Sense of Coherence (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.13575799377921827" CI_START="-0.9864931552330335" DF="0" EFFECT_SIZE="-0.4253675807269076" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.01" MODIFIED="2010-03-17 11:20:13 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.13733921644681102" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.4857728399734014">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.13575799377921827" CI_START="-0.9864931552330335" EFFECT_SIZE="-0.4253675807269076" ESTIMABLE="YES" MEAN_1="12.7" MEAN_2="14.58" MODIFIED="2010-03-17 11:20:13 -0400" MODIFIED_BY="[Empty name]" ORDER="157" SD_1="4.4" SD_2="4.3" SE="0.28629381913760293" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.05.02" MODIFIED="2010-03-17 11:02:42 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Ulcerative colitis</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.6941288799223715" CI_END="0.4024740515031585" CI_START="-0.15742488293589774" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.12252458428363038" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2011-01-05 14:51:02 -0500" MODIFIED_BY="John K MacDonald" NO="6" P_CHI2="0.87458403828266" P_Q="0.9704218020694684" P_Z="0.3909967646100796" Q="0.060048909427063216" RANDOM="YES" SCALE="3.8235121273282187" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="116" TOTAL_2="103" UNITS="" WEIGHT="99.99999999999999" Z="0.8578111428529501">
<NAME>Depression (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7013428237501158" CI_START="-0.40898643669731816" DF="0" EFFECT_SIZE="0.1461781935263988" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.01" MODIFIED="2010-01-21 12:06:04 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6058052906282647" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="25.428205475798773" Z="0.5160703312842788">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.7013428237501158" CI_START="-0.40898643669731816" EFFECT_SIZE="0.1461781935263988" ESTIMABLE="YES" MEAN_1="5.28" MEAN_2="4.76" MODIFIED="2010-01-21 12:06:04 -0500" MODIFIED_BY="[Empty name]" ORDER="73" SD_1="3.6" SD_2="3.4" SE="0.2832524651487398" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="25.428205475798773"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6340799704953084" CI_END="0.5200963630913569" CI_START="-0.2446015672877923" DF="1" EFFECT_SIZE="0.1377473979017823" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.02" MODIFIED="2010-01-21 11:50:09 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.42586292382635504" P_Z="0.4801205336632951" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="51" WEIGHT="53.60921555223378" Z="0.7061087211724014">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.8137240282223082" CI_START="-0.2423224808343274" EFFECT_SIZE="0.2857007736939904" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="3.6" MODIFIED="2010-01-11 05:24:32 -0500" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="4.0" SD_2="4.3" SE="0.2694045700294994" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="26" WEIGHT="28.109504582312674"/>
<CONT_DATA CI_END="0.5290372808931397" CI_START="-0.579734111316668" EFFECT_SIZE="-0.025348415211764133" ESTIMABLE="YES" MEAN_1="3.24" MEAN_2="3.32" MODIFIED="2010-01-21 11:50:09 -0500" MODIFIED_BY="[Empty name]" ORDER="64" SD_1="2.9" SD_2="3.3" SE="0.28285504247926363" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="25.499710969921104"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.947229954172915E-34" CI_END="0.6663464575043729" CI_START="-0.5565432369220429" DF="0" EFFECT_SIZE="0.054901610291165075" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-001.06.03" MODIFIED="2011-01-05 14:51:02 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="0.0" P_Z="0.8603056530844968" STUDIES="2" TAU2="0.0" TOTAL_1="36" TOTAL_2="27" WEIGHT="20.96257897196743" Z="0.17598509392036096">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.6663464575043729" CI_START="-0.5565432369220429" EFFECT_SIZE="0.05490161029116507" ESTIMABLE="YES" MEAN_1="6.7" MEAN_2="6.5" MODIFIED="2010-03-11 03:50:48 -0500" MODIFIED_BY="[Empty name]" ORDER="94" SD_1="3.9" SD_2="3.0" SE="0.3119673892154176" STUDY_ID="STD-Larsson-2003" TOTAL_1="26" TOTAL_2="17" WEIGHT="20.96257897196743"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="5.6" MEAN_2="4.3" MODIFIED="2010-01-21 11:09:18 -0500" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Schwarz-1991" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.9082100004485447" CI_END="0.26947151845669537" CI_START="-0.21906923560594255" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.025201141425376418" ESTIMABLE="YES" I2="0.0" I2_Q="48.07722859745781" ID="CMP-001.07" MODIFIED="2010-05-21 05:13:40 -0400" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.5733019246246915" P_Q="0.16520387437767314" P_Z="0.8397544228421714" Q="1.9259372583317829" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="147" TOTAL_2="119" UNITS="" WEIGHT="100.0" Z="0.20220761175926483">
<NAME>Depression (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.7711246383566374" CI_END="0.1991170580026373" CI_START="-0.435340401048317" DF="2" EFFECT_SIZE="-0.11811167152283987" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.01" MODIFIED="2010-01-21 12:05:07 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6800682928428554" P_Z="0.46554888238981984" STUDIES="3" TAU2="0.0" TOTAL_1="92" TOTAL_2="68" WEIGHT="59.292065769393155" Z="0.7297404074494444">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.45424476370739414" CI_START="-0.45424476370739414" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="7.8" MEAN_2="7.8" MODIFIED="2009-12-09 07:57:44 -0500" MODIFIED_BY="[Empty name]" ORDER="42" SD_1="8.1" SD_2="7.2" SE="0.23176179118107212" STUDY_ID="STD-Jantschek-1998" TOTAL_1="52" TOTAL_2="29" WEIGHT="28.917566707837313"/>
<CONT_DATA CI_END="0.3514230756343621" CI_START="-1.12075660270707" EFFECT_SIZE="-0.38466676353635393" ESTIMABLE="YES" MEAN_1="4.3" MEAN_2="5.7" MODIFIED="2009-11-24 11:36:36 -0500" MODIFIED_BY="[Empty name]" ORDER="6" SD_1="3.9" SD_2="3.1" SE="0.37556294145040353" STUDY_ID="STD-K_x00fc_nsebeck-1987" TOTAL_1="15" TOTAL_2="14" WEIGHT="11.012348829821569"/>
<CONT_DATA CI_END="0.41222141785828204" CI_START="-0.6980368236523443" EFFECT_SIZE="-0.14290770289703117" ESTIMABLE="YES" MEAN_1="4.96" MEAN_2="5.44" MODIFIED="2010-01-21 12:05:07 -0500" MODIFIED_BY="[Empty name]" ORDER="72" SD_1="3.5" SD_2="3.1" SE="0.28323434774011197" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="19.362150231734272"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.21114810376012538" CI_END="0.616791940603607" CI_START="-0.14891267733002778" DF="1" EFFECT_SIZE="0.2339396316367896" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.02" MODIFIED="2010-05-18 11:17:03 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6458690301082936" P_Z="0.23106330887922066" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="51" WEIGHT="40.70793423060685" Z="1.197624362778533">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.8481720923356482" CI_START="-0.20929987533604882" EFFECT_SIZE="0.3194361084997997" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="3.5" MODIFIED="2010-01-11 05:27:40 -0500" MODIFIED_BY="[Empty name]" ORDER="70" SD_1="3.1" SD_2="4.3" SE="0.2697682141133462" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="26" WEIGHT="21.343413074461207"/>
<CONT_DATA CI_END="0.6948012663997851" CI_START="-0.41538900495746117" EFFECT_SIZE="0.13970613072116195" ESTIMABLE="YES" MEAN_1="3.44" MEAN_2="3.0" MODIFIED="2010-05-18 11:17:03 -0400" MODIFIED_BY="[Empty name]" ORDER="65" SD_1="3.1" SD_2="3.1" SE="0.28321700809665007" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="19.364521156145642"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.219871466697076" CI_END="0.2120055283822237" CI_START="-0.3418755265782529" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.0649349990980146" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2011-01-05 14:51:28 -0500" MODIFIED_BY="John K MacDonald" NO="8" P_CHI2="0.7482424375491048" P_Q="0.5660348796193952" P_Z="0.6458334493440153" Q="1.1381997381786135" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="106" TOTAL_2="97" UNITS="" WEIGHT="100.00000000000001" Z="0.4595580889739267">
<NAME>Anxiety (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.29456776227536935" CI_START="-0.8193217199234282" DF="0" EFFECT_SIZE="-0.2623769788240294" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.01" MODIFIED="2010-03-17 10:46:45 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3558299926235732" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="24.72571249634922" Z="0.9233401285958946">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.29456776227536935" CI_START="-0.8193217199234282" EFFECT_SIZE="-0.2623769788240294" ESTIMABLE="YES" MEAN_1="7.12" MEAN_2="8.08" MODIFIED="2010-03-17 10:46:45 -0400" MODIFIED_BY="[Empty name]" ORDER="74" SD_1="3.5" SD_2="3.7" SE="0.2841607016723306" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="24.72571249634922"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.08167172851846255" CI_END="0.44392387966733543" CI_START="-0.3039704907793909" DF="1" EFFECT_SIZE="0.06997669444397224" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.02" MODIFIED="2010-01-21 11:51:44 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7750446005176705" P_Z="0.7137922001639194" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="55" WEIGHT="54.846951419618016" Z="0.3667678385797376">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.6263447792392074" CI_START="-0.3867474647686759" EFFECT_SIZE="0.11979865723526578" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.1" MODIFIED="2010-01-11 05:29:11 -0500" MODIFIED_BY="[Empty name]" ORDER="27" SD_1="4.5" SD_2="3.7" SE="0.2584466479994086" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="29.890628053859267"/>
<CONT_DATA CI_END="0.5646695751447514" CI_START="-0.5440614709673776" EFFECT_SIZE="0.010304052088686939" ESTIMABLE="YES" MEAN_1="6.72" MEAN_2="6.68" MODIFIED="2010-01-21 11:51:44 -0500" MODIFIED_BY="[Empty name]" ORDER="66" SD_1="3.4" SD_2="4.2" SE="0.28284474991827857" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="24.95632336575875"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4245645449673466" CI_START="-0.8009279151687643" DF="0" EFFECT_SIZE="-0.18818168510070882" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.03" MODIFIED="2011-01-05 14:51:28 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="1.0" P_Z="0.5472218373900286" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="17" WEIGHT="20.42733608403277" Z="0.6019283469218285">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.42456454496734647" CI_START="-0.800927915168764" EFFECT_SIZE="-0.18818168510070882" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="9.8" MODIFIED="2010-03-11 03:53:59 -0500" MODIFIED_BY="[Empty name]" ORDER="96" SD_1="4.6" SD_2="3.4" SE="0.3126313722605718" STUDY_ID="STD-Larsson-2003" TOTAL_1="26" TOTAL_2="17" WEIGHT="20.42733608403277"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.7768627271985769" CI_END="0.30071422101832557" CI_START="-0.22019820607954552" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.04025800746939004" ESTIMABLE="YES" I2="0.0" I2_Q="9.2503736012183" ID="CMP-001.09" MODIFIED="2010-05-21 05:13:55 -0400" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.6199828907384379" P_Q="0.2938428043177501" P_Z="0.7619307906963119" Q="1.101932911112706" RANDOM="YES" SCALE="1.3409500025233398" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="130" TOTAL_2="104" UNITS="" WEIGHT="100.0" Z="0.3029462943279874">
<NAME>Anxiety (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.06076923446974878" CI_END="0.2661543069013588" CI_START="-0.44470241785539644" DF="1" EFFECT_SIZE="-0.08927405547701883" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.01" MODIFIED="2010-01-21 12:07:51 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8052842419459836" P_Z="0.6225141414371959" STUDIES="2" TAU2="0.0" TOTAL_1="75" TOTAL_2="53" WEIGHT="53.69888696923223" Z="0.49229029534372404">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.41069018600261253" CI_START="-0.5147163131450158" EFFECT_SIZE="-0.05201306357120163" ESTIMABLE="YES" MEAN_1="39.0" MEAN_2="39.6" MODIFIED="2009-12-09 08:00:27 -0500" MODIFIED_BY="[Empty name]" ORDER="44" SD_1="11.8" SD_2="10.7" SE="0.2360774244953266" STUDY_ID="STD-Jantschek-1998" TOTAL_1="50" TOTAL_2="28" WEIGHT="31.685775882015815"/>
<CONT_DATA CI_END="0.41222141785828204" CI_START="-0.6980368236523443" EFFECT_SIZE="-0.14290770289703117" ESTIMABLE="YES" MEAN_1="4.96" MEAN_2="5.44" MODIFIED="2010-01-21 12:07:51 -0500" MODIFIED_BY="[Empty name]" ORDER="75" SD_1="3.5" SD_2="3.1" SE="0.28323434774011197" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="22.013111087216412"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6141605816161224" CI_END="0.5732570764419923" CI_START="-0.1922848887788761" DF="1" EFFECT_SIZE="0.1904860938315581" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.02" MODIFIED="2010-01-21 11:52:36 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4332257548922386" P_Z="0.3293734681512276" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="51" WEIGHT="46.30111303076778" Z="0.97537666235673">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.8656877442408243" CI_START="-0.19256777153061588" EFFECT_SIZE="0.3365599863551042" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="4.5" MODIFIED="2010-01-11 05:30:33 -0500" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="3.9" SD_2="3.7" SE="0.26996810250566455" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="26" WEIGHT="24.229717744930994"/>
<CONT_DATA CI_END="0.5845235635195507" CI_START="-0.5242677727957885" EFFECT_SIZE="0.030127895361881055" ESTIMABLE="YES" MEAN_1="7.52" MEAN_2="7.4" MODIFIED="2010-01-21 11:52:36 -0500" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="3.5" SD_2="4.3" SE="0.28286013035477786" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="22.071395285836783"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.0555960044538377" CI_END="2.711737576756465" CI_START="0.5778589100282717" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="1.2517993930287703" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="15" I2="2.7046172659111254" I2_Q="2.692989914484503" ID="CMP-001.10" LOG_CI_END="0.4332476592064648" LOG_CI_START="-0.23817818593235032" LOG_EFFECT_SIZE="0.09753473663705721" METHOD="MH" MODIFIED="2010-07-30 14:09:02 -0400" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.3577940982112714" P_Q="0.3578380425138775" P_Z="0.5690652514143368" Q="2.0553503783975655" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.013464322450611558" TOTALS="YES" TOTAL_1="100" TOTAL_2="82" WEIGHT="100.0" Z="0.5694286939779889">
<NAME>Not in remission at/during month 3 to 8</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.192117391611163" CI_START="0.16149564628002055" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-001.10.01" LOG_CI_END="0.7918391812093448" LOG_CI_START="-0.7918391812093448" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-11-24 10:18:38 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="15" WEIGHT="17.699340359081894" Z="0.0">
<NAME>Crohn's disease</NAME>
<DICH_DATA CI_END="6.192117391611163" CI_START="0.16149564628002055" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.7918391812093448" LOG_CI_START="-0.7918391812093448" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-11-24 10:18:38 -0500" MODIFIED_BY="[Empty name]" ORDER="4" O_E="0.0" SE="0.9302605094190635" STUDY_ID="STD-Garcia_x002d_Vega-2004" TOTAL_1="30" TOTAL_2="15" VAR="0.8653846153846154" WEIGHT="17.699340359081894"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.362905918178847" CI_START="0.18275663511254195" DF="0" EFFECT_SIZE="0.6571428571428571" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" ID="CMP-001.10.02" LOG_CI_END="0.37344643004151346" LOG_CI_START="-0.7381268467068791" LOG_EFFECT_SIZE="-0.18234020833268275" MODIFIED="2009-11-30 05:26:38 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.5202130911317273" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="35.36847694327977" Z="0.6430169719642918">
<NAME>Ulcerative colitis</NAME>
<DICH_DATA CI_END="2.362905918178847" CI_START="0.18275663511254195" EFFECT_SIZE="0.6571428571428571" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.37344643004151346" LOG_CI_START="-0.7381268467068791" LOG_EFFECT_SIZE="-0.18234020833268275" MODIFIED="2009-11-30 05:26:38 -0500" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.6529436451384668" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.4263354037267081" WEIGHT="35.36847694327977"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.686795044632618" CI_START="0.733245327808485" DF="0" EFFECT_SIZE="2.2142857142857144" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" I2="0.0" ID="CMP-001.10.03" LOG_CI_END="0.8252180119468414" LOG_CI_START="-0.13475069563477204" LOG_EFFECT_SIZE="0.3452336581560347" MODIFIED="2010-01-11 07:37:24 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.15862115025155113" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="37" WEIGHT="46.932182697638346" Z="1.4097241522413155">
<NAME>IBD (mixed)</NAME>
<DICH_DATA CI_END="6.686795044632618" CI_START="0.733245327808485" EFFECT_SIZE="2.2142857142857144" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.8252180119468414" LOG_CI_START="-0.13475069563477204" LOG_EFFECT_SIZE="0.3452336581560347" MODIFIED="2010-01-11 07:37:24 -0500" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="0.5638903707551803" STUDY_ID="STD-Milne-1986" TOTAL_1="40" TOTAL_2="37" VAR="0.3179723502304147" WEIGHT="46.932182697638346"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3291026340530443" CI_END="1.4788313047132835" CI_START="0.4836086662300078" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="0.845680574952253" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="47" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.16991863538249835" LOG_CI_START="-0.3155059252179065" LOG_EFFECT_SIZE="-0.07279364491770408" METHOD="MH" MODIFIED="2011-01-05 14:51:48 -0500" MODIFIED_BY="John K MacDonald" NO="11" P_CHI2="0.9878588663874761" P_Q="0.88749489434397" P_Z="0.556648171195387" Q="0.23870502917040387" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="165" TOTAL_2="122" WEIGHT="100.00000000000001" Z="0.5878273738997878">
<NAME>Not in remission at/during month 9 to 18</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.09037879498148076" CI_END="1.5726465101045037" CI_START="0.35660001538549824" DF="2" EFFECT_SIZE="0.7488696613558438" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="34" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.19663111552651" LOG_CI_START="-0.4478186424230398" LOG_EFFECT_SIZE="-0.12559376344826495" MODIFIED="2009-12-09 07:39:34 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9558164369666546" P_Z="0.4449052635286125" STUDIES="3" TAU2="0.0" TOTAL_1="98" TOTAL_2="60" WEIGHT="56.736868576311636" Z="0.7639362107129932">
<NAME>Crohn's disease</NAME>
<DICH_DATA CI_END="3.9161644270334697" CI_START="0.16342521156212175" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.5928609181296085" LOG_CI_START="-0.7866809441457213" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2009-11-24 10:17:09 -0500" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="0.8103497187428812" STUDY_ID="STD-Garcia_x002d_Vega-2004" TOTAL_1="30" TOTAL_2="15" VAR="0.6566666666666667" WEIGHT="12.381513198024"/>
<DICH_DATA CI_END="1.8817910491921213" CI_START="0.2417495536832665" EFFECT_SIZE="0.6744791666666666" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="24" LOG_CI_END="0.2745713984638132" LOG_CI_START="-0.6166343190363711" LOG_EFFECT_SIZE="-0.171031460286279" MODIFIED="2009-12-09 07:39:34 -0500" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.5234986499990583" STUDY_ID="STD-Jantschek-1998" TOTAL_1="53" TOTAL_2="31" VAR="0.2740508365508365" WEIGHT="29.66795176531981"/>
<DICH_DATA CI_END="3.7611639735746514" CI_START="0.20356065446206575" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.5753222675532983" LOG_CI_START="-0.6913061615086719" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2009-11-24 11:22:56 -0500" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.7440238091428449" STUDY_ID="STD-K_x00fc_nsebeck-1987" TOTAL_1="15" TOTAL_2="14" VAR="0.5535714285714286" WEIGHT="14.687403612967826"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.543628888699885" CI_START="0.2821965932123575" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" I2="0.0" ID="CMP-001.11.02" LOG_CI_END="0.549448233522865" LOG_CI_START="-0.549448233522865" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-03-10 10:50:29 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="19.513264800085825" Z="0.0">
<NAME>Ulcerative colitis</NAME>
<DICH_DATA CI_END="3.543628888699885" CI_START="0.2821965932123575" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.549448233522865" LOG_CI_START="-0.549448233522865" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-16 08:13:58 -0500" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.6454972243679028" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.4166666666666667" WEIGHT="19.513264800085825"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.7138957052942716E-32" CI_END="3.10149044078104" CI_START="0.3129662229114274" DF="0" EFFECT_SIZE="0.9852216748768473" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" I2="100.0" ID="CMP-001.11.03" LOG_CI_END="0.49157044694788404" LOG_CI_START="-0.5045025314463475" LOG_EFFECT_SIZE="-0.006466042249231715" MODIFIED="2011-01-05 14:51:48 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="0.0" P_Z="0.9796989425259374" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="32" WEIGHT="23.749866623602554" Z="0.02544634822126989">
<NAME>Unspecified IBD</NAME>
<DICH_DATA CI_END="3.10149044078104" CI_START="0.3129662229114274" EFFECT_SIZE="0.9852216748768473" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.49157044694788404" LOG_CI_START="-0.5045025314463475" LOG_EFFECT_SIZE="-0.006466042249231715" MODIFIED="2010-01-11 07:36:16 -0500" MODIFIED_BY="[Empty name]" ORDER="72" O_E="0.0" SE="0.585098198149535" STUDY_ID="STD-Milne-1986" TOTAL_1="37" TOTAL_2="32" VAR="0.3423399014778325" WEIGHT="23.749866623602554"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.465430947525889" CI_END="0.22008127998980817" CI_START="-0.3399571606538918" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.05993794033204183" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2011-01-05 14:52:19 -0500" MODIFIED_BY="John K MacDonald" NO="12" P_CHI2="0.6902715431305262" P_Q="0.4856671429547279" P_Z="0.6748295118006016" Q="1.4444638789864848" RANDOM="YES" SCALE="102.37" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="106" TOTAL_2="93" UNITS="" WEIGHT="100.00000000000001" Z="0.41952907455169425">
<NAME>Disease activity (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5393243406564397" CI_START="-0.5694157471045839" DF="0" EFFECT_SIZE="-0.015045703224072086" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.01" MODIFIED="2010-03-17 10:13:19 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9575775138996102" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="25.5138604002597" Z="0.05319377691269244">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.5393243406564397" CI_START="-0.5694157471045839" EFFECT_SIZE="-0.015045703224072086" ESTIMABLE="YES" MEAN_1="127.6" MEAN_2="128.6" MODIFIED="2010-03-17 10:13:19 -0400" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="72.0" SD_2="58.1" SE="0.28284705650374803" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="25.5138604002597"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.020967068539404762" CI_END="0.42741983863960553" CI_START="-0.33523152724394456" DF="1" EFFECT_SIZE="0.04609415569783049" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.02" MODIFIED="2010-01-21 11:59:34 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8848687144757219" P_Z="0.8127204730122997" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="51" WEIGHT="53.92418259180924" Z="0.23691791323513878">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.5981411954507141" CI_START="-0.452558631961022" EFFECT_SIZE="0.07279128174484605" ESTIMABLE="YES" MEAN_1="2.9" MEAN_2="2.7" MODIFIED="2009-11-30 05:32:04 -0500" MODIFIED_BY="[Empty name]" ORDER="24" SD_1="2.8" SD_2="2.6" SE="0.26804059556693954" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="26" WEIGHT="28.410465757724857"/>
<CONT_DATA CI_END="0.5707375236893275" CI_START="-0.5380056835182065" EFFECT_SIZE="0.0163659200855605" ESTIMABLE="YES" MEAN_1="80.3" MEAN_2="79.6" MODIFIED="2010-01-21 11:59:34 -0500" MODIFIED_BY="[Empty name]" ORDER="68" SD_1="42.1" SD_2="42.1" SE="0.2828478522955419" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="25.513716834084388"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.22381352996940995" CI_START="-1.011239525137477" DF="0" EFFECT_SIZE="-0.39371299758403355" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.03" MODIFIED="2011-01-05 14:52:19 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="1.0" P_Z="0.21144445688446" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="17" WEIGHT="20.561957007931067" Z="1.2496034762542698">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.22381352996940995" CI_START="-1.011239525137477" EFFECT_SIZE="-0.39371299758403355" ESTIMABLE="YES" MEAN_1="28.7" MEAN_2="32.3" MODIFIED="2010-03-11 03:52:23 -0500" MODIFIED_BY="[Empty name]" ORDER="95" SD_1="9.9" SD_2="7.3" SE="0.31507034436571996" STUDY_ID="STD-Larsson-2003" TOTAL_1="26" TOTAL_2="17" WEIGHT="20.561957007931067"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.05920108735972017" CI_END="0.3474094855545494" CI_START="-0.2809685770854181" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.03322045423456567" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.13" MODIFIED="2010-07-30 14:09:02 -0400" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.9708332617700475" P_Q="0.8339463160818463" P_Z="0.8358265087785919" Q="0.043950258917262466" RANDOM="YES" SCALE="59.93" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="80" TOTAL_2="76" UNITS="" WEIGHT="100.0" Z="0.20723477702663043">
<NAME>Disease activity (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5387369179913329" CI_START="-0.5700045269661919" DF="0" EFFECT_SIZE="-0.015633804487429435" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.01" MODIFIED="2010-03-17 10:15:38 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9559210284932524" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="32.12043855026971" Z="0.05527292927680942">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.5387369179913329" CI_START="-0.5700045269661919" EFFECT_SIZE="-0.015633804487429435" ESTIMABLE="YES" MEAN_1="113.8" MEAN_2="114.9" MODIFIED="2010-03-17 10:15:38 -0400" MODIFIED_BY="[Empty name]" ORDER="70" SD_1="70.1" SD_2="68.4" SE="0.2828474027337073" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="32.12043855026971"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.015250828442457707" CI_END="0.43768619554584975" CI_START="-0.32500986122291575" DF="1" EFFECT_SIZE="0.05633816716146697" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.02" MODIFIED="2010-01-21 12:01:01 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9017157348819407" P_Z="0.7721576002993621" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="51" WEIGHT="67.87956144973029" Z="0.2895538205855701">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.5587875991460275" CI_START="-0.491619287191739" EFFECT_SIZE="0.033584155977144266" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.9" MODIFIED="2009-11-30 05:33:02 -0500" MODIFIED_BY="[Empty name]" ORDER="25" SD_1="3.5" SD_2="2.1" SE="0.2679658643279269" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="26" WEIGHT="35.7871331657709"/>
<CONT_DATA CI_END="0.6363243763664841" CI_START="-0.4729008177385694" EFFECT_SIZE="0.08171177931395733" ESTIMABLE="YES" MEAN_1="78.6" MEAN_2="75.1" MODIFIED="2010-01-21 12:01:01 -0500" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="43.1" SD_2="41.2" SE="0.28297081039612976" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="32.092428283959386"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-15.708389754454899" CI_START="-102.4916102455451" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-59.1" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.14" MODIFIED="2010-07-30 14:09:02 -0400" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="1.0" P_Q="1.0" P_Z="0.007596444027196519" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="52" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="2.669499261051497">
<NAME>Days off work (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-15.708389754454899" CI_START="-102.4916102455451" DF="0" EFFECT_SIZE="-59.1" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.01" MODIFIED="2009-12-09 07:47:15 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.007596444027196519" STUDIES="1" TAU2="0.0" TOTAL_1="52" TOTAL_2="29" WEIGHT="100.0" Z="2.669499261051497">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="-15.708389754454906" CI_START="-102.4916102455451" EFFECT_SIZE="-59.1" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="46.1" MODIFIED="2009-12-09 07:47:15 -0500" MODIFIED_BY="[Empty name]" ORDER="40" SD_1="58.6" SD_2="110.9" SE="22.138983464906794" STUDY_ID="STD-Jantschek-1998" TOTAL_1="52" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-2.263454869314124" CI_START="-25.536545130685877" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-13.9" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.15" MODIFIED="2010-07-30 14:09:02 -0400" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.0192217788714097" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="24" UNITS="" WEIGHT="100.0" Z="2.34120171229044">
<NAME>Days in hospital (change from baseline) (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.263454869314124" CI_START="-25.536545130685877" DF="0" EFFECT_SIZE="-13.9" ESTIMABLE="YES" I2="0.0" ID="CMP-001.15.01" MODIFIED="2009-12-09 07:49:07 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.0192217788714097" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="24" WEIGHT="100.0" Z="2.34120171229044">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="-2.263454869314124" CI_START="-25.536545130685877" EFFECT_SIZE="-13.9" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="3.4" MODIFIED="2009-04-17 09:10:48 -0400" MODIFIED_BY="[Empty name]" ORDER="1" SD_1="21.4" SD_2="23.9" SE="5.93712191778699" STUDY_ID="STD-Jantschek-1998" TOTAL_1="40" TOTAL_2="24" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2010-07-30 14:09:47 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Psychotherapy in adolescents</NAME>
<CONT_OUTCOME CHI2="0.7792384293188843" CI_END="1.0709584395179763" CI_START="0.3790249197908276" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.7249916796544019" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2010-05-26 05:04:45 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.854426250742079" P_Q="0.8680935278135959" P_Z="4.0046988137349345E-5" Q="0.027582773913932455" RANDOM="YES" SCALE="3.02" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="67" TOTAL_2="73" UNITS="" WEIGHT="200.0" Z="4.107208397055707">
<NAME>Quality of life and coping at 3 to 8 months</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.7512586943350641" CI_END="1.1812881866935054" CI_START="0.211064172505599" DF="1" EFFECT_SIZE="0.6961761795995522" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.01" MODIFIED="2010-03-19 10:55:05 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3860780461892236" P_Z="0.004912566780828663" STUDIES="2" TAU2="0.0" TOTAL_1="34" TOTAL_2="37" WEIGHT="100.00000000000001" Z="2.812711742765723">
<NAME>Quality of life</NAME>
<CONT_DATA CI_END="1.1824114755111834" CI_START="-0.2651272896291004" EFFECT_SIZE="0.45864209294104147" ESTIMABLE="YES" MEAN_1="73.8" MEAN_2="67.0" MODIFIED="2010-03-19 10:55:05 -0400" MODIFIED_BY="[Empty name]" ORDER="168" SD_1="15.3" SD_2="13.8" SE="0.36927687869733444" STUDY_ID="STD-Grootenhuis-2009" TOTAL_1="13" TOTAL_2="18" WEIGHT="44.92453944146288"/>
<CONT_DATA CI_END="1.543607143548119" CI_START="0.23625389325669732" EFFECT_SIZE="0.8899305184024081" ESTIMABLE="YES" MEAN_1="69.9" MEAN_2="62.8" MODIFIED="2010-03-18 10:50:59 -0400" MODIFIED_BY="[Empty name]" ORDER="156" SD_1="6.7" SD_2="8.9" SE="0.3335146106264342" STUDY_ID="STD-Szigethy-2007" TOTAL_1="21" TOTAL_2="19" WEIGHT="55.07546055853713"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.9696106988794E-4" CI_END="1.2483555375903714" CI_START="0.26127835644293085" DF="1" EFFECT_SIZE="0.7548169470166511" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.02" MODIFIED="2010-05-19 04:29:48 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.984104094092191" P_Z="0.0027214577010452917" STUDIES="2" TAU2="0.0" TOTAL_1="33" TOTAL_2="36" WEIGHT="100.0" Z="2.9975650523160726">
<NAME>Coping</NAME>
<CONT_DATA CI_END="1.4899797531365042" CI_START="0.008422881579273622" EFFECT_SIZE="0.749201317357889" ESTIMABLE="YES" MEAN_1="9.5" MEAN_2="8.1" MODIFIED="2010-05-19 04:29:48 -0400" MODIFIED_BY="[Empty name]" ORDER="170" SD_1="1.7" SD_2="1.9" SE="0.37795512653384505" STUDY_ID="STD-Grootenhuis-2009" TOTAL_1="13" TOTAL_2="18" WEIGHT="44.387999260562395"/>
<CONT_DATA CI_END="1.421114572730903" CI_START="0.09748380960803071" EFFECT_SIZE="0.7592991911694669" ESTIMABLE="YES" MEAN_1="63.3" MEAN_2="54.7" MODIFIED="2010-03-18 10:53:07 -0400" MODIFIED_BY="[Empty name]" ORDER="157" SD_1="6.5" SD_2="14.6" SE="0.3376671136723692" STUDY_ID="STD-Szigethy-2007" TOTAL_1="20" TOTAL_2="18" WEIGHT="55.6120007394376"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0045920743432869855" CI_END="-0.12466918806256033" CI_START="-1.0782749779150065" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6014720829887834" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2010-07-30 14:09:47 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9459728283464438" P_Q="0.9459728283464439" P_Z="0.013419654411204213" Q="0.004592074343286984" RANDOM="YES" SCALE="4.87" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="35" TOTAL_2="37" UNITS="" WEIGHT="200.0" Z="2.4724338566499493">
<NAME>Depression and anxiety at 3 to 8 months</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.013945322649884795" CI_START="-1.2453247508575513" DF="0" EFFECT_SIZE="-0.6156897141038333" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" MODIFIED="2010-07-30 14:09:47 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.05529459306525656" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="19" WEIGHT="100.0" Z="1.9165541859248352">
<NAME>Depression</NAME>
<CONT_DATA CI_END="0.013945322649884795" CI_START="-1.2453247508575513" EFFECT_SIZE="-0.6156897141038333" ESTIMABLE="YES" MEAN_1="10.7" MEAN_2="16.7" MODIFIED="2010-05-26 05:06:00 -0400" MODIFIED_BY="[Empty name]" ORDER="147" SD_1="8.0" SD_2="11.1" SE="0.32124826870299605" STUDY_ID="STD-Szigethy-2007" TOTAL_1="22" TOTAL_2="19" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.14769963771706152" CI_START="-1.3124147762846103" DF="0" EFFECT_SIZE="-0.5823575692837745" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.02" MODIFIED="2010-07-30 14:09:47 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.11794938834559979" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="18" WEIGHT="100.0" Z="1.563438934613764">
<NAME>Anxiety</NAME>
<CONT_DATA CI_END="0.14769963771706152" CI_START="-1.3124147762846103" EFFECT_SIZE="-0.5823575692837745" ESTIMABLE="YES" MEAN_1="29.2" MEAN_2="34.7" MODIFIED="2010-05-26 05:06:34 -0400" MODIFIED_BY="[Empty name]" ORDER="148" SD_1="8.1" SD_2="9.9" SE="0.3724850113366542" STUDY_ID="STD-Grootenhuis-2009" TOTAL_1="13" TOTAL_2="18" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2011-01-05 14:55:11 -0500" MODIFIED_BY="John K MacDonald" NO="3">
<NAME>Patient education in adults</NAME>
<CONT_OUTCOME CHI2="10.253484000498037" CI_END="0.2765978918926586" CI_START="-0.08377501899398523" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.09641143644933667" ESTIMABLE="YES" I2="12.224956906717294" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2011-01-05 14:52:39 -0500" MODIFIED_BY="John K MacDonald" NO="1" NOTES="&lt;p&gt;Results for Waters, IBDQ in education group are not plausible suspect typo will ask - later: corrections received and incorporated.. &lt;/p&gt;" NOTES_MODIFIED="2011-01-05 14:52:39 -0500" NOTES_MODIFIED_BY="John K MacDonald" P_CHI2="0.3303568658869708" P_Q="0.9257051221199886" P_Z="0.2943126337074303" Q="0.15439912166442815" RANDOM="YES" SCALE="2.093903258597915" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.010306389316889156" TOTALS="YES" TOTAL_1="299" TOTAL_2="297" UNITS="" WEIGHT="100.0" Z="1.0487078103265697">
<NAME>Quality of life (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9675777666351907" CI_END="0.493120916098393" CI_START="-0.26180900442183924" DF="2" EFFECT_SIZE="0.11565595583827688" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.01" MODIFIED="2010-05-19 10:52:27 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6164433781170011" P_Z="0.5481487075192402" STUDIES="3" TAU2="0.0" TOTAL_1="60" TOTAL_2="51" WEIGHT="20.651406925337845" Z="0.600536558106926">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.5154495427902755" CI_START="-0.7310269712248013" EFFECT_SIZE="-0.10778871421726284" ESTIMABLE="YES" MEAN_1="98.35" MEAN_2="100.24" MODIFIED="2010-05-19 10:52:27 -0400" MODIFIED_BY="[Empty name]" ORDER="35" SD_1="16.918" SD_2="17.669" SE="0.3179845455955121" STUDY_ID="STD-Jaghult-2007" TOTAL_1="26" TOTAL_2="16" WEIGHT="7.585474681111155"/>
<CONT_DATA CI_END="0.9767117207116354" CI_START="-0.8251836534323864" EFFECT_SIZE="0.07576403363962451" ESTIMABLE="YES" MEAN_1="181.0" MEAN_2="178.9" MODIFIED="2010-05-19 10:52:27 -0400" MODIFIED_BY="[Empty name]" ORDER="156" SD_1="22.3" SD_2="29.7" SE="0.459675633929282" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="9" TOTAL_2="10" WEIGHT="3.8138404052808363"/>
<CONT_DATA CI_END="0.8680137207305931" CI_START="-0.24791706989277157" EFFECT_SIZE="0.31004832541891075" ESTIMABLE="YES" MEAN_1="68.7" MEAN_2="65.2" MODIFIED="2010-03-17 10:17:14 -0400" MODIFIED_BY="[Empty name]" ORDER="137" SD_1="11.6" SD_2="10.6" SE="0.2846814531863045" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="9.252091838945855"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.344615113310157" CI_END="0.4869318712217378" CI_START="-0.35763554947195725" DF="3" EFFECT_SIZE="0.06464816087489028" ESTIMABLE="YES" I2="52.71580787136481" ID="CMP-003.01.02" MODIFIED="2010-05-19 10:52:29 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.09599621499912214" P_Z="0.7641356945351663" STUDIES="4" TAU2="0.0928171806384809" TOTAL_1="128" TOTAL_2="137" WEIGHT="42.35303073746268" Z="0.3000543565307392">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.360649801819742" CI_START="-0.8905614085115294" EFFECT_SIZE="-0.2649558033458937" ESTIMABLE="YES" MEAN_1="105.96" MEAN_2="109.5" MODIFIED="2010-05-19 10:52:28 -0400" MODIFIED_BY="[Empty name]" ORDER="37" SD_1="13.651" SD_2="12.151" SE="0.3191923984829991" STUDY_ID="STD-Jaghult-2007" TOTAL_1="26" TOTAL_2="16" WEIGHT="7.533438906233606"/>
<CONT_DATA CI_END="0.625740412728812" CI_START="-0.00637924142601598" EFFECT_SIZE="0.309680585651398" ESTIMABLE="YES" MEAN_1="175.1" MEAN_2="162.8" MODIFIED="2010-05-19 10:52:28 -0400" MODIFIED_BY="[Empty name]" ORDER="46" SD_1="39.7" SD_2="39.4" SE="0.1612579769681757" STUDY_ID="STD-Kennedy-2003" TOTAL_1="68" TOTAL_2="91" WEIGHT="23.27638759778305"/>
<CONT_DATA CI_END="0.26805263682388725" CI_START="-2.0533783177625633" EFFECT_SIZE="-0.8926628404693381" ESTIMABLE="YES" MEAN_1="170.3" MEAN_2="205.8" MODIFIED="2010-05-19 10:52:29 -0400" MODIFIED_BY="[Empty name]" ORDER="157" SD_1="45.1" SD_2="9.5" SE="0.5922126561757262" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="9" TOTAL_2="5" WEIGHT="2.341068763925438"/>
<CONT_DATA CI_END="0.9362519118570021" CI_START="-0.18308795309062026" EFFECT_SIZE="0.3765819793831909" ESTIMABLE="YES" MEAN_1="69.2" MEAN_2="65.4" MODIFIED="2010-03-17 10:29:45 -0400" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="9.1" SD_2="10.7" SE="0.2855511309842508" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="9.202135469520588"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.2728992545356617" CI_END="0.3130586386483949" CI_START="-0.2725395212796816" DF="2" EFFECT_SIZE="0.02025955868435666" ESTIMABLE="YES" I2="12.006658631748866" ID="CMP-003.01.03" MODIFIED="2011-01-05 14:52:39 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="0.32095687068459566" P_Z="0.8921254897872666" STUDIES="3" TAU2="0.009016518486500862" TOTAL_1="111" TOTAL_2="109" WEIGHT="36.99556233719947" Z="0.13561519854806817">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.44547649583912463" CI_START="-0.24266128544136212" EFFECT_SIZE="0.10140760519888126" ESTIMABLE="YES" MEAN_1="109.0" MEAN_2="107.0" MODIFIED="2010-05-19 10:52:29 -0400" MODIFIED_BY="[Empty name]" ORDER="92" SD_1="20.5" SD_2="18.7" SE="0.17554857811378927" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="64" TOTAL_2="66" WEIGHT="20.552090235954907"/>
<CONT_DATA CI_END="0.22381352996940995" CI_START="-1.011239525137477" EFFECT_SIZE="-0.39371299758403355" ESTIMABLE="YES" MEAN_1="28.7" MEAN_2="32.3" MODIFIED="2010-05-19 10:52:30 -0400" MODIFIED_BY="[Empty name]" ORDER="99" SD_1="9.9" SD_2="7.3" SE="0.31507034436571996" STUDY_ID="STD-Larsson-2003" TOTAL_1="26" TOTAL_2="17" WEIGHT="7.713185994093474"/>
<CONT_DATA CI_END="0.7672931378507041" CI_START="-0.38561544341040166" EFFECT_SIZE="0.19083884722015124" ESTIMABLE="YES" MEAN_1="171.19" MEAN_2="164.85" MODIFIED="2010-03-30 10:24:41 -0400" MODIFIED_BY="[Empty name]" ORDER="164" SD_1="30.47" SD_2="34.32" SE="0.2941147363816635" STUDY_ID="STD-Waters-2005" TOTAL_1="21" TOTAL_2="26" WEIGHT="8.730286107151093"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.775488275482414" CI_END="0.23871659517780622" CI_START="-0.018299528944604487" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.11020853311660087" ESTIMABLE="YES" I2="0.0" I2_Q="5.267405655769021" ID="CMP-003.02" MODIFIED="2011-01-05 14:53:06 -0500" MODIFIED_BY="John K MacDonald" NO="2" P_CHI2="0.7070280807739813" P_Q="0.34798275225113295" P_Z="0.09278906109091495" Q="2.111205772252553" RANDOM="YES" SCALE="1.7905925873590536" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="433" TOTAL_2="514" UNITS="" WEIGHT="100.0" Z="1.6808654043405433">
<NAME>Quality of life (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.12101855375987836" CI_END="0.3781535267667854" CI_START="-0.5405329040876056" DF="1" EFFECT_SIZE="-0.08118968866041013" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.01" MODIFIED="2010-05-20 06:00:02 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7279324607286837" P_Z="0.729021880632029" STUDIES="2" TAU2="0.0" TOTAL_1="36" TOTAL_2="37" WEIGHT="7.8268342424777195" Z="0.34642694252582323">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.8572236199212525" CI_START="-0.7792339351942271" EFFECT_SIZE="0.038994842363512645" ESTIMABLE="YES" MEAN_1="176.7" MEAN_2="175.8" MODIFIED="2010-05-20 06:00:02 -0400" MODIFIED_BY="[Empty name]" ORDER="158" SD_1="14.4" SD_2="27.5" SE="0.4174713331529681" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="11" TOTAL_2="12" WEIGHT="2.466671119992719"/>
<CONT_DATA CI_END="0.41856493319475946" CI_START="-0.6915587470438251" EFFECT_SIZE="-0.1364969069245328" ESTIMABLE="YES" MEAN_1="60.7" MEAN_2="62.2" MODIFIED="2010-03-17 10:31:01 -0400" MODIFIED_BY="[Empty name]" ORDER="139" SD_1="11.4" SD_2="10.2" SE="0.28320002025422364" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="5.360163122485"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.34116970775560834" CI_END="0.5322370199500502" CI_START="-0.005400490119626289" DF="2" EFFECT_SIZE="0.263418264915212" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.02" MODIFIED="2010-05-20 06:00:01 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8431715697920025" P_Z="0.05478355796654815" STUDIES="3" TAU2="0.0" TOTAL_1="102" TOTAL_2="119" WEIGHT="22.852915711516218" Z="1.9205888816683807">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.625740412728812" CI_START="-0.00637924142601598" EFFECT_SIZE="0.309680585651398" ESTIMABLE="YES" MEAN_1="175.1" MEAN_2="162.8" MODIFIED="2010-05-20 06:00:01 -0400" MODIFIED_BY="[Empty name]" ORDER="45" SD_1="39.7" SD_2="39.4" SE="0.1612579769681757" STUDY_ID="STD-Kennedy-2003" TOTAL_1="68" TOTAL_2="91" WEIGHT="16.531876504805062"/>
<CONT_DATA CI_END="1.3209494743496368" CI_START="-1.2923730712268082" EFFECT_SIZE="0.014288201561414391" ESTIMABLE="YES" MEAN_1="165.9" MEAN_2="165.3" MODIFIED="2010-05-20 06:00:00 -0400" MODIFIED_BY="[Empty name]" ORDER="159" SD_1="39.4" SD_2="36.1" SE="0.6666761650188472" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="9" TOTAL_2="3" WEIGHT="0.9672410272468946"/>
<CONT_DATA CI_END="0.7209664906698461" CI_START="-0.3898168871225929" EFFECT_SIZE="0.1655748017736266" ESTIMABLE="YES" MEAN_1="68.0" MEAN_2="66.2" MODIFIED="2010-03-17 10:31:57 -0400" MODIFIED_BY="[Empty name]" ORDER="140" SD_1="10.8" SD_2="10.6" SE="0.2833683135389621" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="5.353798179464261"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.263868255381353" CI_END="0.25974668375588983" CI_START="-0.1267666702413575" DF="1" EFFECT_SIZE="0.06649000675726616" ESTIMABLE="YES" I2="20.877829177039875" ID="CMP-003.02.03" MODIFIED="2011-01-05 14:53:06 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="0.2609202471800657" P_Z="0.5001040275249254" STUDIES="2" TAU2="0.005376818506333927" TOTAL_1="295" TOTAL_2="358" WEIGHT="69.32025004600607" Z="0.6743260859079897">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.253560481880099" CI_START="-0.4598624467106596" EFFECT_SIZE="-0.1031509824152803" ESTIMABLE="YES" MEAN_1="107.0" MEAN_2="109.0" MODIFIED="2010-05-20 06:00:03 -0400" MODIFIED_BY="[Empty name]" ORDER="93" SD_1="18.8" SD_2="19.7" SE="0.18199898932280073" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="59" TOTAL_2="62" WEIGHT="12.978563135652703"/>
<CONT_DATA CI_END="0.2950061500169454" CI_START="-0.047403067386423234" EFFECT_SIZE="0.1238015413152611" ESTIMABLE="YES" MEAN_1="172.3" MEAN_2="167.7" MODIFIED="2010-05-20 05:47:26 -0400" MODIFIED_BY="[Empty name]" ORDER="50" SD_1="36.6" SD_2="37.5" SE="0.08735089524711905" STUDY_ID="STD-Kennedy-2004" TOTAL_1="236" TOTAL_2="296" WEIGHT="56.34168691035337"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.41551745089346" CI_END="0.38555149670393346" CI_START="-0.4188088501742467" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.016628676735156632" ESTIMABLE="YES" I2="46.896174043779844" I2_Q="27.6051616191636" ID="CMP-003.03" MODIFIED="2011-01-05 14:53:26 -0500" MODIFIED_BY="John K MacDonald" NO="3" NOTES="&lt;p&gt;wrong direction at least for Lange - check coping instruments!&lt;/p&gt;" NOTES_MODIFIED="2011-01-05 14:53:26 -0500" NOTES_MODIFIED_BY="John K MacDonald" P_CHI2="0.09359497511354353" P_Q="0.2512484572219117" P_Z="0.9354122649199215" Q="2.76262789548463" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.11426761356992714" TOTALS="YES" TOTAL_1="114" TOTAL_2="90" UNITS="" WEIGHT="100.0" Z="0.08103733019151943">
<NAME>Coping, Sense of Coherence (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.921370091805574" CI_END="0.3105995100908412" CI_START="-0.4401332654166903" DF="2" EFFECT_SIZE="-0.06476687766292452" ESTIMABLE="YES" I2="0.0" ID="CMP-003.03.01" MODIFIED="2010-03-19 06:55:07 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6308513687704325" P_Z="0.7352288668956601" STUDIES="3" TAU2="0.0" TOTAL_1="61" TOTAL_2="51" WEIGHT="54.47482939540048" Z="0.338178248644135">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.34203438935982444" CI_START="-0.9100195252231295" EFFECT_SIZE="-0.2839925679316525" ESTIMABLE="YES" MEAN_1="59.54" MEAN_2="63.47" MODIFIED="2009-12-02 10:08:03 -0500" MODIFIED_BY="[Empty name]" ORDER="42" SD_1="15.066" SD_2="10.643" SE="0.31940737800770713" STUDY_ID="STD-Jaghult-2007" TOTAL_1="26" TOTAL_2="16" WEIGHT="19.46755133047689"/>
<CONT_DATA CI_END="1.1019196890020908" CI_START="-0.6578395176545667" EFFECT_SIZE="0.22204008567376202" ESTIMABLE="YES" MEAN_1="144.2" MEAN_2="139.8" MODIFIED="2010-03-19 06:55:07 -0400" MODIFIED_BY="[Empty name]" ORDER="160" SD_1="16.2" SD_2="21.4" SE="0.4489264140916398" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.333050221597187"/>
<CONT_DATA CI_END="0.5476538654388271" CI_START="-0.5610725802233908" EFFECT_SIZE="-0.006709357392281878" ESTIMABLE="YES" MEAN_1="13.79" MEAN_2="13.82" MODIFIED="2010-03-17 11:18:26 -0400" MODIFIED_BY="[Empty name]" ORDER="76" SD_1="4.3" SD_2="4.5" SE="0.2828435763125523" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="21.674227843326392"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.867731615713125" CI_END="1.128933078995885" CI_START="-2.330718808885866" DF="1" EFFECT_SIZE="-0.6008928649449904" ESTIMABLE="YES" I2="82.95763907602534" ID="CMP-003.03.02" MODIFIED="2010-05-20 05:05:31 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.015420948602008377" P_Z="0.4959750540329456" STUDIES="2" TAU2="1.3070908887567636" TOTAL_1="35" TOTAL_2="21" WEIGHT="27.176780777831326" Z="0.6808363454048914">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.8168435182747849" CI_START="-0.43169342582045633" EFFECT_SIZE="0.19257504622716423" ESTIMABLE="YES" MEAN_1="67.19" MEAN_2="64.86" MODIFIED="2010-05-20 05:05:30 -0400" MODIFIED_BY="[Empty name]" ORDER="43" SD_1="11.679" SD_2="12.184" SE="0.3185101751724882" STUDY_ID="STD-Jaghult-2007" TOTAL_1="26" TOTAL_2="16" WEIGHT="19.519202893073185"/>
<CONT_DATA CI_END="-0.2890260327162766" CI_START="-2.876161829553738" EFFECT_SIZE="-1.5825939311350072" ESTIMABLE="YES" MEAN_1="130.2" MEAN_2="168.2" MODIFIED="2010-05-20 05:05:31 -0400" MODIFIED_BY="[Empty name]" ORDER="161" SD_1="25.9" SD_2="13.2" SE="0.6599957492189801" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="9" TOTAL_2="5" WEIGHT="7.657577884758142"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.1781598849649524" CI_START="-0.1523864275135307" DF="0" EFFECT_SIZE="0.5128867287257108" ESTIMABLE="YES" I2="0.0" ID="CMP-003.03.03" MODIFIED="2011-01-05 14:53:26 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="1.0" P_Z="0.1307839405284515" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="18" WEIGHT="18.3483898267682" Z="1.5110177030643033">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="1.1781598849649524" CI_START="-0.1523864275135307" EFFECT_SIZE="0.5128867287257108" ESTIMABLE="YES" MEAN_1="101.67" MEAN_2="95.0" MODIFIED="2010-05-20 05:05:32 -0400" MODIFIED_BY="[Empty name]" ORDER="169" SD_1="11.88" SD_2="13.5" SE="0.3394313168439988" STUDY_ID="STD-Lange-1996" TOTAL_1="18" TOTAL_2="18" WEIGHT="18.3483898267682"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.889136038809026" CI_END="0.44511701175660234" CI_START="-1.340501641159225" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4476923147013113" ESTIMABLE="YES" I2="66.03916114655648" I2_Q="73.94875908429455" ID="CMP-003.04" MODIFIED="2010-07-30 14:23:57 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.052624884735826605" P_Q="0.05008571033077458" P_Z="0.32570159019027356" Q="3.8385887383857114" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.39191201403018344" TOTALS="YES" TOTAL_1="45" TOTAL_2="40" UNITS="" WEIGHT="100.0" Z="0.9828087442266485">
<NAME>Coping, Sense of Coherence (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.9945925959340303" CI_END="0.5594877371029596" CI_START="-0.823885761066169" DF="1" EFFECT_SIZE="-0.1321990119816047" ESTIMABLE="YES" I2="49.86444840723382" ID="CMP-003.04.01" MODIFIED="2010-05-20 05:59:18 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.15786186053771578" P_Z="0.707958569517391" STUDIES="2" TAU2="0.1285276357842578" TOTAL_1="36" TOTAL_2="37" WEIGHT="80.29433131722985" Z="0.3745991991586448">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="1.116013110895682" CI_START="-0.5307704145490453" EFFECT_SIZE="0.2926213481733183" ESTIMABLE="YES" MEAN_1="143.6" MEAN_2="137.2" MODIFIED="2010-05-20 05:59:18 -0400" MODIFIED_BY="[Empty name]" ORDER="162" SD_1="19.4" SD_2="22.5" SE="0.4201055576618615" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="11" TOTAL_2="12" WEIGHT="36.50620224126767"/>
<CONT_DATA CI_END="0.13575799377921827" CI_START="-0.9864931552330335" EFFECT_SIZE="-0.4253675807269076" ESTIMABLE="YES" MEAN_1="12.7" MEAN_2="14.58" MODIFIED="2010-03-17 11:19:20 -0400" MODIFIED_BY="[Empty name]" ORDER="77" SD_1="4.4" SD_2="4.3" SE="0.28629381913760293" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="43.78812907596217"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.2751867375698962" CI_START="-3.4623849886063383" DF="0" EFFECT_SIZE="-1.8687858630881173" ESTIMABLE="YES" I2="0.0" ID="CMP-003.04.02" MODIFIED="2010-07-30 14:23:57 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.021538150177023308" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="3" WEIGHT="19.705668682770156" Z="2.2984155348850503">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="-0.2751867375698962" CI_START="-3.4623849886063383" EFFECT_SIZE="-1.8687858630881173" ESTIMABLE="YES" MEAN_1="129.6" MEAN_2="179.3" MODIFIED="2010-07-30 14:23:57 -0400" MODIFIED_BY="[Empty name]" ORDER="163" SD_1="27.4" SD_2="3.2" SE="0.8130757187827571" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="9" TOTAL_2="3" WEIGHT="19.705668682770156"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.1874186113263518" CI_END="0.12085424002821651" CI_START="-0.2594727030531164" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.06930923151244994" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.05" MODIFIED="2011-01-05 14:53:43 -0500" MODIFIED_BY="John K MacDonald" NO="5" P_CHI2="0.8801657007548553" P_Q="0.6608901658491508" P_Z="0.4750097410825924" Q="0.8283352781152958" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="209" TOTAL_2="221" UNITS="" WEIGHT="100.0" Z="0.7143516915208414">
<NAME>Depression (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7013428237501158" CI_START="-0.40898643669731816" DF="0" EFFECT_SIZE="0.1461781935263988" ESTIMABLE="YES" I2="0.0" ID="CMP-003.05.01" MODIFIED="2010-03-17 10:42:08 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6058052906282647" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="11.7330417404098" Z="0.5160703312842788">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.7013428237501158" CI_START="-0.40898643669731816" EFFECT_SIZE="0.1461781935263988" ESTIMABLE="YES" MEAN_1="5.28" MEAN_2="4.76" MODIFIED="2010-03-17 10:42:08 -0400" MODIFIED_BY="[Empty name]" ORDER="143" SD_1="3.6" SD_2="3.4" SE="0.2832524651487398" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="11.7330417404098"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.20718449810469816" CI_END="0.13715271116587135" CI_START="-0.41159899328439464" DF="1" EFFECT_SIZE="-0.13722314105926164" ESTIMABLE="YES" I2="0.0" ID="CMP-003.05.02" MODIFIED="2010-03-17 10:42:43 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6489831849465216" P_Z="0.3269708622327283" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="113" WEIGHT="48.0355116674579" Z="0.9802335451187207">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.14224354891124244" CI_START="-0.48927549606948706" EFFECT_SIZE="-0.17351597357912232" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="5.51" MODIFIED="2009-12-10 08:11:34 -0500" MODIFIED_BY="[Empty name]" ORDER="47" SD_1="4.1" SD_2="4.05" SE="0.16110475752668701" STUDY_ID="STD-Kennedy-2003" TOTAL_1="69" TOTAL_2="88" WEIGHT="36.269475976767005"/>
<CONT_DATA CI_END="0.5290372808931397" CI_START="-0.579734111316668" EFFECT_SIZE="-0.025348415211764133" ESTIMABLE="YES" MEAN_1="3.24" MEAN_2="3.32" MODIFIED="2010-03-17 10:42:43 -0400" MODIFIED_BY="[Empty name]" ORDER="144" SD_1="2.9" SD_2="3.3" SE="0.28285504247926363" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="11.766035690690893"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.15189883510635793" CI_END="0.24874284912533706" CI_START="-0.3508746081375681" DF="1" EFFECT_SIZE="-0.051065879506115526" ESTIMABLE="YES" I2="0.0" ID="CMP-003.05.03" MODIFIED="2011-01-05 14:53:43 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="0.6967274925484346" P_Z="0.7385024661748889" STUDIES="2" TAU2="0.0" TOTAL_1="90" TOTAL_2="83" WEIGHT="40.23144659213231" Z="0.333837127183456">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.25939294908907706" CI_START="-0.4286064228784764" EFFECT_SIZE="-0.08460673689469965" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.3" MODIFIED="2010-02-22 07:38:38 -0500" MODIFIED_BY="[Empty name]" ORDER="94" SD_1="9.4" SD_2="9.4" SE="0.17551326896677813" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="64" TOTAL_2="66" WEIGHT="30.558927062635135"/>
<CONT_DATA CI_END="0.6663464575043729" CI_START="-0.5565432369220429" EFFECT_SIZE="0.05490161029116507" ESTIMABLE="YES" MEAN_1="6.7" MEAN_2="6.5" MODIFIED="2009-12-09 08:43:16 -0500" MODIFIED_BY="[Empty name]" ORDER="45" SD_1="3.9" SD_2="3.0" SE="0.3119673892154176" STUDY_ID="STD-Larsson-2003" TOTAL_1="26" TOTAL_2="17" WEIGHT="9.672519529497174"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.0513812014892943" CI_END="0.11974787815921584" CI_START="-0.2852346066407786" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.08274336424078138" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.06" MODIFIED="2011-01-05 14:54:03 -0500" MODIFIED_BY="John K MacDonald" NO="6" P_CHI2="0.7888218990717208" P_Q="0.9383400488723764" P_Z="0.4231930417989058" Q="0.12728575803240627" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="178" TOTAL_2="200" UNITS="" WEIGHT="100.00000000000001" Z="0.8008939643486189">
<NAME>Depression (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.41222141785828204" CI_START="-0.6980368236523443" DF="0" EFFECT_SIZE="-0.14290770289703117" ESTIMABLE="YES" I2="0.0" ID="CMP-003.06.01" MODIFIED="2010-05-19 12:12:12 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6138704412293712" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="13.305293838475228" Z="0.5045564001586395">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.41222141785828204" CI_START="-0.6980368236523443" EFFECT_SIZE="-0.14290770289703117" ESTIMABLE="YES" MEAN_1="4.96" MEAN_2="5.44" MODIFIED="2010-03-17 10:43:52 -0400" MODIFIED_BY="[Empty name]" ORDER="145" SD_1="3.5" SD_2="3.1" SE="0.28323434774011197" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="13.305293838475228"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.924095443456888" CI_END="0.17751972663951898" CI_START="-0.37140373616117983" DF="1" EFFECT_SIZE="-0.09694200476083044" ESTIMABLE="YES" I2="0.0" ID="CMP-003.06.02" MODIFIED="2010-03-17 10:44:28 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3364020803012874" P_Z="0.4887650112105978" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="113" WEIGHT="54.43132329263373" Z="0.6922744272977951">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.14224354891124244" CI_START="-0.48927549606948706" EFFECT_SIZE="-0.17351597357912232" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="5.51" MODIFIED="2009-12-10 08:12:38 -0500" MODIFIED_BY="[Empty name]" ORDER="48" SD_1="4.1" SD_2="4.05" SE="0.16110475752668701" STUDY_ID="STD-Kennedy-2003" TOTAL_1="69" TOTAL_2="88" WEIGHT="41.12440020092038"/>
<CONT_DATA CI_END="0.6948012663997851" CI_START="-0.41538900495746117" EFFECT_SIZE="0.13970613072116195" ESTIMABLE="YES" MEAN_1="3.44" MEAN_2="3.0" MODIFIED="2010-03-17 10:44:28 -0400" MODIFIED_BY="[Empty name]" ORDER="146" SD_1="3.1" SD_2="3.1" SE="0.28321700809665007" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="13.306923091713351"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.32251583665345246" CI_START="-0.3904706353138138" DF="0" EFFECT_SIZE="-0.03397739933018067" ESTIMABLE="YES" I2="0.0" ID="CMP-003.06.03" MODIFIED="2011-01-05 14:54:03 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="1.0" P_Z="0.8518140543929329" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="62" WEIGHT="32.263382868891064" Z="0.18680432685277337">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.32251583665345246" CI_START="-0.3904706353138138" EFFECT_SIZE="-0.03397739933018067" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="12.5" MODIFIED="2010-02-22 07:39:46 -0500" MODIFIED_BY="[Empty name]" ORDER="95" SD_1="18.7" SD_2="9.2" SE="0.1818876463014659" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="59" TOTAL_2="62" WEIGHT="32.263382868891064"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.49112884974247456" CI_END="0.18705408301805632" CI_START="-0.47444382093531695" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.14369486895863032" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.07" MODIFIED="2011-01-05 14:54:17 -0500" MODIFIED_BY="John K MacDonald" NO="7" P_CHI2="0.7822628936067124" P_Q="0.7822628936067124" P_Z="0.3944848974746984" Q="0.4911288497424745" RANDOM="YES" SCALE="2.7298189452046877" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="76" TOTAL_2="67" UNITS="" WEIGHT="100.0" Z="0.851512200534409">
<NAME>Anxiety (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.29456776227536935" CI_START="-0.8193217199234282" DF="0" EFFECT_SIZE="-0.2623769788240294" ESTIMABLE="YES" I2="0.0" ID="CMP-003.07.01" MODIFIED="2010-03-17 10:47:22 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3558299926235732" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="35.26734273891934" Z="0.9233401285958946">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.29456776227536935" CI_START="-0.8193217199234282" EFFECT_SIZE="-0.2623769788240294" ESTIMABLE="YES" MEAN_1="7.12" MEAN_2="8.08" MODIFIED="2010-03-17 10:47:22 -0400" MODIFIED_BY="[Empty name]" ORDER="147" SD_1="3.5" SD_2="3.7" SE="0.2841607016723306" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="35.26734273891934"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5646695751447514" CI_START="-0.5440614709673776" DF="0" EFFECT_SIZE="0.010304052088686937" ESTIMABLE="YES" I2="0.0" ID="CMP-003.07.02" MODIFIED="2010-03-17 10:47:50 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9709394431891728" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="35.596272899050696" Z="0.03643006310587011">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.5646695751447514" CI_START="-0.5440614709673776" EFFECT_SIZE="0.010304052088686939" ESTIMABLE="YES" MEAN_1="6.72" MEAN_2="6.68" MODIFIED="2010-03-17 10:47:50 -0400" MODIFIED_BY="[Empty name]" ORDER="148" SD_1="3.4" SD_2="4.2" SE="0.28284474991827857" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="35.596272899050696"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4245645449673466" CI_START="-0.8009279151687643" DF="0" EFFECT_SIZE="-0.18818168510070882" ESTIMABLE="YES" I2="0.0" ID="CMP-003.07.03" MODIFIED="2011-01-05 14:54:17 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="1.0" P_Z="0.5472218373900286" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="17" WEIGHT="29.13638436202996" Z="0.6019283469218285">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.42456454496734647" CI_START="-0.800927915168764" EFFECT_SIZE="-0.18818168510070882" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="9.8" MODIFIED="2009-12-09 08:45:18 -0500" MODIFIED_BY="[Empty name]" ORDER="46" SD_1="4.6" SD_2="3.4" SE="0.3126313722605718" STUDY_ID="STD-Larsson-2003" TOTAL_1="26" TOTAL_2="17" WEIGHT="29.13638436202996"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.18686281469516738" CI_END="0.33600047549459533" CI_START="-0.44855151237975854" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.056275518442581586" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.08" MODIFIED="2010-05-21 05:14:04 -0400" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.6655406044431103" P_Q="0.6655406044431103" P_Z="0.7785765958338544" Q="0.1868628146951674" RANDOM="YES" SCALE="3.332307989116978" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="50" UNITS="" WEIGHT="100.00000000000001" Z="0.2811744564120428">
<NAME>Anxiety (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.41222141785828204" CI_START="-0.6980368236523443" DF="0" EFFECT_SIZE="-0.14290770289703117" ESTIMABLE="YES" I2="0.0" ID="CMP-003.08.01" MODIFIED="2010-03-17 10:54:22 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6138704412293712" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="49.9338949174942" Z="0.5045564001586395">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.41222141785828204" CI_START="-0.6980368236523443" EFFECT_SIZE="-0.14290770289703117" ESTIMABLE="YES" MEAN_1="4.96" MEAN_2="5.44" MODIFIED="2010-03-17 10:53:48 -0400" MODIFIED_BY="[Empty name]" ORDER="150" SD_1="3.5" SD_2="3.1" SE="0.28323434774011197" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="49.9338949174942"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5845235635195507" CI_START="-0.5242677727957885" DF="0" EFFECT_SIZE="0.030127895361881055" ESTIMABLE="YES" I2="0.0" ID="CMP-003.08.02" MODIFIED="2010-03-17 10:54:30 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9151764234121823" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="50.066105082505814" Z="0.10651163641936064">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.5845235635195507" CI_START="-0.5242677727957885" EFFECT_SIZE="0.030127895361881055" ESTIMABLE="YES" MEAN_1="7.52" MEAN_2="7.4" MODIFIED="2010-03-17 10:53:48 -0400" MODIFIED_BY="[Empty name]" ORDER="151" SD_1="3.5" SD_2="4.3" SE="0.28286013035477786" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="50.066105082505814"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.2586636485464127" CI_END="2.477516491488386" CI_START="0.7308095715491603" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="1.345582686292673" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-003.09" LOG_CI_END="0.3940165540305993" LOG_CI_START="-0.1361957732464815" LOG_EFFECT_SIZE="0.1289103903920589" METHOD="MH" MODIFIED="2010-05-21 05:14:08 -0400" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.7389714989150805" P_Q="0.5469189259401732" P_Z="0.34056418933425003" Q="1.206910341282705" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="125" TOTAL_2="96" WEIGHT="100.0" Z="0.9530511057672847">
<NAME>Not in remission at/during month 3 to 8</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.05141229263560533" CI_END="3.2164395700531854" CI_START="0.442991144948187" DF="1" EFFECT_SIZE="1.1936725881892887" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" I2="0.0" ID="CMP-003.09.01" LOG_CI_END="0.507375396358498" LOG_CI_START="-0.3536049549023828" LOG_EFFECT_SIZE="0.07688522072805767" MODIFIED="2010-05-20 04:34:01 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8206237535565124" P_Z="0.7263026082913819" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="35" WEIGHT="37.92391466794064" Z="0.3500480895986092">
<NAME>Crohn's disease</NAME>
<DICH_DATA CI_END="6.192117391611163" CI_START="0.16149564628002055" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.7918391812093448" LOG_CI_START="-0.7918391812093448" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-05-20 04:34:01 -0400" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.9302605094190635" STUDY_ID="STD-Garcia_x002d_Vega-2004" TOTAL_1="30" TOTAL_2="15" VAR="0.8653846153846154" WEIGHT="11.208969188101724"/>
<DICH_DATA CI_END="4.188478165184851" CI_START="0.39466869810382343" EFFECT_SIZE="1.2857142857142858" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.6220562557783107" LOG_CI_START="-0.4037673169281745" LOG_EFFECT_SIZE="0.10914446942506809" MODIFIED="2010-05-20 04:31:56 -0400" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.6025738445163697" STUDY_ID="STD-Jaghult-2007" TOTAL_1="26" TOTAL_2="20" VAR="0.3630952380952381" WEIGHT="26.714945479838917"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.8457728952471233" CI_START="0.32400210741665236" DF="0" EFFECT_SIZE="0.9602272727272727" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" I2="0.0" ID="CMP-003.09.02" LOG_CI_END="0.45420023858858755" LOG_CI_START="-0.48945216498954014" LOG_EFFECT_SIZE="-0.017625963200476293" MODIFIED="2010-05-20 04:32:25 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9416325042314451" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="24" WEIGHT="31.570069690528328" Z="0.07321817426579934">
<NAME>Ulcerative colitis</NAME>
<DICH_DATA CI_END="2.8457728952471233" CI_START="0.32400210741665236" EFFECT_SIZE="0.9602272727272727" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" LOG_CI_END="0.45420023858858755" LOG_CI_START="-0.48945216498954014" LOG_EFFECT_SIZE="-0.017625963200476293" MODIFIED="2010-05-20 04:32:25 -0400" MODIFIED_BY="[Empty name]" ORDER="45" O_E="0.0" SE="0.5543060930165253" STUDY_ID="STD-Jaghult-2007" TOTAL_1="29" TOTAL_2="24" VAR="0.3072552447552448" WEIGHT="31.570069690528328"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.686795044632618" CI_START="0.733245327808485" DF="0" EFFECT_SIZE="2.2142857142857144" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" I2="0.0" ID="CMP-003.09.03" LOG_CI_END="0.8252180119468414" LOG_CI_START="-0.13475069563477204" LOG_EFFECT_SIZE="0.3452336581560347" MODIFIED="2010-05-20 04:35:32 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.15862115025155113" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="37" WEIGHT="30.50601564153104" Z="1.4097241522413155">
<NAME>IBD (not specified)</NAME>
<DICH_DATA CI_END="6.686795044632618" CI_START="0.733245327808485" EFFECT_SIZE="2.2142857142857144" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.8252180119468414" LOG_CI_START="-0.13475069563477204" LOG_EFFECT_SIZE="0.3452336581560347" MODIFIED="2010-05-20 04:35:32 -0400" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.5638903707551803" STUDY_ID="STD-Milne-1986" TOTAL_1="40" TOTAL_2="37" VAR="0.3179723502304147" WEIGHT="30.50601564153104"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.08775950106221832" CI_END="1.5349162646421828" CI_START="0.654819848890971" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0025435833285692" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="139" I2="0.0" I2_Q="0.0" ID="CMP-003.10" LOG_CI_END="0.1860846880895788" LOG_CI_START="-0.1838781647317354" LOG_EFFECT_SIZE="0.0011032616789216688" METHOD="MH" MODIFIED="2010-05-21 05:14:10 -0400" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.9570690389041838" P_Q="0.772511395636595" P_Z="0.9906732857452061" Q="0.08357387566592485" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="197" TOTAL_2="237" WEIGHT="100.00000000000003" Z="0.011689569045755206">
<NAME>Not in remission at/during month 9 to 18</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.9161644270334697" CI_START="0.16342521156212175" DF="0" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-003.10.01" LOG_CI_END="0.5928609181296085" LOG_CI_START="-0.7866809441457213" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2010-05-20 04:37:51 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7830343135577198" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="15" WEIGHT="7.1919468952343895" Z="0.2753669757057221">
<NAME>Crohn's disease</NAME>
<DICH_DATA CI_END="3.9161644270334697" CI_START="0.16342521156212175" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.5928609181296085" LOG_CI_START="-0.7866809441457213" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2010-05-20 04:37:51 -0400" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.8103497187428812" STUDY_ID="STD-Garcia_x002d_Vega-2004" TOTAL_1="30" TOTAL_2="15" VAR="0.6566666666666667" WEIGHT="7.1919468952343895"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.10.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-11-25 06:25:52 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Ulcerative colitis</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004183365418918036" CI_END="1.5874996400693773" CI_START="0.655667285401276" DF="1" EFFECT_SIZE="1.020231140271552" ESTIMABLE="YES" EVENTS_1="97" EVENTS_2="136" I2="0.0" ID="CMP-003.10.03" LOG_CI_END="0.20071363549730395" LOG_CI_START="-0.1833164849687551" LOG_EFFECT_SIZE="0.008698575264274432" MODIFIED="2010-05-20 04:38:40 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.948429630328809" P_Z="0.9292493140915536" STUDIES="2" TAU2="0.0" TOTAL_1="167" TOTAL_2="222" WEIGHT="92.80805310476563" Z="0.08878935961636722">
<NAME>IBD (not specified)</NAME>
<DICH_DATA CI_END="1.6574863434173457" CI_START="0.635685917455955" EFFECT_SIZE="1.0264700321421818" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="129" LOG_CI_END="0.21944995879450482" LOG_CI_START="-0.19675740952111426" LOG_EFFECT_SIZE="0.011346274636695323" MODIFIED="2009-12-10 09:39:47 -0500" MODIFIED_BY="[Empty name]" ORDER="51" O_E="0.0" SE="0.2444822684082953" STUDY_ID="STD-Kennedy-2004" TOTAL_1="130" TOTAL_2="190" VAR="0.05977157956606574" WEIGHT="79.01266502949315"/>
<DICH_DATA CI_END="3.10149044078104" CI_START="0.3129662229114274" EFFECT_SIZE="0.9852216748768473" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.49157044694788404" LOG_CI_START="-0.5045025314463475" LOG_EFFECT_SIZE="-0.006466042249231715" MODIFIED="2010-05-20 04:38:40 -0400" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="0.585098198149535" STUDY_ID="STD-Milne-1986" TOTAL_1="37" TOTAL_2="32" VAR="0.3423399014778325" WEIGHT="13.795388075272491"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.3765694849588206" CI_END="0.06495678437719143" CI_START="-0.3676855303148028" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.15136437296880567" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.11" MODIFIED="2011-01-05 14:55:11 -0500" MODIFIED_BY="John K MacDonald" NO="11" P_CHI2="0.8820177480403609" P_Q="0.6767171977674217" P_Z="0.1702418225469269" Q="0.7810042213253915" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="166" TOTAL_2="170" UNITS="" WEIGHT="100.00000000000001" Z="1.3714272020412566">
<NAME>Disease activity (3 to 8 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.8377944853232279" CI_END="0.21938899803836687" CI_START="-0.38849314681024705" DF="2" EFFECT_SIZE="-0.08455207438594008" ESTIMABLE="YES" I2="0.0" ID="CMP-003.11.01" MODIFIED="2010-03-19 08:26:40 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6577717988914266" P_Z="0.5855925610616353" STUDIES="3" TAU2="0.0" TOTAL_1="77" TOTAL_2="92" WEIGHT="50.65463759835637" Z="0.5452340458391474">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.43611097401260224" CI_START="-0.4448284144050997" EFFECT_SIZE="-0.004358720196248713" ESTIMABLE="YES" MEAN_1="111.2" MEAN_2="111.6" MODIFIED="2010-02-15 10:52:32 -0500" MODIFIED_BY="[Empty name]" ORDER="89" SD_1="105.2" SD_2="77.3" SE="0.22473356535284306" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="36" TOTAL_2="44" WEIGHT="24.119368337807437"/>
<CONT_DATA CI_END="0.5393243406564397" CI_START="-0.5694157471045839" EFFECT_SIZE="-0.015045703224072086" ESTIMABLE="YES" MEAN_1="127.6" MEAN_2="128.6" MODIFIED="2010-03-17 10:14:42 -0400" MODIFIED_BY="[Empty name]" ORDER="136" SD_1="72.0" SD_2="58.1" SE="0.28284705650374803" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="15.226443891211852"/>
<CONT_DATA CI_END="0.29409283142773196" CI_START="-0.9924381366927324" EFFECT_SIZE="-0.34917265263250025" ESTIMABLE="YES" MEAN_1="126.06" MEAN_2="173.1" MODIFIED="2010-03-19 08:26:40 -0400" MODIFIED_BY="[Empty name]" ORDER="165" SD_1="110.66" SD_2="144.71" SE="0.32820270634268195" STUDY_ID="STD-Waters-2005" TOTAL_1="16" TOTAL_2="23" WEIGHT="11.30882536933708"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.7577707783102012" CI_END="0.19283855801677993" CI_START="-0.5177092004870835" DF="2" EFFECT_SIZE="-0.16243532123515178" ESTIMABLE="YES" I2="0.0" ID="CMP-003.11.02" MODIFIED="2010-03-19 08:27:19 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6846242332967076" P_Z="0.37018966222676797" STUDIES="3" TAU2="0.0" TOTAL_1="63" TOTAL_2="61" WEIGHT="37.07417020402598" Z="0.8961181725728031">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.31907378432853417" CI_START="-0.8020662045370893" EFFECT_SIZE="-0.2414962101042776" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="2.4" MODIFIED="2010-02-15 10:53:17 -0500" MODIFIED_BY="[Empty name]" ORDER="90" SD_1="3.1" SD_2="2.5" SE="0.2860103547077989" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="28" TOTAL_2="22" WEIGHT="14.891495012230045"/>
<CONT_DATA CI_END="0.5707375236893275" CI_START="-0.5380056835182065" EFFECT_SIZE="0.0163659200855605" ESTIMABLE="YES" MEAN_1="80.3" MEAN_2="79.6" MODIFIED="2010-03-17 10:36:46 -0400" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="42.1" SD_2="42.1" SE="0.2828478522955419" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="15.226358212201356"/>
<CONT_DATA CI_END="0.4356221007499168" CI_START="-1.2047384328317987" EFFECT_SIZE="-0.38455816604094095" ESTIMABLE="YES" MEAN_1="102.1" MEAN_2="116.5" MODIFIED="2010-03-19 08:27:19 -0400" MODIFIED_BY="[Empty name]" ORDER="166" SD_1="24.86" SD_2="42.24" SE="0.4184670092207484" STUDY_ID="STD-Waters-2005" TOTAL_1="10" TOTAL_2="14" WEIGHT="6.956316979594579"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.22381352996940995" CI_START="-1.011239525137477" DF="0" EFFECT_SIZE="-0.39371299758403355" ESTIMABLE="YES" I2="0.0" ID="CMP-003.11.03" MODIFIED="2011-01-05 14:55:11 -0500" MODIFIED_BY="John K MacDonald" NO="3" P_CHI2="1.0" P_Z="0.21144445688446" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="17" WEIGHT="12.27119219761765" Z="1.2496034762542698">
<NAME>Unspecified IBD</NAME>
<CONT_DATA CI_END="0.22381352996940995" CI_START="-1.011239525137477" EFFECT_SIZE="-0.39371299758403355" ESTIMABLE="YES" MEAN_1="28.7" MEAN_2="32.3" MODIFIED="2010-03-11 03:56:04 -0500" MODIFIED_BY="[Empty name]" ORDER="98" SD_1="9.9" SD_2="7.3" SE="0.31507034436571996" STUDY_ID="STD-Larsson-2003" TOTAL_1="26" TOTAL_2="17" WEIGHT="12.27119219761765"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.2018059585750196" CI_END="0.39328701198348354" CI_START="-0.21098369077799223" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.09115166060274565" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.12" MODIFIED="2010-05-21 05:18:28 -0400" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.5483165418225744" P_Q="0.35120656449155474" P_Z="0.5543164645148919" Q="0.869093202999642" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="84" TOTAL_2="87" UNITS="" WEIGHT="100.0" Z="0.5913044306002712">
<NAME>Disease activity (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7231898203450029" CI_START="-0.205472356287917" DF="0" EFFECT_SIZE="0.2588587320285429" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.01" MODIFIED="2010-02-15 10:55:25 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.2745452207454878" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="41" WEIGHT="42.33967909080642" Z="1.0926552294811405">
<NAME>Crohn's disease</NAME>
<CONT_DATA CI_END="0.7231898203450029" CI_START="-0.205472356287917" EFFECT_SIZE="0.2588587320285429" ESTIMABLE="YES" MEAN_1="107.0" MEAN_2="87.4" MODIFIED="2010-02-15 10:55:25 -0500" MODIFIED_BY="[Empty name]" ORDER="91" SD_1="83.2" SD_2="67.8" SE="0.23690796972752778" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="32" TOTAL_2="41" WEIGHT="42.33967909080642"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.33271275557537766" CI_END="0.3658952065362979" CI_START="-0.42988477699229055" DF="1" EFFECT_SIZE="-0.03199478522799633" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.02" MODIFIED="2010-03-17 10:38:08 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5640662254475461" P_Z="0.8747696982022409" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="46" WEIGHT="57.66032090919359" Z="0.15760292552700061">
<NAME>Ulcerative colitis</NAME>
<CONT_DATA CI_END="0.41856934349185365" CI_START="-0.723740283687736" EFFECT_SIZE="-0.15258547009794116" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.2" MODIFIED="2010-02-15 10:56:04 -0500" MODIFIED_BY="[Empty name]" ORDER="92" SD_1="2.2" SD_2="3.0" SE="0.2914108718808055" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="27" TOTAL_2="21" WEIGHT="27.98307285906202"/>
<CONT_DATA CI_END="0.6363243763664841" CI_START="-0.4729008177385694" EFFECT_SIZE="0.08171177931395733" ESTIMABLE="YES" MEAN_1="78.6" MEAN_2="75.1" MODIFIED="2010-03-17 10:38:08 -0400" MODIFIED_BY="[Empty name]" ORDER="142" SD_1="43.1" SD_2="41.2" SE="0.28297081039612976" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="29.67724805013157"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-2.263454869314124" CI_START="-25.536545130685877" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-13.9" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.13" MODIFIED="2010-05-21 05:18:28 -0400" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="0.0192217788714097" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="24" UNITS="" WEIGHT="100.0" Z="2.34120171229044">
<NAME>Days in hospital (change from baseline) (9 to 18 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.263454869314124" CI_START="-25.536545130685877" DF="0" EFFECT_SIZE="-13.9" ESTIMABLE="YES" I2="0.0" ID="CMP-003.13.01" MODIFIED="2009-11-25 06:25:52 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.0192217788714097" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="24" WEIGHT="100.0" Z="2.34120171229044">
<NAME>Psychodynamic psychotherapy</NAME>
<CONT_DATA CI_END="-2.263454869314124" CI_START="-25.536545130685877" EFFECT_SIZE="-13.9" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="3.4" ORDER="320" SD_1="21.4" SD_2="23.9" SE="5.93712191778699" STUDY_ID="STD-Jantschek-1998" TOTAL_1="40" TOTAL_2="24" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2011-01-05 14:55:23 -0500" MODIFIED_BY="John K MacDonald" NO="4">
<NAME>All interventions</NAME>
<DICH_OUTCOME CHI2="38.08828640993346" CI_END="1.0504422333530565" CI_START="0.9233276815100142" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9848362259188475" ESTIMABLE="YES" EVENTS_1="736" EVENTS_2="763" I2="63.243292572099584" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.02137217437565626" LOG_CI_START="-0.03464414402690253" LOG_EFFECT_SIZE="-0.0066359848256231065" METHOD="MH" MODIFIED="2010-07-15 05:59:01 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="5.037379189446467E-4" P_Q="0.6363609335152925" P_Z="0.6423790401392231" Q="0.22353315930444237" RANDOM="YES" SCALE="2.43" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.007884843251393627" TOTALS="YES" TOTAL_1="1013" TOTAL_2="1070" WEIGHT="100.0" Z="0.4643750832286583">
<NAME>Number of patients completing programme</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Control more complete</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Therapy more complete</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="19.146233466592818" CI_END="1.0642790200268013" CI_START="0.8743488338908856" DF="6" EFFECT_SIZE="0.9646507762371667" ESTIMABLE="YES" EVENTS_1="210" EVENTS_2="171" I2="68.66224361846908" ID="CMP-004.01.01" LOG_CI_END="0.027055501053237695" LOG_CI_START="-0.05831526483810809" LOG_EFFECT_SIZE="-0.015629881892435197" MODIFIED="2010-03-19 11:33:38 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0039236739901431505" P_Z="0.4729609809632199" STUDIES="7" TAU2="0.009546913113775009" TOTAL_1="245" TOTAL_2="187" WEIGHT="48.716078832047714" Z="0.7176696910691114">
<NAME>Psychotherapy</NAME>
<DICH_DATA CI_END="1.1039286018315015" CI_START="0.9058556851783022" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="15" LOG_CI_END="0.04294098568184562" LOG_CI_START="-0.04294098568184564" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-22 07:45:26 -0500" MODIFIED_BY="[Empty name]" ORDER="96" O_E="0.0" SE="0.05044749510164682" STUDY_ID="STD-Garcia_x002d_Vega-2004" TOTAL_1="30" TOTAL_2="15" VAR="0.0025449497620306794" WEIGHT="10.380747761900444"/>
<DICH_DATA CI_END="0.8930067101422176" CI_START="0.4694500128692733" EFFECT_SIZE="0.6474735605170387" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="18" LOG_CI_END="-0.049145277766784894" LOG_CI_START="-0.3284106446988208" LOG_EFFECT_SIZE="-0.18877796123280283" MODIFIED="2010-03-19 11:33:38 -0400" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.16404185892173903" STUDY_ID="STD-Grootenhuis-2009" TOTAL_1="22" TOTAL_2="18" VAR="0.026909731478499732" WEIGHT="3.1116647155963406"/>
<DICH_DATA CI_END="1.164403270454878" CI_START="0.749883893431712" EFFECT_SIZE="0.9344341913550267" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="29" LOG_CI_END="0.06610341656968638" LOG_CI_START="-0.12500597440216085" LOG_EFFECT_SIZE="-0.029451278916237222" MODIFIED="2009-12-09 07:50:17 -0500" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.11225860226360533" STUDY_ID="STD-Jantschek-1998" TOTAL_1="71" TOTAL_2="37" VAR="0.012601993782178335" WEIGHT="5.28481045189005"/>
<DICH_DATA CI_END="1.373257335615591" CI_START="0.6771104837089308" EFFECT_SIZE="0.9642857142857143" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.13775192759790303" LOG_CI_START="-0.16934046196436678" LOG_EFFECT_SIZE="-0.015794267183231903" MODIFIED="2010-03-08 10:43:57 -0500" MODIFIED_BY="[Empty name]" ORDER="99" O_E="0.0" SE="0.18038758976072203" STUDY_ID="STD-K_x00fc_nsebeck-1987" TOTAL_1="20" TOTAL_2="18" VAR="0.03253968253968255" WEIGHT="2.6783010650700056"/>
<DICH_DATA CI_END="1.3397508337679778" CI_START="0.9887440768307858" EFFECT_SIZE="1.150943396226415" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="26" LOG_CI_END="0.12702403599049122" LOG_CI_START="-0.004916105170535247" LOG_EFFECT_SIZE="0.06105396540997798" MODIFIED="2009-11-30 05:39:55 -0500" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="0.07750229203221896" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.0060066052702473505" WEIGHT="7.79393526258409"/>
<DICH_DATA CI_END="1.039375912177859" CI_START="0.9621158122710843" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="50" LOG_CI_END="0.016772647709607038" LOG_CI_START="-0.01677264770960704" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-01-21 12:12:04 -0500" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.019704672581136715" STUDY_ID="STD-Smith-2002" TOTAL_1="50" TOTAL_2="50" VAR="3.8827412152980106E-4" WEIGHT="13.086850530555301"/>
<DICH_DATA CI_END="1.0481861566536663" CI_START="0.7213829933709242" EFFECT_SIZE="0.8695652173913043" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="19" LOG_CI_END="0.02043841969721347" LOG_CI_START="-0.14183410040443692" LOG_EFFECT_SIZE="-0.0606978403536117" MODIFIED="2010-03-19 11:33:38 -0400" MODIFIED_BY="[Empty name]" ORDER="90" O_E="0.0" SE="0.09531968156963881" STUDY_ID="STD-Szigethy-2007" TOTAL_1="22" TOTAL_2="19" VAR="0.009085841694537342" WEIGHT="6.3797690444514865"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="24.555648173808322" CI_END="1.1245894027073697" CI_START="0.8906383974332311" DF="7" EFFECT_SIZE="1.000800930953647" ESTIMABLE="YES" EVENTS_1="526" EVENTS_2="592" I2="71.49332019072347" ID="CMP-004.01.02" LOG_CI_END="0.050993986725049636" LOG_CI_START="-0.05029858538501055" LOG_EFFECT_SIZE="3.477006700195581E-4" MODIFIED="2010-07-15 05:49:11 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="9.094009679595505E-4" P_Z="0.9892642356185809" STUDIES="8" TAU2="0.018333380699456444" TOTAL_1="768" TOTAL_2="883" WEIGHT="51.28392116795228" Z="0.013455691299817461">
<NAME>Educational interventions</NAME>
<DICH_DATA CI_END="1.0713916587726975" CI_START="0.8810676942099531" EFFECT_SIZE="0.971580453894909" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="67" LOG_CI_END="0.029948260887791414" LOG_CI_START="-0.054990722584081796" LOG_EFFECT_SIZE="-0.012521230848145212" MODIFIED="2010-02-15 10:29:02 -0500" MODIFIED_BY="[Empty name]" ORDER="88" O_E="0.0" SE="0.04989357934612752" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="73" TOTAL_2="72" VAR="0.002489369259968323" WEIGHT="10.436363276982403"/>
<DICH_DATA CI_END="1.5747826326120258" CI_START="1.0731639814930318" EFFECT_SIZE="1.3" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="32" LOG_CI_END="0.19722061655611836" LOG_CI_START="0.03066608805755516" LOG_EFFECT_SIZE="0.11394335230683678" MODIFIED="2009-12-02 10:13:54 -0500" MODIFIED_BY="[Empty name]" ORDER="46" O_E="0.0" SE="0.09783495449826878" STUDY_ID="STD-Jaghult-2007" TOTAL_1="55" TOTAL_2="44" VAR="0.009571678321678323" WEIGHT="6.202212166265857"/>
<DICH_DATA CI_END="0.9150821099544935" CI_START="0.6261542598015621" EFFECT_SIZE="0.7569561157796452" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="90" LOG_CI_END="-0.038539935113635175" LOG_CI_START="-0.2033186605155231" LOG_EFFECT_SIZE="-0.12092929781457913" MODIFIED="2009-12-10 09:11:41 -0500" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.0967918389689146" STUDY_ID="STD-Kennedy-2003" TOTAL_1="119" TOTAL_2="121" VAR="0.009368660090984297" WEIGHT="6.275192251260625"/>
<DICH_DATA CI_END="1.1654395774605197" CI_START="0.9372144281740504" EFFECT_SIZE="1.045115681233933" ESTIMABLE="YES" EVENTS_1="235" EVENTS_2="300" LOG_CI_END="0.06648976232188282" LOG_CI_START="-0.028161034172235026" LOG_EFFECT_SIZE="0.019164364074823904" MODIFIED="2009-12-10 09:41:31 -0500" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="0.05559834638964384" STUDY_ID="STD-Kennedy-2004" TOTAL_1="389" TOTAL_2="519" VAR="0.003091176121262822" WEIGHT="9.86414535226769"/>
<DICH_DATA CI_END="1.2047892021982038" CI_START="0.6919454388150805" EFFECT_SIZE="0.9130434782608695" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="0.08091106655354521" LOG_CI_START="-0.15992814912089245" LOG_EFFECT_SIZE="-0.039508541283673634" MODIFIED="2010-03-23 10:37:24 -0400" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.1414701474605094" STUDY_ID="STD-Lange-1996" TOTAL_1="23" TOTAL_2="21" VAR="0.020013802622498272" WEIGHT="3.8807994829064283"/>
<DICH_DATA CI_END="1.3819505486165231" CI_START="0.967410927864525" EFFECT_SIZE="1.15625" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" LOG_CI_END="0.1404925026277482" LOG_CI_START="-0.01438901113357018" LOG_EFFECT_SIZE="0.06305174574708902" MODIFIED="2010-05-21 09:13:22 -0400" MODIFIED_BY="[Empty name]" ORDER="177" O_E="0.0" SE="0.09097816785925636" STUDY_ID="STD-Milne-1986" TOTAL_1="40" TOTAL_2="40" VAR="0.008277027027027026" WEIGHT="6.6990421662863"/>
<DICH_DATA CI_END="1.711833149912017" CI_START="0.8726476412555778" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.23346143230153626" LOG_CI_START="-0.05916108086373583" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2010-03-15 10:59:31 -0400" MODIFIED_BY="[Empty name]" ORDER="147" O_E="0.0" SE="0.17188791273808218" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="24" TOTAL_2="22" VAR="0.029545454545454555" WEIGHT="2.892551137819321"/>
<DICH_DATA CI_END="1.0027055607066664" CI_START="0.6345459790431395" EFFECT_SIZE="0.7976608187134503" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="38" LOG_CI_END="0.0011734234160434814" LOG_CI_START="-0.19753690355943096" LOG_EFFECT_SIZE="-0.09818174007169371" MODIFIED="2010-02-12 05:59:45 -0500" MODIFIED_BY="[Empty name]" ORDER="91" O_E="0.0" SE="0.11672342969737604" STUDY_ID="STD-Waters-2005" TOTAL_1="45" TOTAL_2="44" VAR="0.013624359040318286" WEIGHT="5.0336153341636605"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="16.832118592324143" CI_END="0.2931124097999479" CI_START="-0.036583472170915926" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.12826446881451598" ESTIMABLE="YES" I2="34.648749415202744" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2010-07-30 14:22:10 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.11294053784601765" P_Q="1.0" P_Z="0.1272581453879236" Q="0.0" RANDOM="YES" SCALE="1.59" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.025666608601384748" TOTALS="YES" TOTAL_1="580" TOTAL_2="638" UNITS="" WEIGHT="100.0" Z="1.5250038178810414">
<NAME>Main outcome (for publication bias)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.13458978849228168" CI_START="-0.5806293012517749" EFFECT_SIZE="-0.2230197563797466" ESTIMABLE="YES" MEAN_1="106.75" MEAN_2="109.0" MODIFIED="2010-03-18 11:00:47 -0400" MODIFIED_BY="[Empty name]" ORDER="125" SD_1="9.5" SD_2="10.5" SE="0.18245720211840968" STUDY_ID="STD-Bregenzer-2005" TOTAL_1="59" TOTAL_2="62" WEIGHT="11.998687248203739"/>
<CONT_DATA CI_END="1.1824114755111834" CI_START="-0.2651272896291004" EFFECT_SIZE="0.45864209294104147" ESTIMABLE="YES" MEAN_1="73.8" MEAN_2="67.0" MODIFIED="2010-03-19 11:29:21 -0400" MODIFIED_BY="[Empty name]" ORDER="172" SD_1="15.3" SD_2="13.8" SE="0.36927687869733444" STUDY_ID="STD-Grootenhuis-2009" TOTAL_1="13" TOTAL_2="18" WEIGHT="4.365862171247958"/>
<CONT_DATA CI_END="0.19724250523566456" CI_START="-0.7286609821827471" EFFECT_SIZE="-0.2657092384735413" ESTIMABLE="YES" MEAN_1="68.4" MEAN_2="73.9" MODIFIED="2010-03-18 11:00:49 -0400" MODIFIED_BY="[Empty name]" ORDER="124" SD_1="22.4" SD_2="16.4" SE="0.2362042095471703" STUDY_ID="STD-Jantschek-1998" TOTAL_1="51" TOTAL_2="28" WEIGHT="8.684235641489899"/>
<CONT_DATA CI_END="0.625740412728812" CI_START="-0.00637924142601598" EFFECT_SIZE="0.309680585651398" ESTIMABLE="YES" MEAN_1="175.1" MEAN_2="162.8" MODIFIED="2010-03-18 11:00:50 -0400" MODIFIED_BY="[Empty name]" ORDER="97" SD_1="39.7" SD_2="39.4" SE="0.1612579769681757" STUDY_ID="STD-Kennedy-2003" TOTAL_1="68" TOTAL_2="91" WEIGHT="13.690715927192251"/>
<CONT_DATA CI_END="0.2950061500169454" CI_START="-0.047403067386423234" EFFECT_SIZE="0.1238015413152611" ESTIMABLE="YES" MEAN_1="172.3" MEAN_2="167.7" MODIFIED="2010-03-18 11:00:53 -0400" MODIFIED_BY="[Empty name]" ORDER="98" SD_1="36.6" SD_2="37.5" SE="0.08735089524711905" STUDY_ID="STD-Kennedy-2004" TOTAL_1="236" TOTAL_2="296" WEIGHT="21.245577346283405"/>
<CONT_DATA CI_END="1.12075660270707" CI_START="-0.3514230756343621" EFFECT_SIZE="0.38466676353635393" ESTIMABLE="YES" MEAN_1="5.7" MEAN_2="4.3" MODIFIED="2010-03-18 11:00:55 -0400" MODIFIED_BY="[Empty name]" ORDER="100" SD_1="3.1" SD_2="3.9" SE="0.37556294145040353" STUDY_ID="STD-K_x00fc_nsebeck-1987" TOTAL_1="14" TOTAL_2="15" WEIGHT="4.243248412699711"/>
<CONT_DATA CI_END="1.1781598849649524" CI_START="-0.1523864275135307" EFFECT_SIZE="0.5128867287257108" ESTIMABLE="YES" MEAN_1="101.67" MEAN_2="95.0" MODIFIED="2010-03-23 10:35:23 -0400" MODIFIED_BY="[Empty name]" ORDER="170" SD_1="11.88" SD_2="13.5" SE="0.3394313168439988" STUDY_ID="STD-Lange-1996" TOTAL_1="18" TOTAL_2="18" WEIGHT="5.021353862274595"/>
<CONT_DATA CI_END="0.561726203879134" CI_START="-0.48869511759230666" EFFECT_SIZE="0.03651554314341368" ESTIMABLE="YES" MEAN_1="173.2" MEAN_2="171.9" MODIFIED="2010-03-18 11:00:57 -0400" MODIFIED_BY="[Empty name]" ORDER="98" SD_1="32.3" SD_2="38.1" SE="0.26796954682765345" STUDY_ID="STD-Langhorst-2007" TOTAL_1="30" TOTAL_2="26" WEIGHT="7.257395757614656"/>
<CONT_DATA CI_END="0.6038223614882026" CI_START="-0.7354882160710605" EFFECT_SIZE="-0.06583292729142902" ESTIMABLE="YES" MEAN_1="171.8" MEAN_2="173.7" MODIFIED="2010-03-18 11:00:59 -0400" MODIFIED_BY="[Empty name]" ORDER="148" SD_1="28.2" SD_2="28.2" SE="0.3416671398361332" STUDY_ID="STD-Oxelmark-2007" TOTAL_1="20" TOTAL_2="15" WEIGHT="4.9676570045557495"/>
<CONT_DATA CI_END="0.7209664906698461" CI_START="-0.3898168871225929" EFFECT_SIZE="0.1655748017736266" ESTIMABLE="YES" MEAN_1="68.0" MEAN_2="66.2" MODIFIED="2010-03-18 11:01:01 -0400" MODIFIED_BY="[Empty name]" ORDER="160" SD_1="10.8" SD_2="10.6" SE="0.2833683135389621" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="6.675928373621775"/>
<CONT_DATA CI_END="0.41856493319475946" CI_START="-0.6915587470438251" EFFECT_SIZE="-0.1364969069245328" ESTIMABLE="YES" MEAN_1="60.7" MEAN_2="62.2" MODIFIED="2010-03-18 11:01:03 -0400" MODIFIED_BY="[Empty name]" ORDER="159" SD_1="11.4" SD_2="10.2" SE="0.28320002025422364" STUDY_ID="STD-Smith-2002" TOTAL_1="25" TOTAL_2="25" WEIGHT="6.68194097644181"/>
<CONT_DATA CI_END="1.543607143548119" CI_START="0.23625389325669732" EFFECT_SIZE="0.8899305184024081" ESTIMABLE="YES" MEAN_1="69.9" MEAN_2="62.8" MODIFIED="2010-03-18 11:01:04 -0400" MODIFIED_BY="[Empty name]" ORDER="155" SD_1="6.7" SD_2="8.9" SE="0.3335146106264342" STUDY_ID="STD-Szigethy-2007" TOTAL_1="21" TOTAL_2="19" WEIGHT="5.167397278374449"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2011-01-07 13:52:01 -0500" MODIFIED_BY="John K MacDonald">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2011-01-07 13:51:59 -0500" MODIFIED_BY="John K MacDonald" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlYAAAEyCAMAAAAP9m78AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2011-01-07 13:51:59 -0500" MODIFIED_BY="John K MacDonald" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAYoAAAPDCAIAAAAi1NvKAABKL0lEQVR42u2dvU4kydKGSxpnjDYw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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2010-12-21 14:41:05 -0500" MODIFIED_BY="John K MacDonald" NO="3" REF_ID="CMP-004.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 All psychological interventions, outcome: 4.1 Number of patients completing programme.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwwAAAIgCAMAAAAfuB6wAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="PsychoFunnel.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2010-07-15 06:04:00 -0400" MODIFIED_BY="[Empty name]" NO="4" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Funnelplot (imported from R)</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAeAAAAHgCAMAAABKCk6nAAADAFBMVEUAAAACAgIDAwMEBAQFBQUG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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2010-12-21 14:41:52 -0500" MODIFIED_BY="John K MacDonald" NO="5" REF_ID="CMP-001.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Psychotherapy in adults, outcome: 1.2 HRQL (9 to 18 months).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwQAAAFACAMAAAA1c0uDAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAAAifElEQVR42u1dTc8tx1Hu++ZYURTH1+UbJxglBCNYgRSxRIJNr4OE
FHasEFF+BKyRWETiJyCxYBdlkwVCqDcsQN6xyhIRAja2r8vGQo5kIJwz0zPTH9Vf83FmzjnPo3vf
MzP9Od1V1dU9Vd3PSAHAY+MJTQCACQAATAAAj43T4Wqku78mFyEXaKqiVdTBpLNenH9tM5ix1LE0
3T/NtNCY8vznEk+rbWt6+/U+HZAxzfxgvVJHnrshoPmVsm6pwqUOel4DXmo/0pNBvW+PCSZCvIgD
o60I6QXE8GhspyGkf3iRQFotkyFdtkYJWTu1uI40GF7I+EOSdscrt5ZjyoEOtXKaxP/rNuy673Rr
9T7+nKBrivN721Yw01M/5HLXEa829skKfBhkrfonK+VfKN32r+33ZPXG19VRrUzfXsZrPu+txkzW
e6cbrPcRmUCf0Q2NPdkldSIja0mm74fr6WdbqYTOa5j0q4+va+a+lTEPXu/jzgmMP5jq+nlAQgLd
FgaVoryGUPW6utSU+oHrfdg5QdiWplpO6z0k91ZskKUMU/+6pjSwmQeu99NxeWBQAT1lM62Gri2E
9x1MguJ14i1TtRQozI3qJ7N3q7zxTdb7sHOCiSQvDTPOEMRlNW8+sMKcwOYZZy2UuN0wMNRBmUC9
MH3pbi0jujHJRoreKt++j1DvZwc3oLsX3QY4MGA2ATw8nsGUGsBIAABgAgAAEwAAmAAAHhnuF+PA
FHx8ml6kHFKUY5ZQNjdPFe7XYQxwqiVXsL3EpQWaqVAThg9XKYOD0VpyjKiialR2mBneRCt3KX80
0lyBqm6rtu5IcPlG21vm1b+ruYpBZaHwsA7GuMZV+sAFGiPxWSKu/X7u2I81t/1kdGmMUYFt1qpd
eVO1PUmV16O1vh4Fl/Ys7D2jTccHYohqjaMcI3DXOSDxzmVzc6Gt+x8tSVDrfZB2MZhR4pICp+Li
dlGDQZk2s6TuZGZvoofR6+h41Bp9KDYXXQesrTcnmEzBp/K1yJujWX9gKmJtvPUg50KO1WX+LZub
e9UtZVThYlBd4goF2qdTu4yt5TgtNFGVCczstQo8IaTX0TuZRh2ztk++kItLs84NonCMUpjgNyVI
U0Et5uZG1dtOyeZEjSUuLzDbKKYiT68btG+CI7Z9yiGjpzq9IYHdUm2fQg21qZD2FFXiQldNs1sK
L2RWV+KKBa5h+2hM83KEpUGb8iyVtbmWbdaRa3uSBuvmCdB6+qJSDebmZilJtpa4qEDTy8Ksw1xj
42tt2hZIjFK7mYgft7ZPSdmky2tRTgrtEZVO0VstDem2OMuXyipKXLdAJz/dIHBMxcwkM9ZpX1XT
vqH4qrrGDdX2yR99AlPw2CLcM992UjgukcavbRwh2WoFc/N4sNSDom5So6nJuRi0lbhCgUJDmsB/
TjcSml/S1G+JSZy2E3f3C4XUtRtNE45Z2zor0qYCtUklgHNAS2tlk8wqZ7cXPHhtT1Us0KbJXW1f
nntAe2uBB9YG/AkAAACOge/uVvIJIwFwEOxGijClBh4eYALg4eGvDrnm36Glu2AYGW6UGJv/YVEU
uLGRYPqEOdlAaiU8rIYBDwA3NRKMFG6EZ4MJd+BRoH0L/Gm0mPwL/J3kxR8AOMpIINsCCNLd3yt+
OJDBSGbywU7y2phttsUHgDWYQFLw645OMspTmoKHzrPJqEZDVQKOOBJkJrmVUwDBts94RoFqNCR2
HwLAQeYEi3nA+hMZ+ZnxRxg9y5sQAK4wEujRLS7wnKww4fbsW3X0TGshIsYC4KDqkBbUmtRe8VKc
yUze30neOK4S5jpb/QNAHrAiBQ6C3ay9YTYBAGACAEyAJgDABAAAJgAAMAEAgAkA4JFxQhMAu+KT
/uf5cZiAw29n4QP/3rnrL7l3l/Z/miAkjepQjhLG7xNQKvQSPGUXV9t7uaoC068/PB1zGGNTIVs5
n+FqeA+bkxsjfkUhff/D6gG/nq41EvBIGuf//k9bPnFSbo8SgHKRbP9P2cXV9l6uXGD29YenHMdm
auGBsL40VYuCGNErSun7H2KoQ45gIe4Ew6V5HFE1/DhypBeyKzYeVQVTC7nkq3iJQbkMuLJqFZFI
CbWhdZorw0OZV9xL9FvjtB+Nd7u5GZ6SIqYTDuTJ9ehKubJmtTGFUiRYQaVpxYFKXFKmMpZJeCmj
sydPFrTc/FfcAya428926JTsHoofkkpoy5Hq0Ovhs+YEHYcVkjK1dG2lVsYutaerVk2PqXeIudy+
8fnfTJW8ulqJ7PmxzShPKfXeoSGpM1mM2/fk8DNnThDpsxUZFKJQdcl2VOtrnxsRqJYypZghKznq
XR2blWVLKgY9OrkXmcARr1yUpFTs0PXUo9QSlbu+sqBzU+/WVqcVJGutkkVycU6h1FafXTnj+f5M
8JRe6onvODtiJMeHZcozkSrwgBClUM9sLJ5Tp2qi2mD1pV4Zup0Jw14jgVV7Am2gXzWzzwUVyVvW
m6Iqmjcn8JOyrFPbFW2uG9/rqjGVmIqfq5NUQTkf/6lbnJ0YtDUUjw1Rrq/3IEo/awZ3H4Bn2f1h
kfKz37AAzzJg3WnUDknvanUIuHHQguCHVAwwEgAPDzABACZAEwBgAgB4cJzCpQHJroUjK/TlfgMp
hFmyMF2LTYcqzfsTtjyhXWzRn6DwwtkCU8XN9yeYDLyHJgv8CcR+irwj9vMn+ORATMCx54n0/T1y
GJhlI5Tq2jBLx0ze5VX/aY15v8oYj0V2sXl/gsILZwtMFTffn2B8+8DgO+ExEKfvE8KfIGhfHmTC
5bI3JiKRKdIPF6Bg+WJNbKrNmSvslD1La5Lao+WFswWub11V1xC0OMLqYF8n/+FuVTlJbcE9C/TS
zBEjV2qagrV2TEZ1ZJDUYUoqAM3vZGok5yUyI9cKXOk0dFWQrw599xD+BDQosdFQTqWeWo9FNuG3
QTlJ1T00w6ywD6JFBcZZLPInqG5U3oAJ70wdogM0BM0k8fkZ0zHeZKk/gZuQZZ8o2VECLgan1tbY
eCCYlfc65v1rDwSFQC7PPdq4y2kFmpVwN27Y26XgaQ2S3FmW1Jn387V5gBt5YONWSG+3YRM+7ogg
zgly46xrez7YpK/4oaDCn6CVAQv28v5LVNnnF144W2DkDbHYn6AcQ2rUKD2rh3UogD/B/QH+BBur
Q8AtcMEuSW8XYIL7Ay347EF7DARf/sVHYALgkfHOl3728R/tygXwLAP2xUdvvafU35jPXzkGE3Sb
Q5rpzoTzFS0F2h0k+8Ta20/Pnlh8frzjWcX9lpd9Dc31SjTJrTWjYKnpKoow/tVwAnsUMOXvVEh7
12MG+uq7gb7z9fcvP+99+7NDMEHXFjrsBi1eTk+6pusSGaetxwxtfjtygbE11yZ+uW3LTBYYBUdN
V+SBIfF4pb3chfyN24NuqFYRq1wPX/2dD89/X7xU//zVvzsdgAkmiWmscNBdowzSXruC32twZ2hw
CL571F9fvW0FmlHXGwiMyhQWBQtN18ZusoAS8tdSpXbtmr/6k5cXDnh5/v/hi+d8BCYIGkmbs7AY
WGK4dEcLHTRmpgv3VIiqKrhBSakCo+A1amb03DfvU+o9BNXzPzj/eTn8f/mt/9p9dajrGC1IGV/y
6ERjGTPsMa+1VkfCIHvNtaSeLSlVYBS8rOmcETdfH53o0f3wsX/7/QOMBH1XmGKTa1+OuPNp04kU
cywm2GES0hK8sOl0c4HHGamf/eqnF01I9f/f/sEh5gRlWRk3udlZrVxOJbeFQLeR3k5Wf/LtoHfh
hE/eePbhZU5w0Ya+/dO9mtRRh5yRWNdPmbT2laSpIfuB5fEGBfvKqTf3g88/QtPldRvjZCVSdhBF
C8WHN12SHYTFRz9782V38Z3f+HV1ACYwnUZqptVqY+96Gncu3YHWLrXZKN6E2X22uzD2KniNklIF
RsFS0zW8jJbnEYn8r94aJbz12dcvP1/7yw/3q8MyK9LahrwzjeSmlb/8eLNDT33+lXdffO8v3rhZ
K1KzekRgjUnDAh64Pl75+Te+eOaBHQF/AuAozAt/AgAAEwAAmAAAwAQAACYAADABAOyAeAe6lk2o
AoS7CFr78GBTaRVv/5/dSH98OOxalc0hOktgeprZ6tdu/hZvChcekxCenZyrTeuJA8ABmGAxKL6P
aYDi8wayG+mHpwFQNofoLAGJ5H0etUHSJmzRMQnDJv5U8T6tJw4Ax1KHmNluSdZduZfnn67TxwBW
7p2a4of5Kfufawljome7kSyXc2DpHAWxTs0ymikcn4bcQeh3OBJM8m4Qhd6xNOzIyOk8p+E0A46p
0D8iZdBNRP0jNbC4ezbnckjtvW4PWnATpQ57StTMk/487fuZfR/wx80xAdcpOu7myXEnU6wDSGcd
zKAOasrBq8RYZcqOO1TOl1XxzJCpzO1OHAC2YoJxM2Uu8wWrOvapCT4EqDZatXSvP3EAOODEmMqk
QQ0UxPHksUYdKugV+RyYMuxIZY5tVWzEVPyQ5+Ddz+pQZqWUZVWaHIU5NRZwq+CdDk1rE91M8lBU
Uey84z4g7u+MCWhcmXf22J82ue+uvIV45046g2JKI0rG/Eb6yYMFxBxGoncW9FPl+nxWla/zIMMP
804cAPbCLH+CRRvgr1bMijnMWS2Fqr8y9CFOr6zr/6oZwI2h8ZsW6P9B5gTzdd/VKISulwO1ZwtG
uBvAgA4AE6AJADABAIAJAAATYwvR+n+yUG6ZCEbGAhwtmLsGdSr3gXayexu/RBRs/x0vABgtAE1M
kFv7XkhKOWIUD1MPjZcmA9AK2//xqlvOBRcAM9QhdnwErPNA4FowhSrZ6cDPi60TwuSR0LseJFlM
stngjdY7AYwEstQffQRocBNwPQiU/800djoI8iLP66D751rkx3qRYMDHJPFC1h7Ouj5iKACamaAg
U32jIPIcH+vtkQW530CrRdt/ED6wjAmseOVqumTxMr7ntQi2KgUYAZjPBFSeKKdoMvIcoHraLag2
LWnGHSfACMBsdah2bZFiVZ2z9Btu6+L6IcyoPmU4BpaewGwm8I36R0JKehAo3+nAM933EjkeCf20
tV/G5CQ1i640Zdt/9nYdAiMABdze+QRzbP+BGwDOJ2jQgBg8ADw4E8yx/QeA+2ICAAATAACYAADA
BAAAJgAAMAEAgAkAAEwAAGACAAATAACYAADABAAAJgAAMAEAgAkAAEwAAGACAAATAMAi+LtNaGXs
rwqvuqDznyGKDG1UPoIaM6mJCgDXZgLt8ILunP+nqypMzJOHqY8KANdkAu3QaHQl0Hr/4/zVl6Fg
DDTReOIMK6qPasAMwLHmBJXEeKbdC/HaH9X9mO6Pl8UYHiXoizJ+JAA4ABMYYXagEoq7MYF+o7V7
E6cyJsdSAHCQkaCeB2yYFhLI4bnZAQYC4DgT40YecIISw0XVHFnvuAEfAEgjgR51Ga3TPGDFtyzF
p8XPKTwh7zWWSYFjjgTChwKjx2fdpRl+1Pio+3FWlsZwIcEQ1XsGAHvgGfbqBI4B7EoNAApMAABg
AgAAEwAAmAAAwAQAACYAADABAFwdz6RjtQUkw2zAcOix+5M+oDid05BmOomYozz8ssQo+fhiidMr
RhHjDPJnYiYL9HLnqfb9G7edPi68/tgXFL0HRxXy0o9NznuddPhJ9/f5LmWf1smG7THa3s9IYrWd
qkbi4ZEgOCINvxAxisrGF0ucahpFjDPghsaQA908hpdgYmptcTFHit6Doxdzb5xsGg/IvQ+ckjKG
h5Pn1XD0PLlhNEiOLpBaBxAhJjtpyKcQDxQGFMqgqhI53f2UTlmKTzWZ7UwCXN2SWxTu6+W8S01O
aRnTC7Oe2p07X9DlhVdDB9PVicIvkeakLPYw1TD9pJfQMmLmGUFOBfZQhchXh/YRCKd0vcYKEUfV
o5gaViZezrAFB1p1qfuae5elDIgbyJ9GuVEUDVZ3vIy4m9MhJwjREWxQhyo0Xpc1aEsRke4Riuko
231tvduTY5wBUyOn142RrsxZQoduQhblk/BiotADE1ipUNfHTsNLnTenQ7leaV5JbkXZ0PpZxoEc
x+Jls1IOZrpx0JHJ/PnhTKm5YmTgLad3nMmZwwCeoQK0xOcNeICIFM3LPSWTxhxTQbxO+9z5SNAv
mfujZnQ3zgfYWV7nfgS2z5ZrSjSsQg05C2F2eYpKxTVVSsrOz6DM7n5jyIFCcXZi0NxCqReL6us9
iNJvrN4eGVWeZQz3s1tCobsKH/p26+v91KHixzJ+6CnTXXLBmrrj3a4OrTxLBK4MWhD8kN0NAzrg
4QEmAMAEaAIATAAAD47oO0FgSU/Bp3zJb0Bts8Kcznz85trqTyBGq3BPWLNA57NAEHuuP0HgFyH4
E0hNOXkh2IT7+hOoHV0KTmFX+90gkV/kN9BsVFPXycnM2Q1Xtf4EKbqtcE9Ys8DRDjcuf6Y/QeAX
oWJ/AqkppxvPhQP+BGP78CATLpdMk3ARO2k72UEqUb0ZmeQIzDO5qXMfoJkF0ryXyLJDZEjS2kF7
GhaN7fDDwKXgejU6SQ3GPQv00mw/K1tel+eSOgwXzOmpumqVBabZe5GkWMUA9eoYy9Y/ui7py0ww
+g1EQ3nRb2CLZuQaw6Ch3hWWApSue8jopdcpCoVSgbEw3NafgFWtX+jDT4zpUA0Re8qW1eNW1SrS
hRaoaTNHrMFCcak/QXYMoslvByhPjGcNnQcXIa3VW/w6TT6nNHeyk863bW7AdIxefL5XwU9rdO9N
8ABfmwe4LvcryGauKulxbYXFOUG6cUS/Ad7kQ0HJzL1sUC/WuVCO6MGwZoHr+xOUY0gOEVF6Vg/r
UICTau4P8CfYWB0CboELdkl6uwAT3B8oL8xpQdpN8eqXPoI6BDwyPv/mT9Sbn72CkQB4WLx89SdK
ffDFN/YeCfqjiKc7E85XtBRojze25xh3J3kbJ8PuYO9dj6y3r+W/3RUKVMmj0LUNdY6KDpuuogjj
5jY+0OEB1MrtIVPIYLdDpd/85D/7iz//0+vzwZPXNcbSStij0eX05JLKduP5wmvCKUjpXaVMV7Px
52oF6hyTnOl9auyo6Yo8MCXW4QMTRLFXbpRkBnsJq8+444EXSv3ZL39+9dJDAzrTC4ZBVl3k0yDt
tSv4ldvgvtAbpFn3qL82OzKBHiSkuW6BBcZ3BbWJh9q2YSfPkcfXhV7/wgdnDnipXp7/v/vmp1/a
c06g/RbV/fBsrJjoL40nT7zEelFfbUiVfc3yFdygwAT1jUJirM+imi2lcb0/k7z2Lx9eZgX2/wdf
/vv9mMCEbGDEJk91WM8c+qrUVquc9HLXXIsVTZVy7SgwC5quioQvg03Xcyadjd5PGfp+MEf+2x3V
ob4rTLE9vX4yntS7aFPnafCRmMBcWykoNaBJVnCrptOjlhv3rp50Mr3XoPCDt3/zxxdtqP//7PkP
dp0TlGVlLC7M3tPeW4PeXAfR0QLFrtUp4+Pv/ePLy3zgog2d/vt/91wd0uH6RZ3+6ytJU3v2A8vu
DGJrcL2KFEryV4LOkYWmW1iSswymdcADXhqtmxemtsEfv/hOxwFK/fV71/9eJn0n6DQe+29YLFLu
pQ3pu00Pa+L214RL1bph/XsryRsuk1+jwMJ3AqdxhKarKkJPXyPiMqePNM4gb6bFMjmD3SYG7/xu
t0j69sc7lL3MbKK2yfQtrNPdi7LVOic5SE999Ps/Vl/76Vvq5pigVsJr8MAVxz2zhAf2E1f6n/7v
011Mh2BABxyGfeFPAABgAgAAEwAAmAAAwAQAACYAgB0Q70DH8zd4DXcR9HYKdx/G+09lNtJX7G0Q
yZTNYYoWVi3e6JPDzd/iDanDTfzDl8zVpvXEAeAATLAYFN/HNBAfrZ7fSD/capSyOWR2WxP3wZ2C
pI1Yo038h81zqeJ9Wk8cAI6lDjGz3ZKsu3Ivzz9dp48BrNw7NcUP81P2P9cSxnQ2ht1Ilss5iOOA
WKelO5ROp2yA0O9xJBgOLZlksrd9OTsycjrPaTjNgONBwT8ixT2ppfpMXXfP5lwO0hbTfZVpOtRI
kR9HOpeGZB6w6g+Tqnof8MfNMQHXKTru5slxJ1OsA1CJTNu0rTl7qbMqJeKYOVpqJTXElicOABsx
wbiZMpf5glUd+9QEHwJVtMqtpxjsc8YPsMLEmMqkQQ0UxPHksUYdKlBfYw7VibKKDacYQUzFOBTj
pleHMiul8jlx4524IhIt2lQTL6UOoqFm2q9LRPmwhGCHuL8zJqBxZd7ZY3/a5L678pbynTtpeWZK
I0rG/Eb6DaeWsSy+i8cUJRcyc/mmtZyZJw4Ae2GWP8GiDfBXK2bFHOaslkLVXxn7+RM0fyzjqhnA
jaHxmxbo/0HmBPMXUVajELpeDtSeLRjhbgADOgBMgCYAwAQAACYAAEyMLUTr/+lLadO3KYqM0sIF
c9egTuU9DKy18uQwULD997wSsJIDNDBBbu17ISnlLGjydvzTZyf3M1w+jWf2Cot+YI46xI6PgHUe
CFwLplAlOx34ebF1Qpg8EnrXgwoWm0vChDVMYMZIEIhUV5AGrgWBrI6dDoK8yPM66P65Fvk5vUix
SqhRmTSe8oahAGhngkBVyT3zfQfqpS9J0j5pmMaS+p/7YjVqX6B/YCYTWPHK1TTN4mV8z+0azyyT
TZA+sJQJqDxRThFd5DlA9cQ5xz8gnwYDAbBAHap1iCKmkN44S4qxmsKUY5FCLfLeMeABYCYT+Eb9
01JlyoNA+U4Hnum+l8jxSOjytZ7vwqp/ysNAVdn+D1f4UABU4fbOJ1i4UwpwVOB8gno0uu2CB4D7
Y4I5tv8AcF9MAABgAgAAEwAAmAAAwAQAACYAADABAIAJAABMAABgAgAAEwAAmAAAwAQAACYAADAB
AIAJgHsAvQYmAB4b73zyr6/vV/ozeF4B++OL76kXT/9zACbQ3d/R23nye9b24fmJ7mN0UY2+XI/R
+qBz3P0cpiPoobLGfY/9CnSDx1hjy7mtWSwnSmyfaD/AudJe7zo3Tq20Unv03i8+vvz9+Vv7q0PG
9P9dlggaXl8i9BzQxfb7d+gLfRwecCumdy/QDZ7aa7gyTbzmJzZm6jkjR3E6yOstP59d+umzfuOf
X/l8Jzo5JaSMdgW/17q+hBtEV/eovzb6SDygTJKrNypwbrBatutIkoJN0HvNtdoan7/2/ouXSr14
/63/eOMgE+NeJph+cPaEhxtJ60W9fR0MDNrTh7lagSmK3ktPtA2gZT7ZXXt9/r4688D5/7vfPODq
kFEpWu+ZQxfZ4Qg80K5trMIDzcHLWjOnylhR5ki0I/GA+sXeFXhqalnLFVb/PI8TZ2lnFLCGarNv
a6bl3fb49zdfnP+e///Svx1mTpCTLuZA097Dc4HaZGtBeVDzumrOuLdjz77xD7910YZefOHdNw7I
BHJTO6sIUx8brfdbXZitJ2ysG1UU7Uap4xhTfjU/ivbWa7WcgbOwcX383uuXJdKXr+7EA4I6ZPoJ
VE/SzhhpbJgZo3izYPfZoVjBpCaEOxU4ta+NJbVmdREmPd0Nongxo2S2Z3fCsz88q0Nfe2W34uu/
GNeSksY04cgDX57Wd+q8d7/x4a/99i3sSm1WjwhsNReZzwP74K2vfIv3azHYDgFHYV6cTwAAYAIA
ABMAAJgAAMAEwC2AN4r7w93qACYAHh6u2UR40HbzwY/hEeCWByliTIp4lbwr78hk5R+ozCTkMJVr
AzmIwt0zShRrM41P+ZNr5rykWJsxLuH0zFtjgsWg+D6mAYoGKCaXAS0n+bzoZENCDu49CWlEnnbi
XH4oG8WrmXegePJ9un/ggZtlgl7edd1oSXm8vMg3HkUtD8fTj3c8xo9E40ActceqOiNTn98gWqMc
eDzcWCQ6tgfcU5Zla3mcorHnXgmdrzspuHJcyjPBJO+YQvHcc0MQMEpMGsiREjK3qxKP0pNqBxZy
tK04BxJ1HFdLm/hIKDbiWFkzovHnklfV+9z2QEAZ2dQix44e91THXl4+xLl2olgHoLQ8ndMn2Rwm
BUasMgl0HcxVKDffCac9mdpcBkm+43HiTtWhkXi4zBfcMjpdzziKXAIsR/bmGg26UHVdYqYBbmRO
UEEaLfo1J6ey1fQhUFI2B8qyI5U5tnllTNazGCR2w6tDmZVSeRI63okrIhwOCdVERpxYaKRMtZkS
QxGVdcV5gvtxxD3dXdyTTHfDWE7sahj9nLC/8iagzp1EhVMaUTLSuHg0leEsrxLXvnQih0S5U77J
hcxczdJazphxn+4O2aNew6vuu4aYbXErajvLn4BppSZSG+fDtE1J/NhfweoZu76hWpq0rfnLtT21
N0DNDODWRvi2OmOqu6+SuHaup/UrQMd5V9qmKHqsSUAsA/i+agsDOuAo84fdcj2hl4AWXbj6uwcf
Y7CsqS2YAGhVL7mKtOggA0FFbcEEQDsnMG1ArdvwQE1tTx7LCBO+Yd2/aWyLjAU4WjD3HADyHgaB
f0C17f+jr2QeQn+q1YqoQX3ilXWtUx3PLCSlnAVN3o4/Judq2/+evWDRv5latGbEraJWRZdWh5h5
/GFrUMfDY7ai24aqIMSm9fM6h7iBQ75cwWLDV+NNx2zgsXGS6S5wogpcCwJZHTsdBHmR53XQ/XMt
8nN6kegnWUpjjf6HcRbMACyYGFPhme87QNUSm+qlPcW+z7W2/wAwmwm4dabC4mV8z+3zDZqj5YEB
gKVMQK1qNfnqT5IeqYKV2qbmDKJfG/0JvWtlZmrCtFm3fG1q65BVh2oVCuLomwhnyVdQbSjHIpz/
5gLyXx9m57yuvzn1k0TY3C1D9j8jUQ/38Z1zTcwk5BVm3OfbLxVd1oyCJaUhJjtXQ5ykOVSUpkbb
AtLiVA/nkw6Hag4305MgnrYnGw3RtY3exfcC4mwWlC/lXMo9MxJQoA55f/3pqxuJvEtyp8jkTpmD
NFRS+uNSyxMFiusIzFQptImv+9vpSX9ltLGPnECbxB5m5wd0ScKMZ5Yv5azyuRdHgoOj0Y4XA8Gs
IcAqJUanzyQ3JU3GiWfkaGaV8o1UgRal6gZth2jD2MBIPllNwuggntEmmNsmJ93ZB+3lb7Q6BAC9
LpHlFEv2JiZZUzvnzRRSXf42E2MAGAnbBMuNogTXVjY7j6sHA728/MWnDWIkAFIKh9G+8uE8mtSR
/upMqqb7b+PJg0EQcJnCToXML98IOTfpTDi9ElhVhbpFrONP0LxZgz0uYOamPK0HFsRHHsgHFng7
jtU6LQQfFvMHFih/SzOcYHA0JtjQn0Bas5lv5dZ0YEHCvFV8KfaC6pwWemO+2gMLpi/gI/vcEQ/c
6inuy/wJpt17R08BDmIrNTgUDJkrmwuz6IvAU15BXYaSe+PuMU6XMknfPnW6lWCJVlvYOMmkmV25
IfWPPRKIcqvGn0A5xxSwq++E4UqNUZTvYxBfhi4IKnBAqD6wYBLzrioiHViQMrXIWulZ9cd91/SB
BTy5n/NGYyyw9upQ3p9AEnAk71AX7EyaLYnk0jNb8ua3TWdpj3T5wIJIOcpus5U36hN8JkINECcY
HJcJavwJaC1X54wvQm1diooL05zk1Vtotufo+k/DA+iQTFDlT7DWsgZVjTtxaa0HFuSZcM6BBeOB
OBWuDsJW8YN6iBMMjqoOFcVT4D8QbKASEUPoG5miZ8H3QFAiZhxYkByAqIlPo4ypytVBmClD+h+a
Cfyt+KehWzqRYNj6n9i9S4Wr+KyA+AAER19W1z2wIOCzjBbYzazDVf80Wdu4/ls4FQQ/7IvVvxjL
Z6gepZtxYAEQ4/8BontMw9FRhSIAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2010-07-15 10:39:48 -0400" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-002.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Psychotherapy in adolescents, outcome: 4.1 Various outcomes at 3 to 8 months.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwQAAAEwCAMAAAA+UUZCAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2010-07-15 10:41:41 -0400" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-001.07" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Psychotherapy in adults, outcome: 1.5 Depression (9 to 18 months).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAv0AAAFQCAMAAAAbcjGLAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2010-07-30 14:09:48 -0400" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-002.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Psychotherapy in adolescents, outcome: 2.2 Depression and anxiety at 3 to 8 months.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwYAAAEQCAMAAAA9CJNJAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2011-01-05 14:51:50 -0500" MODIFIED_BY="John K MacDonald" NO="9" REF_ID="CMP-001.11" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Psychotherapy in adults, outcome: 1.6 Not in remission at/during month 9 to 18.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtYAAAHgCAMAAAC2BdrZAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-10" MODIFIED="2011-01-07 13:52:01 -0500" MODIFIED_BY="John K MacDonald" NO="10" REF_ID="CMP-003.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Patient education in adults, outcome: 2.2 HRQL (9 to 18 months).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwQAAAHACAMAAAArw19bAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-11" MODIFIED="2010-07-15 10:50:49 -0400" MODIFIED_BY="[Empty name]" NO="11" REF_ID="CMP-003.10" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Patient education in adults, outcome: 2.8 Not in remission at/during month 9 to 18.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtYAAAHACAMAAACxqd/vAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="edu_qol_no_nrct.png" FILE_TYPE="PNG" ID="FIG-12" MODIFIED="2010-07-15 10:50:49 -0400" MODIFIED_BY="[Empty name]" NO="12" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Sensitivity analysis: HRQL at 12 months, NRCT excluded</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwQAAAHACAMAAAArw19bAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="edu_qol_rct_only.png" FILE_TYPE="PNG" ID="FIG-13" MODIFIED="2010-07-15 06:04:00 -0400" MODIFIED_BY="[Empty name]" NO="13" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Sensitivity analysis, HRQL at 12 months, RCT only</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwQAAAHACAMAAAArw19bAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2010-08-05 12:37:20 -0400" MODIFIED_BY="John K MacDonald">
<APPENDIX ID="APP-01" MODIFIED="2010-08-05 12:37:20 -0400" MODIFIED_BY="John K MacDonald" NO="1">
<TITLE MODIFIED="2010-06-24 10:40:58 -0400" MODIFIED_BY="[Empty name]">Detailed search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2010-08-05 12:37:20 -0400" MODIFIED_BY="John K MacDonald">
<P>
<B>Ovid MEDLINE(R) 1950 to April Week 3 2010</B>
</P>
<P>
<B>Searched 2010-04-29</B>
</P>
<P>
<B> </B>
</P>
<TABLE COLS="3" ROWS="95">
<TR>
<TD>
<P>
<B>#</B>
</P>
</TD>
<TD>
<P>
<B>Searches</B>
</P>
</TD>
<TD>
<P>
<B>Results</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>1</P>
</TD>
<TD>
<P>exp Inflammatory Bowel Diseases/pc, px, rh, th [Prevention &amp; Control, Psychology, Rehabilitation, Therapy]</P>
</TD>
<TD>
<P>5760</P>
</TD>
</TR>
<TR>
<TD>
<P>2</P>
</TD>
<TD>
<P>Enterocolitis/pc, px, rh, th</P>
</TD>
<TD>
<P>137</P>
</TD>
</TR>
<TR>
<TD>
<P>3</P>
</TD>
<TD>
<P>exp Proctitis/pc, px, rh, th</P>
</TD>
<TD>
<P>246</P>
</TD>
</TR>
<TR>
<TD>
<P>4</P>
</TD>
<TD>
<P>Ileitis/pc, px, th [Prevention &amp; Control, Psychology, Therapy]</P>
</TD>
<TD>
<P>89</P>
</TD>
</TR>
<TR>
<TD>
<P>5</P>
</TD>
<TD>
<P>crohn*.tw,ot.</P>
</TD>
<TD>
<P>23716</P>
</TD>
</TR>
<TR>
<TD>
<P>6</P>
</TD>
<TD>
<P>(ulcer* adj5 colit*).tw,ot.</P>
</TD>
<TD>
<P>21155</P>
</TD>
</TR>
<TR>
<TD>
<P>7</P>
</TD>
<TD>
<P>(ulzer* adj5 kolit*).ot.</P>
</TD>
<TD>
<P>16</P>
</TD>
</TR>
<TR>
<TD>
<P>8</P>
</TD>
<TD>
<P>(regional* adj2 enter*).tw,ot.</P>
</TD>
<TD>
<P>856</P>
</TD>
</TR>
<TR>
<TD>
<P>9</P>
</TD>
<TD>
<P>ileitis.tw,ot.</P>
</TD>
<TD>
<P>1413</P>
</TD>
</TR>
<TR>
<TD>
<P>10</P>
</TD>
<TD>
<P>(enterocolit* or entero-colit*).tw. or (enterokolit* or entero-kolit*).ot.</P>
</TD>
<TD>
<P>10581</P>
</TD>
</TR>
<TR>
<TD>
<P>11</P>
</TD>
<TD>
<P>(proktiti* or proktokolit* or prokto-kolit*).ot.</P>
</TD>
<TD>
<P>37</P>
</TD>
</TR>
<TR>
<TD>
<P>12</P>
</TD>
<TD>
<P>(proctiti* or proctocolit* or procto-colit*).tw,ot.</P>
</TD>
<TD>
<P>1779</P>
</TD>
</TR>
<TR>
<TD>
<P>13</P>
</TD>
<TD>
<P>(inflamm* adj5 bowel* adj5 disease*).tw.</P>
</TD>
<TD>
<P>17867</P>
</TD>
</TR>
<TR>
<TD>
<P>14</P>
</TD>
<TD>
<P>entzundliche* darm*.ot.</P>
</TD>
<TD>
<P>344</P>
</TD>
</TR>
<TR>
<TD>
<P>15</P>
</TD>
<TD>
<P>or/1-14</P>
</TD>
<TD>
<P>61148</P>
</TD>
</TR>
<TR>
<TD>
<P>16</P>
</TD>
<TD>
<P>exp Psychotherapy/</P>
</TD>
<TD>
<P>126602</P>
</TD>
</TR>
<TR>
<TD>
<P>17</P>
</TD>
<TD>
<P>exp mind-body therapies/</P>
</TD>
<TD>
<P>36096</P>
</TD>
</TR>
<TR>
<TD>
<P>18</P>
</TD>
<TD>
<P>exp spiritual therapies/</P>
</TD>
<TD>
<P>10384</P>
</TD>
</TR>
<TR>
<TD>
<P>19</P>
</TD>
<TD>
<P>exp Adaptation, Psychological/</P>
</TD>
<TD>
<P>81469</P>
</TD>
</TR>
<TR>
<TD>
<P>20</P>
</TD>
<TD>
<P>Patient Education/</P>
</TD>
<TD>
<P>58052</P>
</TD>
</TR>
<TR>
<TD>
<P>21</P>
</TD>
<TD>
<P>exp "Psychology, Social"/</P>
</TD>
<TD>
<P>534988</P>
</TD>
</TR>
<TR>
<TD>
<P>22</P>
</TD>
<TD>
<P>social support/</P>
</TD>
<TD>
<P>37995</P>
</TD>
</TR>
<TR>
<TD>
<P>23</P>
</TD>
<TD>
<P>self care/</P>
</TD>
<TD>
<P>17751</P>
</TD>
</TR>
<TR>
<TD>
<P>24</P>
</TD>
<TD>
<P>or/16-23</P>
</TD>
<TD>
<P>751460</P>
</TD>
</TR>
<TR>
<TD>
<P>25</P>
</TD>
<TD>
<P>(Acceptance adj2 Commitment).tw.</P>
</TD>
<TD>
<P>61</P>
</TD>
</TR>
<TR>
<TD>
<P>26</P>
</TD>
<TD>
<P>adler*.tw,ot.</P>
</TD>
<TD>
<P>556</P>
</TD>
</TR>
<TR>
<TD>
<P>27</P>
</TD>
<TD>
<P>(art therap* or attack therap* or attachment therap*).tw.</P>
</TD>
<TD>
<P>486</P>
</TD>
</TR>
<TR>
<TD>
<P>28</P>
</TD>
<TD>
<P>Autogen* training.tw,ot.</P>
</TD>
<TD>
<P>581</P>
</TD>
</TR>
<TR>
<TD>
<P>29</P>
</TD>
<TD>
<P>(behavio* adj (treat* or therap* or modif*)).tw. or verhaltenstherap*.ot.</P>
</TD>
<TD>
<P>12804</P>
</TD>
</TR>
<TR>
<TD>
<P>30</P>
</TD>
<TD>
<P>(Biodynami* or Bioenergeti* or Biofeedback or Bionomi*).tw,ot. or (Body Mind or Breathwork).tw.</P>
</TD>
<TD>
<P>8197</P>
</TD>
</TR>
<TR>
<TD>
<P>31</P>
</TD>
<TD>
<P>(characteranalyti* or character-analyti*).tw,ot.</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>32</P>
</TD>
<TD>
<P>(Client-centered or client-centred).tw.</P>
</TD>
<TD>
<P>655</P>
</TD>
</TR>
<TR>
<TD>
<P>33</P>
</TD>
<TD>
<P>(counselling or counseling).tw.</P>
</TD>
<TD>
<P>42999</P>
</TD>
</TR>
<TR>
<TD>
<P>34</P>
</TD>
<TD>
<P>(cognitive adj1 behavio*).tw.</P>
</TD>
<TD>
<P>9318</P>
</TD>
</TR>
<TR>
<TD>
<P>35</P>
</TD>
<TD>
<P>CBT.tw,ot.</P>
</TD>
<TD>
<P>2511</P>
</TD>
</TR>
<TR>
<TD>
<P>36</P>
</TD>
<TD>
<P>(coherence therap* or contemplative or conversational).tw.</P>
</TD>
<TD>
<P>1379</P>
</TD>
</TR>
<TR>
<TD>
<P>37</P>
</TD>
<TD>
<P>(cope* or coping).tw,ot.</P>
</TD>
<TD>
<P>42858</P>
</TD>
</TR>
<TR>
<TD>
<P>38</P>
</TD>
<TD>
<P>(core energetic* or core process*).tw,ot.</P>
</TD>
<TD>
<P>176</P>
</TD>
</TR>
<TR>
<TD>
<P>39</P>
</TD>
<TD>
<P>dance.tw. or tanz*.ot. or daseins*.tw,ot.</P>
</TD>
<TD>
<P>1661</P>
</TD>
</TR>
<TR>
<TD>
<P>40</P>
</TD>
<TD>
<P>(Developmental Needs Meeting Strateg* or DNMS).tw.</P>
</TD>
<TD>
<P>109</P>
</TD>
</TR>
<TR>
<TD>
<P>41</P>
</TD>
<TD>
<P>(Dialectical or DBT).tw.</P>
</TD>
<TD>
<P>1194</P>
</TD>
</TR>
<TR>
<TD>
<P>42</P>
</TD>
<TD>
<P>(Dreamwork or Drama or Dyadic or DDP).tw.</P>
</TD>
<TD>
<P>4349</P>
</TD>
</TR>
<TR>
<TD>
<P>43</P>
</TD>
<TD>
<P>(Emotional Freedom Techni* or EFT).tw.</P>
</TD>
<TD>
<P>231</P>
</TD>
</TR>
<TR>
<TD>
<P>44</P>
</TD>
<TD>
<P>(encounter group* or eye movement*).tw.</P>
</TD>
<TD>
<P>19043</P>
</TD>
</TR>
<TR>
<TD>
<P>45</P>
</TD>
<TD>
<P>(EMDR or (Desensiti* adj2 (Reprocessing or re-processing))).tw.</P>
</TD>
<TD>
<P>216</P>
</TD>
</TR>
<TR>
<TD>
<P>46</P>
</TD>
<TD>
<P>(Experient* Dynamic or Existential therap*).tw.</P>
</TD>
<TD>
<P>26</P>
</TD>
</TR>
<TR>
<TD>
<P>47</P>
</TD>
<TD>
<P>(Exposure adj2 response prevent*).tw.</P>
</TD>
<TD>
<P>175</P>
</TD>
</TR>
<TR>
<TD>
<P>48</P>
</TD>
<TD>
<P>expressive therap*.tw,ot.</P>
</TD>
<TD>
<P>35</P>
</TD>
</TR>
<TR>
<TD>
<P>49</P>
</TD>
<TD>
<P>(Family Constellation* or Family System* or Family therap* or Feminist therap* or functional analytic or Focusing or Freudian).tw. or feldenkr*.tw,ot. or (familien* or freud*).ot.</P>
</TD>
<TD>
<P>50915</P>
</TD>
</TR>
<TR>
<TD>
<P>50</P>
</TD>
<TD>
<P>(goal setting or Gestalt* or Group Analy* or group-based or (group adj (therap* or treatment* or intervention))).tw. or (gruppenpsychotherap* or gruppentherap* or gruppenanaly* or gestalt*).ot.</P>
</TD>
<TD>
<P>13395</P>
</TD>
</TR>
<TR>
<TD>
<P>51</P>
</TD>
<TD>
<P>(Hakomi or Holistic or Holotropic or Humanistic or Human givens).tw. or (Hypnos* or Hypnot* or hypno-therap*).tw,ot.</P>
</TD>
<TD>
<P>23331</P>
</TD>
</TR>
<TR>
<TD>
<P>52</P>
</TD>
<TD>
<P>(Integral* Strateg* or (Intensive adj2 dynami*) or Interaction Therap* or Interperson* therap* or IPT).tw,ot. or interaktionstherap*.ot.</P>
</TD>
<TD>
<P>1051</P>
</TD>
</TR>
<TR>
<TD>
<P>53</P>
</TD>
<TD>
<P>(interpersonal or inter-personal).tw. or (interpersonell* or inter-personell*).ot.</P>
</TD>
<TD>
<P>15609</P>
</TD>
</TR>
<TR>
<TD>
<P>54</P>
</TD>
<TD>
<P>(Jungian or Logotherap*).tw,ot.</P>
</TD>
<TD>
<P>290</P>
</TD>
</TR>
<TR>
<TD>
<P>55</P>
</TD>
<TD>
<P>(Meditati* or Milieu Therap* or milieutherap* or Mindfulness* or MBSR or (Method adj2 Levels) or Morita Therap* or Multimodal* Therap* or multi-modal* therap* or Multitheoreti* or Multi-theoreti* or Music therap*).tw,ot. or musiktherap*.ot.</P>
</TD>
<TD>
<P>6502</P>
</TD>
</TR>
<TR>
<TD>
<P>56</P>
</TD>
<TD>
<P>(Narrative Therap* or Needs Meeting* or Neuro-linguistic program* or NLP).tw,ot.</P>
</TD>
<TD>
<P>483</P>
</TD>
</TR>
<TR>
<TD>
<P>57</P>
</TD>
<TD>
<P>(Object* Relation* or Orgonom*).tw. or (objektrelation* or orgonom*).ot.</P>
</TD>
<TD>
<P>1362</P>
</TD>
</TR>
<TR>
<TD>
<P>58</P>
</TD>
<TD>
<P>(parent-child interact* or PCIT).tw. or eltern-kind interakt*.ot.</P>
</TD>
<TD>
<P>618</P>
</TD>
</TR>
<TR>
<TD>
<P>59</P>
</TD>
<TD>
<P>patient education.tw.</P>
</TD>
<TD>
<P>8490</P>
</TD>
</TR>
<TR>
<TD>
<P>60</P>
</TD>
<TD>
<P>(person-centered or person-centred).tw. or personenzentriert*.ot.</P>
</TD>
<TD>
<P>545</P>
</TD>
</TR>
<TR>
<TD>
<P>61</P>
</TD>
<TD>
<P>(Personal construct or PCP or Play therap* or Primal therap* or Process Oriented or Provocative Therap* or Psychedelic or Psychoanaly* or psycho-analyti* or Psychodrama or psycho-drama or Psychodynamic or psycho-dynamic or (psycho* adj3 (care* or treat* or therap* or intervent* or support*))).tw.</P>
</TD>
<TD>
<P>52231</P>
</TD>
</TR>
<TR>
<TD>
<P>62</P>
</TD>
<TD>
<P>psychotherap*.mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier]</P>
</TD>
<TD>
<P>57294</P>
</TD>
</TR>
<TR>
<TD>
<P>63</P>
</TD>
<TD>
<P>Pulsing.tw.</P>
</TD>
<TD>
<P>1535</P>
</TD>
</TR>
<TR>
<TD>
<P>64</P>
</TD>
<TD>
<P>(Radix therap* or Rational Emoti* or REBT or Rational Living Therap* or RLT or Rebirthing or re-birthing or Reiki or Relationship counsel* or Relational-Cultural or relaxation or (relax* adj3 (techni* or train* or treatment* or therap*)) or Reprogram* or re-program* or Reality therap* or Rogerian or Rubenfeld Synergy or Reichian or Rolfing).tw.</P>
</TD>
<TD>
<P>67913</P>
</TD>
</TR>
<TR>
<TD>
<P>65</P>
</TD>
<TD>
<P>(self-manag* or selfmanag*).tw. or (selbstmanagement* or selbst-management*).ot.</P>
</TD>
<TD>
<P>4607</P>
</TD>
</TR>
<TR>
<TD>
<P>66</P>
</TD>
<TD>
<P>(SHEN or social support* or Social Therap* or social care or Solution focused or Somatic Psychology or Sophia analys* or supportive-expressive or Systematic Treatment Selection* or STS or Systemic Constellation* or Systemic Therap*).tw. or soziale unterst*.ot.</P>
</TD>
<TD>
<P>27106</P>
</TD>
</TR>
<TR>
<TD>
<P>67</P>
</TD>
<TD>
<P>(supporti* adj3 (therap* or care or treat* or intervent*)).tw.</P>
</TD>
<TD>
<P>13145</P>
</TD>
</TR>
<TR>
<TD>
<P>68</P>
</TD>
<TD>
<P>(Thought Field Therap* or Transactional* or trans-actional* or Transperson* or trans-person* or twelve-step program* or Vegetotherap* or vegeto-therap*).tw.</P>
</TD>
<TD>
<P>972</P>
</TD>
</TR>
<TR>
<TD>
<P>69</P>
</TD>
<TD>
<P>or/25-68</P>
</TD>
<TD>
<P>432478</P>
</TD>
</TR>
<TR>
<TD>
<P>70</P>
</TD>
<TD>
<P>24 or 69</P>
</TD>
<TD>
<P>1027712</P>
</TD>
</TR>
<TR>
<TD>
<P>71</P>
</TD>
<TD>
<P>15 and 70</P>
</TD>
<TD>
<P>1852</P>
</TD>
</TR>
<TR>
<TD>
<P>72</P>
</TD>
<TD>
<P>randomized controlled trial.pt.</P>
</TD>
<TD>
<P>288897</P>
</TD>
</TR>
<TR>
<TD>
<P>73</P>
</TD>
<TD>
<P>controlled clinical trial.pt.</P>
</TD>
<TD>
<P>81122</P>
</TD>
</TR>
<TR>
<TD>
<P>74</P>
</TD>
<TD>
<P>random*.mp.</P>
</TD>
<TD>
<P>624926</P>
</TD>
</TR>
<TR>
<TD>
<P>75</P>
</TD>
<TD>
<P>placebo.mp.</P>
</TD>
<TD>
<P>122347</P>
</TD>
</TR>
<TR>
<TD>
<P>76</P>
</TD>
<TD>
<P>Clinical Trials as Topic/</P>
</TD>
<TD>
<P>147960</P>
</TD>
</TR>
<TR>
<TD>
<P>77</P>
</TD>
<TD>
<P>trial.ti,ab.</P>
</TD>
<TD>
<P>246097</P>
</TD>
</TR>
<TR>
<TD>
<P>78</P>
</TD>
<TD>
<P>groups.ab.</P>
</TD>
<TD>
<P>962209</P>
</TD>
</TR>
<TR>
<TD>
<P>79</P>
</TD>
<TD>
<P>exp Cohort Studies/</P>
</TD>
<TD>
<P>758306</P>
</TD>
</TR>
<TR>
<TD>
<P>80</P>
</TD>
<TD>
<P>cohort*.ti,ab. or kohort*.ot.</P>
</TD>
<TD>
<P>151905</P>
</TD>
</TR>
<TR>
<TD>
<P>81</P>
</TD>
<TD>
<P>course.ti,ab.</P>
</TD>
<TD>
<P>333684</P>
</TD>
</TR>
<TR>
<TD>
<P>82</P>
</TD>
<TD>
<P>prospectiv*.ti,ab.</P>
</TD>
<TD>
<P>303149</P>
</TD>
</TR>
<TR>
<TD>
<P>83</P>
</TD>
<TD>
<P>longitudinal.ti,ab.</P>
</TD>
<TD>
<P>91686</P>
</TD>
</TR>
<TR>
<TD>
<P>84</P>
</TD>
<TD>
<P>follow-up*.ti,ab.</P>
</TD>
<TD>
<P>435172</P>
</TD>
</TR>
<TR>
<TD>
<P>85</P>
</TD>
<TD>
<P>control*.ti,ab.</P>
</TD>
<TD>
<P>1871611</P>
</TD>
</TR>
<TR>
<TD>
<P>86</P>
</TD>
<TD>
<P>Comparative Study.pt.</P>
</TD>
<TD>
<P>1477135</P>
</TD>
</TR>
<TR>
<TD>
<P>87</P>
</TD>
<TD>
<P>or/72-86</P>
</TD>
<TD>
<P>4854026</P>
</TD>
</TR>
<TR>
<TD>
<P>88</P>
</TD>
<TD>
<P>exp animals/ not humans/</P>
</TD>
<TD>
<P>3462178</P>
</TD>
</TR>
<TR>
<TD>
<P>89</P>
</TD>
<TD>
<P>87 not 88</P>
</TD>
<TD>
<P>3799663</P>
</TD>
</TR>
<TR>
<TD>
<P>90</P>
</TD>
<TD>
<P>("retraction of publication" or retracted publication).pt.</P>
</TD>
<TD>
<P>2722</P>
</TD>
</TR>
<TR>
<TD>
<P>91</P>
</TD>
<TD>
<P>published erratum.pt.</P>
</TD>
<TD>
<P>1058</P>
</TD>
</TR>
<TR>
<TD>
<P>92</P>
</TD>
<TD>
<P>71 and 89</P>
</TD>
<TD>
<P>824</P>
</TD>
</TR>
<TR>
<TD>
<P>93</P>
</TD>
<TD>
<P>92 not 91 not 90</P>
</TD>
<TD>
<P>824</P>
</TD>
</TR>
<TR>
<TD>
<P>94</P>
</TD>
<TD>
<P>remove duplicates from 93</P>
</TD>
<TD>
<P>815</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>
<B>Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations April 29, 2010</B>
</P>
<P>
<B>Searched 2010-04-29</B>
</P>
<P> </P>
<TABLE COLS="3" ROWS="91">
<TR>
<TD>
<P>
<B>#</B>
</P>
</TD>
<TD>
<P>
<B>Searches</B>
</P>
</TD>
<TD>
<P>
<B>Results</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>1</P>
</TD>
<TD>
<P>exp Inflammatory Bowel Diseases/pc, px, rh, th [Prevention &amp; Control, Psychology, Rehabilitation, Therapy]</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>2</P>
</TD>
<TD>
<P>Enterocolitis/pc, px, rh, th</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>3</P>
</TD>
<TD>
<P>exp Proctitis/pc, px, rh, th</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>4</P>
</TD>
<TD>
<P>Ileitis/pc, px, th [Prevention &amp; Control, Psychology, Therapy]</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>5</P>
</TD>
<TD>
<P>crohn*.tw,ot.</P>
</TD>
<TD>
<P>743</P>
</TD>
</TR>
<TR>
<TD>
<P>6</P>
</TD>
<TD>
<P>(ulcer* adj5 colit*).tw,ot.</P>
</TD>
<TD>
<P>498</P>
</TD>
</TR>
<TR>
<TD>
<P>7</P>
</TD>
<TD>
<P>(ulzer* adj5 kolit*).ot.</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>8</P>
</TD>
<TD>
<P>(regional* adj2 enter*).tw,ot.</P>
</TD>
<TD>
<P>12</P>
</TD>
</TR>
<TR>
<TD>
<P>9</P>
</TD>
<TD>
<P>ileitis.tw,ot.</P>
</TD>
<TD>
<P>26</P>
</TD>
</TR>
<TR>
<TD>
<P>10</P>
</TD>
<TD>
<P>(enterocolit* or entero-colit*).tw. or (enterokolit* or entero-kolit*).ot.</P>
</TD>
<TD>
<P>148</P>
</TD>
</TR>
<TR>
<TD>
<P>11</P>
</TD>
<TD>
<P>(proktiti* or proktokolit* or prokto-kolit*).ot.</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>12</P>
</TD>
<TD>
<P>(proctiti* or proctocolit* or procto-colit*).tw,ot.</P>
</TD>
<TD>
<P>29</P>
</TD>
</TR>
<TR>
<TD>
<P>13</P>
</TD>
<TD>
<P>(inflamm* adj5 bowel* adj5 disease*).tw.</P>
</TD>
<TD>
<P>694</P>
</TD>
</TR>
<TR>
<TD>
<P>14</P>
</TD>
<TD>
<P>entzundliche* darm*.ot.</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>15</P>
</TD>
<TD>
<P>or/1-14</P>
</TD>
<TD>
<P>1644</P>
</TD>
</TR>
<TR>
<TD>
<P>16</P>
</TD>
<TD>
<P>exp Psychotherapy/</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>17</P>
</TD>
<TD>
<P>exp mind-body therapies/</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>18</P>
</TD>
<TD>
<P>exp spiritual therapies/</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>19</P>
</TD>
<TD>
<P>exp Adaptation, Psychological/</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>20</P>
</TD>
<TD>
<P>Patient Education/</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>21</P>
</TD>
<TD>
<P>exp "Psychology, Social"/</P>
</TD>
<TD>
<P>12</P>
</TD>
</TR>
<TR>
<TD>
<P>22</P>
</TD>
<TD>
<P>social support/</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>23</P>
</TD>
<TD>
<P>self care/</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>24</P>
</TD>
<TD>
<P>or/16-23</P>
</TD>
<TD>
<P>13</P>
</TD>
</TR>
<TR>
<TD>
<P>25</P>
</TD>
<TD>
<P>(Acceptance adj2 Commitment).tw.</P>
</TD>
<TD>
<P>9</P>
</TD>
</TR>
<TR>
<TD>
<P>26</P>
</TD>
<TD>
<P>adler*.tw,ot.</P>
</TD>
<TD>
<P>18</P>
</TD>
</TR>
<TR>
<TD>
<P>27</P>
</TD>
<TD>
<P>(art therap* or attack therap* or attachment therap*).tw.</P>
</TD>
<TD>
<P>19</P>
</TD>
</TR>
<TR>
<TD>
<P>28</P>
</TD>
<TD>
<P>Autogen* training.tw,ot.</P>
</TD>
<TD>
<P>8</P>
</TD>
</TR>
<TR>
<TD>
<P>29</P>
</TD>
<TD>
<P>(behavio* adj (treat* or therap* or modif*)).tw. or verhaltenstherap*.ot.</P>
</TD>
<TD>
<P>591</P>
</TD>
</TR>
<TR>
<TD>
<P>30</P>
</TD>
<TD>
<P>(Biodynami* or Bioenergeti* or Biofeedback or Bionomi*).tw,ot. or (Body Mind or Breathwork).tw.</P>
</TD>
<TD>
<P>309</P>
</TD>
</TR>
<TR>
<TD>
<P>31</P>
</TD>
<TD>
<P>(characteranalyti* or character-analyti*).tw,ot.</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>32</P>
</TD>
<TD>
<P>(Client-centered or client-centred).tw.</P>
</TD>
<TD>
<P>14</P>
</TD>
</TR>
<TR>
<TD>
<P>33</P>
</TD>
<TD>
<P>(counselling or counseling).tw.</P>
</TD>
<TD>
<P>1292</P>
</TD>
</TR>
<TR>
<TD>
<P>34</P>
</TD>
<TD>
<P>(cognitive adj1 behavio*).tw.</P>
</TD>
<TD>
<P>579</P>
</TD>
</TR>
<TR>
<TD>
<P>35</P>
</TD>
<TD>
<P>CBT.tw,ot.</P>
</TD>
<TD>
<P>192</P>
</TD>
</TR>
<TR>
<TD>
<P>36</P>
</TD>
<TD>
<P>(coherence therap* or contemplative or conversational).tw.</P>
</TD>
<TD>
<P>36</P>
</TD>
</TR>
<TR>
<TD>
<P>37</P>
</TD>
<TD>
<P>(cope* or coping).tw,ot.</P>
</TD>
<TD>
<P>1666</P>
</TD>
</TR>
<TR>
<TD>
<P>38</P>
</TD>
<TD>
<P>(core energetic* or core process*).tw,ot.</P>
</TD>
<TD>
<P>16</P>
</TD>
</TR>
<TR>
<TD>
<P>39</P>
</TD>
<TD>
<P>dance.tw. or tanz*.ot. or daseins*.tw,ot.</P>
</TD>
<TD>
<P>102</P>
</TD>
</TR>
<TR>
<TD>
<P>40</P>
</TD>
<TD>
<P>(Developmental Needs Meeting Strateg* or DNMS).tw.</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>41</P>
</TD>
<TD>
<P>(Dialectical or DBT).tw.</P>
</TD>
<TD>
<P>107</P>
</TD>
</TR>
<TR>
<TD>
<P>42</P>
</TD>
<TD>
<P>(Dreamwork or Drama or Dyadic or DDP).tw.</P>
</TD>
<TD>
<P>217</P>
</TD>
</TR>
<TR>
<TD>
<P>43</P>
</TD>
<TD>
<P>(Emotional Freedom Techni* or EFT).tw.</P>
</TD>
<TD>
<P>10</P>
</TD>
</TR>
<TR>
<TD>
<P>44</P>
</TD>
<TD>
<P>(encounter group* or eye movement*).tw.</P>
</TD>
<TD>
<P>377</P>
</TD>
</TR>
<TR>
<TD>
<P>45</P>
</TD>
<TD>
<P>(EMDR or (Desensiti* adj2 (Reprocessing or re-processing))).tw.</P>
</TD>
<TD>
<P>8</P>
</TD>
</TR>
<TR>
<TD>
<P>46</P>
</TD>
<TD>
<P>(Experient* Dynamic or Existential therap*).tw.</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>47</P>
</TD>
<TD>
<P>(Exposure adj2 response prevent*).tw.</P>
</TD>
<TD>
<P>10</P>
</TD>
</TR>
<TR>
<TD>
<P>48</P>
</TD>
<TD>
<P>expressive therap*.tw,ot.</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>49</P>
</TD>
<TD>
<P>(Family Constellation* or Family System* or Family therap* or Feminist therap* or functional analytic or Focusing or Freudian).tw. or feldenkr*.tw,ot. or (familien* or freud*).ot.</P>
</TD>
<TD>
<P>4190</P>
</TD>
</TR>
<TR>
<TD>
<P>50</P>
</TD>
<TD>
<P>(goal setting or Gestalt* or Group Analy* or group-based or (group adj (therap* or treatment* or intervention))).tw. or (gruppenpsychotherap* or gruppentherap* or gruppenanaly* or gestalt*).ot.</P>
</TD>
<TD>
<P>562</P>
</TD>
</TR>
<TR>
<TD>
<P>51</P>
</TD>
<TD>
<P>(Hakomi or Holistic or Holotropic or Humanistic or Human givens).tw. or (Hypnos* or Hypnot* or hypno-therap*).tw,ot.</P>
</TD>
<TD>
<P>654</P>
</TD>
</TR>
<TR>
<TD>
<P>52</P>
</TD>
<TD>
<P>(Integral* Strateg* or (Intensive adj2 dynami*) or Interaction Therap* or Interperson* therap* or IPT).tw,ot. or interaktionstherap*.ot.</P>
</TD>
<TD>
<P>68</P>
</TD>
</TR>
<TR>
<TD>
<P>53</P>
</TD>
<TD>
<P>(interpersonal or inter-personal).tw. or (interpersonell* or inter-personell*).ot.</P>
</TD>
<TD>
<P>545</P>
</TD>
</TR>
<TR>
<TD>
<P>54</P>
</TD>
<TD>
<P>(Jungian or Logotherap*).tw,ot.</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>55</P>
</TD>
<TD>
<P>(Meditati* or Milieu Therap* or milieutherap* or Mindfulness* or MBSR or (Method adj2 Levels) or Morita Therap* or Multimodal* Therap* or multi-modal* therap* or Multitheoreti* or Multi-theoreti* or Music therap*).tw,ot. or musiktherap*.ot.</P>
</TD>
<TD>
<P>270</P>
</TD>
</TR>
<TR>
<TD>
<P>56</P>
</TD>
<TD>
<P>(Narrative Therap* or Needs Meeting* or Neuro-linguistic program* or NLP).tw,ot.</P>
</TD>
<TD>
<P>32</P>
</TD>
</TR>
<TR>
<TD>
<P>57</P>
</TD>
<TD>
<P>(Object* Relation* or Orgonom*).tw. or (objektrelation* or orgonom*).ot.</P>
</TD>
<TD>
<P>26</P>
</TD>
</TR>
<TR>
<TD>
<P>58</P>
</TD>
<TD>
<P>(parent-child interact* or PCIT).tw. or eltern-kind interakt*.ot.</P>
</TD>
<TD>
<P>16</P>
</TD>
</TR>
<TR>
<TD>
<P>59</P>
</TD>
<TD>
<P>patient education.tw.</P>
</TD>
<TD>
<P>253</P>
</TD>
</TR>
<TR>
<TD>
<P>60</P>
</TD>
<TD>
<P>(person-centered or person-centred).tw. or personenzentriert*.ot.</P>
</TD>
<TD>
<P>50</P>
</TD>
</TR>
<TR>
<TD>
<P>61</P>
</TD>
<TD>
<P>(Personal construct or PCP or Play therap* or Primal therap* or Process Oriented or Provocative Therap* or Psychedelic or Psychoanaly* or psycho-analyti* or Psychodrama or psycho-drama or Psychodynamic or psycho-dynamic or (psycho* adj3 (care* or treat* or therap* or intervent* or support*))).tw.</P>
</TD>
<TD>
<P>1601</P>
</TD>
</TR>
<TR>
<TD>
<P>62</P>
</TD>
<TD>
<P>psychotherap*.mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier]</P>
</TD>
<TD>
<P>554</P>
</TD>
</TR>
<TR>
<TD>
<P>63</P>
</TD>
<TD>
<P>Pulsing.tw.</P>
</TD>
<TD>
<P>149</P>
</TD>
</TR>
<TR>
<TD>
<P>64</P>
</TD>
<TD>
<P>(Radix therap* or Rational Emoti* or REBT or Rational Living Therap* or RLT or Rebirthing or re-birthing or Reiki or Relationship counsel* or Relational-Cultural or relaxation or (relax* adj3 (techni* or train* or treatment* or therap*)) or Reprogram* or re-program* or Reality therap* or Rogerian or Rubenfeld Synergy or Reichian or Rolfing).tw.</P>
</TD>
<TD>
<P>7572</P>
</TD>
</TR>
<TR>
<TD>
<P>65</P>
</TD>
<TD>
<P>(self-manag* or selfmanag*).tw. or (selbstmanagement* or selbst-management*).ot.</P>
</TD>
<TD>
<P>278</P>
</TD>
</TR>
<TR>
<TD>
<P>66</P>
</TD>
<TD>
<P>(SHEN or social support* or Social Therap* or social care or Solution focused or Somatic Psychology or Sophia analys* or supportive-expressive or Systematic Treatment Selection* or STS or Systemic Constellation* or Systemic Therap*).tw. or soziale unterst*.ot.</P>
</TD>
<TD>
<P>1227</P>
</TD>
</TR>
<TR>
<TD>
<P>67</P>
</TD>
<TD>
<P>(supporti* adj3 (therap* or care or treat* or intervent*)).tw.</P>
</TD>
<TD>
<P>563</P>
</TD>
</TR>
<TR>
<TD>
<P>68</P>
</TD>
<TD>
<P>(Thought Field Therap* or Transactional* or trans-actional* or Transperson* or trans-person* or twelve-step program* or Vegetotherap* or vegeto-therap*).tw.</P>
</TD>
<TD>
<P>30</P>
</TD>
</TR>
<TR>
<TD>
<P>69</P>
</TD>
<TD>
<P>or/25-68</P>
</TD>
<TD>
<P>21841</P>
</TD>
</TR>
<TR>
<TD>
<P>70</P>
</TD>
<TD>
<P>24 or 69</P>
</TD>
<TD>
<P>21854</P>
</TD>
</TR>
<TR>
<TD>
<P>71</P>
</TD>
<TD>
<P>15 and 70</P>
</TD>
<TD>
<P>32</P>
</TD>
</TR>
<TR>
<TD>
<P>72</P>
</TD>
<TD>
<P>randomized controlled trial.pt.</P>
</TD>
<TD>
<P>473</P>
</TD>
</TR>
<TR>
<TD>
<P>73</P>
</TD>
<TD>
<P>controlled clinical trial.pt.</P>
</TD>
<TD>
<P>31</P>
</TD>
</TR>
<TR>
<TD>
<P>74</P>
</TD>
<TD>
<P>random*.mp.</P>
</TD>
<TD>
<P>26042</P>
</TD>
</TR>
<TR>
<TD>
<P>75</P>
</TD>
<TD>
<P>placebo.mp.</P>
</TD>
<TD>
<P>3119</P>
</TD>
</TR>
<TR>
<TD>
<P>76</P>
</TD>
<TD>
<P>Clinical Trials as Topic/</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>77</P>
</TD>
<TD>
<P>trial.ti,ab.</P>
</TD>
<TD>
<P>8649</P>
</TD>
</TR>
<TR>
<TD>
<P>78</P>
</TD>
<TD>
<P>groups.ab.</P>
</TD>
<TD>
<P>42372</P>
</TD>
</TR>
<TR>
<TD>
<P>79</P>
</TD>
<TD>
<P>exp Cohort Studies/</P>
</TD>
<TD>
<P>7</P>
</TD>
</TR>
<TR>
<TD>
<P>80</P>
</TD>
<TD>
<P>cohort*.ti,ab. or kohort*.ot.</P>
</TD>
<TD>
<P>6184</P>
</TD>
</TR>
<TR>
<TD>
<P>81</P>
</TD>
<TD>
<P>course.ti,ab.</P>
</TD>
<TD>
<P>8251</P>
</TD>
</TR>
<TR>
<TD>
<P>82</P>
</TD>
<TD>
<P>prospectiv*.ti,ab.</P>
</TD>
<TD>
<P>9288</P>
</TD>
</TR>
<TR>
<TD>
<P>83</P>
</TD>
<TD>
<P>longitudinal.ti,ab.</P>
</TD>
<TD>
<P>4950</P>
</TD>
</TR>
<TR>
<TD>
<P>84</P>
</TD>
<TD>
<P>follow-up*.ti,ab.</P>
</TD>
<TD>
<P>13869</P>
</TD>
</TR>
<TR>
<TD>
<P>85</P>
</TD>
<TD>
<P>control*.ti,ab.</P>
</TD>
<TD>
<P>76895</P>
</TD>
</TR>
<TR>
<TD>
<P>86</P>
</TD>
<TD>
<P>Comparative Study.pt.</P>
</TD>
<TD>
<P>948</P>
</TD>
</TR>
<TR>
<TD>
<P>87</P>
</TD>
<TD>
<P>((singl* or doubl* or trebl* or tripl*) adj3 (blind* or mask*)).ti,ab.</P>
</TD>
<TD>
<P>2311</P>
</TD>
</TR>
<TR>
<TD>
<P>88</P>
</TD>
<TD>
<P>volunteer*.ti,ab.</P>
</TD>
<TD>
<P>2763</P>
</TD>
</TR>
<TR>
<TD>
<P>89</P>
</TD>
<TD>
<P>or/72-88</P>
</TD>
<TD>
<P>148407</P>
</TD>
</TR>
<TR>
<TD>
<P>90</P>
</TD>
<TD>
<P>71 and 89</P>
</TD>
<TD>
<P>17</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>
<B> </B>
</P>
<P>
<B>Cochrane Library</B> (via Wiley Interscience)</P>
<P>Searched 2010-04-29</P>
<P>
<B> </B>
</P>
<TABLE COLS="3" ROWS="71">
<TR>
<TD>
<P>
<B>ID</B>
</P>
</TD>
<TD>
<P>
<B>Search</B>
</P>
</TD>
<TD>
<P>
<B>Hits</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#1</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=1">MeSH descriptor Inflammatory Bowel Diseases explode all trees</A>
</P>
</TD>
<TD>
<P>1550</P>
</TD>
</TR>
<TR>
<TD>
<P>#2</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=2">MeSH descriptor Enterocolitis, this term only</A>
</P>
</TD>
<TD>
<P>6</P>
</TD>
</TR>
<TR>
<TD>
<P>#3</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=3">MeSH descriptor Proctitis explode all trees</A>
</P>
</TD>
<TD>
<P>97</P>
</TD>
</TR>
<TR>
<TD>
<P>#4</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=4">MeSH descriptor Ileitis, this term only</A>
</P>
</TD>
<TD>
<P>18</P>
</TD>
</TR>
<TR>
<TD>
<P>#5</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=5">(#1 OR #2 OR #3 OR #4)</A>
</P>
</TD>
<TD>
<P>1626</P>
</TD>
</TR>
<TR>
<TD>
<P>#6</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=6">crohn*:ti,ab,kw</A>
</P>
</TD>
<TD>
<P>1138</P>
</TD>
</TR>
<TR>
<TD>
<P>#7</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=7">((ulcer* near colit*) or (ulzer* near kolit*)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>1153</P>
</TD>
</TR>
<TR>
<TD>
<P>#8</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=8">(regional* near enter*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>11</P>
</TD>
</TR>
<TR>
<TD>
<P>#9</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=9">ileitis:ti,ab,kw</A>
</P>
</TD>
<TD>
<P>37</P>
</TD>
</TR>
<TR>
<TD>
<P>#10</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=10">(enterocolit* or entero-colit* or enterokolit* or entero-kolit*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>462</P>
</TD>
</TR>
<TR>
<TD>
<P>#11</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=11">(proctiti* or proctocolit* or procto-colit* or proktiti* or proktokolit* or prokto-kolit*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>198</P>
</TD>
</TR>
<TR>
<TD>
<P>#12</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=12">(inflamm* near bowel* near disease*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>553</P>
</TD>
</TR>
<TR>
<TD>
<P>#13</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=13">entz* next darm*</A>
</P>
</TD>
<TD>
<P>9</P>
</TD>
</TR>
<TR>
<TD>
<P>#14</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=14">(#6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13)</A>
</P>
</TD>
<TD>
<P>2943</P>
</TD>
</TR>
<TR>
<TD>
<P>#15</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=15">(#5 OR #14)</A>
</P>
</TD>
<TD>
<P>2943</P>
</TD>
</TR>
<TR>
<TD>
<P>#16</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=16">MeSH descriptor Psychotherapy explode all trees</A>
</P>
</TD>
<TD>
<P>11005</P>
</TD>
</TR>
<TR>
<TD>
<P>#17</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=17">MeSH descriptor Mind-Body Therapies explode all trees</A>
</P>
</TD>
<TD>
<P>3266</P>
</TD>
</TR>
<TR>
<TD>
<P>#18</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=18">MeSH descriptor Spiritual Therapies explode all trees</A>
</P>
</TD>
<TD>
<P>606</P>
</TD>
</TR>
<TR>
<TD>
<P>#19</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=19">MeSH descriptor Adaptation, Psychological explode all trees</A>
</P>
</TD>
<TD>
<P>2825</P>
</TD>
</TR>
<TR>
<TD>
<P>#20</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=20">MeSH descriptor Patient Education as Topic, this term only</A>
</P>
</TD>
<TD>
<P>4897</P>
</TD>
</TR>
<TR>
<TD>
<P>#21</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=21">MeSH descriptor Psychology, Social explode all trees</A>
</P>
</TD>
<TD>
<P>10717</P>
</TD>
</TR>
<TR>
<TD>
<P>#22</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=22">MeSH descriptor Social Support, this term only</A>
</P>
</TD>
<TD>
<P>1691</P>
</TD>
</TR>
<TR>
<TD>
<P>#23</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=23">MeSH descriptor Self Care, this term only</A>
</P>
</TD>
<TD>
<P>1811</P>
</TD>
</TR>
<TR>
<TD>
<P>#24</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=24">(#16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23)</A>
</P>
</TD>
<TD>
<P>26423</P>
</TD>
</TR>
<TR>
<TD>
<P>#25</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=25">((Acceptance near Commitment) or adler*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>35</P>
</TD>
</TR>
<TR>
<TD>
<P>#26</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=26">((art next therap*) or (attack next therap*) or (attachment next therap*)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>76</P>
</TD>
</TR>
<TR>
<TD>
<P>#27</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=27">(Autogen* next training):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>146</P>
</TD>
</TR>
<TR>
<TD>
<P>#28</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=28">((behavio* near (treat* or therap* or modif*)) or verhaltenstherap*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>10785</P>
</TD>
</TR>
<TR>
<TD>
<P>#29</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=29">(biodynami* or bio-dynami* or bioenergeti* or bio-energeti* or biofeedback or bio-feedback or Bionomi* or (Body next Mind) or Breathwork):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>1448</P>
</TD>
</TR>
<TR>
<TD>
<P>#30</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=30">(characteranalyti* or character-analyti* or client-centered or client-centred):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>80</P>
</TD>
</TR>
<TR>
<TD>
<P>#31</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=31">(counselling or counseling):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>5389</P>
</TD>
</TR>
<TR>
<TD>
<P>#32</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=32">((cognitive near behavio*) or CBT):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>4851</P>
</TD>
</TR>
<TR>
<TD>
<P>#33</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=33">((coherence next therap*) or contemplative or conversational):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>69</P>
</TD>
</TR>
<TR>
<TD>
<P>#34</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=34">(cope* or coping or (core next energetic*) or (core next process*)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>3227</P>
</TD>
</TR>
<TR>
<TD>
<P>#35</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=35">(dance or tanz* or daseins*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>553</P>
</TD>
</TR>
<TR>
<TD>
<P>#36</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=36">((Developmental next Needs next Meeting next Strateg*) or DNMS or Dialectical or DBT):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>84</P>
</TD>
</TR>
<TR>
<TD>
<P>#37</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=37">(Dreamwork or Drama or Dyadic or DDP):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>363</P>
</TD>
</TR>
<TR>
<TD>
<P>#38</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=38">((Emotional next Freedom next Techni*) or EFT or (encounter next group*) or (eye next movement*)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>1493</P>
</TD>
</TR>
<TR>
<TD>
<P>#39</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=39">((Desensiti* near (reprocessing or re-processing)) or EMDR):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>85</P>
</TD>
</TR>
<TR>
<TD>
<P>#40</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=40">(Experient* next Dynamic) or (Existential next therap*)</A>
</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>#41</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=41">(Exposure near (response next prevent*)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>75</P>
</TD>
</TR>
<TR>
<TD>
<P>#42</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=42">expressive next therap*</A>
</P>
</TD>
<TD>
<P>17</P>
</TD>
</TR>
<TR>
<TD>
<P>#43</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=43">((Family next Constellation*) or (Family next System*) or (Family next therap*) or (Feminist next therap*) or (functional next analytic) or Focusing or Freudian or familien* or freud* or feldenkr*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>8706</P>
</TD>
</TR>
<TR>
<TD>
<P>#44</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=44">((goal next setting) or gestalt* or (group next analy*) or gruppenpsychotherap* or gruppentherap* or gruppenanaly*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>963</P>
</TD>
</TR>
<TR>
<TD>
<P>#45</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=45">((group next therap*) or (group next treatment*) or (group next intervention*) or (group next based)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>4038</P>
</TD>
</TR>
<TR>
<TD>
<P>#46</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=46">(Hakomi or Holistic or Holotropic or Humanistic or (Human next givens) or Hypnos* or Hypnot* or hypno-therap*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>4446</P>
</TD>
</TR>
<TR>
<TD>
<P>#47</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=47">(integral* next strateg*) or ((intensive near/2 dynami*) or (interaction next therap*) or (interperson* next therap*) or IPT or interpersonal or inter-personal or interpersonell* or inter-personell* or interaktionstherap*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>2263</P>
</TD>
</TR>
<TR>
<TD>
<P>#48</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=48">(Jungian or Logotherap*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>#49</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=49">(Meditati* or (Milieu next Therap*) or milieutherap* or Mindfulness* or MBSR or (Method near/2 Levels) or (Morita next Therap*) or (Multimodal* next Therap*) or (multi-modal* next therap*) or Multitheoreti* or Multi-theoreti* or (Music next therap*) or musiktherap*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>1690</P>
</TD>
</TR>
<TR>
<TD>
<P>#50</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=50">((Narrative next Therap*) or (Needs next Meeting*) or (Neuro-linguistic next program*) or NLP):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>22</P>
</TD>
</TR>
<TR>
<TD>
<P>#51</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=51">((Object* next Relation*) or Orgonom* or objektrelation*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>31</P>
</TD>
</TR>
<TR>
<TD>
<P>#52</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=52">((parent-child next interact*) or PCIT or (eltern-kind next interakt*) or (patient next education)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>5663</P>
</TD>
</TR>
<TR>
<TD>
<P>#53</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=53">(person-centered or person-centred or personenzentriert*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>33</P>
</TD>
</TR>
<TR>
<TD>
<P>#54</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=54">((Personal next construct) or PCP or (Play next therap*) or (Primal next therap*) or (Process next Oriented)):ti,ab,kw </A>
</P>
</TD>
<TD>
<P>374</P>
</TD>
</TR>
<TR>
<TD>
<P>#55</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=55">((Provocative next Therap*) or Psychedelic or Psychoanaly* or psycho-analyti* or Psychodrama or psycho-drama):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>287</P>
</TD>
</TR>
<TR>
<TD>
<P>#56</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=56">(Psychodynamic or psycho-dynamic or (psycho* near (care* or treat* or therap* or intervent* or support*))):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>28246</P>
</TD>
</TR>
<TR>
<TD>
<P>#57</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=57">psychotherap*:ti,ab,kw</A>
</P>
</TD>
<TD>
<P>4923</P>
</TD>
</TR>
<TR>
<TD>
<P>#58</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=58">pulsing:ti,ab,kw</A>
</P>
</TD>
<TD>
<P>8547</P>
</TD>
</TR>
<TR>
<TD>
<P>#59</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=59">((Radix next therap*) or (Rational next Emoti*) or REBT or (Rational next Living next Therap*) or RLT):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>100</P>
</TD>
</TR>
<TR>
<TD>
<P>#60</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=60">(Rebirthing or re-birthing or Reiki or (Relationship next counsel*) or Relational-Cultural):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>25</P>
</TD>
</TR>
<TR>
<TD>
<P>#61</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=61">(relaxation or (relax* near (techni* or train* or treatment* or therap*))):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>4824</P>
</TD>
</TR>
<TR>
<TD>
<P>#62</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=62">(Reprogram* or re-program* or (Reality next therap*) or Rogerian or (Rubenfeld next Synergy) or Reichian or Rolfing):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>85</P>
</TD>
</TR>
<TR>
<TD>
<P>#63</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=63">(self-manag* or selfmanag* or selbstmanagement* or selbst-management*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>1117</P>
</TD>
</TR>
<TR>
<TD>
<P>#64</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=64">(SHEN or (social next support*) or (Social next Therap*) or (social next care) or (Solution next focused) or (Somatic next Psychology) or (Sophia next analys*)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>2680</P>
</TD>
</TR>
<TR>
<TD>
<P>#65</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=65">((supportive next therap*) or (supportive next care) or (supportive next treat*) or (supportive next intervent*) or supportive-expressive or (Systematic next Treatment next Selection*) or STS or (Systemic next Constellation*) or (Systemic next Therap*) or (soziale next unterst*)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>1616</P>
</TD>
</TR>
<TR>
<TD>
<P>#66</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=66">((Thought next Field next Therap*) or Transactional* or trans-actional* or Transperson* or trans-person* or (twelve-step next program*)):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>37</P>
</TD>
</TR>
<TR>
<TD>
<P>#67</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=67">(Vegetotherap* or vegeto-therap*):ti,ab,kw</A>
</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>#68</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=68">(#25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67)</A>
</P>
</TD>
<TD>
<P>75799</P>
</TD>
</TR>
<TR>
<TD>
<P>#69</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=69">(#24 OR #68)</A>
</P>
</TD>
<TD>
<P>82244</P>
</TD>
</TR>
<TR>
<TD>
<P>#70</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=70">(#15 AND #69)</A>
</P>
<P>Cochrane Reviews [11], Issue 4/2010</P>
<P>Other Reviews [4], Issue 2/2010</P>
<P>
<B>Clinical Trials [128], Issue 2/2010</B>
</P>
<P>Methods Studies [2], Issue 2/2010</P>
<P>Technology Assessments [1], Issue 2/2010</P>
<P>Economic Evaluations [7], Issue 2/2010</P>
</TD>
<TD>
<P>153</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P> </P>
<P>
<B>PSYNDEXplus Literature and Audiovisual Media 1977 to March 2010</B>
</P>
<P>
<B>Searched 2010-04-26</B>
</P>
<P>
<B> </B>
</P>
<TABLE COLS="3" ROWS="11">
<TR>
<TD>
<P>
<B>#</B>
</P>
</TD>
<TD>
<P>
<B>Searches</B>
</P>
</TD>
<TD>
<P>
<B>Results</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>1</P>
</TD>
<TD>
<P>ulcerative colitis/</P>
</TD>
<TD>
<P>119</P>
</TD>
</TR>
<TR>
<TD>
<P>2</P>
</TD>
<TD>
<P>entz* darm*.mp. [mp=author name, title, abstract, key phrase, heading word, free descriptors word]</P>
</TD>
<TD>
<P>75</P>
</TD>
</TR>
<TR>
<TD>
<P>3</P>
</TD>
<TD>
<P>((ulcer* or ulzer*) adj5 (colit* or kolit*)).mp. [mp=author name, title, abstract, key phrase, heading word, free descriptors word]</P>
</TD>
<TD>
<P>209</P>
</TD>
</TR>
<TR>
<TD>
<P>4</P>
</TD>
<TD>
<P>crohn*.mp. [mp=author name, title, abstract, key phrase, heading word, free descriptors word]</P>
</TD>
<TD>
<P>213</P>
</TD>
</TR>
<TR>
<TD>
<P>5</P>
</TD>
<TD>
<P>(proctocolit* or proktokolit* or procto-colit* or prokto-kolit* or enterocolit* or enterokolit*).mp. [mp=author name, title, abstract, key phrase, heading word, free descriptors word]</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>6</P>
</TD>
<TD>
<P>(entero-colit* or entero-kolit*).mp. [mp=author name, title, abstract, key phrase, heading word, free descriptors word]</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>7</P>
</TD>
<TD>
<P>(regional* adj2 enter*).mp. [mp=author name, title, abstract, key phrase, heading word, free descriptors word]</P>
</TD>
<TD>
<P>8</P>
</TD>
</TR>
<TR>
<TD>
<P>8</P>
</TD>
<TD>
<P>(inflamm* adj5 bowel* adj5 disease*).mp. [mp=author name, title, abstract, key phrase, heading word, free descriptors word]</P>
</TD>
<TD>
<P>25</P>
</TD>
</TR>
<TR>
<TD>
<P>9</P>
</TD>
<TD>
<P>ileiti*.mp.</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>10</P>
</TD>
<TD>
<P>or/1-9</P>
</TD>
<TD>
<P>349</P>
</TD>
</TR>
</TABLE>
<P>
<B> </B>
</P>
<P>
<B> </B>
</P>
<P>
<B> </B>
</P>
<P>
<B> </B>
</P>
<P>
<B>Psycinfo</B> (via EBSCO)</P>
<P>Searched 2010 April 26</P>
<P> </P>
<TABLE COLS="3" ROWS="10">
<TR>
<TD>
<P>
<B># </B>
</P>
</TD>
<TD>
<P>
<B>Query </B>
</P>
</TD>
<TD>
<P>
<B>Results </B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>S9</P>
</TD>
<TD>
<P>S8 or S7 or S6 or S5 or S4 or S3 or S2 or S1</P>
</TD>
<TD>
<P>930</P>
</TD>
</TR>
<TR>
<TD>
<P>S8</P>
</TD>
<TD>
<P>enterocoliti* or entero-coliti*</P>
</TD>
<TD>
<P>41</P>
</TD>
</TR>
<TR>
<TD>
<P>S7</P>
</TD>
<TD>
<P>ileiti* or proctiti* or proctocoliti* or procto-coliti*</P>
</TD>
<TD>
<P>22</P>
</TD>
</TR>
<TR>
<TD>
<P>S6</P>
</TD>
<TD>
<P>inflamm* N5 bowel* N5 disease*</P>
</TD>
<TD>
<P>311</P>
</TD>
</TR>
<TR>
<TD>
<P>S5</P>
</TD>
<TD>
<P>ulcer* N3 colit*</P>
</TD>
<TD>
<P>493</P>
</TD>
</TR>
<TR>
<TD>
<P>S4</P>
</TD>
<TD>
<P>regional* N5 entero* or regional* N5 enteri*</P>
</TD>
<TD>
<P>14</P>
</TD>
</TR>
<TR>
<TD>
<P>S3</P>
</TD>
<TD>
<P>TI M Crohn or AB M Crohn or KW M Crohn</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>S2</P>
</TD>
<TD>
<P>(morbus W5 crohn*) or (crohn* W5 disease)</P>
</TD>
<TD>
<P>270</P>
</TD>
</TR>
<TR>
<TD>
<P>S1</P>
</TD>
<TD>
<P>DE "Ulcerative Colitis"</P>
</TD>
<TD>
<P>219</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P> </P>
<P>
<B>CCMed (via DIMDI www.dimdi.de), </B>01.01.2000 to 18.02.2010</P>
<P>Searched 2010-05-03</P>
<P> </P>
<TABLE COLS="3" ROWS="57">
<TR>
<TD>
<P>
<B>No </B>
</P>
</TD>
<TD>
<P>
<B>Hits  </B>
</P>
</TD>
<TD>
<P>
<B>Search Expression </B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1</P>
</TD>
<TD VALIGN="TOP">
<P>578290 </P>
</TD>
<TD>
<P>CC00</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2</P>
</TD>
<TD VALIGN="TOP">
<P>21 </P>
</TD>
<TD>
<P>(INFLAMM* AND BOWEL AND DISEASE*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3</P>
</TD>
<TD VALIGN="TOP">
<P>589 </P>
</TD>
<TD>
<P>CROHN*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4</P>
</TD>
<TD VALIGN="TOP">
<P>296 </P>
</TD>
<TD>
<P>(ULCER* AND COLIT*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5</P>
</TD>
<TD VALIGN="TOP">
<P>1 </P>
</TD>
<TD>
<P>(REGIONAL* AND ENTER*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>6</P>
</TD>
<TD VALIGN="TOP">
<P>4 </P>
</TD>
<TD>
<P>ILEITIS OR PROCTITIS OR PROCTOCOLITIS OR PROCTO-COLITIS</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>7</P>
</TD>
<TD VALIGN="TOP">
<P>24 </P>
</TD>
<TD>
<P>ENTEROCOLIT* OR ENTERO-COLIT*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>8</P>
</TD>
<TD VALIGN="TOP">
<P>858 </P>
</TD>
<TD>
<P>2 TO 7</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>9</P>
</TD>
<TD VALIGN="TOP">
<P>0 </P>
</TD>
<TD>
<P>(ACCEPTANCE AND COMMITMENT)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>10</P>
</TD>
<TD VALIGN="TOP">
<P>110 </P>
</TD>
<TD>
<P>ADLER* OR ART THERAP* OR ATTACK THERAP* OR ATTACHMENT THERAP* OR AUTOGEN* TRAINING</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>11</P>
</TD>
<TD VALIGN="TOP">
<P>86 </P>
</TD>
<TD>
<P>(BEHAVIO* AND (TREAT* OR THERAP* OR MODIF*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>12</P>
</TD>
<TD VALIGN="TOP">
<P>150 </P>
</TD>
<TD>
<P>BIODYNAMI* OR BIO-DYNAMI* OR BIOENERGETI* OR BIO-ENERGETI* OR BIOFEEDBACK OR BIO-FEEDBACK OR BIONOMI* OR BODY MIND OR BREATHWORK*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>13</P>
</TD>
<TD VALIGN="TOP">
<P>51 </P>
</TD>
<TD>
<P>CHARACTERANALYTI* OR CHARACTER-ANALYTI* OR CLIENT-CENTERED OR CLIENT-CENTRED OR COUNSELLING OR COUNSELING</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>14</P>
</TD>
<TD VALIGN="TOP">
<P>24 </P>
</TD>
<TD>
<P>(COGNITIVE AND BEHAVIO*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>15</P>
</TD>
<TD VALIGN="TOP">
<P>124 </P>
</TD>
<TD>
<P>CBT OR COHERENCE THERAP* OR CONTEMPLATIVE OR CONVERSATIONAL OR COPE* OR COPING OR CORE ENERGETIC* OR CORE PROCESS*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>16</P>
</TD>
<TD VALIGN="TOP">
<P>81 </P>
</TD>
<TD>
<P>DANCE OR DASEINS* OR DEVELOPMENTAL NEEDS MEETING STRATEG* OR DNMS OR DIALECTICAL OR DBT OR DREAMWORK OR DRAMA OR DYADIC OR DDP</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>17</P>
</TD>
<TD VALIGN="TOP">
<P>40 </P>
</TD>
<TD>
<P>EMOTIONAL FREEDOM TECHNI* OR EFT OR ENCOUNTER GROUP* OR EYE MOVEMENT* OR EMDR</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>18</P>
</TD>
<TD VALIGN="TOP">
<P>0 </P>
</TD>
<TD>
<P>(DESENSITI* AND (REPROCESSING OR RE-PROCESSING))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>19</P>
</TD>
<TD VALIGN="TOP">
<P>0 </P>
</TD>
<TD>
<P>EXPERIENT* DYNAMIC OR EXISTENTIAL THERAP* OR EXPRESSIVE THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>20</P>
</TD>
<TD VALIGN="TOP">
<P>0 </P>
</TD>
<TD>
<P>(EXPOSURE AND RESPONSE PREVENT*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>21</P>
</TD>
<TD VALIGN="TOP">
<P>94 </P>
</TD>
<TD>
<P>FAMILY CONSTELLATION* OR FAMILY SYSTEM* OR FAMILY THERAP* OR FEMINIST THERAP* OR FUNCTIONAL ANALYTIC OR FOCUSING OR FREUDIAN OR FELDENKR*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>22</P>
</TD>
<TD VALIGN="TOP">
<P>25 </P>
</TD>
<TD>
<P>(GROUP # # (THERAP* OR TREATMENT* OR INTERVENTION))</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>23</P>
</TD>
<TD VALIGN="TOP">
<P>9 </P>
</TD>
<TD>
<P>GROUP-BASED OR GOAL SETTING OR GROUP ANALY*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>24</P>
</TD>
<TD VALIGN="TOP">
<P>336 </P>
</TD>
<TD>
<P>HAKOMI OR HOLISTIC OR HOLOTROPIC OR HUMANISTIC OR HUMAN GIVENS OR HYPNOS* OR HYPNOT* OR HYPNO-THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>25</P>
</TD>
<TD VALIGN="TOP">
<P>5 </P>
</TD>
<TD>
<P>INTEGRAL* STRATEG* OR INTERACTION THERAP* OR INTERPERSON* THERAP* OR IPT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>26</P>
</TD>
<TD VALIGN="TOP">
<P>1 </P>
</TD>
<TD>
<P>(INTENSIVE AND DYNAMI*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>27</P>
</TD>
<TD VALIGN="TOP">
<P>288 </P>
</TD>
<TD>
<P>JUNGIAN OR LOGOTHERAP* OR MEDITATI* OR MILIEU THERAP* OR MILIEUTHERAP* OR MINDFULNESS* OR MBSR OR METHOD LEVELS OR MORITA THERAP* OR MULTIMODAL* THERAP* OR MULTI-MODAL* THERAP* OR MULTITHEORETI* OR MULTI-THEORETI* OR MUSIC THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>28</P>
</TD>
<TD VALIGN="TOP">
<P>17 </P>
</TD>
<TD>
<P>NARRATIVE THERAP* OR NEEDS MEETING* OR NEURO-LINGUISTIC PROGRAM* OR NLP</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>29</P>
</TD>
<TD VALIGN="TOP">
<P>1 </P>
</TD>
<TD>
<P>OBJECT* RELATION* OR ORGONOM*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>30</P>
</TD>
<TD VALIGN="TOP">
<P>20 </P>
</TD>
<TD>
<P>PARENT-CHILD INTERACT* OR PCIT OR PATIENT EDUCATION OR PERSON-CENTERED OR PERSON-CENTRED</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>31</P>
</TD>
<TD VALIGN="TOP">
<P>922 </P>
</TD>
<TD>
<P>PERSONAL CONSTRUCT OR PCP OR PLAY THERAP* OR PRIMAL THERAP* OR PROCESS ORIENTED OR PROVOCATIVE THERAP* OR PSYCHEDELIC OR PSYCHOANALY* OR PSYCHO-ANALY* OR PSYCHODRAMA OR PSYCHODYNAMIC OR PSYCHO-DYNAMIC</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>32</P>
</TD>
<TD VALIGN="TOP">
<P>652 </P>
</TD>
<TD>
<P>(PSYCHO* AND (CARE* OR TREAT* OR THERAP* OR INTERVENT* OR SUPPORT))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>33</P>
</TD>
<TD VALIGN="TOP">
<P>3182 </P>
</TD>
<TD>
<P>PSYCHOTHERAP* OR PULSING</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>34</P>
</TD>
<TD VALIGN="TOP">
<P>16 </P>
</TD>
<TD>
<P>RADIX THERAP* OR RATIONAL EMOTI* OR REBT OR RATIONAL LIVING THERAP* OR RLT OR REBIRTHING OR RE-BIRTHING OR REIKI OR RELATIONSHIP COUNSEL* OR RELATIONAL-CULTURAL</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>35</P>
</TD>
<TD VALIGN="TOP">
<P>17 </P>
</TD>
<TD>
<P>REPROGRAM* OR RE-PROGRAM* OR REALITY THERAP* OR ROGERIAN OR RUBENFELD SYNERGY OR REICHIAN OR ROLFING</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>36</P>
</TD>
<TD VALIGN="TOP">
<P>16 </P>
</TD>
<TD>
<P>RELAXATION</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>37</P>
</TD>
<TD VALIGN="TOP">
<P>5 </P>
</TD>
<TD>
<P>(RELAX* AND (TECHNI* OR TRAIN* OR TREATMENT* OR THERAP*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>38</P>
</TD>
<TD VALIGN="TOP">
<P>45 </P>
</TD>
<TD>
<P>SELF-MANAG* OR SELFMANAG* OR SHEN OR SOCIAL SUPPORT* OR SOCIAL THERAP* OR SOLUTION FOCUSED OR SOMATIC PSYCHOLOGY OR SOPHIA ANALYS* OR SUPPORTIVE-EXPRESSIVE OR SYSTEMATIC TREATMENT SELECTION* OR STS OR SYSTEMIC CONSTELLATION* OR SYSTEMIC THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>39</P>
</TD>
<TD VALIGN="TOP">
<P>65 </P>
</TD>
<TD>
<P>(SUPPORTI* AND (THERAP* OR CARE OR TREAT* OR INTERVENT*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>40</P>
</TD>
<TD VALIGN="TOP">
<P>20 </P>
</TD>
<TD>
<P>THOUGHT FIELD THERAP* OR TRANSACTIONAL* OR TRANSPERSON* OR TWELVE-STEP PROGRAM* OR VEGETOTHERAP* OR VEGETO-THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>41</P>
</TD>
<TD VALIGN="TOP">
<P>54 </P>
</TD>
<TD>
<P>(LEIB AND SEELE) /SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>42</P>
</TD>
<TD VALIGN="TOP">
<P>3230 </P>
</TD>
<TD>
<P>SELBSTMANAGEMENT* OR PATIENTENSCHULUNG* OR PATIENTENTRAINING* OR PATIENTENERZIEHUNG* OR ERZIEHUNG* OR BIO-ENERGETI* OR BIO-DYNAMI* OR KÖRPER* OR KORPER* OR KOERPER* OR CHARAKTERANALY* OR CHARAKTER-ANALY* OR KLIENTEN*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>43</P>
</TD>
<TD VALIGN="TOP">
<P>30 </P>
</TD>
<TD>
<P>PROGRESSIV* MUSKEL*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>44</P>
</TD>
<TD VALIGN="TOP">
<P>16 </P>
</TD>
<TD>
<P>KURZZEITPSYCH* OR LANGZEITPSYCH* OR KURZZEIT-PSYCH* OR LANGZEIT-PSYCH*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>45</P>
</TD>
<TD VALIGN="TOP">
<P>53 </P>
</TD>
<TD>
<P>INTERPERSON* OR INTER-PERSON*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>46</P>
</TD>
<TD VALIGN="TOP">
<P>3332 </P>
</TD>
<TD>
<P>VERHALTENSTHERAP* OR FAMILIENTHERAP* OR BEWEGUNGSTHERAP* OR INTER-PERSON* THERAP* OR TIEFENPSYCHO* OR GESPRÄCH* OR GESPRAECH* OR GESPRACH* OR KOGNITI*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>47</P>
</TD>
<TD VALIGN="TOP">
<P>5974 </P>
</TD>
<TD>
<P>GRUPPENPSYCHO* OR GRUPPENTHERAP* OR ENTSPANNUNG* OR ANPASSUNG* OR SOZIAL* OR SELBSTHILFE*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>48</P>
</TD>
<TD VALIGN="TOP">
<P>6504 </P>
</TD>
<TD>
<P>CHARAKTERANALY* OR CHARAKTER-ANALY* OR KLIENTEN* OR BEWALTIG* OR BEWAELTIG* OR ANGST* OR ÄRGER* OR AERGER* OR ARGER* OR TANZ* OR MUSIK* OR KUNST* OR ATEM* OR DASEINS* OR KONFRONTATIONSVERFAHREN* OR FESTHALTETHERAP* OR FOKALTHERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>49</P>
</TD>
<TD VALIGN="TOP">
<P>23812 </P>
</TD>
<TD>
<P>9 TO 48</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>50</P>
</TD>
<TD VALIGN="TOP">
<P>439 </P>
</TD>
<TD>
<P>((ENTZUNDL* OR ENTZUENDL* OR ENTZÜNDL*) AND DARM*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>51</P>
</TD>
<TD VALIGN="TOP">
<P>304 </P>
</TD>
<TD>
<P>((ULCER* OR ULZER*) AND (COLIT* OR KOLIT*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>52</P>
</TD>
<TD VALIGN="TOP">
<P>2 </P>
</TD>
<TD>
<P>PRO%TO-%OLITI* OR PRO%TO%OLITI*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>53</P>
</TD>
<TD VALIGN="TOP">
<P>24 </P>
</TD>
<TD>
<P>PROKTITI* OR ENTEROKOLITI* OR ENTERO-KOLITI*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>54</P>
</TD>
<TD VALIGN="TOP">
<P>754 </P>
</TD>
<TD>
<P>50 TO 53</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>55</P>
</TD>
<TD VALIGN="TOP">
<P>1290 </P>
</TD>
<TD>
<P>8 OR 54</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>56</P>
</TD>
<TD VALIGN="TOP">
<P>19 </P>
</TD>
<TD>
<P>49 AND 55</P>
</TD>
</TR>
</TABLE>
<P>
<B> </B>
</P>
<P>
<B> </B>
</P>
<P>
<B>CINAHL (via Ebsco)</B>
</P>
<P> </P>
<P>Searched 2010-05-06</P>
<P> </P>
<TABLE COLS="3" ROWS="37">
<TR>
<TD>
<P>
<B># </B>
</P>
</TD>
<TD>
<P>
<B>Query </B>
</P>
</TD>
<TD>
<P>
<B>Results </B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>S36</P>
</TD>
<TD>
<P>S10 and S35</P>
</TD>
<TD>
<P>706</P>
</TD>
</TR>
<TR>
<TD>
<P>S35</P>
</TD>
<TD>
<P>S21 or S34</P>
</TD>
<TD>
<P>650059</P>
</TD>
</TR>
<TR>
<TD>
<P>S34</P>
</TD>
<TD>
<P>S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32 or S33</P>
</TD>
<TD>
<P>406754</P>
</TD>
</TR>
<TR>
<TD>
<P>S33</P>
</TD>
<TD>
<P>Family or group therap* or group-based</P>
</TD>
<TD>
<P>89340</P>
</TD>
</TR>
<TR>
<TD>
<P>S32</P>
</TD>
<TD>
<P>supportive</P>
</TD>
<TD>
<P>7207</P>
</TD>
</TR>
<TR>
<TD>
<P>S31</P>
</TD>
<TD>
<P>behavio*</P>
</TD>
<TD>
<P>108177</P>
</TD>
</TR>
<TR>
<TD>
<P>S30</P>
</TD>
<TD>
<P>psych*</P>
</TD>
<TD>
<P>249269</P>
</TD>
</TR>
<TR>
<TD>
<P>S29</P>
</TD>
<TD>
<P>interpersonal or inter-personal</P>
</TD>
<TD>
<P>16887</P>
</TD>
</TR>
<TR>
<TD>
<P>S28</P>
</TD>
<TD>
<P>social W1 support* or Social W1 Therap* or social W1 care</P>
</TD>
<TD>
<P>10660</P>
</TD>
</TR>
<TR>
<TD>
<P>S27</P>
</TD>
<TD>
<P>parent-child interact* or PCIT</P>
</TD>
<TD>
<P>261</P>
</TD>
</TR>
<TR>
<TD>
<P>S26</P>
</TD>
<TD>
<P>Interaction Therap* or Interperson* therap* or IPT</P>
</TD>
<TD>
<P>173</P>
</TD>
</TR>
<TR>
<TD>
<P>S25</P>
</TD>
<TD>
<P>Hypnos* or Hypnot* or hypno-therap*</P>
</TD>
<TD>
<P>3403</P>
</TD>
</TR>
<TR>
<TD>
<P>S24</P>
</TD>
<TD>
<P>Autogen* training</P>
</TD>
<TD>
<P>38</P>
</TD>
</TR>
<TR>
<TD>
<P>S23</P>
</TD>
<TD>
<P>relaxation</P>
</TD>
<TD>
<P>5267</P>
</TD>
</TR>
<TR>
<TD>
<P>S22</P>
</TD>
<TD>
<P>patient educat*</P>
</TD>
<TD>
<P>33196</P>
</TD>
</TR>
<TR>
<TD>
<P>S21</P>
</TD>
<TD>
<P>S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20</P>
</TD>
<TD>
<P>486021</P>
</TD>
</TR>
<TR>
<TD>
<P>S20</P>
</TD>
<TD>
<P>(MH "Mental Health Services+")</P>
</TD>
<TD>
<P>27911</P>
</TD>
</TR>
<TR>
<TD>
<P>S19</P>
</TD>
<TD>
<P>(MH "Rehabilitation, Psychosocial+")</P>
</TD>
<TD>
<P>2912</P>
</TD>
</TR>
<TR>
<TD>
<P>S18</P>
</TD>
<TD>
<P>(MH "Coping+")</P>
</TD>
<TD>
<P>14530</P>
</TD>
</TR>
<TR>
<TD>
<P>S17</P>
</TD>
<TD>
<P>(MH "Self Care")</P>
</TD>
<TD>
<P>12372</P>
</TD>
</TR>
<TR>
<TD>
<P>S16</P>
</TD>
<TD>
<P>(MH "Support, Psychosocial+")</P>
</TD>
<TD>
<P>26342</P>
</TD>
</TR>
<TR>
<TD>
<P>S15</P>
</TD>
<TD>
<P>(MH "Psychology, Social+")</P>
</TD>
<TD>
<P>413269</P>
</TD>
</TR>
<TR>
<TD>
<P>S14</P>
</TD>
<TD>
<P>(MH "Patient Education")</P>
</TD>
<TD>
<P>30994</P>
</TD>
</TR>
<TR>
<TD>
<P>S13</P>
</TD>
<TD>
<P>(MH "Adaptation, Psychological+")</P>
</TD>
<TD>
<P>10704</P>
</TD>
</TR>
<TR>
<TD>
<P>S12</P>
</TD>
<TD>
<P>(MH "Mind Body Techniques+")</P>
</TD>
<TD>
<P>12417</P>
</TD>
</TR>
<TR>
<TD>
<P>S11</P>
</TD>
<TD>
<P>(MH "Psychotherapy+")</P>
</TD>
<TD>
<P>60827</P>
</TD>
</TR>
<TR>
<TD>
<P>S10</P>
</TD>
<TD>
<P>S9 or S8 or S7 or S6 or S5 or S4 or S3 or S2 or S1</P>
</TD>
<TD>
<P>4393</P>
</TD>
</TR>
<TR>
<TD>
<P>S9</P>
</TD>
<TD>
<P>(MH "Enterocolitis/ED/NU/PC/PF/PR/RH/TH")</P>
</TD>
<TD>
<P>15</P>
</TD>
</TR>
<TR>
<TD>
<P>S8</P>
</TD>
<TD>
<P>enterocoliti* or entero-coliti*</P>
</TD>
<TD>
<P>999</P>
</TD>
</TR>
<TR>
<TD>
<P>S7</P>
</TD>
<TD>
<P>ileiti* or proctiti* or proctocoliti* or procto-coliti*</P>
</TD>
<TD>
<P>74</P>
</TD>
</TR>
<TR>
<TD>
<P>S6</P>
</TD>
<TD>
<P>inflamm* N5 bowel* N5 disease*</P>
</TD>
<TD>
<P>1536</P>
</TD>
</TR>
<TR>
<TD>
<P>S5</P>
</TD>
<TD>
<P>regional* N5 enter*</P>
</TD>
<TD>
<P>15</P>
</TD>
</TR>
<TR>
<TD>
<P>S4</P>
</TD>
<TD>
<P>ulcer* N5 colit*</P>
</TD>
<TD>
<P>1226</P>
</TD>
</TR>
<TR>
<TD>
<P>S3</P>
</TD>
<TD>
<P>crohn*</P>
</TD>
<TD>
<P>1778</P>
</TD>
</TR>
<TR>
<TD>
<P>S2</P>
</TD>
<TD>
<P>(MH "Enteritis+/ED/NU/PC/PF/PR/RH/TH")</P>
</TD>
<TD>
<P>32</P>
</TD>
</TR>
<TR>
<TD>
<P>S1</P>
</TD>
<TD>
<P>(MH "Inflammatory Bowel Diseases+/ED/NU/PC/PF/PR/RH/TH")</P>
</TD>
<TD>
<P>711</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>
<B>Strategy LILACS</B> via <A HREF="http://www.bireme.br/">www.bireme.br</A>
</P>
<P> </P>
<P>Searched 2010-005-03</P>
<P> </P>
<P>806 hits:</P>
<P> </P>
<P>Strategy:</P>
<P>C06.405.205.731 or C06.405.205.731.249 or C06.405.205.731.500 or C06.405.205.865 or C06.405.205.865 or C06.405.469.363 or C06.405.205.462.624 [DeCS Category]</P>
<P> </P>
<P>DeCS Categories:</P>
<P> </P>
<P>Inflammatory Bowel Diseases [C06.405.205.731]</P>
<P>                  Colitis, Ulcerative [C06.405.205.731.249]</P>
<P>                  Crohn Disease [C06.405.205.731.500]</P>
<P>       Proctitis [C06.405.205.865]</P>
<P>                  Proctocolitis [C06.405.205.865]</P>
<P>       Enterocolitis [C06.405.469.363]</P>
<P>       Ileitis [C06.405.205.462.624]</P>
<P> </P>
<P>
<B> </B>
</P>
<P>
<B>Embase,  (via DIMDI www.dimdi.de) 01.01.1974 - 29.04.2010</B>
</P>
<P>Searched 2010-04-29</P>
<P> </P>
<P> </P>
<TABLE COLS="3" ROWS="87">
<TR>
<TD>
<P>
<B>No </B>
</P>
</TD>
<TD>
<P>
<B>Hits  </B>
</P>
</TD>
<TD>
<P>
<B>Search Expression </B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1</P>
</TD>
<TD VALIGN="TOP">
<P>13623639 </P>
</TD>
<TD>
<P>EM74</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2</P>
</TD>
<TD VALIGN="TOP">
<P>23424 </P>
</TD>
<TD>
<P>CT=ULCERATIVE COLITIS</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3</P>
</TD>
<TD VALIGN="TOP">
<P>2091 </P>
</TD>
<TD>
<P>CT=PROCTITIS</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4</P>
</TD>
<TD VALIGN="TOP">
<P>348 </P>
</TD>
<TD>
<P>CT=PROCTOCOLITIS</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5</P>
</TD>
<TD VALIGN="TOP">
<P>1799 </P>
</TD>
<TD>
<P>CT=ILEITIS</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>6</P>
</TD>
<TD VALIGN="TOP">
<P>29159 </P>
</TD>
<TD>
<P>CT=CROHN DISEASE</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>7</P>
</TD>
<TD VALIGN="TOP">
<P>1368 </P>
</TD>
<TD>
<P>CT=COLON CROHN DISEASE</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>8</P>
</TD>
<TD VALIGN="TOP">
<P>2223 </P>
</TD>
<TD>
<P>CT=ENTEROCOLITIS</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>9</P>
</TD>
<TD VALIGN="TOP">
<P>19135 </P>
</TD>
<TD>
<P>(INFLAMM* AND BOWEL AND DISEASE*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>10</P>
</TD>
<TD VALIGN="TOP">
<P>33308 </P>
</TD>
<TD>
<P>CROHN*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>11</P>
</TD>
<TD VALIGN="TOP">
<P>26341 </P>
</TD>
<TD>
<P>(ULCER* AND COLIT*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>12</P>
</TD>
<TD VALIGN="TOP">
<P>733 </P>
</TD>
<TD>
<P>(REGIONAL* AND ENTER*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>13</P>
</TD>
<TD VALIGN="TOP">
<P>5198 </P>
</TD>
<TD>
<P>ILEITIS OR PROCTITIS OR PROCTOCOLITIS OR PROCTO-COLITIS</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>14</P>
</TD>
<TD VALIGN="TOP">
<P>11537 </P>
</TD>
<TD>
<P>ENTEROCOLIT* OR ENTERO-COLIT*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>15</P>
</TD>
<TD VALIGN="TOP">
<P>68243 </P>
</TD>
<TD>
<P>2 TO 14</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>16</P>
</TD>
<TD VALIGN="TOP">
<P>138343 </P>
</TD>
<TD>
<P>CT D PSYCHIATRIC TREATMENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>17</P>
</TD>
<TD VALIGN="TOP">
<P>44675 </P>
</TD>
<TD>
<P>CT D MENTAL HEALTH CARE</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>18</P>
</TD>
<TD VALIGN="TOP">
<P>38893 </P>
</TD>
<TD>
<P>CT D SOCIAL ADAPTATION</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>19</P>
</TD>
<TD VALIGN="TOP">
<P>29662 </P>
</TD>
<TD>
<P>CT=PATIENT EDUCATION</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>20</P>
</TD>
<TD VALIGN="TOP">
<P>42755 </P>
</TD>
<TD>
<P>CT D SOCIAL CARE</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>21</P>
</TD>
<TD VALIGN="TOP">
<P>28157 </P>
</TD>
<TD>
<P>CT D SOCIAL PSYCHOLOGY</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>22</P>
</TD>
<TD VALIGN="TOP">
<P>7860 </P>
</TD>
<TD>
<P>CT=SELF CARE</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>23</P>
</TD>
<TD VALIGN="TOP">
<P>3341 </P>
</TD>
<TD>
<P>CT=SELF HELP</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>24</P>
</TD>
<TD VALIGN="TOP">
<P>22227 </P>
</TD>
<TD>
<P>CT D COPING BEHAVIOR</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>25</P>
</TD>
<TD VALIGN="TOP">
<P>4 </P>
</TD>
<TD>
<P>CT=SUPPORTIVE THERAPY</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>26</P>
</TD>
<TD VALIGN="TOP">
<P>302441 </P>
</TD>
<TD>
<P>16 TO 25</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>34</P>
</TD>
<TD VALIGN="TOP">
<P>158 </P>
</TD>
<TD>
<P>(ACCEPTANCE AND COMMITMENT)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>35</P>
</TD>
<TD VALIGN="TOP">
<P>2460 </P>
</TD>
<TD>
<P>ADLER* OR ART THERAP* OR ATTACK THERAP* OR ATTACHMENT THERAP* OR AUTOGEN* TRAINING</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>36</P>
</TD>
<TD VALIGN="TOP">
<P>77840 </P>
</TD>
<TD>
<P>(BEHAVIO* AND (TREAT* OR THERAP* OR MODIF*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>37</P>
</TD>
<TD VALIGN="TOP">
<P>7862 </P>
</TD>
<TD>
<P>BIODYNAMI* OR BIO-DYNAMI* OR BIOENERGETI* OR BIO-ENERGETI* OR BIOFEEDBACK OR BIO-FEEDBACK OR BIONOMI* OR BODY MIND OR BREATHWORK*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>38</P>
</TD>
<TD VALIGN="TOP">
<P>66850 </P>
</TD>
<TD>
<P>CHARACTERANALYTI* OR CHARACTER-ANALYTI* OR CLIENT-CENTERED OR CLIENT-CENTRED OR COUNSELLING OR COUNSELING</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>39</P>
</TD>
<TD VALIGN="TOP">
<P>22740 </P>
</TD>
<TD>
<P>(COGNITIVE AND BEHAVIO*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>40</P>
</TD>
<TD VALIGN="TOP">
<P>47474 </P>
</TD>
<TD>
<P>CBT OR COHERENCE THERAP* OR CONTEMPLATIVE OR CONVERSATIONAL OR COPE* OR COPING OR CORE ENERGETIC* OR CORE PROCESS*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>41</P>
</TD>
<TD VALIGN="TOP">
<P>6625 </P>
</TD>
<TD>
<P>DANCE OR DASEINS* OR DEVELOPMENTAL NEEDS MEETING STRATEG* OR DNMS OR DIALECTICAL OR DBT OR DREAMWORK OR DRAMA OR DYADIC OR DDP</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>42</P>
</TD>
<TD VALIGN="TOP">
<P>29556 </P>
</TD>
<TD>
<P>EMOTIONAL FREEDOM TECHNI* OR EFT OR ENCOUNTER GROUP* OR EYE MOVEMENT* OR EMDR</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>43</P>
</TD>
<TD VALIGN="TOP">
<P>229 </P>
</TD>
<TD>
<P>(DESENSITI* AND (REPROCESSING OR RE-PROCESSING))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>44</P>
</TD>
<TD VALIGN="TOP">
<P>92 </P>
</TD>
<TD>
<P>EXPERIENT* DYNAMIC OR EXISTENTIAL THERAP* OR EXPRESSIVE THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>45</P>
</TD>
<TD VALIGN="TOP">
<P>321 </P>
</TD>
<TD>
<P>(EXPOSURE AND RESPONSE PREVENT*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>46</P>
</TD>
<TD VALIGN="TOP">
<P>50012 </P>
</TD>
<TD>
<P>FAMILY CONSTELLATION* OR FAMILY SYSTEM* OR FAMILY THERAP* OR FEMINIST THERAP* OR FUNCTIONAL ANALYTIC OR FOCUSING OR FREUDIAN OR FELDENKR*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>47</P>
</TD>
<TD VALIGN="TOP">
<P>23180 </P>
</TD>
<TD>
<P>(GROUP # # (THERAP* OR TREATMENT* OR INTERVENTION))</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>48</P>
</TD>
<TD VALIGN="TOP">
<P>4274 </P>
</TD>
<TD>
<P>GROUP-BASED OR GOAL SETTING OR GROUP ANALY*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>49</P>
</TD>
<TD VALIGN="TOP">
<P>26739 </P>
</TD>
<TD>
<P>HAKOMI OR HOLISTIC OR HOLOTROPIC OR HUMANISTIC OR HUMAN GIVENS OR HYPNOS* OR HYPNOT* OR HYPNO-THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>50</P>
</TD>
<TD VALIGN="TOP">
<P>984 </P>
</TD>
<TD>
<P>INTEGRAL* STRATEG* OR INTERACTION THERAP* OR INTERPERSON* THERAP* OR IPT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>51</P>
</TD>
<TD VALIGN="TOP">
<P>279 </P>
</TD>
<TD>
<P>(INTENSIVE AND DYNAMI*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>52</P>
</TD>
<TD VALIGN="TOP">
<P>7587 </P>
</TD>
<TD>
<P>JUNGIAN OR LOGOTHERAP* OR MEDITATI* OR MILIEU THERAP* OR MILIEUTHERAP* OR MINDFULNESS* OR MBSR OR METHOD LEVELS OR MORITA THERAP* OR MULTIMODAL* THERAP* OR MULTI-MODAL* THERAP* OR MULTITHEORETI* OR MULTI-THEORETI* OR MUSIC THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>53</P>
</TD>
<TD VALIGN="TOP">
<P>359 </P>
</TD>
<TD>
<P>NARRATIVE THERAP* OR NEEDS MEETING* OR NEURO-LINGUISTIC PROGRAM* OR NLP</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>54</P>
</TD>
<TD VALIGN="TOP">
<P>3507 </P>
</TD>
<TD>
<P>OBJECT* RELATION* OR ORGONOM*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>55</P>
</TD>
<TD VALIGN="TOP">
<P>32466 </P>
</TD>
<TD>
<P>PARENT-CHILD INTERACT* OR PCIT OR PATIENT EDUCATION OR PERSON-CENTERED OR PERSON-CENTRED</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>56</P>
</TD>
<TD VALIGN="TOP">
<P>38697 </P>
</TD>
<TD>
<P>PERSONAL CONSTRUCT OR PCP OR PLAY THERAP* OR PRIMAL THERAP* OR PROCESS ORIENTED OR PROVOCATIVE THERAP* OR PSYCHEDELIC OR PSYCHOANALY* OR PSYCHO-ANALY* OR PSYCHODRAMA OR PSYCHODYNAMIC OR PSYCHO-DYNAMIC</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>57</P>
</TD>
<TD VALIGN="TOP">
<P>99182 </P>
</TD>
<TD>
<P>(PSYCHO* AND (CARE* OR TREAT* OR THERAP* OR INTERVENT* OR SUPPORT))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>58</P>
</TD>
<TD VALIGN="TOP">
<P>54535 </P>
</TD>
<TD>
<P>PSYCHOTHERAP* OR PULSING</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>59</P>
</TD>
<TD VALIGN="TOP">
<P>493 </P>
</TD>
<TD>
<P>RADIX THERAP* OR RATIONAL EMOTI* OR REBT OR RATIONAL LIVING THERAP* OR RLT OR REBIRTHING OR RE-BIRTHING OR REIKI OR RELATIONSHIP COUNSEL* OR RELATIONAL-CULTURAL</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>60</P>
</TD>
<TD VALIGN="TOP">
<P>3750 </P>
</TD>
<TD>
<P>REPROGRAM* OR RE-PROGRAM* OR REALITY THERAP* OR ROGERIAN OR RUBENFELD SYNERGY OR REICHIAN OR ROLFING</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>61</P>
</TD>
<TD VALIGN="TOP">
<P>68317 </P>
</TD>
<TD>
<P>RELAXATION</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>62</P>
</TD>
<TD VALIGN="TOP">
<P>13869 </P>
</TD>
<TD>
<P>(RELAX* AND (TECHNI* OR TRAIN* OR TREATMENT* OR THERAP*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>63</P>
</TD>
<TD VALIGN="TOP">
<P>38245 </P>
</TD>
<TD>
<P>SELF-MANAG* OR SELFMANAG* OR SHEN OR SOCIAL SUPPORT* OR SOCIAL THERAP* OR SOLUTION FOCUSED OR SOMATIC PSYCHOLOGY OR SOPHIA ANALYS* OR SUPPORTIVE-EXPRESSIVE OR SYSTEMATIC TREATMENT SELECTION* OR STS OR SYSTEMIC CONSTELLATION* OR SYSTEMIC THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>64</P>
</TD>
<TD VALIGN="TOP">
<P>20167 </P>
</TD>
<TD>
<P>(SUPPORTI* AND (THERAP* OR CARE OR TREAT* OR INTERVENT*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>65</P>
</TD>
<TD VALIGN="TOP">
<P>779 </P>
</TD>
<TD>
<P>THOUGHT FIELD THERAP* OR TRANSACTIONAL* OR TRANSPERSON* OR TWELVE-STEP PROGRAM* OR VEGETOTHERAP* OR VEGETO-THERAP*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>66</P>
</TD>
<TD VALIGN="TOP">
<P>582571 </P>
</TD>
<TD>
<P>34 TO 65</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>67</P>
</TD>
<TD VALIGN="TOP">
<P>693783 </P>
</TD>
<TD>
<P>26 OR 66</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>68</P>
</TD>
<TD VALIGN="TOP">
<P>2072 </P>
</TD>
<TD>
<P>15 AND 67</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>69</P>
</TD>
<TD VALIGN="TOP">
<P>199973 </P>
</TD>
<TD>
<P>CT D CONTROLLED CLINICAL TRIAL</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>70</P>
</TD>
<TD VALIGN="TOP">
<P>27471 </P>
</TD>
<TD>
<P>CT=RANDOMIZATION</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>71</P>
</TD>
<TD VALIGN="TOP">
<P>79518 </P>
</TD>
<TD>
<P>CT=DOUBLE BLIND PROCEDURE</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>72</P>
</TD>
<TD VALIGN="TOP">
<P>9214 </P>
</TD>
<TD>
<P>CT=SINGLE BLIND PROCEDURE</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>73</P>
</TD>
<TD VALIGN="TOP">
<P>92301 </P>
</TD>
<TD>
<P>CT=PROSPECTIVE STUDY</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>74</P>
</TD>
<TD VALIGN="TOP">
<P>61392 </P>
</TD>
<TD>
<P>CT=COHORT ANALYSIS</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>75</P>
</TD>
<TD VALIGN="TOP">
<P>21839 </P>
</TD>
<TD>
<P>CT=LONGITUDINAL STUDY</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>76</P>
</TD>
<TD VALIGN="TOP">
<P>313928 </P>
</TD>
<TD>
<P>CT=FOLLOW UP</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>77</P>
</TD>
<TD VALIGN="TOP">
<P>488213 </P>
</TD>
<TD>
<P>RANDOM*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>78</P>
</TD>
<TD VALIGN="TOP">
<P>134269 </P>
</TD>
<TD>
<P>((SINGL* OR DOUBL*) AND (BLIND* OR MASK*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>79</P>
</TD>
<TD VALIGN="TOP">
<P>223636 </P>
</TD>
<TD>
<P>(CONTROLLED AND TRIAL)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>80</P>
</TD>
<TD VALIGN="TOP">
<P>149705 </P>
</TD>
<TD>
<P>COHORT*</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>81</P>
</TD>
<TD VALIGN="TOP">
<P>357766 </P>
</TD>
<TD>
<P>TI=(COURSE OR CONTROL* OR PROSPECTIV* OR LONGITUDINAL OR FOLLOW-UP*)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>82</P>
</TD>
<TD VALIGN="TOP">
<P>2363012 </P>
</TD>
<TD>
<P>AB=(COURSE OR CONTROL* OR PROSPECTIV* OR LONGITUDINAL OR FOLLOW-UP*)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>83</P>
</TD>
<TD VALIGN="TOP">
<P>604917 </P>
</TD>
<TD>
<P>TI=(TRIAL OR STUDY)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>84</P>
</TD>
<TD VALIGN="TOP">
<P>3238025 </P>
</TD>
<TD>
<P>69 TO 83</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>85</P>
</TD>
<TD VALIGN="TOP">
<P>840 </P>
</TD>
<TD>
<P>68 AND 84</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>86</P>
</TD>
<TD VALIGN="TOP">
<P>3277 </P>
</TD>
<TD>
<P>CT=RETRACTED ARTICLE</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>87</P>
</TD>
<TD VALIGN="TOP">
<P>840 </P>
</TD>
<TD>
<P>85 NOT 86</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>88</P>
</TD>
<TD VALIGN="TOP">
<P>42988 </P>
</TD>
<TD>
<P>INTERPERSONAL OR INTER-PERSONAL</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>89</P>
</TD>
<TD VALIGN="TOP">
<P>51 </P>
</TD>
<TD>
<P>15 AND 88</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>90</P>
</TD>
<TD VALIGN="TOP">
<P>21 </P>
</TD>
<TD>
<P>89 AND 84</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>91</P>
</TD>
<TD VALIGN="TOP">
<P>10 </P>
</TD>
<TD>
<P>90 NOT 87</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>92</P>
</TD>
<TD VALIGN="TOP">
<P>10 </P>
</TD>
<TD>
<P>91 NOT 86</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>93</P>
</TD>
<TD VALIGN="TOP">
<P>850</P>
</TD>
<TD>
<P>92 OR 87</P>
</TD>
</TR>
</TABLE>
<P>
<B> </B>
</P>
<P>
<B> </B>
</P>
<P>
<B>EMBASE Alert (via DIMDI www.dimdi.de)  01.03.2010 - 29.04.2010 </B>
</P>
<P>Searched 2010-04-29</P>
<P> </P>
<TABLE COLS="5" ROWS="59">
<TR>
<TD COLSPAN="2">
<P>
<B>No </B>
</P>
</TD>
<TD>
<P>
<B>Hits  </B>
</P>
</TD>
<TD COLSPAN="2">
<P>
<B>Search Expression </B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>1</P>
</TD>
<TD VALIGN="TOP">
<P>106974 </P>
</TD>
<TD COLSPAN="2">
<P>EA08</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>2</P>
</TD>
<TD VALIGN="TOP">
<P>324 </P>
</TD>
<TD COLSPAN="2">
<P>(INFLAMM* AND BOWEL AND DISEASE*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>3</P>
</TD>
<TD VALIGN="TOP">
<P>349 </P>
</TD>
<TD COLSPAN="2">
<P>CROHN*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>4</P>
</TD>
<TD VALIGN="TOP">
<P>226 </P>
</TD>
<TD COLSPAN="2">
<P>(ULCER* AND COLIT*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>5</P>
</TD>
<TD VALIGN="TOP">
<P>3 </P>
</TD>
<TD COLSPAN="2">
<P>(REGIONAL* AND ENTER*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>6</P>
</TD>
<TD VALIGN="TOP">
<P>18 </P>
</TD>
<TD COLSPAN="2">
<P>ILEITIS OR PROCTITIS OR PROCTOCOLITIS OR PROCTO-COLITIS</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>7</P>
</TD>
<TD VALIGN="TOP">
<P>71 </P>
</TD>
<TD COLSPAN="2">
<P>ENTEROCOLIT* OR ENTERO-COLIT*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>8</P>
</TD>
<TD VALIGN="TOP">
<P>694 </P>
</TD>
<TD COLSPAN="2">
<P>2 TO 7</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>9</P>
</TD>
<TD VALIGN="TOP">
<P>3 </P>
</TD>
<TD COLSPAN="2">
<P>(ACCEPTANCE AND COMMITMENT)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>10</P>
</TD>
<TD VALIGN="TOP">
<P>10 </P>
</TD>
<TD COLSPAN="2">
<P>ADLER* OR ART THERAP* OR ATTACK THERAP* OR ATTACHMENT THERAP* OR AUTOGEN* TRAINING</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>11</P>
</TD>
<TD VALIGN="TOP">
<P>672 </P>
</TD>
<TD COLSPAN="2">
<P>(BEHAVIO* AND (TREAT* OR THERAP* OR MODIF*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>12</P>
</TD>
<TD VALIGN="TOP">
<P>88 </P>
</TD>
<TD COLSPAN="2">
<P>BIODYNAMI* OR BIO-DYNAMI* OR BIOENERGETI* OR BIO-ENERGETI* OR BIOFEEDBACK OR BIO-FEEDBACK OR BIONOMI* OR BODY MIND OR BREATHWORK*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>13</P>
</TD>
<TD VALIGN="TOP">
<P>416 </P>
</TD>
<TD COLSPAN="2">
<P>CHARACTERANALYTI* OR CHARACTER-ANALYTI* OR CLIENT-CENTERED OR CLIENT-CENTRED OR COUNSELLING OR COUNSELING</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>14</P>
</TD>
<TD VALIGN="TOP">
<P>341 </P>
</TD>
<TD COLSPAN="2">
<P>(COGNITIVE AND BEHAVIO*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>15</P>
</TD>
<TD VALIGN="TOP">
<P>426 </P>
</TD>
<TD COLSPAN="2">
<P>CBT OR COHERENCE THERAP* OR CONTEMPLATIVE OR CONVERSATIONAL OR COPE* OR COPING OR CORE ENERGETIC* OR CORE PROCESS*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>16</P>
</TD>
<TD VALIGN="TOP">
<P>57 </P>
</TD>
<TD COLSPAN="2">
<P>DANCE OR DASEINS* OR DEVELOPMENTAL NEEDS MEETING STRATEG* OR DNMS OR DIALECTICAL OR DBT OR DREAMWORK OR DRAMA OR DYADIC OR DDP</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>17</P>
</TD>
<TD VALIGN="TOP">
<P>142 </P>
</TD>
<TD COLSPAN="2">
<P>EMOTIONAL FREEDOM TECHNI* OR EFT OR ENCOUNTER GROUP* OR EYE MOVEMENT* OR EMDR</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>18</P>
</TD>
<TD VALIGN="TOP">
<P>0 </P>
</TD>
<TD COLSPAN="2">
<P>(DESENSITI* AND (REPROCESSING OR RE-PROCESSING))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>19</P>
</TD>
<TD VALIGN="TOP">
<P>0 </P>
</TD>
<TD COLSPAN="2">
<P>EXPERIENT* DYNAMIC OR EXISTENTIAL THERAP* OR EXPRESSIVE THERAP*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>20</P>
</TD>
<TD VALIGN="TOP">
<P>3 </P>
</TD>
<TD COLSPAN="2">
<P>(EXPOSURE AND RESPONSE PREVENT*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>21</P>
</TD>
<TD VALIGN="TOP">
<P>542 </P>
</TD>
<TD COLSPAN="2">
<P>FAMILY CONSTELLATION* OR FAMILY SYSTEM* OR FAMILY THERAP* OR FEMINIST THERAP* OR FUNCTIONAL ANALYTIC OR FOCUSING OR FREUDIAN OR FELDENKR*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>22</P>
</TD>
<TD VALIGN="TOP">
<P>178 </P>
</TD>
<TD COLSPAN="2">
<P>(GROUP # # (THERAP* OR TREATMENT* OR INTERVENTION))</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>23</P>
</TD>
<TD VALIGN="TOP">
<P>56 </P>
</TD>
<TD COLSPAN="2">
<P>GROUP-BASED OR GOAL SETTING OR GROUP ANALY*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>24</P>
</TD>
<TD VALIGN="TOP">
<P>200 </P>
</TD>
<TD COLSPAN="2">
<P>HAKOMI OR HOLISTIC OR HOLOTROPIC OR HUMANISTIC OR HUMAN GIVENS OR HYPNOS* OR HYPNOT* OR HYPNO-THERAP*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>25</P>
</TD>
<TD VALIGN="TOP">
<P>16 </P>
</TD>
<TD COLSPAN="2">
<P>INTEGRAL* STRATEG* OR INTERACTION THERAP* OR INTERPERSON* THERAP* OR IPT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>26</P>
</TD>
<TD VALIGN="TOP">
<P>6 </P>
</TD>
<TD COLSPAN="2">
<P>(INTENSIVE AND DYNAMI*)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>27</P>
</TD>
<TD VALIGN="TOP">
<P>69 </P>
</TD>
<TD COLSPAN="2">
<P>JUNGIAN OR LOGOTHERAP* OR MEDITATI* OR MILIEU THERAP* OR MILIEUTHERAP* OR MINDFULNESS* OR MBSR OR METHOD LEVELS OR MORITA THERAP* OR MULTIMODAL* THERAP* OR MULTI-MODAL* THERAP* OR MULTITHEORETI* OR MULTI-THEORETI* OR MUSIC THERAP*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>28</P>
</TD>
<TD VALIGN="TOP">
<P>4 </P>
</TD>
<TD COLSPAN="2">
<P>NARRATIVE THERAP* OR NEEDS MEETING* OR NEURO-LINGUISTIC PROGRAM* OR NLP</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>29</P>
</TD>
<TD VALIGN="TOP">
<P>5 </P>
</TD>
<TD COLSPAN="2">
<P>OBJECT* RELATION* OR ORGONOM*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>30</P>
</TD>
<TD VALIGN="TOP">
<P>103 </P>
</TD>
<TD COLSPAN="2">
<P>PARENT-CHILD INTERACT* OR PCIT OR PATIENT EDUCATION OR PERSON-CENTERED OR PERSON-CENTRED</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>31</P>
</TD>
<TD VALIGN="TOP">
<P>115 </P>
</TD>
<TD COLSPAN="2">
<P>PERSONAL CONSTRUCT OR PCP OR PLAY THERAP* OR PRIMAL THERAP* OR PROCESS ORIENTED OR PROVOCATIVE THERAP* OR PSYCHEDELIC OR PSYCHOANALY* OR PSYCHO-ANALY* OR PSYCHODRAMA OR PSYCHODYNAMIC OR PSYCHO-DYNAMIC</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>32</P>
</TD>
<TD VALIGN="TOP">
<P>884 </P>
</TD>
<TD COLSPAN="2">
<P>(PSYCHO* AND (CARE* OR TREAT* OR THERAP* OR INTERVENT* OR SUPPORT))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>33</P>
</TD>
<TD VALIGN="TOP">
<P>232 </P>
</TD>
<TD COLSPAN="2">
<P>PSYCHOTHERAP* OR PULSING</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>34</P>
</TD>
<TD VALIGN="TOP">
<P>5 </P>
</TD>
<TD COLSPAN="2">
<P>RADIX THERAP* OR RATIONAL EMOTI* OR REBT OR RATIONAL LIVING THERAP* OR RLT OR REBIRTHING OR RE-BIRTHING OR REIKI OR RELATIONSHIP COUNSEL* OR RELATIONAL-CULTURAL</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>35</P>
</TD>
<TD VALIGN="TOP">
<P>148 </P>
</TD>
<TD COLSPAN="2">
<P>REPROGRAM* OR RE-PROGRAM* OR REALITY THERAP* OR ROGERIAN OR RUBENFELD SYNERGY OR REICHIAN OR ROLFING</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>36</P>
</TD>
<TD VALIGN="TOP">
<P>377 </P>
</TD>
<TD COLSPAN="2">
<P>RELAXATION</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>37</P>
</TD>
<TD VALIGN="TOP">
<P>67 </P>
</TD>
<TD COLSPAN="2">
<P>(RELAX* AND (TECHNI* OR TRAIN* OR TREATMENT* OR THERAP*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>38</P>
</TD>
<TD VALIGN="TOP">
<P>367 </P>
</TD>
<TD COLSPAN="2">
<P>SELF-MANAG* OR SELFMANAG* OR SHEN OR SOCIAL SUPPORT* OR SOCIAL THERAP* OR SOLUTION FOCUSED OR SOMATIC PSYCHOLOGY OR SOPHIA ANALYS* OR SUPPORTIVE-EXPRESSIVE OR SYSTEMATIC TREATMENT SELECTION* OR STS OR SYSTEMIC CONSTELLATION* OR SYSTEMIC THERAP*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>39</P>
</TD>
<TD VALIGN="TOP">
<P>299 </P>
</TD>
<TD COLSPAN="2">
<P>(SUPPORTI* AND (THERAP* OR CARE OR TREAT* OR INTERVENT*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>40</P>
</TD>
<TD VALIGN="TOP">
<P>8 </P>
</TD>
<TD COLSPAN="2">
<P>THOUGHT FIELD THERAP* OR TRANSACTIONAL* OR TRANSPERSON* OR TWELVE-STEP PROGRAM* OR VEGETOTHERAP* OR VEGETO-THERAP*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>41</P>
</TD>
<TD VALIGN="TOP">
<P>4632 </P>
</TD>
<TD COLSPAN="2">
<P>9 TO 40</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>42</P>
</TD>
<TD VALIGN="TOP">
<P>21 </P>
</TD>
<TD COLSPAN="2">
<P>8 AND 41</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>43</P>
</TD>
<TD VALIGN="TOP">
<P>5549 </P>
</TD>
<TD COLSPAN="2">
<P>RANDOM*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>44</P>
</TD>
<TD VALIGN="TOP">
<P>1229 </P>
</TD>
<TD COLSPAN="2">
<P>PLACEBO*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>45</P>
</TD>
<TD VALIGN="TOP">
<P>845 </P>
</TD>
<TD COLSPAN="2">
<P>((SINGL* OR DOUBL*) AND (BLIND* OR MASK*))/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>46</P>
</TD>
<TD VALIGN="TOP">
<P>813 </P>
</TD>
<TD COLSPAN="2">
<P>(CONTROLLED AND TRIAL)/SAME SENT</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>47</P>
</TD>
<TD VALIGN="TOP">
<P>2840 </P>
</TD>
<TD COLSPAN="2">
<P>COHORT*</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>48</P>
</TD>
<TD VALIGN="TOP">
<P>3421 </P>
</TD>
<TD COLSPAN="2">
<P>TI=(COURSE OR CONTROL* OR PROSPECTIV* OR LONGITUDINAL OR FOLLOW-UP*)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>49</P>
</TD>
<TD VALIGN="TOP">
<P>23970 </P>
</TD>
<TD COLSPAN="2">
<P>AB=(COURSE OR CONTROL* OR PROSPECTIV* OR LONGITUDINAL OR FOLLOW-UP*)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>50</P>
</TD>
<TD VALIGN="TOP">
<P>5234 </P>
</TD>
<TD COLSPAN="2">
<P>TI=(TRIAL OR STUDY)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>51</P>
</TD>
<TD VALIGN="TOP">
<P>30245 </P>
</TD>
<TD COLSPAN="2">
<P>43 TO 50</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>52</P>
</TD>
<TD VALIGN="TOP">
<P>11 </P>
</TD>
<TD COLSPAN="2">
<P>42 AND 51</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>53</P>
</TD>
<TD COLSPAN="3" VALIGN="TOP">
<P>106 </P>
</TD>
<TD>
<P>INTERPERSONAL OR INTER-PERSONAL</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>54</P>
</TD>
<TD COLSPAN="3" VALIGN="TOP">
<P>1 </P>
</TD>
<TD>
<P>8 AND 53</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>55</P>
</TD>
<TD COLSPAN="3" VALIGN="TOP">
<P>1 </P>
</TD>
<TD>
<P>54 NOT 52</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>56</P>
</TD>
<TD COLSPAN="3" VALIGN="TOP">
<P>0 </P>
</TD>
<TD>
<P>55 AND 51</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>57</P>
</TD>
<TD COLSPAN="3" VALIGN="TOP">
<P>11 </P>
</TD>
<TD>
<P>52 OR 56</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<P> </P>
<P> </P>
<P> </P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>